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Abstract 
Background: The implementation of human papillomavirus (HPV) DNA detection as the 
primary screening tool for screening and management of cervical intraepithelial neoplasia 
(CIN) proposed for roll-out in 2019-2020 will diagnose more women as HPV positive than are 
currently diagnosed with CIN due to the relative differences in prevalence between conditions 
(Sargent et al. 2008; Peto et al. 2004). At present there is no acceptable treatment for HPV 
(McRae et al. 2014). Anxiety over positivity (Friedman & Shepeard 2007), stigma (Kim 2012), 
and uncertainty (Kosenko et al. 2012) may constitute a biographical disruption. The 
stigmatised nature of HPV mean support from regular channels may be restricted due to fears 
of social rejection following disclosure (Kosenko et al. 2012; Crandall & Moriarty 1995). Online 
support might instead be utilised to allow access to disease information and social support. 
Methods: The study was a mixed methods study based on the follow-up explanations model, 
involving the administration of an online survey questionnaire (N = 107). Following descriptive 
data analysis, individuals were recruited for email interviews to describe their lived 
experiences of HPV positivity (N = 3). These narratives were then analysed using thematic 
analysis. 
Findings: Women responding to the questionnaire and the interviews reported anxiety over 
fears of transmission to loved ones. Interview narratives disclosed themes of anxiety caused by 
the mismanagement of information (too much/too little, conflicting or given at the wrong 
moment), uncertainty over viral clearance and residual issues of stigma. Women reported the 
use of online support to exchange information and experiences and provide emotional 
support. 
Conclusions: Both the questionnaire and the interview data indicate that uncertainty, anxiety 
over cancer development and guilt over transmission constitute a biographical disruption 
among women aware of their HPV positive status, and that the use of online support may be 
helpful in managing the uncertainty of HPV positivity.  
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Chapter One 
1.1.  Introduction 
The introduction of human papillomavirus testing as the primary screening method may 
constitute a change to the social context of cervical screening. This chapter will commence 
with a synopsis of the study and introduce the research problem by examining the prevalence 
of the human papillomavirus and cervical intraepithelial neoplasia and the current use of 
human papillomavirus testing in the NHS cervical screening programme. Background literature 
examining the biomedical aspects of cervical screening including the aetiology and 
epidemiology of cervical cancer and the public awareness of screening will then be discussed. 
 
1.2.  Synopsis of the Study 
The study adopted a mixed methods approach, utilising a combination of questionnaires 
and semi-structured online interviews. A questionnaire was utilised to obtain descriptive data 
regarding the characteristics of an online support population, and online interviews were used 
to add depth and explanatory data to this description (Ivankova et al. 2006). The questionnaire 
aimed to examine the demographic and usage characteristics of women using or subscribing to 
human papillomavirus (HPV)- and cervical cancer-related online resources such as internet 
forums and online support groups, while the semi-structured online interviews were employed 
to gain insight into the day-to-day lived experiences of the diagnostic and treatment arc, of 
HPV positivity and/or cervical cancer or pre-cancer as a biographical disruption, and the role 
that online support groups play in the meaning-making processes and biographical 
renegotiation of affected women. 
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Following the gathering of questionnaire data, participants were recruited from HPV-
specific online and social media platforms and invited to participate in semi-structured online 
interviews, in order to obtain data pertaining to individuals’ views on the reality of HPV 
positivity and their online informational and support needs. Transcripts from these interviews 
were then analysed using thematic analysis in order to understand the meanings these users 
applied to both the condition of HPV positivity and any benefits derived from sharing 
information and emotional support with other users (Oliver et al. 2015; Hu et al. 2012; Powell 
et al. 2011; Beaudoin & Tao 2008). 
 
1.3.  Statement of the Research Problem 
In 1999 a five site multicentre study established that the human papillomavirus (HPV) 
was a “necessary cause of cervical cancer worldwide” (Walboomers et al. 1999). The authors 
concluded from their findings that, in combination with data from a 1995 paper and the IARC 
monograph of the same year (Bosch & Manos 1995; IARC 1995), molecular evidence of HPV 
was found in 99.7% of some 869 biopsies that the group examined. Research into HPV DNA 
detection methods had already been ongoing for some years (Schiffman 1992; Schiffman et al. 
1991; van den Brule et al. 1990) allowing for the classification of HPV subtypes into ‘high’ and 
‘low’ risk according to their oncogenic potential (Doorbar et al. 2012). However, the 
identification of a single, necessary cause for cervical cancer also allowed for the concept that 
the disease might be preventable through vaccination. Similar to virus detection studies, 
research into the development of a vaccine in animal models had been ongoing since the late 
1990s (Suzich et al. 1995) and results of the first human trials of vaccine models were 
published from 2004 (Harper et al. 2006; Villa et al. 2005; Harper et al. 2004). 
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Following the publication of outcomes from the TOMBOLA trial (Cotton et al. 2006; 
2010), recommendations from the 2007 Cancer Reform Strategy (DoH 2007) and early 
outcomes from the ARTISTIC trial (Albrow et al. 2012; Kitchener et al. 2011; Kelly et al. 2011; 
Kitchener & Walker 2008) the UK National Screening Committee (UK NSC) made 
recommendations to the four UK Governments (of England, Scotland, Wales and Northern 
Ireland) to implement molecular testing for high-risk human papillomavirus (HR-HPV) nucleic 
acids in cervical cytology samples. HPV testing is used to triage the cervical cytology samples of 
women who demonstrate a cytologic borderline or low grade abnormality by microscopy 
(Kitchener et al. 2009; Howard et al. 2008), and as a triage tool for previously untreated, 
biopsy-proven low-grade cervical intraepithelial neoplasia (clinically termed CIN1) – these 
triage tests are known as ‘triage-untreated’ (TUT). Additionally, HR-HPV DNA or RNA testing is 
used as a follow-up test at six months post-treatment as a ‘test-of-cure’ (TOC) – in the case of 
HPV negativity these women are returned to normal 3- or 5- year screening intervals 
(dependent on age) where they would have previously been on annual cytological surveillance 
for ten years (NHS Cancer Screening Programmes 2011). In England, the current 
implementation of HR-HPV testing (for triage, TUT and TOC) is an interim measure – as of 
January 2016, Public Health England (PHE) announced that the UK NSC had recommended that 
PHE implement the use of molecular detection of HR-HPV DNA/RNA as a primary screening 
tool, using microscopy as an adjunct test in the case of HR-HPV positivity (PHE 2016b). 
However, a change to the screening method is likely to impact and alter the social and 
cultural context of cervical screening. Cervical screening will subsequently change from its 
current form – a biomedical test that examines for the presence of a treatable condition (pre-
malignant intraepithelial neoplasia of the cervix (CIN) - to a test that examines for the presence 
of a currently untreatable sexually transmitted infection (HPV). This change in detection 
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method also constitutes a change to the social context of the screening, from a health-seeking 
behaviour that reduces the incidence of cervical cancer to the detection of a socially and 
culturally stigmatised infection which – as will be demonstrated in the literature review – may 
lead to increased felt or enacted stigma and the concomitant effects of stigma on identity,  a 
‘new type of sickness experience’ (Forss et al. 2004) and a state of liminality (Trusson et al. 
2016; Blows et al. 2012; Little et al. 1998). This change will have profound implications for 
several reasons – the increased prevalence of HPV compared to positivity for pre-cancer or 
cancer of the cervix; will mean that the number of women diagnosed with HPV will increase. In 
addition, no treatment is currently offered for high-risk HPV positivity, in comparison to the 
well-established treatment regimens for cancer or pre-cancer (PDQ Adult Treatment Editorial 
Board 2002). Levels of support for HPV positive women have not been widely studied, and 
support outside of the clinical setting may be mixed due to the associated stigma. A lack of 
awareness or social support in turn has attendant implications for and effects on women’s 
social identities – including a reduction in self-esteem and self-worth (Crocker 1999), fears of 
disclosure and social exclusion (Wilson et al, 2014), and adverse effects on personal 
relationships (Newton & McCabe 2008a). In the case of persistent infection these factors also 
constitute a real risk for a state of liminality and biographical disruption. 
 
1.4.  Comparative Prevalence of Human Papillomavirus and CIN 
The lifetime risk of contracting HPV exceeds 50% (Barr & Tamms 2007). An older study 
by Syrjänen et al. (1990) indicated that the risk of developing HPV for a female between the 
ages of 20 and 79 years was 79%.  Woodman et al. (2007) found that in a sample of 2011 
women (aged between 15-19, who had recently become sexually active) 1075 women who 
were HPV and cytologically negative at recruitment had a cumulative risk of infection at 3 year 
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follow-up was 44% (for any HPV type), and that incidence rates for infection with a separate 
HPV strain at 3 year follow-up was a further 26%. In comparison, Peto et al. (2004) studied a 
cohort of 13,000 women, finding that the highest prevalence of CIN1 was 6% (in women aged 
30-34 years), and that the prevalence of CIN2 or CIN3 peaked at 1.0 and 1.1% respectively in 
women aged 35-39 years. When the factors of prevalence and lifetime risk are combined with 
the time interval between testing positive for any strain of HPV and developing microscopically 
detectable pre-malignant changes to the cervical epithelium, which studies estimate to be 
between two years (Moscicki, 2005) and five years (Schlecht, 2003), it is reasonable to predict 
that more women will test positive for HPV than the screening programme currently diagnoses 
with either pre-malignant disease of the cervix, or invasive cancer of the cervix. 
 
1.5.  Lack of Treatment or Cure for Persistent HR-HPV Infection 
At present, there is no effective cure for a high risk HPV infection (Kling, 1992). Cervical 
intraepithelial neoplasia (CIN) and cervical cancer (the clinical endpoint of persistent high-risk 
HPV infection) may be treated by surgical excision of the affected area – known as a Long Loop 
Excision of Transformation Zone (LLETZ) procedure (Gunasekera et al. 1990), by cryocautery 
(Kaufman & Irwin 1978) or by laser ablation (Alvarez et al. 1994) or in more advanced cases by 
cervical amputation (trachelectomy), partial or total hysterectomy (NHSCSP 2016; Pomel et al. 
2003; Landoni et al. 2001; Piver et al. 1974). Genital warts – the clinical endpoint of low-risk 
HPV infection are, similarly, treatable (Kling, 1992). Treatment is, generally, well-tolerated by 
women, although these procedures do represent significant long-term reproductive health 
sequelae (Ang et al. 2011) and short-to-medium term psychosocial sequelae (Sharp et al. 
2011). However, ablation, surgical excision or hysterectomy for HPV infection alone – which 
may or may not regress without intervention (Evander et al. 1995; Ho et al. 1995) represents 
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over-treatment that incurs significant health and reproductive sequelae for women, and an 
overuse of clinical resources. Thus, at present, no curative procedure is routinely offered to 
women diagnosed with HPV. This is contentious as  the original Wilson and Jungner (1968) 
recommendations for a disease screening programme state that an acceptable treatment 
should be offered for the disease entity for which the population is being screened; although 
these recommendations have since been revised in the light of population screening for 
genetic conditions (Andermann 2008). In addition, research by McRae et al., has demonstrated 
that the screening population has also voiced this concern (McRae et al. 2014) 
 
1.6.  Support Outside of the Clinical Setting 
Clinical support for cancer sufferers, including cervical cancer sufferers, is well 
established and organised – both in primary and secondary care (NICE 2016). However, social 
support for cervical cancer patients and women undergoing treatment for CIN, outside of the 
clinical setting, is less well organised – relying on friends, family and peers (Hoey et al. 2008), 
although stigma associated with cervical cancer may reduce social support or perceptions of 
social support among non-peers (Gregg, 2011). Far fewer resources exist to deal solely with 
the support needs of women with HPV infection (Harvey-Knowles et al. 2012; Nack 2002; 
2000). Information and advice is given in the clinical setting but reports of support amongst 
patients vary, with some patients reporting enacted stigma from healthcare providers during 
the diagnostic interview (Kosenko et al. 2012). Additionally, support may be given through 
provision by private providers in the form of charitable bodies such as MacMillan Cancer 
Support, The Eve Appeal and Jo’s Cervical Cancer Trust; but the emotional support, 
reassurance and reinforcement amongst friends and loved ones may be less forthcoming, due 
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to the sexual nature of transmission, and the possibility of stigmatization that may result from 
disclosing disease status (Marhefka et al. 2012; Newton & McCabe 2005; Perrin et al. 2006). 
 
1.7.  Social Identity and Biographical Disruption 
Despite the apparent transient nature of HPV (Evander et al. 1995) once diagnosed 
affected women may not be aware that they have cleared the virus until they test negative 
(which may not be until sometime after clearance), and women with persistent infection may 
report HPV positivity for several years in the absence of CIN (Stensen et al. 2016). Extended 
periods of uncertainty over HPV positivity, along with fears of developing cancer, of cancer 
recurrence and the effects of transmission to loved ones may lead to extended periods of 
anxiety (Kosenko et al. 2012) In addition, the fear of the consequences of disclosure – 
anticipated or enacted stigmas such as social exclusion, stereotyping and discrimination may 
have deleterious effects on identity and self-esteem, and negative psychological sequelae  
(Piñeros et al. 2013; Pirotta et al. 2009; Waller et al. 2007). Lastly, the liminal nature of a “new 
type of illness experience where neither health nor disease is confirmed or excluded” (Forss et 
al. 2004; Little et al. 1998; Rajaram et al. 1997; Murphy et al. 1988) all serve to indicate that 
HPV positivity can serve as a disruption to biography. 
 
1.8.  Aetiology of Cervical Cancer 
HPV is neither the first nor the only oncogenic virus endemic in the human population – 
other examples are members of the Herpesviridae family such as Epstain-Barr virus (Young & 
Murray 2003) and hepatitis-B virus (Kremsdorf et al. 2006).  Research on the lifecycle of 
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papillomaviruses has been ongoing since the early 1990s and is thus well established and 
understood. Human papillomaviruses are members of the Papillomaviridae family of which, 
currently, over 180 types have been classified (Bernard et al. 2010; de Villiers et al. 2004). Viral 
particles are long, circular DNA molecules, approximately 8000 base-pairs in length and are 
composed of eight (currently known) genes: E1-2, E4-7 and L1 and 2. In the relative chronology 
of genome activation, ‘E’ and ‘L’ denote ‘early’ and ‘late’ genes respectively (Castellsagué 
2008). Of the strains identified, approximately 40 can infect the genital tract (Srivastava et al. 
2001; Tieben et al. 1993; Schneider & Koutsky 1992).  
Genital infection with HPV occurs during intimate or sexual contact, but is not confined 
to transmission through penetrative sex – skin-to-skin contact is sufficient to allow infection – 
and thus barrier contraceptives such as condoms are of limited efficacy (Waller et al. 2003; 
Manhart & Koutsky 2002). The epithelium of the genital mucosa is a non-keratinising, stratified 
squamous epithelium. The multilayered nature of the tissue structure is the reason for one of 
its main functions: protection. HPV infection in superficial layers of epithelia is not considered 
to be an oncogenic risk, as the host cell genome is stable at this stage of differentiation 
(Hildesheim & Wang 2002).  The risk of oncogenic potential is heightened when the virus 
penetrates to the basal layers of the epithelium. This is thought to occur via microscopic 
traumas, which may be sustained during intercourse (Muñoz et al. 2006).  At the basal layer, 
the host cell genome is still undergoing transcription and modification and (relative to later 
stages of growth) is far more active (Fehrmann & Laimins 2003).  HPV virions dock with and 
infect basal layer cells.  The L1 protein (as encoded by the L1 gene) is thought to play a role in 
the initial attachment and docking on the cell surface (Joyce et al. 1999). Once the virus has 
entered the cell, the E6 and E7 genes are the first proteins to be expressed in the replication 
process – these two proteins increase the rate at which host DNA is synthesized by reactivating 
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DNA replicating mechanisms (Cheng et al. 1995). It is this activation that gives the virus its 
oncogenic potential, and the subsequent  deregulation of host cell DNA replication that causes 
malignant transformation within the cell (Werness et al. 1990; Phelps et al. 1988). As the 
infected cells continue to grow and differentiate, HPV genes E4 and E5 are activated, resulting 
in the production and assembly of ‘progeny’ virions. 
HPV subtypes can be divided into two classes – low-risk HPV types which manifest as 
condyloma accuminata or genital warts; these subtypes do not present a significant clinical risk 
for  cervical cancer (de Sanjosé et al. 2007; Clifford et al. 2006; Stubenrauch & Laimins 1999); 
and high-risk HPV subtypes (Walboomers et al. 1999) associated with increased risk for cervical 
cancer.  As previously stated, the lifetime risk of contracting HPV  varies – with some 
authorities giving a relative risk of 50% (Barr & Tamms 2007) and others estimating between 
60% (Baseman & Koutsky 2005) to above 80% (Chesson et al. 2014). The majority of individuals 
will naturally clear an HPV infection within two years (Trottier & Franco 2006; Franco et al. 
1999), but repeated infections or infection in individuals who are immunosuppressed or who 
indulge in other risk factors such as smoking (Castellsague et al. 2002) may lead to a state of 
persistent infection which may progress to cancer (Hildesheim et al. 1994).   
 
1.9.  Prevalence of HPV 
As previously stated, estimates of the relative lifetime risks of contracting HPV vary from 
50 to 80% (Barr & Tamms 2007; Baseman & Koutsky 2005; Syrjänen & Syrjänen 1990). 
According to Fenton et al. (2001) HPV is the most common sexually transmitted infection 
encountered in the UK, specifically HPV-6, which presents as genital warts. Of the high-risk 
sub-types HPV-16 is the most commonly reported variant, with HPV-16 DNA being detected in 
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some 40% of cervical cancers, and HPV-18 DNA being detected in approximately 30% of 
cervical cancers (Kitchener et al. 2006; de Sanjosé et al. 2007). 
 
1.10.  Origins of the Screening Programme 
Cervical screening was introduced in the United Kingdom in 1964 (Albrow et al. 2012).  
However, at the time, screening invitations were sporadic and opportunistic.  The current call-
recall system did not exist which meant it was difficult to manage women effectively following 
a positive diagnosis.  In addition, at the time little was known about the aetiology of the 
disease. Initially, it was thought that socio-economic status played a part since efficacy trials on 
small closed populations (such as female prisoners) had indicated that cervical cancer was 
more common in those of a lower socio-economic status, and to explore this, a woman was 
asked to indicate her husband’s occupation on the screening request form.  The first suspicion 
of HPV as an aetiology was posited in 1975 by Harald zur Hausen. The question was resolved in 
1999 when the study by Walboomers et al. determined HPV as a “necessary cause of cervical 
cancer” (Walboomers et al. 1999). 
 Currently, a screening test for cervical cancer involves the exfoliation of cells from the 
surface of the cervix (NHSCSP 2013)  These cells are preserved in a vial of alcohol and a slide is 
then prepared from the preserved cells, stained and examined by microscopy to identify any 
changes in the appearance of the nuclei of the cells (cytomorphology).  Abnormal changes in 
the nuclei (known as dyskaryosis) indicate the presence of neoplastic disease.  The degree of 
the abnormality is currently graded from borderline to mild dyskaryosis (low grade disease) 
and moderate to severe dyskaryosis (high grade disease) (NHSCSP 2013).  The more severe the 
degree of abnormality, the greater is the likelihood that disease will progress from pre-cancer 
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(pre-malignancy) to cancer (malignancy).  The grade of abnormality has shown a high degree 
of correlation with the advancement of the disease through tissue (histology) (Abulafia et al. 
2003).  At present, the National Health Service Cervical [NHSCSP] recommends that women are 
screened every three years (25-49 years) or every five years (50-65 years)  (NHSCSP 2013). 
 
1.11.  HPV Vaccination 
In 2008, the four UK governments and the Department of Health implemented a 
vaccination programme with the Cervarix® vaccine manufactured by GlaxoSmithKline on the 
advice of the Joint Committee on Vaccination and Immunisation (Department of Health 2009). 
Cervarix® was directed against HPV -16 and -18, the two viral subtypes responsible for up to 
70% of all HPV-related cervical cancers (Muñoz et al. 2006). The vaccine was administered to 
girls aged 12-13 years, with a ‘catch-up’ programme running concurrently in the same year for 
older girls, with a view to immunising all girls aged 12-18 years in 2008, and focusing on 12-13 
year girls thereafter. In 2012, the Department of Health changed its vaccination policy, opting 
to administer Gardasil® vaccine, a quadrivalent vaccine effective against HPV-6 and -11 
(responsible for the development of genital warts) in addition to the high risk subtypes -16 and 
-18. Although both males and females may contract and transmit the virus, and both sexes 
may develop HPV-related cancers; currently only females are vaccinated against HPV. Since the 
implementation of the HPV vaccination programme, there have been calls for vaccination in 
males, in order to offer them the same health protection benefits (Chesson et al. 2011; Reiter 
et al. 2011; Kim et al. 2007), and research is currently being undertaken to model the cost-
effectiveness, acceptance and uptake of the vaccine in males (Stanley, 2014).  The case for 
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vaccination in males is advancing, with Public Health England announcing a scheme for 
vaccinating men who have sex with men (MSM) (PHE 2016a) in May 2018. 
The vaccine has met with some controversy among faith schools, parents and religious 
groups both in the UK and in North America (Haber et al. 2007; Larkin 2007).  Objections raised 
in the media covered the possibilities and consequences of physical side-effects (Reiter et al. 
2009), the need for booster vaccinations, the possibility of sexual disinhibition in young girls 
(Brewer et al. 2007) and the perception of vaccinated girls by society (Casper & Carpenter 
2008). Objections to vaccine acceptability among parental groups were associated with ethnic 
differences, with ‘religious reasons’ often cited in declining the vaccine (Marlow et al. 2009). 
Nonetheless, the majority of healthcare professionals welcomed the advent of the vaccine – 
hoping that it would reduce the incidence of disease (Goldie et al. 2004). Data from Scotland 
indicate that this is indeed the case with Pollock et al. (2014) reporting a reduction in both low 
and high-grade cervical lesions in vaccinated women in the Scottish Cervical Screening 
Programme (SCSP). Scotland is used as a data source here as women in Scotland are invited for 
their first screen at age 20, and the cohort of women vaccinated as girls at ages 12-13 years 
have already entered the screening programme, whereas women vaccinated at age 12 in 2008 
in England will not enter the NHS Cervical Screening Programme until 2020-2021. Studies 
published in Australia also indicate that the incidence of genital warts is also reducing as a 
result of vaccination (Ali et al. 2013; Read et al. 2011).  
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1.12. HR-HPV Triage and Test of Cure Algorithms 
The current programme algorithms for high-risk HPV triage and test of cure are shown 
overleaf. This version of the algorithm was implemented in 2012 in order to manage women 
showing a borderline or low-grade abnormality (triage); women who demonstrate CIN1 on 
biopsy which has been left untreated (conservative management) and women who 
demonstrate persistent high-risk HPV positivity post conisation. The aims of this algorithm are 
to reduce the number of women needlessly referred to Colposcopy with a high-risk HPV-
negative borderline or low-grade abnormality (which poses a risk of over-treatment); and to 
reduce the number of women on ten years’ annual cytology surveillance following treatment 
for a high-grade abnormality. The algorithm charts are shown here to help identify populations 
of women who are high-risk HPV positive but either do not demonstrate CIN and are not 
treated (and for whom HPV-infected cervical tissue is therefore not excised) or who remain 
HPV positive after treatment. 
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Figure 1.1: Screening Protocol Algorithm for HR-HPV Triage and Test-of-Cure from April 2014 
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Figure 1.2: Protocol Algorithm for Management of Untreated CIN 1 
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As is demonstrated in the screening protocols in figures 1.1 and 1.2, there are a 
number of women who will be diagnosed with a low-grade abnormality and sent for HR-HPV 
triage.  In the case of HPV-negativity, the woman remains under the care of her GP or other 
health professional and may expect to be called for cervical screening in either 36 or 60 
months (dependent on age).  In the case of HR-HPV positivity, the patient is referred to 
Colposcopy for further examination (NHSCSP 2016).  Colposcopy is a process of macroscopic 
examination of the cervix and vagina using a colposcope by a Consultant Gynaecologist or by 
an appropriately qualified Nurse Colposcopist.  At Colposcopy, dependent on the outcome of 
a visual examination of the cervix via the colposcope, the clinician may decide: 
 To arrange treatment of the patient  
 To biopsy suspected areas of abnormality 
 Not to treat the patient by excision of any suspected areas of abnormality 
but arrange for a follow-up examination in 6 months.     
Thus, in the case of women for whom possible CIN1 remains untreated (at the 
clinician’s discretion), or who are HPV-positive post treatment, or who have low-grade 
dyskaryosis that has not been re-tested to confirm HPV-negativity; there is the real 
possibility that these women will be carrying the sociological and psychological stigma of 
positivity for an STI and the fear of progression to or recurrence of a cervical malignancy.  
Women who might possibly fall into these categories are marked in red on figures 1.1 and 
1.2.  These women will have had some reassurance in clinic, but may need further 
information or support outside of the clinical setting. 
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Figure 1.3: HPV Primary Screening Pilot Protocol Algorithm identifying HPV positive, cytology 
normal women 
In the future, once HPV primary screening is implemented, women who test positive 
for HPV but demonstrate no nuclear abnormalities on cytology (marked in red on figure 1.3) 
will be at risk of the sociological and psychological sequelae of HPV positivity and anxieties 
surrounding progression or recurrence, without the reassurance or resolution that excisional 
or destructive treatment of CIN might bring.  
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1.13. Public Awareness of Cervical Screening 
Cervical cancer and the cervical screening programme have received increased public 
attention in recent years. In 2004, the National Health Service Screening Programme raised 
the entry age to the cervical screening programme (‘first call’) from 20 to 25 years (Sasieni et 
al. 2010). Although studies have found that this change is unrelated to an increase in cervical 
cancer incidence in women between the ages of 20-29 years (Patel et al. 2012), affected 
individuals and patient groups have become increasingly vocal in their petitions to get the 
entry age returned to 20 years (Albrow et al. 2012). Inevitably, in the years following the 
increase in age at first screen, tragic cases of women who were diagnosed with inoperable 
cancers prior to the age of screening commencement or at their first screen have received 
coverage in the newsprint media (Bell & Seale 2011). In the years following the change to the 
screening age, advertising/uptake campaigns released prior to and during the 
implementation of the HPV vaccine have increased public awareness since 2007 (Dodd et al. 
2014; Bowyer et al. 2013; Marlow et al. 2013; Klug et al. 2008; Marlow et al. 2007). Following 
the introduction of the vaccine campaign, the newsprint media frequently featured stories of 
adverse reactions to the vaccine (Habel et al. 2009; Hilton et al. 2010), provoking further 
controversy and debate. Less than a year after vaccine implementation, media coverage of 
the death of reality TV personality Jade Goody of cervical cancer ensured that cervical cancer 
stayed in the public consciousness (Hilton & Hunt 2010; Hilton et al. 2010). Thus the cervical 
screening programme and the implementation of HPV vaccination have courted much 
discourse surrounding the politics of embodiment and ownership (Casper & Carpenter 2008); 
and the dichotomy of vaccinating pre-pubertal/pubertal girls against a potentially oncogenic, 
STI versus vaccinating to encourage sexual disinhibition through misunderstood notions of 
complete protection against STIs (Brewer et al. 2007; Haber et al. 2007). It is against the 
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backdrop of these developments that the introduction of HPV triage and test-of-cure in 2012 
took place, and against which the roll out of HPV primary screening by 2019-2020 is 
proposed (PHE 2016b).  
The degree of argument in both clinical and public domains surrounding the screening 
age and HPV vaccination give some indication of the stigma and debate that awaits women 
who actually test HPV positive. This research project intends to examine women’s views on 
the use of HPV-related online resources to manage their questions, information needs and to 
document the lived experiences of women who are HPV-positive. 
 
1.14.  Research Project Overview 
It is thus within the complicated and changing social and cultural contexts and values 
surrounding screening, awareness campaigns for and media coverage of HPV vaccination, 
the stigmatised nature of STIs and the state of liminality invoked by screening and persistent 
HPV infection, that this research project is situated. This research is specifically intended to 
examine the lived experiences of women who have high-risk HPV (with or without 
accompanying cervical neoplasia) with a focus on the use of online resources in the physical 
and sociological self-management of persistent infection with a stigmatised virus. This 
research aims to document the ways in which women view persistent HPV infection and 
their interactions with online resources and support and to examine how both HPV positivity 
and online support have impacted on their lives. 
This chapter reviewed the current literature on the human papillomavirus from a 
biomedical perspective – examining the aetiology of cervical cancer and the current and 
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future proposals for the screening programme and identifying the instances of persistent 
HPV infection within these programmes where women are not routinely offered treatment 
and are thus at risk of liminality and biographical disruption. 
Chapter 2 will examine the self-concept, stigma theory and the sociological effects of 
stigmatised disease, both from an individual and a societal perspective, and demonstrate 
how these effects when combined with uncertainty and liminality, persistent HPV positivity 
may constitute a biographical disruption similar to the descriptions of chronic illness as a 
disruption to biography as described by Bury (1982). Strategies to mitigate both stigma and 
biographical disruption will then been explored, including peer support and the specific role 
that online support plays within this sphere. 
Chapter 3 will examine the methodology and philosophical underpinnings of the study, 
including the overarching ontology, epistemology, theoretical assumptions and research 
philosophy. This will include an examination of the phenomenology of illness, a critique of 
phenomenological research in healthcare, the advantages and disadvantages of mixed 
methods research and a discussion of qualitative data gathering techniques such as 
interviews. 
Chapter 4 will describe the collection and analysis of the quantitative, questionnaire 
data. This data will be used to describe the characteristics of a population of individuals using 
a  social media based support group and online resources in the management of HPV 
positivity drawing on the issues identified in the literature review.  Demographic aspects of a 
social media based population will be discussed, along with information surrounding disease 
stage and screening history. Internet use and behaviour will be examined and reported.  
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Chapter 5 will examine the qualitative data obtained from online 
interviews/narratives. The demographics of the participants and summaries of their stories 
will be reported. The super-ordinate and sub-themes that became apparent in their 
responses will be demonstrated and discussed. As the study was exploratory in nature, and 
mixed-methods by design equal weighting will be given to the results from each method and 
analysis. 
Finally, Chapter 6 will present a detailed synthesis and discussion of the key findings, 
focusing on areas for action, practice improvement, applications and recommendations to 
public health. The limitations of the study, the claims of contributions to knowledge, 
suggestions for further study and the application of the findings to the researcher’s 
professional practice will also be described in this section. 
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Chapter Two – Literature Review 
2.1.  Introduction 
The first chapter examined HPV positivity from a biomedical standpoint and focused 
on the aetiology of the disease and its clinical endpoints – namely the incidence and 
prevalence of HPV, the development of CIN and cervical cancer and the use of HPV DNA in 
cervical disease detection, management and prevention through a vaccination programme. 
However, to focus only on these aspects of the human papillomavirus is to neglect an entire 
field of research surrounding the invisible effects of HPV positivity – namely the 
psychological effects on the self (Daley et al. 2010; East et al. 2010; McCaffery et al. 2010) 
and the sociological effects on identity (Charles 2014; Boyd 2010; Nack 2002, 2000). A review 
of the qualitative literature on STIs in general, and HPV in particular, shows stigma to be a 
common theme reported among affected individuals (Kim 2012; McCaffery et al. 2006; 
Perrin et al. 2006). As the concept of stigma is intricately associated with both the self in 
terms of perceptions of self-worth and self-esteem; and with identity in terms of identity 
negotiation and role-behaviour, many of the psychological sequelae of HPV-positivity are 
bound up with and emanate from the social consequences of disclosure. For example, the 
disclosure of positivity for a sexually transmitted disease may result in social rejection or 
exclusion – affecting identity and perceived role fulfilment. These effects on identity may, in 
turn, lead to negative psychological sequelae such as anxiety and depression. The literature 
review will therefore encompass theories of the self-concept and identity, in addition to the 
theory of stigma. In addition, stigma management and communication (Heijnders & Van Der 
Meij 2006) and the notion of stigma as a gendered social construct (Brankovic et al. 2013) 
will be discussed. The concept of disease as a biographical disruption (Bury, 1982) will also be 
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examined along with the concepts of social and peer support and the role that online 
support plays in this arena (Wright 2016; Rains et al. 2015; Hong et al. 2012; Eysenbach et al. 
2004b; Klemm et al. 2003).  
 
2.2.  Self and Identity 
Whilst ‘self-concept’, ‘self’ and ‘identity’ are used interchangeably throughout the 
literature examined in this section, and it is important to make distinctions between them, as 
the different meanings they possess are important within the context of both the literature 
and the wider research project. The self-concept is largely associated with the field of 
symbolic interactionism (Elliott 2013, p.30) and the writings of George Herbert Mead. Mead 
was a founding figure in the field of pragmatist philosophy and a major figure in the 
development of the American School of philosophy (Cronk 2017). Apart from his work on the 
self, Mead (along with Charles Horton Cooley) is most regarded for his work in founding the 
field of symbolic interactionism – a sociological perspective that postulates that individuals 
act toward objects based on the meaning that those object have for them (Mead et al. 2015, 
p.136). However, whilst the theoretical lens through which this research is viewed is 
interpretivist rather than symbolic interactionist, the two fields are closely allied and aligned 
and sit under the same paradigmatic umbrella of constructionism. Moreover, both fields are 
amenable to phenomenological study. In addition, the definitions of self advanced by Mead 
et al (2015) are the best fit, philosophically, with the other constructions advanced in this 
chapter (such as stigma and social support) and thus will be used here, despite the research 
being interpretivist in nature. 
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The development of the self-concept in sociology can be traced back to Cooley (Gecas 
1982; Epstein 1973), who, expanding on the work of psychologist and philosopher William 
James’ 1890 treatise on the principles of psychology, described the concept of the ‘looking 
glass self’. Epstein recapitulates several models of the self as described by sociologists in the 
first part of the nineteenth century, including Cooley who in 1902 first described the 
possibility of alternative modes of self-perception (Shaffer, 2005). The looking glass self has 
three components:  
‘First, actors learn about themselves in every situation by exercising their 
imagination to reflect on their social performance. In doing so, they imagine 
themselves as others must see them, and this construction of what others must 
see is fundamentally like an image reflected back in a mirror. Secondly, Cooley 
argued that actors next imagine what those others must think of them. In other 
words, actors imagine the others’ evaluations of the actor’s performance. Third, 
and most important, the actor experiences an affective reaction to the 
imagined evaluation of the other.’  
Shaffer (2005)   
Cooley’s writings were contemporaneous to and often critiqued by Mead. In his 
posthumous work Mind, Self & Society, Mead abandons the concept of ‘a substantive soul 
endowed at birth’ (Mead et al. 2015, p.22) and holds that the individual develops the idea of 
self and self-consciousness from experience. In describing his definition of social psychology, 
Mead states ‘...minds and selves are essentially social products, products or phenomena of 
the social side of human experience’. Mead therefore viewed the self as a social construct 
and the development of the self as a social process, and this notion was fundamental to his 
later writings on and espousal of symbolic interactionism as a sociological philosophy. 
Inghilleri puts forward the notion that Mead expanded on Cooley’s writings, describing the 
self as having two main aspects: the ‘I’ and the ‘me’. The ‘me’ is the concept of self as 
learned through interaction with others. According to Inghilleri: 
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‘…other people’s attitudes as specific or generalised as they may be, 
once internalised in the self, will constitute the ‘Me’. The ‘Me’ is that part of 
the self that can be observed as an object and that can be described as a 
subject.’ In tandem with the concept of the ‘me’ arises the entity that is the ‘I’. 
The ‘I’ ‘reacts to the self that which arises through the taking of the attitude 
of others.’   
(Inghilleri 1999, p.26) 
 
Additionally, the ‘I’ is: 
‘…the principle of action and of impulse; and in its action changes the 
social structure... [T]he individual is no thrall of society. He constitutes society 
as genuinely as society constitutes the individual.’  
(Mead et al. 2015, p.xxv)  
Both Cooley and Mead posit that our conception of the self is constructed through 
interaction with others. Stryker and Burke – prominent authors in the field of identity theory, 
claiming Mead as their intellectual heritage – agree that his framework (albeit highly 
simplified for the purposes of their writing) asserts that ‘society shapes self, shapes 
behaviour’ (Stryker & Burke 2013). Stryker and Burke expand on the socially constructed 
Meadian self, stating that individuals inhabit, enact and negotiate multiple roles in multiple 
groups. 
 
2.2.1. Identity – The Content of Self-Concepts   
Consequently, if as argued above, interaction with and observation of society shapes 
the self, the question of locating identity in the self-concept framework arises. According to 
Tajfel, sociology refers to identity as our ability to locate ourselves in a social world. This 
locating occurs through the negotiation and membership of various groups such as family, 
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friendship groups, gender groups, race groups, school or educational institutions, 
occupations, religious groups, sports teams and political affiliations (Tajfel 2010, p.122). He 
also goes on to describe social identity as ‘that part of an individual’s self-concept which 
derives from his knowledge of his membership in a social group (or groups) together with the 
value and emotional significance attached to that membership’. In his review of the self-
concept, Gecas (1982) posits that identity is constructed within the self, and is ‘situated, 
emergent, reciprocal and negotiated’.  Luhtanen & Crocker (1992) define personal identity as 
how individuals view themselves, whereas social identity refers to how an individual views 
the social groups to which he or she belongs. Writing of the effect of chronic illness on 
identity, Nettleton defines the difference as follows: ‘chronic illness can impact upon 
sufferers’ daily living, their social relationships, their identity (the view that others hold of 
them) and their sense of self (their private view of themselves)’ (Nettleton 2006, p.72). Thus 
a number of scholars have argued that identity emerges  through the negotiation and 
habitation of roles within chosen social groups (Stets & Burke 2000; Swann 1987). 
 
2.2.2. Threats to Identity 
The previous section established an argument for the self-concept as created via 
interaction with and feedback from society; and the construction of identities within that self 
being achieved through the negotiation and habitation of social roles and membership of 
social groups. How then, does an individual react when his or her membership of a chosen 
group is jeopardised? Social membership may be threatened by the acquisition of a 
characteristic that breaches group rules, or that other group members find distasteful or 
socially discrediting; membership of the group is threatened, and thus that area of an 
Page | 28  
 
individual’s identity is threatened. If the discrediting characteristic – such as illness – is 
disclosed to a group, social rejection may ensue (Crandall & Moriarty, 1995) – whether 
familial, romantic or among peers – resulting in social isolation (Fife & Wright 2000). 
HPV can be interpreted as a socially discrediting characteristic as the sexual nature of 
transmission (Burchell et al. 2006) and lack of awareness surrounding prevalence (Dodd et al. 
2014; Bowyer et al. 2013; Waller et al. 2007) imply promiscuity or infidelity among HPV 
positive individuals (Newton & McCabe 2005). Promiscuity and infidelity are viewed as 
socially deviant, particularly among women (Nack 2000) and thus the disclosure of positivity 
for an STI implies deviance from social or cultural norms (Gregg 2011).  Hence the 
examination of the self as a social construct (arising from interaction with others), and of 
identity (arising from role negotiation and habitation) are both important as the sociological 
and psychological sequelae of HPV positivity are derived from the social consequences of 
disclosure. Disclosure of HPV positivity can be construed through the Meadian lens as an 
interaction or social transaction with social groups (Hult et al. 2012). If, as argued above, the 
content of self – identity – is formed through the habitation of roles and membership of 
groups, and those memberships are threatened, identity itself must be threatened. Due to 
the intimate nature of transmission – HPV is only transmitted by intimate genital or sexual 
contact (Manhart & Koutsky 2002; Koutsky 1997) the social consequences of disease 
disclosure are associated with the stigma of implied deviations from social/moral norms 
(Scambler 2009; Scambler 2006). Stigma is, in itself, a social construct, the origin and 
structures of which are discussed below.  
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2.3. Stigma 
Stigma was first examined as a social concept by Émile Durkheim, who, alongside 
Weber and Marx, is considered one of the founding figures of sociology (Calhoun et al. 2012, 
p.107; Franzese 2009, p.12). Durkheim published The Rules of the Sociological Method in 
1895, and in doing so became the first writer to apply scientific methods to sociology, and to 
argue that sociology be acknowledged as an academic discipline (Poggi 2000, p.2). Durkheim 
felt it was important to study the patterns of behaviour or social facts that are attributable to 
or enacted by any specific group (Berkman et al. 2000). Durkheim was also the first writer to 
examine the concept of stigma in depth, in his work Le Suicide – describing stigma as a 
consequence of deviation from a societal norm or set of norms (Douglas 2015, p.9). 
Aside from Durkheim, writing on the concept of stigma is dominated by the work of 
another prominent sociologist, Erving Goffman. Since its publication in 1963, Goffman’s 
seminal work Stigma: Notes on the Management of a Spoiled Identity has been a reference 
point for many authors of stigma research. Goffman had already expanded on the Meadian 
concept of self in his 1959 work The Presentation of Self in Everyday Life. Whereas Mead 
described the self as a social construct, Goffman took this idea one step further, describing 
the self not only as socially constructed, but created, supported (by props such as the choice 
of clothes, jobs and houses) acted and performed as a piece of theatre (Goffman 1990a, 
p.18). His later work, Stigma, went on to examine the coping mechanisms and consequences 
that arise in the event that the role(s) assumed as social identity are discredited. 
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2.3.1. Origins of Stigma 
Both Goffman and, later, Jones (1987) cite Greco-Roman society as the origin of 
stigma, where it was originally utilised as a method of publicly identifying persons of ill-
repute. Ritual marks or blemishes – brands, burns, scars or tattoos – indicated that the 
bearer was the possessor of unusual or unsavoury traits, such as membership of the slave or 
criminal classes. Stigmata were applied to such individuals in order that ‘normals’ might 
avoid them socially (Goffman, 1990b p.11). Speaking in a more modern and universal 
context, Falk notes ‘...we and all societies will always stigmatize some conditions and some 
behaviours because doing so provides for group solidarity by delineating ‘outsiders’ from 
‘insiders’’ (Falk 2001, p.13). Scambler (2009) reiterates this, stating ‘...it is the disgrace itself 
that is marked. In this way the solidarity of normals is affirmed’. Goffman described stigma 
as ‘an attribute that is deeply discrediting’ but opined that ‘a language of relationships, not 
attributes, is really needed’ (Goffman, 1990b, p.13). This example illustrates a theory 
delivered later in his work – that society can be divided into the stigmatised and the 
stigmatisers, or, as later authors describe, ‘in-groups and out-groups’ (Oyserman 2001). 
Goffman’s work on the stigmatising characteristics of mental health and disability as 
deviations from social norms (Goffman 1992, 1991) form the basis of theoretical models for 
understanding other, more recent stigmatised conditions such as HIV/AIDS (Judgeo & 
Moalusi 2014; Alonzo & Reynolds 1995) and, as will be demonstrated later in the chapter, 
positivity for HPV and the development of cervical cancer. 
According to Campbell and Deacon’s readings of Goffman, they attribute the 
application of Goffman’s model of stigma to three universal and historical forms (Campbell 
and Deacon, 2006):  
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1. The possession of overt or external deformities, such as missing a limb or 
being confined to a wheelchair. 
2. Known deviations in personal traits – such as gambling or alcoholism, or 
affliction with mental disorders.  
3. Tribal stigma – association or affiliation with a specific nationality, religion or 
race. 
 
2.3.2. Overt or External Deformities 
In the case of HPV, the first form of stigma – overt or external deformity – is difficult 
for society to apply to affected women until disclosure has been undertaken, as high-risk 
HPV is largely asymptomatic and also affects an intimate area that is neither visible nor 
spoken of in everyday life, thus positivity for high-risk HPV can be construed as an ‘invisible 
stigma’. However, in a quantitative study examining internalised shame, intrusive thoughts 
and quality of life scores between a control group of orthopaedic patients and a sample of 
women with external genital warts (which have a lower risk of developing into cervical 
cancer then non-wart causing HPV strains), Jeynes et al. (2009) found that women with 
genital warts showed higher levels of shame, greater frequency of intrusive thoughts and 
lower quality of life scores than the group with orthopaedic injuries. In addition the Jeynes 
study found that women report feelings of disgust and self-disgust to a diagnosis of genital 
warts. In short, these women felt or anticipated stigma on the basis of Goffman’s first 
criterion, that of the deformed physical body. Even in the case of asymptomatic HPV, a 
participant in a study by McCaffery et al (2006) who was HPV positive but cytologically 
normal reported ‘there’s a leper type deal to it’. 
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2.3.3. Deviations in Personal Traits 
Once the sexual nature of transmission is understood, however, Goffman’s second 
criterion is more often, although inaccurately, applied – as a known deviation in a personal 
trait. In the case of HPV the assumed flaw is moral – the assumption of promiscuity or 
infidelity. An earlier study by McCaffery et al. (2003) conducted a series of  focus groups 
among ethnic minority women which showed that the women felt that HPV positivity was 
associated with infidelity, mistrust and blame; and that participating in HPV screening 
implied feelings of mistrust and suspicions of infidelity to their partners and family. It should 
be noted that these attitudes were produced only by the question of participating in 
screening and the anticipation of a positive result.  These women had not been invited for 
HPV screening at the time of the study, nor were they in expectation of HPV positive results, 
thus these attitudes were in response to hypothetical HPV positivity. 
 
2.3.4. Tribal Stigma 
Research into HPV positivity and stigma has tended to focus on the first two criteria of 
Goffman’s model, but studies by Nack (2008, p.80; 2002, 2000)  indicate that women 
affected by HPV and/or herpes had, until the point of their own diagnosis, imagined a 
dichotomous population of ‘good girls’ and ‘fallen women’; terms that Nack considered to 
indicate that perceptions of STIs were gateways to a tribal model of stigma. Both the 
terminology used by participants, and the responses given in interview, lead Nack to believe 
that HPV was also a gendered stigma, with blame being attributed to and shame being more 
overtly felt by women who were affected by the virus (Brankovic et al. 2013). This finding 
was reiterates an ethnographic study by Gregg (2011) of Brazilian women suffering cervical 
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cancer. While we know that HPV is a necessary cause of cervical cancer, whether the women 
in Gregg’s study knew of this is not made clear, but Gregg found that ‘women with cervical 
cancer were not just considered ill, they were also assumed to be dirty, lazy and 
promiscuous’. Gregg also states within her paper that ‘men are expected to control the 
sexuality of women in their families and to have complete sexual liberty themselves’. 
 
2.3.5. The Discreditable and the Discredited 
According to Goffman’s classification, stigmas may be separated into ‘discredited’ 
stigmas (those that are immediately visible or known to others (e.g. skin colour or visible 
disability such as a missing limb or being in a wheelchair), and ‘discreditable’ stigmas – 
invisible or concealable stigmas, such as sexual minority status, HIV or mental illness. As an 
asymptomatic infection HPV is thus categorised as a ‘discreditable’ condition or an ‘invisible 
stigma’. A discreditable individual is one whose stigmatising characteristic is not immediately 
visible or not yet disclosed. Discredited individuals are those whose stigmatising attribute is 
either patently visible or has been disclosed to non-stigmatised individuals (Chaudoir et al. 
2013). This aspect of stigma is particularly important when considering the disclosure of a 
positive HPV diagnosis to others, which may affect access to support channels. As the 
stigmatising characteristic is both asymptomatic and invisible it need not be disclosed to 
many others in an individual’s social circle, unless that individual must disclose in order to 
access social support, an act that may in itself risk social rejection. 
As part of the discredited/discreditable dichotomy, Goffman also described two 
methods of stigma management – passing and covering. According to Leary (1999) passing is 
‘a cultural performance whereby one member of a defined social group masquerades as 
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another’ in order to enjoy the social privileges afforded to the dominant group (Kanuha, 
1999). Due to the invisible nature of the stigma, HPV positive individuals may pass as 
uninfected to partners, family or friends by omitting to disclose the nature of their condition. 
Research on HPV disclosure has determined that fear of social reprisals (rejection, exclusion, 
public shaming) are major reasons why women fail to disclose their condition (Keller et al. 
2000). However, as the results of data collection show in later chapters, the majority of 
women affected by HPV indicated that they would disclose their condition to significant 
others. 
Goffman expanded on Durkheim’s theory of stigma as a consequence of deviance 
from a norm, describing it as a social process. Stigma as a social process echoes Mead’s 
concept of the construction of the self as a social process. Goffman tied the concept of 
stigma to the notion of the self by describing stigma as a cause of spoiling an individual’s 
social identity. This disqualification comes about as society or societies ‘establish a means of 
categorising persons and the complement of attributes felt to be ordinary and natural for 
members of each of these categories’ (Goffman, 1990b, p.11)  – and that visible evidence of 
failing to meet these standards, be they physical, mental, behavioural, socioeconomic, tribal 
or religious will result in that individual failing to be accepted by that group, and thus 
stigmatised. Goffman reiterates Mead’s concept of the ‘I’ and the ‘Me’ in his model of 
stigma, stating that society assumes demands and imputes characteristics to ourselves and 
categorise both ourselves and others we see as ‘us’. Goffman refers to this construct of our 
self as ‘the virtual identity’ – corresponding to Mead’s concept of ‘I’. In contrast to this, the 
actual character or categories and attributes that individuals could actually be proved to 
possess is the actual social identity – Mead’s ‘Me’ (Goffman 1990b, p.55). Goffman theorised 
that stigma arises as a discrepancy between the virtual social identity – one that we 
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construct subjectively to make sense of how we see others’ perceptions of us – and the 
actual social identity – one that we form in the receipt of actual, objective feedback from 
others in our daily interactions. 
  
2.3.6. The Own, the Normals and the Wise 
Goffman theorised that the structure of stigma relied on three specific populations: 
the stigmatised (the ‘own’), the ‘normals’ and the ‘wise’. Normals are individuals who are 
unaware of the stigmatised condition of the affected person and to whom disclosure of the 
stigma may represent the risk of being socially discredited. In relation to HPV positivity, 
normals represent the individuals to whom affected persons would not wish to disclose their 
HPV positive status – this may include family, friends, loved ones, employees and their wider 
social world. The ‘wise’ refers to individuals who have been apprised of the stigmatising 
condition but who accept the stigmatised individual as a ‘normal’; with whom the 
stigmatised individual can interact without the anticipating stigma or shame. The wise may 
be seen as ‘honorary members’ of the stigmatised group. The wise population includes 
fellow sufferers, members of the close social circle who have been informed of the 
individual’s disease status and healthcare staff, who would be expected to suspend moral 
judgement based on their professional knowledge of the condition. However, according to 
participants in a study by Nack (2002, 2000) some healthcare practitioners have exercised 
moral judgement during the diagnostic encounter, emphasising the stigmatising nature of 
the condition at the point of diagnosis. Originally purely theoretical, the ‘own and the wise’ 
model of different populations within a sphere of stigma was recently demonstrated by  
Smith (2012), and within this research study was the author’s experience in the acceptance 
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to the groups from which participants were recruited – once gatekeepers had accepted the 
researcher’s professional credentials, the researcher was accepted as one of the ‘wise’ 
within participant populations. 
 
2.3.7. Other Models of Stigma 
Goffman’s model has been the dominant theory in the field since it was published. 
However, more recently authors have sought to expand on the traditional model. Jones et al. 
(1984) describe a further model of stigma based on Goffman’s two conditions: the 
discreditable and the discredited. On the basis of these groups and the management 
techniques of passing and covering, Jones’ team proposed six dimensions of stigma, by which 
the level of social censure might be determined. These six dimensions are as follows: 
1. Concealability – extent to which the condition is concealable from others – 
invisible conditions will evince less stigma than highly visible ones. 
2. The course of the mark – whether the stigma's prominence increases, 
decreases, or remains consistent over time. Examples might be leprosy, or 
Kaposi’s sarcoma; the more overt or spreading the ‘mark’, the greater the 
stigma. 
3. Disruptiveness – the degree to which the stigma and/or others' reactions to it 
impede social interactions. Epileptic grand mal seizures, acute 
schizophrenic/manic episodes or autistic ‘meltdowns’ in public (Ryan, 2010) are 
examples of stigmatised attributes that are more stigmatised  based on the 
amount of attention they draw – the more attention, the more stigma. 
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4. Aesthetics – the subset of others' reactions to the stigma comprising reactions 
that are positive/approving or negative/disapproving but represent estimations 
of qualities other than the stigmatized person's inherent worth or dignity 
5. Origin – The origin of the stigma – whether present at birth, the result of 
accident or the result of deliberate behaviour will affect the degree to which it is 
stigmatised. 
6. Peril – The threat that ‘normals’ perceive the danger might pose to them – 
whether accurately or otherwise. 
Taken from Jones (1984) In: (Heatherton 2003, p.6))  
Although developed in relation to mental health stigma, later writings by Corrigan 
(2006, 2001, 2000)  added the dimensions of stability, controllability and pity to existing 
models of stigma. According to Scambler (2009), Goffman’s model is still relevant, but 
researchers need to go beyond this original model as it doesn’t necessarily reflect aspects of 
modern life. In their paper reconceptualising stigma, Link & Phelan note that the definition of 
stigma has varied widely, principally due to the application of the concept to a wide range of 
subjects and the multidisciplinary nature of the research (Link et al. 2001). They raise two 
challenges to literature framed by Goffman’s concept; firstly that the majority of researchers 
do not belong to stigmatised groups, and secondly that research on stigma has a largely 
individualistic focus. The first challenge definitely bears relevance for this researcher – as an 
HPV-negative individual, the researcher carried the label of ‘normal’ which made it difficult 
to establish rapport with some groups that fitted the sample population. Nack (2002, 2000) 
reports that her own status as a fellow sufferer was helpful in her research surrounding HPV 
stigma. Within this piece of research, the position that the researcher occupied within the 
group was as ‘one of the wise’ due to the nature of her profession, but the absence of the 
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stigmatising condition was still a barrier to some individuals. This is discussed further in the 
qualitative data gathering and analysis section. Link & Phelan’s second criticism – that stigma 
research has a largely individualistic focus is also undeniable.  
 
2.3.8. HPV as a Source of Social Stigma 
The stigma concept has been applied to many disciplines within the field of healthcare 
research, including cancer (Fife & Wright 2000; Koller et al. 1996) and mental illness 
(Corrigan 2006); however in recent years, research on health related stigma has focused on 
sexually transmitted diseases [STDs], particularly HIV/AIDS (Flowers et al. 2006; Visser et al. 
2006; Bunting 1996). However, there is a paucity of sociological research into the social 
stigma attached to a diagnosis of HPV – research into the psychological sequelae of HPV 
positivity is more plentiful, and will be discussed in the next section. Entering the search 
terms ‘HPV’, ‘stigma’ and including the words ‘knowledge’ and ‘attitudes’ and into various 
databases including Google Scholar produces some 8,300 article results. The same search run 
through Medline, CINAHL and the Cochrane Database produces remarkably fewer results – 
63 in all – although this may be due to the fact Medline largely deals with 
quantitative/positivist studies and the article titles of qualitative studies tend to have rather 
more descriptive and abstract titles that do not always include the search terms initially 
entered (Evans 2002). However, the majority of these papers examine knowledge and 
attitudes of HPV vaccination as opposed to HPV positivity, and those that examine stigma 
examine the effects of stigma on psychology. When this search is refined to include the 
terms ‘social stigma’ or ‘sociology’ or ‘sociological’ and to exclude the terms ‘vaccine’, 
‘vaccination’, ‘psychology’ and ‘psychological stigma’, a total of five studies were returned. 
Aside from Nack’s two studies surrounding the social aspects of HPV stigma (2002, 2000), 
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East et al.’s 2010 paper on the stigma of sexually transmitted infections and Gregg’s (2011) 
study of the social stigma associated with cervical cancer; one study reviews the stigma of 
sexually transmitted infections, including HPV, although it is not the main focus of the 
research (Hood et al. 2011). Where research does examine social stigma among women it 
studies perceived, anticipated stigma or enacted stigma. Enacted stigma ‘is when people 
who are considered to be morally, socially, racially, or physically tainted are actively 
discriminated against by so-called ‘normals’: felt stigma is the fear or experience of this type 
of discrimination’ (Lichtenstein et al. 2005: 44). Participants in Nack’s 2002 study – examining 
chronic STD diagnoses (including HPV) report (perceived) enacted stigma by health 
professionals: 
‘Practitioners also expressed negative feelings verbally about the 
women to whom they delivered news of a serious shift in health status. 
Louise, a twenty-eight year-old white middle-class graduate student, received 
a harsh HPV diagnosis over the telephone. ‘He was very accusatory, like now I 
was this big pain in the ass for having a bad pap smear... I got him on the 
phone, and he’s like: ‘You have cancerous growth all over your cervix. It’s 
everywhere. It’s probably HPV. You probably picked it up from some guy’’. Not 
only had her doctor described a very significant part of her body as ravaged 
by cancer, but he had also marked her as promiscuous.’ 
(Nack 2002) 
Additionally East et al. report anticipated stigma on the part of parents upon a 
disclosure of herpes: 
‘Bree’s feelings of stigma had been exacerbated by how she believed 
her mother looked at her sometimes. Bree occasionally felt rejected by her 
mother due to having a sexual infection: ‘It all comes back to the way society 
perceives a person with it [herpes]. And sometimes, I see a bit of disgust in my 
mother’s eyes, and it just makes me feel sh***y’.’ 
 (East et al. 2012, p.17) [No asterix in original] 
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2.3.9. Psychological Aspects of HPV Diagnosis 
Previous sections have examined the concept of stigma as a social construct and 
situated HPV in the context of this social construct. However, in addition to literature 
examining the sociological sequelae of HPV positivity, the psychological aspects of HPV 
positivity – arising as a consequence of social stigma – should not be ignored. The first major 
study examining the psychosocial impact of HPV positivity was published in 1996 (Clarke et 
al. 1996).  Clarke and team recruited 489 individuals from a selected population of 839 
subscribers to HPV News, a quarterly journal published by the American Sexual Health 
Association (ASHA).  Responses to the questionnaire showed that 75% of sufferers 
experienced depression and anger and 66% expressed feelings of shame.  In addition, 
respondents indicated dissatisfaction with information and counselling services that were 
provided by their clinician.  Conversely, a later study by Reed et al. found no significant 
difference in adverse psychosexual effect in women with occult HPV infection compared to 
those without (Reed et al. 1999).  This may be because the infection was occult – unknown 
prior to the trial, or ameliorated by the fact that these individuals had few predisposing risk 
behaviours.  Also, the study looked at a psychosexual aspect as opposed to a psychological or 
psychosocial aspect to the virus.  In a meta-analysis of 54 studies covering a range of 
disorders including: heart disease, cancer, AIDS, diabetes and Huntington’s disease; 
immediate adverse effects (depression and anxiety) were reported in the majority of studies, 
although for the most part, the duration of anxiety was limited, and positive interventions 
could be implemented to improve mental health (Shaw et al. 1999). 
Since the initial identification of HPV as a necessary cause of cervical cancer, many 
studies have since shown that there are significant negative emotions attached to the 
diagnosis of HPV. Kwan et al. (2011) demonstrated that HPV positive women showed higher 
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scores for stress than HPV negative women. Waller et al. (2007) reported that women with 
awareness of the role of HPV in cervical abnormalities reported feelings of stigma and shame 
compared to women who were unaware of the role of HPV. McCaffery et al. (2006) also 
showed that women interviewed about the inclusion of HPV testing in cervical screening 
reported feeling anxious, stigmatised and worried about disclosure due to the sexual nature 
of transmission; whilst Perrin et al (2006) reported how the use of the pejorative terms for 
description (‘warts’, ‘wart virus’) increased feelings of stigma. These feelings, combined with 
a lack of information about the relatively high lifetime risk of contracting the virus 
(awareness of which might otherwise reduce stigma) may lead to feelings of shame and guilt 
amongst patients who have been diagnosed – male or female (Jeynes et al. 2009). 
 
2.3.10. Feelings of Shame, Guilt or Contamination Associated with HPV Positivity 
As noted above, in contrast to the limited sociological literature, there is significant 
body of literature which exists examining the psychological aspects of HPV positivity. Waller 
et al. (2007) hypothesised that feelings of shame and stigma would be greater among 
patients who were aware that HPV was sexually transmitted, and set up an online survey to 
test their expectations.  Their hypotheses proved correct – women who were aware that 
HPV was sexually transmitted reported higher levels of shame toward a hypothetical HPV 
positive result than women who were not aware.  Scores for shame and stigma were highest 
in women who were aware of the sexual nature of transmission but unaware of the high 
prevalence of HPV within the population and the lifetime risk of infection of 1:2 (50%).   
McCaffery conducted a series of  focus groups amongst ethnic minority women which 
revealed how HPV positivity was largely associated with infidelity, mistrust and blame; and 
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that participating in HPV screening implied feelings of mistrust and suspicions of infidelity to 
their partners and family (McCaffery et al. 2003).  It should, however, be noted that these 
attitudes were produced only by the question of participating in screening and the 
anticipation of a positive result.  These women were not invited for HPV screening at the 
time of the study. 
As well as shame, guilt is a commonly reported emotion following the diagnosis of 
HPV, or cervical cancer, especially when in possession of the knowledge that disease is 
caused by a sexually transmitted infection (Nack 2002, 2000).  Given the latent nature of the 
HPV life cycle (Stubenrauch & Laimins 1999), and thus the relative delay between modal age 
of infection (18-25 years) and the modal age of cancer onset (30-35 years) (Smith et al. 
2008), women may assume that they have had HPV for some time, and guilt may be elicited 
at the thought that they may have transmitted the virus to their partner or partners.  The 
limited efficacy of condoms (Burchell et al. 2006) in preventing the transmission of HPV may 
compound feelings of guilt.   
Alternatively, at the opposite end of the continuum to guilt (a self-imposed construct) 
is the concept of blame – a construct imposed by others.  Where there is a lack of knowledge 
surrounding the latent nature of HPV, women may report having suspicions that their 
partner has been unfaithful (Fernandez et al., 2009; Friedman et al., 2007), which can in turn 
have concomitant negative repercussions on patient relationships, adversely affecting their 
overall wellbeing.  This may in turn lead to a fear of disclosure based on the psychosocial 
(and possibly physical) repercussions that may follow the disclosure of a stigmatized disease 
and the uncertainty such a diagnosis may bring (Kosenko et al., 2012).   
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2.3.11. Stigma Following a Diagnosis of Cancer 
The reporting of negative emotions or perceptions of stigma are also found following 
the diagnosis of malignant disease, which are relevant in the case of HPV as malignant 
disease of the cervix is the clinical endpoint of persistent HPV infection.  Some cultures view 
illness or disability itself as a stigmatised disease (Scambler, 2009; Saetermoe et al., 2006).  
Sontag drew attention to the fact that ‘societies need to have one illness which becomes 
identified with evil, and attaches blame to its ‘victims’’ (Sontag 2002, p.97). Feelings of 
shame, stigma and models of identity threat have been associated with cancers to which 
patient behaviours or choices are perceived to have had a possible contributory effect to the 
disease, for example, smoking and lung cancer (Marlow et al. 2015b; Knapp et al. 2014; 
Marlow & Wardle 2014; Chambers et al. 2012; Else-Quest et al. 2009; LoConte et al. 2008). 
 
2.4. HPV Positivity as a Biographical Disruption 
The literature reviewed in the previous sections has demonstrated HPV to be both a 
stigmatising condition and one that has negative psychosocial sequelae for affected 
individuals. This section will examine whether these aspects of HPV positivity can be argued 
to pose a disruption to biography in affected women.  The concept of illness as a disruptive 
event in the life of an individual was first suggested by Bury (1982). Bury conducted semi-
structured interviews with individuals suffering rheumatoid arthritis (RA), concluding that 
both the symptoms of RA and the effects on an individual’s identity constituted a disruptive 
event in the individual’s life. At first glance, drawing parallels between chronic illness such as 
rheumatoid arthritis, diabetes or cancer and HPV would seem an unlikely comparison. HPV 
is, for example, thought to be transient (Harper et al. 2006; Evander et al. 1995) and may be 
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asymptomatic (Srivastava et al. 2012; Franco et al. 1999; Villa & Franco 1989) or present in 
cytologically normal women (Melkert et al. 2009). The usually transient nature of HPV does 
not sit with the nature of a chronic illness; equally, the asymptomatic nature of HPV does not 
agree with the chronic pain reported by arthritis sufferers (Fitzpatrick et al. 1988) or the 
lifestyle interruptions seen in diabetes (Williams, 2000). However, viral persistence over 
several years has been reported after excision of neoplastic areas by LLETZ or cone biopsy 
(Louvanto et al. 2010; Nam et al. 2009; Park et al. 2008; Syrjänen et al. 2005; Sarian et al. 
2004), viral infection being a chronic entity in these case. In addition to the fears surrounding 
viral persistence, a number of women present with lesions that are high-risk HPV negative 
(despite the virus being a necessary cause of the disease) or present with disease recurrence 
following treatment and a negative ‘test-of-cure’ HPV test (del Pino et al. 2011), that are 
thought to be either due to HPV latency or complete integration of the viral genome to the 
extent that it is undetectable using viral probes (Walboomers & Meijer 1997). Thus the 
combined effects of HPV-associated stigma on identity -  combined with the uncertainty 
surrounding HPV positivity and the risk of disease recurrence, or false test-of-cure HPV-
negativity (due to dormancy) post-LLETZ - make a feasible case for HPV persistence as a 
biographical disruption.  
Bury’s model of chronic illness as a biographical disruption (Bury, 1991, 1982) stated 
that chronically ill individuals had to accommodate changes to various aspects of their lives, 
as stated below. 
1)  Taken-for-granted assumptions and behaviours;  
2) Profound disruptions in the explanatory systems used by people – including a 
fundamental rethinking of biography and self-concept and finally;  
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3) A response to disruption through the mobilisation of resources (Bury, 1982; 
1991). 
Much of Bury’s work on the first point includes the strategic management of 
symptoms, and this point is the first deviation from this model in the case HPV positivity. 
Some cases of HPV are determined as a result of the individual reporting symptoms such as 
dysfunctional bleeding patterns or genital tract discomfort and are thus symptomatic 
(Gordon et al. 2003). However, the vast majority of cases of HPV-positivity are often 
asymptomatic (Srivastava et al. 2012; Fife et al. 1987) and are screen-detected, thus do not 
fit with Bury’s description of a ‘creeping onset’ of symptoms  that might be normalised or 
explained away by the individual. However, once diagnosed (through screening) HPV 
positivity may adversely affect taken-for-granted assumptions around fertility, or partner 
fidelity and the estimation of one’s self-worth and the taken-for-granted behaviours within 
relationships (Newton & McCabe 2008a). 
However, the second point surrounding the rethinking of biography is pertinent to the 
case of HPV positivity. Rajaram et al (1997) describe the case of an abnormal Pap smear as a 
biographical disruption at three levels, to the sense of self; disruption to social relationships 
with intimates and society at large; and in their daily activities. They also go on to highlight 
the concept of uncertainty, which Bury (1982) states is a key element in biographical 
disruption. In the case of cervical abnormalities, the uncertainty was in the inability for 
medicine to either confirm or exclude disease – in this case genital warts rather than cervical 
neoplasia.  Forss et al. (2001) highlight this uncertainty with the following report from a 
participant: 
‘The doctor said it doesn’t positively say I did [have warts], it just says it 
looks like it... And this is one thing to me that is kinda upsetting. I guess what 
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I’d like to know – couldn’t they tell? Don’t they take biopsies to tell for sure if 
it is, or it isn’t? So far as I am concerned, I really don’t know. And to me, you 
should be able to know one way or the other and be told.’  
(Forss et al, 2001) 
A later study by Forss et al. (2004) reiterates this concept – highlighting that an abnormal 
cervical screening result did not ‘create order’ in women’s lives as they had perceived it 
might through taking responsibility for their health in complying with screening – thus 
demonstrating health-seeking behaviours. East et al. (2010) reiterated this – the act of 
undertaking screening was a health-seeking behaviour, and to be diagnosed HPV was scant 
reward for this societal compliance.  All of these studies highlight that notification of an 
abnormal Pap smear had neither confirmed health nor excluded disease. This sense of 
biomedical limbo led Forss and others to discuss cervical cancer screening as ‘a new kind of 
sickness experience’ where one was neither ill nor well, which Forss describes as an 
experience of liminality. 
According to Little (1998) liminality is a sociological term derived from the Latin līmen 
first used by anthropologist van Gennep in the study of rites of passage (Thomassen 2009; 
Hockley 2002). Individuals mid-rite were ‘on-the-threshold’ of the next stage of their 
evolution; possessing neither their pre-rite naïveté nor post-rite enlightenment. Use of the 
term has since come to describe states of uncertainty. Further, Little reports that liminality is 
a major experience among cancer sufferers through the effects on their identity (from 
‘normal’ to ‘cancer patient’) and through alienation from loved one due to ‘a persistent 
sense of the boundedness of time’. The study highlighted the sense of loss and the loss of 
control that patients reported as a biographical disruption felt during the initial stages of 
diagnosis (Little, 1998).  Although not specifically exploring liminality, East et al. (2010) 
undertook a study on women who had taken up cervical screening and tested positive for 
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HPV, reporting a disrupted sense of self among participants who had tested positive for HPV. 
Here though, the disruption was not due to a sense of liminality due to uncertainty over 
disease, but because the women had assumed that they would not test positive for HPV due 
to their preconceptions about ‘the type of women who contract these infections’ which were 
incompatible with their self-perceived views. 
 
2.5.  Social Support in Illness 
In the model of illness as a biographical disruption given by Bury previously, the final 
point of the model is the response to disruption through the mobilisation of resources. In the 
case of HPV positivity the mobilisation of clinical resources may include a referral to 
Colposcopy and treatment (in the case of cytologic abnormality) or early recall for repeat 
cytology in 12 months. In either case, clinical support does not wholly fulfil emotional and 
social needs of the affected individual, and thus personal resources such as social support 
may be mobilised. The writings and research of Cohen are major reference points in the field 
of social support. Early work by Cohen indicated that social support has a role in buffering 
the stress of illness and also in the aetiology of illness (Cohen 1988; Cohen & Wills 1985). 
Further works based on his findings have shown that the existence of a secure social network 
can have important implications for health in cardiovascular disease and diabetes (Compare 
et al. 2013; Reblin & Uchino 2008; Gallant 2003; Penninx et al. 1997; Uchino et al. 1996). In a 
systematic analysis of research into major ailments in the last two decades,  Braveman & 
Gottlieb (2014) describe adequate social support as one of the major social determinants of 
health. According to Heaney & Israel (2008) social support can be described as taking four 
forms: 
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1) Emotional support, involving the provision of empathy, love and trust;  
2) Instrumental support – involving the giving of tangible aid and services that 
directly assist an individual;  
3) Informational support – in the form of advice, information or suggestions; 
4) Appraisal support – involving the provision of information useful for self-
evaluation that provide, as Heaney and Israel state: opportunities for 
‘constructive feedback and self-affirmation’. 
(Heaney & Israel 2008; In Glanz et al. 2008, p.189)  
 
Due to the stigmatised nature of both HPV and cervical cancer; the types of social 
support which would be sought among regular channels – such as partners, family or friends 
(Barrera & Ainlay 1983) – may be reduced, as the affected woman may not feel able to 
access these support structures without having to disclose her HPV status due to the effects 
of social stigma, including rejection and social exclusion that may result (Forbes & Roger 
1999). Even among women who anticipate less social stigma, the implementation of these 
forms of social support – Bury’s ‘mobilisation of resources’ – may be delayed while the 
woman decides on how to disclose and who to inform of her HPV status. In these situations, 
the social support provided by peers may be a more appropriate avenue as a ‘first response’. 
In order to measure perceptions of social support, Sarason developed and validated 
the social support scale in the 1980s (Sarason et al., 1983). Research in to social support 
occurs across many disciplines including anthropology, environmental design, epidemiology, 
psychology, social work and sociology (Cohen & Syme 1985). 
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According to Doull et al. (2005), peer support is generally ill-defined – although the 
general structures of social support (as defined by Heaney & Israel (2008)) – may be fulfilled 
by peer patients. Dennis (2003b) defines peer support as the ‘provision of emotional, 
appraisal and informational assistance created by a social network member who possesses 
experiential knowledge of a specific behaviour or stressor and similar characteristics as the 
target population’ which leads to the ‘sharing of information and experience, mutual 
counselling and exchange among peers’.  The emphasis on shared experience is of particular 
value among cancer patients (Kuijpers et al. 2013; Hong et al. 2012; Setoyama et al. 2011; 
van Uden-Kraan et al. 2009; Campbell et al. 2004) including women who have undergone 
radical surgery as a result of gynaecological surgery (Lloyd et al. 2014). However, again, due 
to the invisible stigma and reluctance to disclose positivity for HPV, identifying peer patients 
in real life may not be easy. The development in recent years of online communities offering 
social support for specific illnesses facilitates the identification of particular peer support 
groups, and it is the role that online or computer-mediated support can supply that the 
literature review will now examine. 
 
2.6. The Role of the Internet in Social Support 
The rapid expansion of the Internet and widespread adoption of handheld data 
devices, broadband and wireless technology has contributed greatly to the accessibility and 
thus adoption of the Internet in daily life. According to the Office for National Statistics, an 
estimated 45 million adults had accessed the Internet during the first quarter of 2017 (Jan-
Mar 2017) with 89% of households having access to the Web. Of individual users up to 90% 
of adults aged between 16 and 34 years of age were ‘recent’ Internet users (90% of males, 
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88% of females) and 78% of the population reported using the Internet on a daily basis. 
Internet use among older adults (those over age 75) has historically always been lower than 
other reported age groups, but has increased since the inception of the survey in 2011 – over 
41% of adults over age 75 years now use the Internet (ONS 2017a). In contrast, according to 
the British Audience Research Board (BARB), the estimated daily reach of any/all television 
channels (on any day in the week 23-29 January 2017) is also approximately 45 million 
people (BARB 2017) (www.barb.org.uk, accessed July 17th 2017). Thus the reach of the 
Internet is significant, equivalent in scope to television, and growing; and previous criticisms 
that have stated that reliance on Internet use is a limitation to research scope are 
diminishing (Yildiz 2007). 
 
2.6.1. ‘Dr Google’ – Online Health Information Seeking 
In tandem with the increasing use of the Internet, the use of the Internet to research 
healthcare information has similarly grown, with the Office for National Statistics reporting 
that 51% of individuals report using the Internet to access healthcare information, with 
adults between the ages of 25 and 44 years the most likely to use the Internet for this 
purpose (ONS, 2016), an increase of 33% since 2007. Eysenbach (2001) attempted to define 
(and refine) the concept of ‘e-health’ in an 2001 editorial:  
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‘It seems quite clear that e-health encompasses more than a mere 
technological development. …e-health is an emerging field in the intersection 
of medical informatics, public health and business, referring to health services 
and information delivered or enhanced through the Internet and related 
technologies. In a broader sense, the term characterizes not only a technical 
development, but also a state-of-mind, a way of thinking, an attitude, and a 
commitment for networked, global thinking, to improve health care locally, 
regionally, and worldwide by using information and communication 
technology.’  
(Eysenbach, 2001) 
A systematic review of the terminology was published in 2005 (Oh et al. 2005), finding 
51 separate published definitions of the term – 49 of which mentioned ‘health’ but largely in 
the context of ‘health-service’, ‘health-industry’ and ‘health-sector’, indicating that the focus 
of e-health was largely on health services and systems rather than the physical or mental 
wellbeing of individuals. Since the origin of the term e-health, the individual health focus has 
developed, as shown by the ONS report, and has been widely dubbed ‘Dr Google’ by both 
the public and in various research papers (Lee et al. 2015; Lee et al. 2014; Robertson et al. 
2014; Pías-Peleteiro et al. 2013; Lam-Po-Tang & McKay 2010). Approaches to online support 
can be divided into two areas – health information seeking and online health communication 
(Powell et al. 2011).  
Since the advent of online health information-seeking, researchers have been 
undertaking studies to understand the characteristics and motivations of online health 
information seekers. Cotten (2004) compared offline and online seekers of health 
information and concluded that the relative age, education and socioeconomic (SE) status of 
participants followed the pattern of the ‘digital divide’, with younger, better-educated, 
higher SE status individuals being more likely to access health information online; and that 
individuals who reported being physically well were less likely to indulge in health 
information seeking, indicating that it is an activity undertaken out of necessity rather than 
Page | 52  
 
choice. In developing a profile of health information consumerism Dutta-Bergman (2005) 
noted that the majority of both research and participants took a situational approach, with 
individuals reporting seeking health information on specific topics such as asthma, AIDS, 
cancer or diabetes. Rice’s (2006) study of two nationally representative datasets – the Pew 
Internet Survey and the American Life Project indicate that several factors predicted 
proclivity for health information seeking online including gender (females), engaging in other 
Internet activities (such as social media use), specific health conditions and supporting 
another through an illness. Within the field of online health related support the use of 
communication – to ask questions, to share experiences, to seek emotional reassurance and 
comfort are some of the primary motivating factors among users (Magnezi et al. 2015; 
Powell et al. 2011; Armstrong & Powell 2009; Atkinson et al. 2009; Kalichman et al. 2003), 
indicating that interaction with others is as important as seeking impersonal information. 
 
2.6.2. Online Health Communities and Support Groups 
Physical, face-to-face (FtF) peer support groups have a long established history of 
helping individuals overcome specific problems (Ford et al. 2013; Repper & Carter 2011; 
Hoey et al. 2008) – well known examples include groups for dependency such as Alcoholics 
Anonymous and Gamblers Anonymous.  In addition to dependency, peer support groups 
exist for individuals with chronic or life-limiting conditions such as diabetes and cancer (Tang 
et al. 2011).  However, whilst such groups have been shown to be beneficial to individuals in 
terms of their recovery, the difficulty in accessing groups, or the disclosure implied in the act 
of joining a support group for a stigmatised condition may deter uptake, as FtF support 
Page | 53  
 
groups require a physical venue and visual or physical interaction with other affected 
individuals.  The disinhibiting qualities of the internet may alleviate these difficulties.  
In 2004, Suler published his now seminal paper on the disinhibiting power of the 
internet – known as the ‘Online Disinhibition Effect’ (Suler 2004).  The six concepts he 
outlined are: dissociative anonymity, invisibility, asynchronous communication, dissociative 
imagination, solipsistic introjections and the minimisation of authority.   These factors 
(particularly anonymity, invisibility and asynchronicity), combined with the increasing 
popularity, accessibility, ubiquity and anonymity of the Internet may facilitate individuals in 
receiving peer support through online support groups (OSGs) (Eysenbach et al. 2004a; 
Eysenbach 2001).  Anonymity and invisibility are invaluable to the disclosure of sensitive or 
stigmatized information, and the simultaneous synchronous/asynchronous nature of online 
support allows both the exchange of messages in real time and the acquiring/assimilation of 
information at the participant’s own pace (White & Dorman 2001). 
 
2.6.3. Theories of Peer Support – Online and Offline 
Peer support differs vastly from clinical support, but the role it has to play should not 
be underestimated (Davis, 2010).  Clinical support tends to deal with the quantitative aspects 
of a disease process – the chances of survival, the stage of disease and the options for 
treatment.  In contrast, peer support is based on the experiential knowledge of diagnosis, 
treatment and recovery (Dennis, 2003a).  The underlying concepts of peer support are based 
on four factors: experiential knowledge, social support, social learning theory and social 
comparison.  Individuals wishing to learn about the lived experience of diagnosis, treatment 
and recovery can learn from peer patients (Solomon 2004; Dennis 2003b).  In addition peer 
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support groups may increase individuals perceptions of social support, both online (Barrera 
et al. 2002) and offline (Helgeson et al. 2000).  Social support has been found to be 
associated with better recovery during a disease process (Von Ah et al. 2007).  Social 
comparison can be helpful in terms of self-recognition and acceptance following a diagnosis 
and a disrupted sense of self (East et al. 2010). Beaudoin & Tao (2008, 2007) demonstrated 
that both the Internet and social media groups have been beneficial to the psychological 
health outcomes of cancer patients in terms of both information-gathering and 
social/emotional support.  Beaudoin & Tao found that cancer patients who went online for 
information regarding their condition and who sought emotional support from peer patients 
reported lower stress and depression scores and better coping scores than non-internet 
users.  The use of dedicated sites and forums for women diagnosed with HPV could be very 
beneficial for patients who wish to get more information or discuss their fears and feelings 
with others who may be able to provide emotional support and reinforcement in a private 
environment within their own homes. 
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2.7. Summary of Literature Review 
The reviewed literature has demonstrated the existence of a model of the self which is 
reflexive and responsive to feedback based on the perceptions and actions of others; 
composed of identities constructed through the habitation of socially negotiated roles and 
the membership of chosen social groups. The possession of what Goffman describes as ‘a 
discrediting social characteristic’, such as a stigmatised, sexually transmitted infection may 
present a threat to identity if disclosure of the condition is likely to result in rejection or 
exclusion from the individual’s chosen social groups. The structures and models by which 
stigma can be defined lead to the formation, in the affected individual’s social world, of 
three populations – the own (others who share the discrediting characteristic), the wise 
(individuals who do not share the characteristic but are sympathetic to the condition) and 
‘normals’ – unaffected individuals who are unaware of the stigmatised person’s condition. 
The affected individual may wish to draw on social support from all three groups at different 
times and in different ways – the ‘own’ may fulfil the roles of support through sharing 
experiences; the ‘wise’ may extend support through providing acceptance; and the ‘normals’ 
may unwittingly provide support by allowing the affected individual to ‘pass’ as a normal. 
Uncertainty due to liminality or altered sickness experience inferred by the use of a 
screening tool on an ostensibly healthy population in tandem the uptake of screening as a 
health-seeking or health-confirming behaviour, and the anticipated or felt stigma following 
HPV-positivity, uncertainty over relational issues such as fidelity or reproductive health and 
carcinogenesis all contribute in essence to the constitution of HPV as a biographical 
disruption. Use of peer support accessed online negates many of the issues of location, 
mobility and disclosure (through anonymity) that non-internet users may face. 
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2.8. Research Questions 
The literature review examined in previous chapters led to the formulation of the following 
research questions: 
1. Does a diagnosis of HPV or HPV & CIN represent a biographical disruption? 
2. If either diagnosis constitutes a biographical disruption, what factors 
contribute to this? 
3. What role(s) might online support play in the management of the self, stigma 
and biography during the diagnostic and treatment arc? 
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Chapter Three – Methodology 
3.1. Introduction 
This section will commence with a discussion of the philosophies underpinning the 
research, the guiding theoretical perspectives and epistemology that informed the 
methodology and why these were the most appropriate for the project. As an early-career 
researcher trained in a discipline grounded in a positivist philosophy and quantitative 
methodologies – and therefore new to the practical aspects of qualitative research (outside 
of early modules offered in the taught phase of the degree); the interchangeable and 
conflicting use of terminology in articles and textbooks was initially confusing. Early 
conversations with the supervisory team centred on the nature of research philosophies and 
methods – in short, was phenomenology a philosophy or a research approach, or both? 
Where should it be positioned within the final draft of the chapter? The answers to these 
questions might seem obvious to a practitioner experienced in qualitative or mixed-methods 
research, but as a result of this confusion, early drafts of the chapter lacked clarity and an 
ordered narrative. The use of the organising framework expounded by Cresswell (2010) was 
very helpful in categorising and clarifying the various ideas and terms encountered during 
the preparatory phase of this study, and as such will be used to structure the methodology 
chapter.  
Creswell organises research according to overarching worldviews. These worldviews 
are described by various characteristics, which are given in the table overleaf. 
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Post-positivist 
Worldview 
Constructivist 
Worldview 
Participatory 
Worldview 
Pragmatist 
Worldview 
Determination 
 
Understanding Political  Consequences of 
actions 
Reductionism Multiple participant 
meanings 
Empowerment and 
issue oriented 
Problem centred 
Empirical observation 
and measurement  
Social and historical 
construction 
Collaborative Pluralistic 
Theory verification  Theory generation Change oriented Real-world practice 
oriented. 
Table 3.1: Basic characteristics of four worldviews used in research (from Creswell 2010, p.40). 
If the researcher were to orientate research for this current study on the basis of 
aspirations, Creswell’s stance of taking ‘multiple stances from multiple world views’ would 
be most applicable. The first phase of the research was originally planned and written from 
the stance of a biomedical scientist for whom positivism was the default approach (Broom & 
Willis 2007). The second phase of the research is largely constructivist; and thus  pragmatist 
aspects of mixed methods research should also be considered (Feilzer, 2010). In addition, 
from the perspective of a practitioner in cytology, elements can be borrowed from the 
participatory worldview, as the researcher would like the research outcomes to be 
empowering (for the participants) and because the research questions are issue-oriented 
and problem-centred. As the outcomes and recommendations might appeal to various 
audiences including future patients, clinicians and policy-makers; the research could also be 
described as oriented toward real-world practice. However, to attempt to undertake and 
understand multiple worldviews (at a first attempt in mixed methods research) would be 
ambitious, foolhardy and would lead to a large, unwieldy project that attempts breadth 
without depth. Therefore the approach used to organise the research will focus on the 
constructivist worldview which informed the concepts of self, identity and stigma discussed 
in Chapter 2, and the interview phase of data collection. 
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Worldview Element Post-positivism Constructivism Participatory Pragmatism 
Ontology  
(What is the nature of reality) 
Singular reality 
(Researchers reject or fail 
to reject hypotheses) 
Multiple realities 
(Researchers provide quotes to 
illustrate different perspectives) 
Political reality  
(Findings are negotiated with 
participants) 
Singular & multiple realities 
(Researchers test hypotheses and 
provide multiple perspectives) 
Epistemology 
(What is the relationship 
between the researcher and 
the researched) 
Distance and impartiality  
(Researchers objectively 
collect data on 
instruments) 
Closeness  
(e.g. researchers visit participants 
at their sites to collect data) 
Collaboration  
(e.g. researchers actively involve 
participants as collaborators) 
Practicality  
(e.g. researchers collect data by ‘what 
works’ to address research question 
Axiology 
(What is the role of values?) 
Unbiased  
Researcher uses checks to 
eliminate bias) 
Biased  
(Researchers actively talk about 
their biases and interpretations) 
Negotiated 
(Researchers negotiate their 
biases with participants) 
Multiple stances 
(researchers include both biased and 
unbiased perspectives) 
Methodology 
(What Is the process of 
research?) 
Deductive 
(Researchers test an a 
priori theory) 
Inductive  
(Researchers start with 
participants’  views and build ‘up’ 
to patterns, theories and 
generalizations) 
Participatory 
(Researchers involve participants 
in all stages of the research and 
engage in cyclical reviews of 
results) 
Combining  
(Researchers collect both quantitative 
and qualitative data and mix them) 
Rhetoric 
(What is the language of 
research/) 
Formal style  
(Researchers use agreed-
on definitions of variables) 
Informal style  
(Researchers write in a literary, 
informal style) 
Advocacy/change  
(Researchers use language that 
will help bring about change and 
advocate for participants) 
Formal or informal 
(Researchers may employ both formal 
and informal styles of writing) 
Table 3.2: Elements of worldviews and implications for practice (from Creswell 2010, p.41). 
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3.2. Ontology 
3.2.1. Objectivism/Realism 
Ontology describes the nature of reality (Dillon & Wals 2006). In table 3.1 Creswell 
describes four worldviews upon which research may be based: post-positivist, constructivist, 
participatory and pragmatist. These are then further differentiated on the basis of the 
elements from which they are composed (as shown in table 3.2). Kuhn’s seminal work The 
Structure of Scientific Revolutions described different knowledge schools or branches as 
‘paradigms’ (Kuhn 2012, p.11). Kuhn describes a paradigm as ‘the set of common beliefs and 
agreements shared between scientists about how problems should be understood and 
addressed’.  Guba (1990) explains that paradigms can be characterised on the basis of 
assumptions about their ontology (the theory of reality, or being); their epistemology (the 
theory of knowledge) and their methodology (the means by which we find things out). 
Creswell adds axiology (the nature of values), and the form of language used in 
communicating findings, to this list. Thus on the basis of these elements, paradigms 
determine the nature of knowledge existence and how it may be generated in a valid 
manner.  
Echoing Kuhn, Higgs posits that a paradigm is composed of a ‘set of beliefs, 
conventions and assumptions that define what meaningful and relevant research questions 
can be asked, what constitutes a meaningful answer and how the researcher can go about 
providing an appropriate answer’ (Higgs 2001, p.154). These elements shape the research 
arc by informing the manner in which the researcher views and determines reality and the 
way in which variables are known and measured within that reality. Applying Cresswell’s 
framework to this research project – the study is situated in a constructivist ontology – the 
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elements examined in the literature review (self, identity, illness, stigma and social support) 
have all been shown to be socially constructed (Gergen 2011; Conrad & Barker 2010; 
LaCoursiere 2001; Crocker 1999). Constructivist ontology informs the interpretivist 
epistemological or theoretical perspective. This interpretivist perspective focuses on 
establishing how meanings emerge and are manifested and applied to social worlds (Walter 
2013, p.17), and this informed the research approach of phenomenology. In turn, 
phenomenology studies the structures of consciousness as experience from the first-person 
point of view (Smith, 2017). This approach, in turn, informs the research methods employed 
– namely questionnaires and interviews. 
Positivism – the philosophical approach which is espoused by and fits (ontologically 
and epistemologically) with the natural science disciplines, including biomedical science – 
holds that the researcher and the external ‘world’ of discovery (the object under study) are 
completely separate. As a research philosophy, positivism owes its intellectual origins to the 
writings of Comté (Howell 2013, p.32). However, whilst holding a similar ontological view, 
advocates of post-positivism hold that there is a single reality, existing objectively and  
independently of human perception (Crotty 1998, p.12); that ‘the truth is out there’ and that 
research must work to uncover this truth independent of any bias that might be introduced 
by subjective reasoning or researcher perception induced by gender (Kane & Macaulay 
1993), race (Cotter et al. 1982) or type of interview (Hansen, 2006). Objectivist ontology 
‘holds that meaning, and therefore meaningful reality, exists as such apart from the 
operation of any consciousness’ (Crotty 1998, p.8). The equivalent area in Higgs’ model is the 
ontology of the empirico-analytical paradigm (Higgs 2001, p.156). For both authors, the 
nature of this paradigm embraces positivist and empiricist philosophies; theories are pre-
formulated and verified by testing hypotheses through deductive reasoning. Objectivist 
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ontology and a hypothetico-deductive approach to theory verification using quantifiable 
methods have historically informed the natural science disciplines such as physics and 
chemistry (Higgs 2008, p.155); for example, the empirico-analytical paradigm has historically 
dominated the fields of healthcare and biomedical research. The researcher’s day-to-day 
discipline – biomedical science –favours an objective ontology (Broom & Willis 2007, p.17). 
This is largely due to the fact that the researcher’s practice – cytology – operates according 
to Bayesian constructs (Reid, 2017) disease is either present or absent and, if present, 
malignant or non-malignant. Here, the presence of disease is an objective truth that must be 
discovered, or excluded. Thus, the human papillomavirus fits with Crotty and Higgs’ 
definitions of objective knowledge in that the reality of the virus as an entity exists 
independently of its perception both by the individual and by a population of individuals – 
HPV being asymptomatic in the majority of cases means that the virus can be contracted and 
spread independently of an individual’s perception of it.  
As with HPV positivity, carcinogenicity from persistent HPV infection exists 
independently of our perception of it (i.e. an individual can be infected without perceiving 
the fact, and may develop pre-cancerous and cancerous changes prior to being aware of the 
fact). HPV positivity can be operationalised as a variable (as a positive or negative test 
result), quantified and measured as viral load (Constandinou-Williams et al. 2010). HPV 
antibodies can be detected, quantified and measured to determine vaccine efficacy (Dillner 
et al. 2011). All of the features of the virus described above – detection methods; 
determinants of mutagenicity, carcinogenicity, immunogenicity are quantifiable and can be 
scrutinised by quantifiable methods that support an objective ontology. However, according 
to Higgs (2001, p.155), once the research gaze focuses on interpersonal relationships, the 
examination of personhood or the construction of meanings, as with this study, the model of 
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objective ontology and quantifiable methods becomes increasingly inadequate because 
these factors are subject to constructions and interpretations that vary. Thus while the fact 
of HPV positivity is objective, the effects on personhood of knowing one is HPV positive 
become subject to social constructs, and so the research gaze turns to constructionism. 
 
3.2.2. Constructionism 
Crotty applies the following definition to constructionism:  
‘All knowledge and therefore all meaningful reality as such, is contingent upon 
practices, being constructed in and out of interaction between human beings and their 
world, and developed and transmitted within an essentially social context. ...In the 
constructionist view, as the word suggests, meaning is not discovered, but constructed.’  
(Crotty, 1998, p.42). 
Greenwood offers the example of a chair to illustrate the difference between physical 
and social phenomena: 
‘Physical and social phenomena...differ in one essential respect. Chairs may exist 
independently of our knowing that they do; our knowledge of the existence of chairs is 
not constitutive of their existence. In contrast, social phenomena do not exist 
independently of our knowledge of them...Social realities, therefore, are constructed 
and sustained by the observation of the social rules which obtain in any social situation 
by all the social interactors involved...Social reality is, therefore, a function of shared 
meanings; it is constructed, sustained and reproduced through social life.’ 
(Greenwood, 1994, p.45, cited in Crotty, 1998 p54-55) 
The concept of HPV fits into this idea of physical and social phenomena differing in 
terms of their existence independent of our knowing of them. The physical, biomedical, 
pathogenic phenomena of HPV can exist, asymptomatically infecting and affecting epithelial 
cells independently of the individual being aware of it. However, the existence of the social 
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phenomena surrounding HPV positivity – stigma (Waller et al. 2007), shame (Kim 2012), 
anxiety over mortality (Maggino et al. 2007), disclosure and social rejection (McCurdy et al. 
2011; Brown et al. 2007) cannot exist, or at least the reality of these phenomena cannot 
affect the individual until s/he is are aware of the existence of the virus within their body. 
  
3.2.3. Relativism 
On the basis of embracing a constructionist worldview, the ontological assumptions of 
this study are relativist in nature. According to Denzin & Lincoln (quoting Guba, Lincoln and 
Lytham) constructionism adopts: ‘a relativist ontology, a transactional epistemology and a 
hermeneutic, dialectical methodology’ (Denzin & Lincoln 2017, p.212). Literature examined 
in previous chapters supports these ideas – the concepts of self and identity, and also those 
of threats to identity (such as social exclusion and rejection) have all been demonstrated to 
be constructed on the basis of social transactions. Similarly, the effects on identity (such as 
stigma and shame) have also been shown to be constructed on the basis of social 
transactions and interactions (Major et al. 2005; Pettigrew 1985). Thus, it follows that a 
research philosophy that supports the notion of a constructed and negotiated reality would 
be the best fit for this research. In addition, this study thus assumes that the reality of HPV 
positivity is unique and subjective to each participant and should be determined ‘according 
to each individual’s personal, cultural and experiential background’ (Eatough & Smith 2017, 
p.193). 
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3.3. Theoretical Assumptions: The Interpretative Paradigm 
The interpretive paradigm sits within the constructionist epistemology; and recognises 
that meaning is a human construction (Maines, 2000). According to the interpretive 
paradigm, the meanings that individuals attribute to things in the world are not only 
constructed but contingent. Constructed meaning is contingent, reliant and relative to 
context – constructed meaning may be affected by/depend on spatial, cultural or historical 
features that individuals apply to the meaning-making act (Harré, 2002). Thus, the scope for 
variation in the construction of valid meanings – both between individuals, and within 
individuals (because meanings can change over time according to circumstances) is infinite. It 
is the need to examine the individual construction of meaning and experience which informs 
the research approach of phenomenology. 
 
3.4. Research Approach: Phenomenology 
The term phenomenology is derived from the Greek phainesthai (to flare up/to show 
itself), phainómenon (that which appears) and lógos (to study) (Moustakas, 1994) and thus 
literally means ‘the study of that which appears’. The Stanford Encyclopaedia of Philosophy 
lists phenomenology as one of the main branches of philosophy, along with ontology (the 
study of ‘what is’, ‘being’ and the nature of reality); epistemology (the study of how we can 
know ‘what is’); logic (the study of reason); ethics (examining right and wrong action). The 
same source further broadens Moustaka’s definition, describing phenomenology as: ‘the 
study of consciousness as experienced from the first-person point of view’ (Steup, 2016). 
Moran re-iterates this concept in more depth, at the beginning of his Introduction of 
Phenomenology, telling us that: 
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 ‘Phenomenology is best understood as a radical, anti-traditional style of 
philosophising, which emphasises the attempt to get to the truth of matters, to 
describe phenomena, in the broadest sense as whatever appears in the manner in 
which it appears, that is as it manifests itself to consciousness, to the 
experiencer.’ (Moran 2000, p.4).  
 
LeMay & Pitts (1996, p.27) re-iterate the focus on experience – defining phenomenology as 
‘how we experience the world’. Within the context of this research, phenomenology 
questions and examines the experience of being HPV-positive, the diagnostic and treatment 
process and the use of HPV-related online support.   
According to McAleer (2005), the development of phenomenology was the defining 
philosophical movement of the last century. However, whilst the 20th century saw the most 
developments within phenomenology, the origins of the movement are far older. According 
to Moran (2000, p.200) the philosophy of phenomenology can be traced back to Aristotle. 
Whilst not specifically mentioned in his writings (specifically De Anima), Aristotle’s 
discussions on different modes of being ‘...as property, being in the sense of categories, being 
in the sense of possibility and actuality’ were among the first speculations on being, although 
the term as recognised today would not appear for centuries. In fact, it was nearly two 
thousand years before the term ‘phenomenologia’ was first introduced by German 
theologian Christophe Oetinger in 1736 in reference to the nature of God (Davis & Steinbock 
2016). Religion and theology would later become common topics for modern scholars such 
as Scheler and Levinas also used the term phenomenology in reference to theological texts 
and refined their ideas of phenomenology through the prism of religion (McAleer, 2005). 
Though introduced in the mid-18th century, the term phenomenology was first used in 
modern philosophical literature by Hegel – in his work Phenomenology of the Spirit – but did 
not come into common usage until Edmund Husserl adopted the term in his 1901 work 
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Logische Untersuchungen (‘Logical investigations’) (Husserl 2001, p.xviii). Today, the modern 
practice and pursuit of phenomenology is generally considered to be based on the 
foundations of Husserl’s work (Husserl 2001, p.xxxvi). 
 
3.5. Svenaeus: Towards a Phenomenology of Illness 
As this study makes particular reference to illness, it is important to link 
phenomenology and the Heideggerian nature of being with a phenomenology of illness. 
Unfortunately, neither Husserl in his work on the lived-experience nor Heidegger in his 
efforts of being-in-the-world focused much attention on the concept of illness and its impact 
on being, but other authors have chosen to exercise Heideggerian perspectives on these 
topics. Svenaeus (2000) dissects some of the Heideggerian terminology, specifically asking 
‘what is it like...from the patient’s perspective...to suffer from illness’ – focusing his attention 
on the individual as an ill person as well as a diseased organism. In order to do this, Svenaeus 
turns to the Heideggerian concept of Umheimlichkeit literally ‘un-home-like-ness’; suggesting 
that the unwell individual, whilst being in familiar surroundings, suddenly feels unfamiliar 
and ‘not at-home’ with his/her body or the functions that it previously undertook (but no 
longer performs) or new processes that must be executed that were not previously required 
(such as rehabilitation post-stroke, or daily injections following a diagnosis of diabetes).  
In addition to a new unfamiliarity with the body, Svenaeus also suggests that there is a 
new anxiety present from the point of diagnosis which is separate from the Heideggerian 
concepts of Angst (the background existential anxiety of an authentic existence) and also 
from the anxiety that Heidegger termed Sein-zum-Tode (‘Being-towards-death’). This ‘being-
toward-death’ is not necessarily a literal decease, but the call or need to re-evaluate one’s 
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being from the standpoint of an ending (Wheeler, 2016). With respect to HPV, the 
contraction of a stigmatised virus that predisposes an individual to cancer, and the anxiety 
surrounding both disclosure and the possible transmission to will serve to increase 
existential anxiety. As HPV asymptomatic, the discussion surrounding the lived-experience 
will be different to the discussion of the lived-experience of an amputee, or an individual 
living with cancer, or one living with a chronic disease such as diabetes. This is principally due 
to an absence of symptoms that might be encountered with other conditions (such as a 
phantom limb, or the pain and sickness associated with cancer treatment, or the experience 
of hypoglycaemia). The phenomenology of the lived experience is more likely to be due to an 
unhomelikeness or anxiety caused by a forced re-evaluation of the self (in terms of self-
worth or one’s estimation of one’s sexual or reproductive self, or a foreshadowing of 
mortality (Svenaeus 2011) or anxiety about changes to others’ perceptions of one. 
Svenaeus also makes the point that, as part of the process of treatment, the 
healthcare professional has a responsibility to help the individual suffering unhomelikeness 
through illness to either regain the original feeling of homelikeness or familiarity through 
curative processes or to help the individual achieve a feeling of homelikeness through re-
adjustment to new circumstances or states. This process of achieving familiarity with the self 
or of returning ‘home’ within the body is analogous to resolving the biographical disruption 
that follows a diagnosis of an illness or the occurrence of a life-changing injury or event. 
Within the contact of this research the act of narrating either lived experiences or the 
biographical work involved in acceptance may allow the narrator to achieve perspective on 
or acknowledge a ‘returning home’ to the self as lived now. 
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3.6. A Critique of Phenomenology in Qualitative Healthcare Research 
Although discussion of previous literature in the field of phenomenology demonstrates 
it is the most appropriate research approach for this study, it is important to be mindful of 
critics to the technique, in order to avoid the pitfalls that invoked criticism. The use of 
phenomenology in healthcare research was established in the 1980s, when Benner 
established a method of interpretive phenomenology in nursing (Petrovskaya, 2014), where 
it is used to elucidate the lived experiences of patients (Crotty, 1996). Literature discussed in 
this section is devoted to the critique of the use of phenomenology in nursing, as this is the 
most prominent healthcare field in which phenomenology has been used as a research 
method.  
The focus on human existence, patient experience, and the ‘accounts of time, body, 
space and human relations as people experience them, altered by health and illness’ (Matua 
& Van Der Wal 2015; Matua, 2015; Earle 2010) are all valued as enabling and developing 
healthcare in an era dominated by holism and evidence-based practice. However, this 
explosion in phenomenological healthcare research is still evolving, and may be subject to 
limitations arising through amateur attempts or as according to Ray (1994) a lack of 
understanding of phenomenology and its philosophical underpinnings. Paley has been a 
vociferous critic of the use of Husserlian phenomenology in healthcare research stating: 
‘...their methods do not entitle them to lay claim to anything resembling 
‘objectivity’ or generalisability, or ‘reality’, or theoretical abstraction. Like other 
researchers, they want to talk in generalisable terms about reality; they want to be 
objective, they want to do theory. But they are saddled with a philosophy that is 
disabling, because it says they can only talk about perceptions, and meanings, and 
uniqueness.’ 
Paley (2005) 
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In previous works, Paley has scathingly concluded that nursing phenomenology lacks 
credible instances of what and how ‘essences’ are derived and that ‘the project of identifying 
an ‘essential structure’ of a phenomenon, typically adopted by nurse researchers who cite 
Husserl as an authority, comes close to being unintelligible.’ (Paley, 1997). Other authors 
critiquing the use of phenomenology are less outspoken but do address the question of 
undertaking successful phenomenological research in nursing (Morse & Field 1996, p.194). 
Crotty, whose work on research philosophy was discussed at length in the previous chapter, 
has also voiced a cautionary tone in the use of phenomenological research methods in 
nursing research, stating that nursing phenomenology is too subjective. Whilst this may 
seem an odd accusation to level at qualitative research, he discusses at length the distinction 
of and interplay between objectivity and subjectivity in the introduction to his text The 
Foundations of Social Research  (1998, p.7). In addition, Crotty accuses nurse researchers of 
‘dressing their studies in ‘Heideggerian livery’’ rather than genuinely attempting to apply 
Heideggerian philosophy to their researches (Crotty 1996, p.76). 
 
3.7. Research Design 
Having thoroughly examined the research philosophies, theoretical assumptions and 
approaches considered most apposite to the research, the research design must be 
appraised. There is ongoing debate as to whether the approach is simply a combination of 
the two (historically opposed) quantitative and qualitative paradigms (Denscombe 2010, 
p.10), or a distinct research paradigm in its own right. This argument formed much of the 
substance of Creswell’s ‘paradigm debate period’.  Johnson and Omwuegbuzie (2004) 
contend that mixed-methods research occupies a unique third paradigm or ‘chair’, sitting 
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between quantitative and qualitative endeavours or –in the words of Greene (2007, p.8) – a 
third ‘community of practice’; whereas other authors argue that mixed-methods research is 
merely a blending of the most advantageous aspects of the quantitative and qualitative 
paradigms (Mertens 2005, p.4). The decision to begin the project with quantitative data is 
largely a reflection of the researcher’s own scientific background – quantitative data being a 
natural choice for an author educated in a natural science/positivist tradition. In addition to 
fulfilling the research need and the recommendations of the examiners, the decision to 
widen the scope of the research to include qualitative data also represents the author’s own 
evolution into a more rounded researcher and practitioner.  
 
3.7.1. Mixed Methods Research: Follow-Up Explanations Model 
Whilst mixed methods research has been described by Denscombe as any method that 
combines two or more research methods (Denscombe, 2010, p.10), this combination is not 
haphazard. Any research model that combines two or more methods places emphasis on the 
structure of that model – the sequence in which one method follows another  (Tashakkori & 
Teddlie 2010, p.27). In the case of this study, the quantitative data was gathered first, and 
this fact largely dictated the structure of the mixed methods model that followed.   
Creswell et al. (2003, p.73) describe four designs of mixed methods models: 
triangulation, embedded, explanatory and exploratory designs. According to their rationale, 
the model used for this research study cannot be described as a triangulation design, as the 
data collection period did not occur in a single phase – the quantitative and qualitative data 
were not collected concurrently.  Although an exploratory study in nature, the research is 
not of the exploratory design, as qualitative data was not collected first. At first glance, the 
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embedded and explanatory models would seem difficult to differentiate in the context of 
this project, as both models may involve two-phase data collection; and may allow for the 
collection of quantitative data in the first phase, as in this study. However, the two structures 
differ in terms of the weighting given to each type of data. The embedded model describes 
research where the secondary data type (in this case, qualitative data) plays a more 
supplemental/supportive role rather than being given equal weighting with the quantitative 
data. Therefore according to the descriptions set out by Creswell et al. (2003, p.73) this 
mixed methods study has an explanatory design model, as the data are collected according 
to a two-phase model (sequentially, with qualitative data being collected in the second 
phase, to explain or enrich quantitative data) and with equal weighting being given to both 
data types. 
 
3.7.2. Advantages of an Explanatory Mixed Methods Design 
According to Denscombe (2010, p.11) mixed methods research refers to: ‘a research 
strategy that crosses the boundaries of conventional paradigms by deliberately combining 
methods drawn from different traditions with different assumptions’.  At its simplest, a 
mixed methods strategy combines quantitative and qualitative methods. As a scientist 
educated in a largely positivist tradition, the collection and analysis of quantitative data was 
not alien, and in devising the original project the use of a questionnaire to gather the 
quantitative data seemed the most natural method of achieving this objective. The 
questionnaire as an instrument of collecting survey data was relatively cheap, swift and a 
large audience of individuals could be approached in order to achieve sufficient statistical 
power for the analysis phase.  However, the structure of the instrument and the data 
obtained were very much researcher-led, comprising questions the researcher wanted to 
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ask, rather than the questions or issues the participants wished to answer or expand upon; 
and thus, researcher bias may have been introduced. 
Qualitative data gathered by performing and transcribing electronic interviews will 
offer thick description of subjects first introduced in the questionnaire – namely the 
elucidation of women’s further information needs, their perceptions of social support and 
the benefits derived from the membership of online support groups devoted to HPV 
awareness. In addition, the act of narrating their experience will allow the participants to 
construct, re-construct or revisit their own meanings surrounding diagnosis and the lived-
experience of being HPV-positive.    
The main advantage of a mixed methods approach is that the researcher gains a better 
understanding of the topic under study by combining methods than by either research 
approach used alone (Denscombe 2010, p.11). In addition to research outcomes, this aspect 
of mixing methods is immensely valuable to the author’s professional practice as increased 
understanding of the lived experiences of HPV positive women can be used to help inform 
training protocols for primary healthcare givers and literature enclosed with screening 
invitations. The greater understanding obtained is gained by viewing the research problem 
from multiple perspectives, rather than relying on a single approach, viewpoint and data 
collection method. Multiple viewpoints allow for different methods of data collection and 
thus richer data and more opportunities for analysis. In addition to richer data, multiple 
perspectives and data collection methods allow for data triangulation – cross verification of 
findings by using more than one source for the data through ‘convergence, corroboration 
and correspondence of results from the different methods’ (Greene et al. 1989). 
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3.7.3. Disadvantages of a Mixed Methods Design 
In addition to the advantages of a mixed methods approach, it is important, given the 
timeframe of the research, to consider the disadvantages. The only real disadvantage 
encountered during the evaluation of research approaches was the aspect of time, as mixed 
methods research tends to consume both time and resources. However, as the majority of 
the quantitative data had been gathered and analysed during the initial stage of the project, 
this factor did not present a significant issue.   
 
3.8. Methodological Considerations  
3.8.1. Choice of Qualitative Data Collection Methods 
As the study was a mixed methods endeavour, and aimed to gather information 
surrounding the online and lived experiences of women with HPV, various collection 
methods were considered to determine the best means of gathering this type of data. The 
quantitative arm of the study will utilise a survey questionnaire, so the use of another such 
instrument would be of limited use in reporting individual experiences; would be researcher-
led in terms of the content and order of the questions and subsequently the responses, 
though belonging to the participants, would be influenced by the researcher (Choi & Pak 
2005); and therefore invalidate the concept of mixed methods research. Thus, in order to 
allow the study to be a truly mixed methods undertaking, a complementary method of data 
collection was required to allow the advancement of participants’ ideas and narratives 
around the research topic, to harmonise with the researcher-led questionnaire.   
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The aims of the study required entering in to the lifeworlds of participants and, 
according to Opdenakker (2006) and Dickson-Swift et al. (2008), qualitative research 
interviews were considered the most appropriate, efficient, sensitive and time-sensitive 
method of collecting this type of data. Case studies and ethnography were both considered 
during the research design process as both allow descriptions of everyday life and practice 
(Tashakkori & Teddlie 2010, pp.36, 42). However, although the research project aims to 
examine the everyday lives and experience of HPV-positive women, the individuals of a 
sample population may not necessarily share the same geographical locations or social 
groups; thus outside of a virtual environment are unlikely to live in close enough proximity to 
make ethnographic study feasible, and virtual focus groups may be open to the same privacy 
and confidentiality issues as actual focus groups. In addition, as the researcher works full-
time, the prolonged and repeated contact required for successful case study was similarly 
not feasible.  A variation on ethnography, ‘netnography’ – a specialised form of ethnography 
directed to the study of online groups was considered for the examination of themes and 
dynamics within groups. This idea was abandoned due to possible ethical issues around 
observing individuals online without their knowledge (Kozinets 2015, pp.127–129). 
 
3.8.2. Qualitative Research Interviews 
Creswell (2007a) argued that interviewing is perhaps the oldest, most recognised, 
familiar and utilised method of qualitative data collection (although Gubrium & Holstein 
(2002, p.4) added that the interviews practiced today did not exist forty years ago. However, 
more recently, the social prevalence and ubiquity of interviews in everyday life – through 
television, radio, social and printed news media, blogs and vlogs –  has resulted in the rise of 
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the ‘interview society’ (Silverman 2006, p.30). Arksey and Knight have suggested that 
interviews are not a specific method but ‘a family of approaches which have one thing in 
common – conversation between people in which one person has the role of researcher’ 
(Arksey & Knight 1999). Kvale (2006) reiterated this, dubbing the interview ‘a professional 
conversation’, noting that such conversations are considered ‘a fundamental part of the 
research process’ (Kvale & Brinkmann, 2009; Kvale, 1996). Patton stated that ‘the power and 
purpose of interviewing is ‘to find out what is in and on a person’s mind..., to access the 
perspective of the person being interviewed..., to find out from them things we cannot 
directly observe’ (Patton, 1990 p.278; cited in (Arksey & Knight 1999, p.32). In this family of 
approaches, Novick (2008) considered face-to-face (FTF) or on-site interviews to be the gold 
standard method for gathering data on participant’s interpretations of their lived 
experiences. Other forms of interviews, such as postal and telephone interviews (Mealer & 
Jones 2014; Edwards et al. 2002) have been utilised successfully, both historically and in the 
recent past. The FTF qualitative research interview entails meeting with a participant for a 
specified/pre-arrange length of time, in an environment which is private, neutral and 
unthreatening to the participant.  
 
3.8.3. Building Rapport in Interviews 
Perhaps one of the most difficult tasks during an interview is gaining enough trust and 
rapport from the participant in a very limited time; the opening minutes of the interview 
process are very important to build up sufficient trust in order that the participant will trust 
the interviewer enough to give truthful, meaningful answers to questions, in order that a 
‘real’ experience can be captured (Henderson & Gilding 2004). If the effort to gain trust and 
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rapport is begun too early, or the conversation is too fast, the rapport-building process can 
feel rushed or forced, and reduce the amount of trust the participant has, and consequently 
have a deleterious effect on the whole interview and resulting transcript (DiCicco-Bloom & 
Crabtree 2006). Conversely, if rapport is not built until the final minutes of the interview, the 
interviewer has no way of knowing whether the participant has disclosed a true personal 
experience or instead constructed an experience based on their perception of a socially 
desirable response (Presser & Stinson 1998, Nederhof, 1985). This dilemma is particularly 
important during semi-structured or unstructured interviews and interviews surrounding 
sensitive topics such as health, sexual behaviours and stigmatised conditions. Peter and 
Valkenberg have researched and written on the subject of obtaining trust and achieving 
rapport during the online data collection, focusing on the issue of sensitive topics such as the 
disclosure of highly personal information (i.e. disease status, or the discussion of stigmatised 
behaviours such as substance abuse). They reported that the use of ’forgiving’ language 
during the introduction of an online survey increased the amount of sensitive information 
disclosed by respondents who had scored highly on social desirability scale. These individuals 
reported more sensitive behaviour than individuals who scored low on social desirability 
scales (Peter & Valkenburg 2011). 
  
3.8.4  Reciprocity 
As the research population were recruited from online  sources, to help build rapport, 
and in order to demonstrate both trust and reciprocity, the researcher decided to use her 
own Facebook profile in order to approach gatekeepers, and through gatekeepers, 
participants. The use of a faceless profile page, using a professional title (such as ‘HPV 
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Facebook Study’) and the De Montfort University logo was considered (ethical approval had 
been granted for the use of the University logo), but abandoned as too impersonal, formal 
and unlikely to foster trust. Duncombe and Jessop (2002) quote Glesne and Peshkin on the 
ethical naïveté of gaining trust: 
‘Rapport is tantamount to trust, and trust is the foundation for acquiring the 
fullest, most accurate disclosure a respondent is able to make… when you are 
warm and caring, you promote rapport, you make yourself appealing to talk 
to, and, not least, you communicate to your respondents, ‘I see you as a 
human being with interests, experience, and needs beyond those I tap for my 
own purposes’… In an effective interview, both researcher and respondent 
feel good, rewarded and satisfied by the process and the outcomes. The 
warm and caring researcher is on the way to achieve such effectiveness.’  
Glesne & Peshkin, 1992 cited in Duncombe & Jessop, 2002, p110  
 
The quote given above is included the demonstrate that the researcher was aware of 
the fine line between honesty and reciprocity and the ethics of ‘faking friendship’ 
(Duncombe & Jessop 2002, p.108). Honesty and reciprocity were paramount in view of both 
the sensitive nature of the topic (Fahie 2014) and the question of power within the research 
interaction (Oakley 2015). If the aim of the research was to ask participants to share details 
of their day-to-day lives with HPV, it seemed reasonable and reciprocal to allow potential 
participants to examine the day-to-day life of researcher before they committed to the 
interview process. In terms of preserving confidentiality, access to the identities of the 
researcher’s family and friends was restricted in order to protect their privacy; and possible 
contentious posts (political views, photographs of friends and/or children) were similarly 
restricted in order to keep the view of the researcher as neutral as possible. There were 
some aspects of the researcher identity that could not be hidden that may have affected 
participants’ perceptions of the researcher – such as race, gender and an indication of SE 
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status, but to hide these by creating a fictional identity to minimise the interviewer effect 
(Davis et al 2010; Kane & Macaulay 1993; Cotter et al. 1982) would have been as unethical as 
the ‘fake friendship’ that Duncombe & Jessops object to. The use of the researcher’s 
personal Facebook profile to establish trust and rapport; along with a position as one of the 
‘wise’ (to use Goffman’s terminology (Smith 2012; Nack 2008, p.56; Goffman 1990a p.23))  
due to a healthcare background lead to the consideration of the researcher’s position as an 
insider researcher. Methodological considerations associated with insider research are 
discussed in section 3.8.6. 
 
3.8.5. Electronic Interviews 
Although FTF interviews are established as the gold standard technique in qualitative 
research interviews, there may be occasions where they are not suitable – where the 
sensitivity, privacy or perceived stigma surrounding the discussion material may make 
individuals unwilling to meet (Paechter 2013). Physical or other disabilities may make it 
difficult for the participant to travel to a neutral place (Braun & Clarke 2013, p.82); the 
geographical spread of individuals may also add difficulties in reaching all participants for a 
physical interview. As mentioned in Chapter 2, the rapid growth of the Internet and 
online/communication technologies has led to other forms of interview. Braun and Clarke 
(2013, p.80) divide electronic interviews into synchronous and asynchronous interviews, and 
further into text-based and image-based audio-visual interviews. Real-time AV interviews 
such as Skype or video-conference interviews  (Janghorban et al. 2014) are very similar in 
concept to the original FTF interview and were offered to participants; albeit with strengths 
and weaknesses particular to that technique: non-verbal cues are still present, but the visual 
Page | 80  
 
field is restricted to the head and face only, and thus any inferences gleaned from body-
language are lost. Text-based interviews, both synchronous (such as messenger interviews 
(Stieger & Göritz 2006) and asynchronous interviews such as email (Hooley et al. 2012) - 
must, necessarily, be lacking in any non-verbal cues and as such  were previously considered 
– at best – to be adjuncts of extensions to the FTF interview or as “poor substitutes” to the 
gold standard, but are nonetheless increasingly being utilised and accepted as different 
interview techniques in their own right (Braun & Clarke 2013, p.79). 
The original project proposal had planned for FTF interviews from the outset, hence 
the focus in previous sections on building rapport and reciprocity in interviewing. However, 
during the proposal preparation stage provision for electronic interviews was also included in 
the project proposal in order that ethical approval would be granted for these – as the 
anonymity and invisibility might ameliorate any embarrassment felt by participants. Please 
refer to Appendices 4, 5, 6 and 7 for ethical approval documentation for the interview study. 
This foresight was later confirmed by the gatekeeper for the social media support group, 
who expressed the following opinion: 
‘Is there any scope to offer online interviews? In my experience with our 
support group, people are very private about HPV & quite ashamed; I’m not 
sure that you would get many participants with face to face interviewing 
alone.’ 
Gatekeeper – personal communication, Feb 2017 
The researcher reconfirmed with the gatekeeper that interviews were the most 
suitable data collection method, but that online interviews could be offered, as they had 
been approved as a data collection method in the application for ethical approval. During the 
research process, once contact had been made, all participants were offered a choice 
between face-to-face, online AV interviews (via Skype), online synchronous (messenger) 
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interviews or online asynchronous (email) interviews. All participants chose or requested 
email interviews. Both communications with the gatekeeper and with participants during the 
data collection process led to the reflections on insider research. 
   
3.8.6. Insider Research  
According to Costley et al. (2010, p.2) an insider researcher is an individual who 
studies an area in their own field of practice – the insider researcher occupies ‘a unique 
position to study a particular issue in depth and with special knowledge about that issue.’ In 
addition, Costley et al. also state that ‘when researchers are insiders, they draw upon the 
shared understandings and trust of their immediate and more removed colleagues.’ Whilst 
this project is not based in the researcher’s actual workplace, it does involve examination of 
the outcomes of the field of practice, and in this context, the colleagues to whom Costley’s 
team refers to include HPV positive women, other stakeholders in the NHSCSP service such 
as healthcare professionals and PHE, and the charitable institutions who provide support and 
guidance to affected individuals. Both Costley et al. (ibid) and Voloder & Kirpitchenko (2016, 
p.13) speak of the concept of ‘social situatedness’, arguing that ‘organizational, professional 
and personal contexts will affect the way a piece of research and development is 
undertaken.’ 
Reed and Proctor (1995, p.195) list the idealised criteria for practitioner research in 
health care. They define research as a social process, which should educate all participants, 
focusing on aspects of practice for which the researcher may initiate change. Additionally, 
the insider researcher in the healthcare setting should be able to identify and explore socio-
political factors and expose values for critical enquiry and discussion in order to yield insights 
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that can be communicated to wider audiences. According to these criteria, this study can be 
considered a piece of insider research, as the findings will aim to initiate changes to the post-
diagnosis practice, to promote experience sharing and information supply to HPV positive 
women on the basis of themes identified in the research. These findings aim to yield insights 
that can be communicated to wider audiences – such as stakeholders, other HPV-positive 
audiences and policy-makers such as PHE. Socio-political factors abound within the topic, as 
covered in the first two chapters – including the politicisation of vaccination, the change in 
social context brought about by the change in screening method and the gender lens 
currently applied to the subject of HPV. 
Within the specific research context of HPV, there is a dearth of literature on the 
perspective of insider research. Nack (2002, 2000) took a literal approach to the concept in 
her studies surrounding STD stigma, relating her own issues with HPV positivity to 
participants in order to foster a sense of trust and reciprocity.  This aspect of the research 
cannot be shared by this author, although there is a significant argument to be made for this 
research to have been undertaken by what both Dwyer & Buckle (2009) and Kerstetter 
(2012) call an ‘insider-outsider’ researcher – occupying ‘the space between’, from the 
perspective of both the researcher and the participants. The researcher is an insider as the 
study is situated in the field of practice – HPV diagnosis, by examining the day-to-day 
consequence of this diagnosis. In addition, the shared knowledge of clinical terms and 
acceptance into the online community (after applying to and communicating with group 
administrators) lent an insider perspective to the researcher. From the perspective of 
participants, the researcher, whilst not being HPV positive, could be considered one of 
Goffman’s ‘wise’ – having knowledge of the subject and the attached stigma, but who was 
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able to treat the participants as ‘normals’ (again, using Goffman’s terminology). However, in 
terms of lived experience of HPV positivity, the researcher is definitely an outsider.  
The position of insider/outsider did affect the researcher’s actions and influence 
reflexivity. For example, once accepted (by the administrator/gatekeeper) to the social 
media support group, the researcher did not ‘lurk’ before announcing her presence as a 
researcher. Beaulieu & Estalella (2012) define lurking as a slang term for membership 
of/subscription to an online resource/forum whereby the individual reads posts rather than 
or prior to posting or engaging with the online community. Beaulieu (2004) cited in Tsatsou 
2016, p.178) found that prolonged ‘lurking’ prior to announcing oneself as a researcher lead 
to anger and rejection by the online community, as it led to suspicions of observation/data 
collection without consent. Aware of this dilemma, the researcher worked with the 
administrator/gatekeeper who announced her addition to the sample groups straight away. 
 
 3.8.7. Sensitive Topics 
Having considered and provided for the deontological ethical issues surrounding 
academic research, the research focus moved on to examine the specific ethical 
considerations regarding the ethical issues surrounding research sensitive topics, the ethics 
of phenomenology and the ethical issues encountered in Internet-mediated research. Elmir 
et al. (2011) note that the identification and definition of material that is construed as 
sensitive may be controversial. Lee & Renzetti (1990) contend that any topic may be 
construed as sensitive, and  this may be true since the sensitivity of a topic may vary 
according to the individual. So a universal definition may not necessarily include a list of 
topics, but rather the emotions or responses they evoke. Elmir et al (ibid) conclude that a 
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sensitive topic is any that might have the potential to cause ‘physical, psychological or 
emotional distress to the participant’. Sieber and Stanley (1988) extend this potential harm 
to the researcher or research team  either through emotional distress or fatigue. 
This research project asked women to recall or relate aspects of the lived experience 
of HPV positivity. As is demonstrated in the literature review chapter, HPV positivity is 
associated with anticipated, felt or enacted stigma (Chaudoir & Quinn 2015; Kosenko et al. 
2012), relational issues (Kahn et al. 2005), has implications for fertility (Perino et al. 2011) 
and the prospect of malignant disease and death (McCurdy et al. 2011); all of which might 
trigger negative emotions in participants, thus prior to undertaking research, it was 
necessary to understand how such topics might be broached in a manner that might 
minimise distress to participants. Elmir et al. (ibid) recommend that to minimise the 
possibility of psychological distress, rapport should be created between interviewer and 
participant and that any power imbalance is similarly minimised, through the establishment 
of trust (Kryzszczuk 2001). In addition, Elmir et al. recommend using sensitive and open 
questioning, the creation of a comfortable and intimate interview environment and 
considering the timing of interviews.  
Although previously viewed as a ‘poor substitute’ to the FTF interview, due to the lack 
of non-verbal cues and/or context, the use of email interviews was thus a particularly 
pertinent choice as it allowed the participant to choose which of the questions they felt able 
to answer, at a time, place and in an environment of their choosing, thus placing the power 
in the interview with the participant. In addition, the use of asynchronous interviewing was 
helpful, as the participants were used to sitting at a keyboard and viewing a screen whilst 
posting about their own or reading about others’ experiences, perhaps whilst within their 
own homes; participants were thus in an environment and context with which they were 
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already familiar and comfortable. Throughout this research any power imbalance was 
minimised by allowing the participants to choose with questions within the schedule they 
answered, and the timeline in which they answered them, as the method of data collection 
was via email (text-based, asynchronous interviews). In addition, reciprocity (as an approach 
to minimise power imbalances as espoused by Oakley (2005, 1998, 1990) was encouraged by 
allowing participants to know something about the project, the interviewer’s life and 
professional practice.   
Mann & Stewart 2002 (cited in: Gubrium & Holstein 2002, p.2) advocate the use of 
computer-mediated communication (CMC) in qualitative research interviews, as it allows 
both participants and researchers to ‘read, reply, print or forward... at their leisure’. CMC 
may be advantageous in the collection of data surrounding sensitive topics (Elmir et al. 
2011), as participants may feel uncomfortable or embarrassed about disclosing sensitive 
information in person; and the geographical distance, relative anonymity and invisibility of 
CMC (Suler 2004) may help reduce these feelings. Ison (2009) also advocates the use of email 
interviews in the case of individuals with disabilities that prevent the verbal communication 
demanded by a face-to-face interview, and notes that due to the asynchronous nature of 
email, that communication may be enhanced as it allows participants time to consider their 
response. 
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3.9. Sources of Bias 
3.9.1. Interviewer Effect 
The existence of the interviewer effect has been noted across sociological and 
psychological literature surrounding qualitative data gathering. The interviewer effect is 
defined as “the distortion of response to a personal or telephone interview which results 
from differential reactions to the social style and personality of interviewers or to their 
presentation of particular questions” (Himelein, 2015; Catania et al. 1996; Kane & Macaulay 
1993; Cotter et al. 1982). This may manifest as social desirability bias whereby respondents 
give answers that portray them in the best light possible rather than the answers that are the 
most accurate reflection of actual behaviours (van de Mortel 2008; Holbrook et al. 2003; 
Presser & Stinson 1998; Nederhof, 1985) – the issues surrounding social desirability bias will 
be covered in the next  section.  
The fact of the interviewer effect may be important in the case of stigmatised 
diseases, such as HPV or cervical cancer; however, very little literature exists on the subject 
of the interviewer effect in relation to HPV. The closest analogues are the interviewer effect 
in research surrounding HIV positivity (as a stigmatised disease), and research on the 
reporting of intravenous drug behaviours (as stigmatised behaviours); where several studies 
demonstrate that participation bias and mode of interview may affect reporting of drug and 
alcohol use and sexual behaviours (Aquilino, 1994; Catania et al., 1990).  Newman et al. 
(2002) invited individuals subscribing to a needle exchange programme to participate in 
interviews that administered a questionnaire. Respondents were randomly assigned to one 
of two conditions – a face-to-face interview or a computer-assisted self-interview. The 
questionnaire had three overall sections – “stigmatised behaviours”, “neutral behaviours” 
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and “psychological distress”. Newman found that individuals in the computer-assisted self-
interview condition reported stigmatised behaviours more often, and that individuals in the 
face-to-face interview condition reported psychological distress more often, indicating that 
the relative anonymity and invisibility offered by computer based interviewing increased 
truthfulness (validity) in reporting whilst minimising distress. Additionally, Perlis et al. 2003 
conducted a similar study that randomly assigned injecting drug-users to one of two 
interviewing conditions (either an assisted personal interview or a computer-assisted self-
interview). The computer-assisted self-interview was associated with greater reporting of 
potentially stigmatised drug, sex or HIV behaviours. Moreover, 41% of the computer-assisted 
self-interview group indicated that they would prefer all further interviews to be carried out 
in this manner. These findings are in accord with Davis et al (2009) who noted that 
interviewer effects may be particularly operant within public health surveys where 
respondents are “likely to be queried about racial attitudes, sensitive behaviours or other 
topics prone to socially desirable responding.”  Therefore, by using asynchronous electronic 
interviews, the researcher effectively minimised her presence as an interviewer, potentially 
maximising the validity of data obtained, whilst hypothetically minimising the psychological 
distress entailed in the interview process. 
 
3.9.2. Social Desirability Bias 
According to van der Mortel, social desirability bias (SDB) arises through either self-
deception or other-deception (van der Mortel, 2008).  SDB arises from the individual’s need 
to construct a favourable image of themselves in the eyes of others (Goffman 1990b, p.19). 
Research has found differences in social desirability bias according to the mode of 
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survey/interview employed to collect data. Holbrook et al. (2003) found that in a review of 
surveys comparing FTF interviews with random-digit dialling (RRD) telephone interviews, 
individuals responding via telephone were more likely to satisfice the interviewer – 
responding to questions using minimal engagement, such as no-opinion responses or 
acquiescence – (Krosnick 2000), were less engaged and less co-operative. Holbrook et al. also 
found that telephone participants took less time to complete the survey/interview but were 
more dissatisfied with the interview length, were more suspicious of the interviewer and 
more likely to engage in socially desirable responses. Holbrook’s team identify several 
reasons for the lack of engagement among telephone interview participants: interview pace 
– interview via telephone may result in the participant wishing to get off the phone as 
quickly as possible to get on with their day; rapport – telephone interviews may not allow 
the establishment of trust and rapport among the interviewer and participant in the same 
way as FTF interviews, since a major factor in the establishment of rapport is the sharing or 
mimicking of non-verbal behaviours or cues (Drolet & Morris 2000). 
Electronic asynchronous interviews might be prey to all of the factors and pitfalls 
described above for telephone interviews, but there are important differences in the 
recruitment process of these individuals that might mitigate some of these factors. Firstly, 
unlike FTF random street surveys or RRD telephone interviews, the participants in the study 
were recruited from a group of like individuals, emotionally invested in the topic (Sundar 
2015, p.264). Moreover, the use of asynchronicity removed the time pressure factor which 
featured in satisficing theory propounded by Krosnick (2000). Rapport is more difficult to 
establish, but the researcher represented the position of one of ‘the wise’ in Goffman’s 
model of stigma, and thus understood and was sympathetic to the common feature of the 
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group; and in addition, in demonstrating a willingness to share some information about her 
life encouraged reciprocity among participants.  
 
3.10. Axiology – Value-Free vs. Value-Laden Research  
In tandem with the long-standing divide between quantitative/positivist and 
qualitative/interpretivist research, there has long been debate surrounding value-free versus 
value-laden research. The German sociologist Max Weber first voiced the argument that 
sociological research should be and remain value-free (Cooke & Philpin 2008, p.197). As this 
study is situated within sociology it is reasonable to ask whether this research is value-free, 
or value-laden. Within sociology, the definition of values pertains to the personal values held 
within a community or group, and whether and how these values may change under 
particular conditions (Cooke & Philpin, ibid) As this research forms part of a doctoral 
qualification in professional practice, the values of that profession as espoused by the 
researcher’s employer (CARE: Compassion, Accountability, Respect and Engagement’ – KGH, 
2016), statutory body (the Health Care Professions Council: Transparency, Collaboration and 
Responsiveness – HCPC, 2016) and regulatory body (the Institute of Biomedical Science : 
Integrity, Professionalism and Respect); cannot be separated from the research that inspired 
them. However, in addition to the values of the researcher, the values of the sample 
population have to be considered, which may include valuing rights to privacy or non-
engagement – and on the basis of all the researcher values described above, these values 
would have to be respected. Moreover, the study is motivated by and concerned with 
mitigating the social and psychological impact of a stigmatised disease, which embodies a 
change in the perception of an individual according to societal values – such as the social 
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exclusion of the stigmatised, (Becker & Arnold 1986). By being motivated to change these 
societal values, the research cannot be value-free. 
 
3.11. Summary of Methodology Chapter 
This chapter has examined the ontological and epistemological approaches espoused 
by different research philosophies and the theoretical assumptions they demand in order to 
demonstrate that the research philosophy of constructionism was the best fit for the 
research questions. Following on from the philosophical and theoretical arguments, the 
philosophical underpinnings of the research approach of phenomenology were elucidated – 
with particular reference to Svenaeus’ writings on the phenomenology of illness. The chapter 
also examined the advantages and disadvantages of the chosen research design (mixed 
methods, follow-up explanations model), discussed the stance of the research being value-
laden (as opposed to value-free). The chapter closed with an examination of the chosen data 
collection method for the qualitative portion of the study, namely exploring the various 
types of qualitative research interview (in particular electronic interviews) and discussed the 
possible sources of bias that might arise during the qualitative data collection process.  
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Chapter Four – Quantitative Data 
Study 1: Questionnaire Study Exploring a Population of HPV-Focused Online Support Users 
4.1. Introduction 
In order to answer the research questions given in Chapter 1, this mixed methods 
research project was organised using the follow-up explanations model, and was comprised 
of two studies. Study 1 sought to explore the characteristics of a group of women who 
subscribed to and used online support groups focused on living with HPV and/or cervical 
cancer, and gathered quantitative data using a questionnaire, administered via 
SurveyMonkey™. This questionnaire was delivered to women subscribing to HPV-related 
online support groups. The questionnaire development process, identification and 
recruitment of sample populations and the results of data analysis and discussion make up 
the body of this chapter. Study 2 was composed of a series of electronic interviews delivered 
via email. The development of the questions and interview schedule, identification and 
recruitment of sample populations and qualitative data analysis and discussion for Study 2 
make up the body of Chapter 5.  
Chapter 1 made the case for the comparative prevalence of HPV in the general 
population under HPV primary screening against the current incidence of cervical 
intraepithelial neoplasia, underlining the predicted increase in women being diagnosed 
positive for high-risk HPV; demonstrating that there will be a cohort of women with a 
diagnosis of HPV, who may not demonstrate neoplastic changes to the cervical epithelium 
(CIN) that warrant treatment. Chapter 2 examined literature on stigma, demonstrating that 
the stigma associated with HPV has negative psychological and sociological impacts – women 
being diagnosed with HPV reporting feelings of anxiety, shame and stigma (Jeynes et al. 
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2009; Waller et al. 2007); and also that access to social support can reduce these effects 
(Loane & D’Alessandro 2013). Chapter 2 also made the case for persistent high-risk HPV 
positivity as a case of biographical disruption, not in terms of physical disease or illness, but 
in terms of the effects of HPV as a stigmatised condition on access to social support as a 
‘mobilisation of resources’ (Bury, 1982); and in terms of the anxiety and uncertainty of a 
liminal state in which ‘neither health is confirmed nor disease excluded’ (Forss et al. 2004). 
Chapter 2 also examined the role of online social support and its application in the case of 
stigmatising conditions.  
Chapter 3 discussed the research philosophy underpinning the study, and the 
ontological and epistemological assumptions informing the theoretical perspectives of the 
research and the philosophers whose work influenced the chosen research approach of 
phenomenology and the ethical issues that might be encountered. Chapter 4 will describe 
the process of developing the instrument and for gathering and reporting data for Study 1 – 
the quantitative study, the aims for which are given below. 
 
4.1.1 Aims of the Questionnaire Study 
The overarching aims of the study are given in Chapter 1 – the research aims to 
explore the lived experiences of women currently or previously diagnosed with HPV, to 
examine the ways in which they interact with online support. Within the context of these 
aims, the questionnaire study intended to examine the demographic characteristics of 
women subscribing to HPV-related online support. The aims of the questionnaire study are 
summarised as follows: 
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1) To examine the characteristics of a population of users of HPV-related online 
support in terms of demography, HPV awareness, screening and treatment 
history and reported scores for perceived stress and social support. 
2) To explore the reasons women use HPV-related online support in terms of 
emotional support, exchanging information, helping others or sharing 
experiences. 
3) To explore the outcomes of HPV-related online support in terms of women 
feeling better informed about HPV, or in gaining better acceptance of HPV. 
4) To explore women’s current feelings of anxiety and/or embarrassment 
regarding HPV positivity (whether hypothetical or actual) and the reasons for 
this. 
5) To explore the relationship between perceived availability of and satisfaction 
with social support and opinions regarding disclosure. 
6) To explore the relationship between perceived availability of and satisfaction 
with social support, and the reasons for and outcomes of HPV-related online 
support use (as given in 3 and 4) 
7) To explore the relationship between perceived stress and the reasons for and 
outcomes of HPV-related online support use (as given in 3 and 4). 
 
4.1.2. Research Questions 
The research questions for this study draw on the main research questions set out in 
Chapter 1 and are informed by the literature examined in Chapter 2, specifically investigating 
the possibility of HPV as a biographical disruption by exploring the reasons for anxiety over 
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HPV positivity; and through examining the possible benefits women may gain from using 
online support. The research questions for the questionnaire study are given below: 
1) What are the demographic characteristics of a group of online support users?  
2) Is there a relationship between perceived social support and disclosure of HPV 
positivity – do women who indicate their agreement with disclosure report 
higher social support? 
3) Are the reasons for HPV-related online support use (for emotional support, 
exchanging information, helping others or sharing experiences) associated 
with increased perceived availability of and satisfaction with social support? 
4) Are the outcomes of HPV-related online support use (being better informed 
about HPV and better acceptance of HPV) associated with reduced perceived 
stress? 
 
4.1.3. Hypotheses 
Based on the literature reviewed in Chapter 2 and the research aims and questions 
above, the following experimental hypotheses are put forward. 
HE1: The data will show a significant relationship between reported intent to disclose 
HPV positivity and increased scores for the availability of and satisfaction with social 
support. Linear regression will be performed to test whether increased social support 
scores predict agreement with disclosing HPV positivity. 
H01: There will be no significant relationship between social support scores and 
disclosure intention. 
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HE2: The data will show a significant relationship between a reported lack of anxiety 
over HPV positivity and increased scores for availability of and satisfaction with social 
support. Analysis of variance will be performed to examine whether the differences in 
social support scores and perceived stress scores between ‘Anxious’ and ‘Not Anxious’ 
participants are significant. 
H02: There will be no significant relationship between social support and/or perceived 
stress and anxiety over HPV positivity. 
HE3: That agreement with the uses of online support for emotional support, exchange 
information, to help others and to share experiences will be significantly associated 
with increased scores for social support, and with reduced scores for perceived stress. 
A multivariate general linear model will be used to examine whether agreement with 
reasons for online support use (for emotional support, exchanging information, 
helping others or sharing experiences) is associated with increased scores for social 
support and reduced scores for perceived stress. 
H03: There will be no significant relationship between uses of online support and 
scores for social support and perceived stress. 
HE4: That agreement with the outcomes of online support use to feel better informed 
about HPV, and to gain better acceptance of HPV will be significantly associated with 
increased scores for social support, and with reduced scores for perceived stress. A 
multivariate general linear model will be used to examine whether agreement with 
outcomes of online support use (feeling better informed about HPV, and gaining 
better acceptance of HPV) is associated with increased scores for social support and 
reduced scores for perceived stress. 
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H04: There will be no significant relationship between outcomes of online support use 
and scores for social support and perceived stress. 
 
4.2. Methods: Questionnaire Design 
The research instrument took the form of a survey, administered as a questionnaire. 
The questionnaire was designed to allow both quantitative analysis, through the use of close-
ended, multiple-choice questions; and limited qualitative analysis through the use of free 
text entry questions. Ethical approval was sought from and granted by De Montfort 
University (please refer to Appendix 1). The questionnaire was created and administered 
using SurveyMonkey™. Sites that might attract appropriate respondents were approached 
and the project proposal, ethical approval, a document containing the questionnaire text and 
links to the live questionnaire were submitted for consideration. The sample populations 
identified are described in section 4.3. The questionnaire was composed of five sections – 
demographic information, cervical screening and HPV testing history, participants’ use of the 
internet and social media, a social support questionnaire and a perceived stress scale. These 
sections are discussed in more depth below. A copy of the questionnaire text can be found in 
Appendix 2. 
 
4.2.1. Demographics 
The first section of the questionnaire was designed to explore the demographic 
characteristics of women who subscribe to online resources devoted to HPV positivity, 
abnormal cervical screening results or colposcopic examinations and groups devoted to 
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cervical cancer. Respondents were requested to indicate their age according to age brackets. 
The age range of the instrument was 18 to 64 years of age, chosen to include women who 
had been vaccinated (>18 years) or diagnosed outside of the programme and at the upper 
end to include women still receiving follow-up for treated CIN. Relationship status was 
chosen as a demographic as studies show that older women and women in established 
relationships have lower anxiety about HPV positivity and disclosure than younger or single 
women (Kwan et al. 2011; Newton & McCabe 2008a; Newton & McCabe 2008b; Filiberti et 
al. 1993). In addition, women who do not foster close personal relationships (such as those 
that might arise through co-habitation) are more likely to resort to online support (Horgan et 
al. 2013; Eastin & Larose 2005). Additionally, respondents were requested to identify 
themselves by ethnic group in order to examine whether or not use of online support 
reflects the overall ethnic proportions reflected in cervical cancer incidence as reported by 
Cancer Research UK.  
 
4.2.2. Cytology Screening & HPV Testing History; Knowledge of HPV 
The second section of the questionnaire examined respondents' cytology screening 
and HPV testing history; to explore awareness of HPV within the population and to 
examine for whom the topic had been researched – for themselves or on behalf of others. 
In addition, relative stage within the diagnostic and treatment arc was reported in order 
to investigate at which point women had recruited online assistance and the duration of 
their memberships. Awareness of HPV was a single-item question, with two response 
options (‘Yes’/’No’). HPV testing and cervical screening history questions each contained 
multiple response options. Response options for HPV testing included different options 
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for ‘No’ (such as ‘I have not been invited yet’ – to accommodate women under 25 years of 
age – and ‘I choose not to participate’). Response options for screening history included 
different categories to accommodate the different stages of the diagnostic and treatment 
arc (such as ‘I have an appointment but have not attended yet’, ‘I have had a biopsy’, ‘I 
have had treatment’).  
Originally, a 6-item measure of HPV knowledge was included in order to compare 
women’s knowledge of HPV against perceived stress, to examine whether increased 
knowledge of HPV reduced or increased perceived stress. The HPV knowledge score 
results are not included here as an outcome, as validated HPV knowledge measures were 
published shortly after the questionnaire was released (Waller et al. 2013). A frequency 
analysis of responses to individual questions from this 6-item measure is included to 
examine potential knowledge gaps in the sample. Knowledge statements included ‘HPV is 
a sexually transmitted infection’, ‘HPV is the most common STI in the UK’, ‘HPV may go 
away by itself (self-resolve)’, ‘HPV may not be stopped by condoms’, ‘HPV may not cause 
any outward signs’ and ‘HPV may cause cervical cancer’. All of the statements included in 
the instrument were true – no untrue statements or ‘distracters’ were included. In 
addition, participants were asked to select which items they believed to be true, as 
opposed being offered a ‘true/false’ option. Therefore missing responses do not 
necessarily indicate that women believed unselected statements to be false. 
  
4.2.3.  Anxiety & Embarrassment Over HPV-Positivity; Reasons for Anxiety 
Measures for this section of the instrument examined women’s anxiety and 
women’s embarrassment about an actual or hypothetical HPV-positive test result. For 
anxiety, women were asked to rate their level of anxiety on a five point Likert scale from 
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‘Extremely anxious’ to ‘Not at all anxious’. Similarly, women were asked to rate their 
embarrassment about an actual or hypothetical HPV-positive test result on a five point 
Likert scale from ‘Extremely embarrassed’ to ‘Not at all embarrassed’. These questions 
were included as studies by (Kim 2012; McCaffery et al. 2010; Waller et al. 2009; Waller et 
al. 2007; McCaffery et al. 2004) variously report from face-to-face interviews that women 
feel shame and anxiety over testing HPV positive. Additionally, women were asked to 
select reasons for their anxiety over HPV-positivity. There were seven response 
categories: ‘Disclosure – I am anxious about telling my partner, family or friends’, ‘Fertility 
– I am anxious that HPV might affect my ability to have children’, ‘Health – I am worried 
about developing cancer’, ‘Health – I am worried about cancer returning’, ‘Life – I am 
worried about dying’, ‘None of the above – I am not concerned’ and a free text box in 
which participants could enter other reasons that did not fit into the responses given 
above. Women could select multiple responses. These response categories reflected the 
major themes in literature identified in Chapter 2 – namely stigma (Daley et al. 2010; 
Brown et al. 2007; Newton & McCabe 2005; Nack 2002); disclosure (Harvey-Knowles & 
Kosenko 2012; Kosenko et al. 2012; Perrin et al. 2006) and themes identified in literature 
examining women’s most salient information needs and messages associated with HPV. 
These included associations with cancer development and mortality (Hendry et al. 2016; 
León-Maldonado et al. 2016; Lee Mortensen & Adeler 2010) and questions surrounding 
fertility (Souho et al. 2015).  
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4.2.4. Use of the Internet and Social Media for Social Support 
Section 3 comprised questions regarding respondents' use of the Internet.  This 
section of the questionnaire asked how long participants had been using the Internet, and 
for an approximation of the frequency of use (as sessions per day).  The rationale behind 
asking these questions was to explore whether an association existed between Internet 
use and perception of social support. In addition, this section used questions formulated 
by Beaudoin and Tao (2007) in their study examining the empowering effect of online 
support groups among cancer patients. Four of their questions specifically explored the 
reasons participants used online support groups and online healthcare information 
gathering – by asking participants to indicate agreement with statements about using 
online support for: emotional support, exchanging information, helping others or sharing 
experiences. Four questions examining reasons for online support use were thus included, 
in the questionnaire asking participants to indicate their agreement on a 5 point Likert 
with using online support for these reasons – emotional support, exchanging information, 
helping others and sharing experiences. The final two questions examined the possible 
outcomes of HPV-related online support use using 5 point Likert scale of 
agreement/disagreement with statements about: being better informed about HPV and 
gaining better acceptance of HPV. 
 
4.2.5. Measurement of Social Support 
Section 4 consisted of a short form of the Social Support Questionnaire (SSQ). The 
SSQ was introduced by Sarason et al. (1983) as a means of assessing social support by 
examining the availability of social support and the participant’s satisfaction with the 
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available support. The original SSQ contains 27 items, takes around 15 minutes to 
complete and shows good test-retest reliability (Sarason et al. 1987). Two short forms of 
the questionnaire exist – a 3-item version (SSQ3) and a 6-item version (SSQ6). To 
reduce attrition rates associated with lengthy questionnaires (Rolstad et al. 2011) the 6-
item version, SSQ6 was used in this study. SSQ6 also shows good internal validity and test-
retest reliability (Rascle et al. 2005) and has been used in the examination of social 
support among breast cancer patients (Boinon et al. 2014) and gynaecological cancer 
patients (Torkzahrani et al. 2013). 
 
4.2.6. Measurement of Perceived Stress 
Section 5 of the research instrument consisted of a short form of the Perceived 
Stress Scale [PSS]. The original PSS is a 14-item instrument developed by Cohen et al. 
(1983) to provide a reliable measure of volunteers' perceptions of the level of stress they 
were currently undergoing. A shorter 10-item instrument was introduced by Cohen & 
Williamson (1988), which has since undergone further reliability and validity testing 
(Nordin & Nordin 2013; Lee 2012; Roberti et al. 2006).  Since it was introduced, both the 
PSS and PSS-10 have been used to measure individuals’ perceived stress following a 
cancer diagnosis, including breast cancer and mastectomy (Golden-Kreutz et al. 2005, 
2004) and in the relationship between stress and immunity in breast cancer recovery 
(Thornton et al. 2007). The PSS-10 has also been used in tandem with the SSQ in studies 
examining the management of anxiety (Panayiotou & Karekla 2013). Beaudoin & Tao 
(2008) used the PSS in modelling the impact online cancer resources in cancer patients’ 
supporters, finding that self-perception of life stress reduced proportionally with the 
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length of time volunteers were using online support groups.  Cassidy (2013) employed the 
PSS-10 in examining perceptions of stress in female cancer caregivers recruited via online 
support groups. The PSS-10 was thus chosen as means of measuring perceived stress for 
this study as it has been repeatedly tested for validity and reliability, has been used with 
populations of individuals either suffering from or supporting others with cancer, and has 
been used with populations recruited through online sources. 
 
4.2.7. Development of the Questionnaire 
The development of the final questionnaire was an iterative process.  For the main 
body of the questionnaire, many of the items were derived from instruments used in 
previous studies analogous to the current research with a good track record of citations or 
which have been proved by other methods such as national statistics (the demographic 
section, which is derived from the UK Census).  This decision was made in order to 
maintain the academic validity of the instrument as far as possible, without introducing 
researcher bias. Section 2 of the questionnaire was the section which contained the most 
original questions and responses.  As previously described, these questions explored 
volunteers’ screening and HPV testing history.  In order to minimise researcher bias and 
possible psychological harm to volunteers (by introducing anxiety), these questions were 
developed by the author, with the reference to the HPV Triage and Test of Cure 
algorithms (PHE 2016) and NHSCSP documentation (NHSCSP 2016) and the local screening 
policy.  These questions were then examined by a ‘working group’ at Kettering General 
Hospital (the author’s workplace) at the request of the author.  The working group 
comprised of the Advanced Practitioner (AP) and Cervical Screening Lead, the Consultant 
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Pathologist specialising in gynaecological malignancy, a Consultant Gynaecologist and the 
Lead Nurse Colposcopist.  
The questionnaire was then examined by Professor Lixian Jin of De Montfort 
University, an academic specialising in questionnaire design.  Professor Jin made some 
recommendations to the structure of the questions (for example the use of age categories 
instead of entering age as a set of digits; and the questions used to identify the 
independent variables as set out in the aims and objectives).  The recommended 
amendments were made.  The questionnaire document is available in Appendix 2. 
 
4.3 Sample Populations 
In order to locate appropriate and relevant populations – online support or social 
media groups of women – searches were carried using internet search engines including 
Google, Bing and Yahoo!. Another search was carried out using the search facilities of social 
media platforms. Facebook, Mumsnet, Twitter, Instagram, Gaia Online and Reddit were all 
searched for appropriate support groups. The search terms used for both types of search 
engine (Internet and social media) are given in Table 4.1., and the participant groups 
identified are described in the following paragraphs.  
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Search terms utilised to identify possible sources of participants 
Abnormal smears 
Abnormal colposcopy 
Cervical cancer support 
Cervical cancer minority ethnic population 
Colposcopy support 
HPV awareness 
HPV support 
HPV minority ethnic population 
STD/STI support 
Table 4.1: Terms used in the identification of participant populations 
 
4.3.1. The Teal Ladies 
The ‘Cervical Cancer Awareness’ Facebook page, also known as ‘The Teal Ladies’ is an 
online not-for-profit peer support group run by cancer survivors for sufferers and survivors 
of female genital tract (FGT) cancers. Although individuals with HPV positivity and/or cervical 
cancer are both supported, the group is not specific to either condition, as it additionally 
provides peer support to women with endometrial and ovarian cancers.   The page and 
group was set up in December 2009; at the time of writing, the group had 3,515 members 
with large member bases in the United Kingdom, the US, Canada and Australia.  The group 
does not purport to give expert help, clinical advice or liaison but is run purely for the 
purposes of emotional support.  The majority of individuals posting in the group do so to 
‘diarise’ their experiences or to ask for reassurance or informal advice on their symptoms 
from peer patients.  Respondents from this group were recruited from the UK branch of the 
group. 
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4.3.2. Jo’s Cervical Cancer Trust 
Jo’s Cervical Cancer Trust is a UK charity dedicated to supporting women affected by 
cervical cancer.  The charity was founded as a trust in 1999 by James Maxwell, following the 
death of his wife from cervical cancer in the same year.  The trust was incorporated as a 
charity in 2010.  According to the mission statement on its website, the charity aims to 
reduce the impact of cervical cancer of the lives of sufferers and their families.  Through its 
website and associated Facebook page and Twitter feed the group organises fundraising, 
provides support via an online forum and access to clinical advice and gives information 
regarding the diagnosis and treatment process and follow-up.  In addition, Jo’s Trust also 
hosts research pages to recruit volunteers to studies exploring the field of cervical cancer.  
 
4.3.3. BME Cancer Voice 
BME Cancer Voice is a UK organisation based in Leeds which aims to provide informal 
support and advice to British Minority Ethnic individuals.  BME Cancer Voice is not 
specifically dedicated to the support of HPV sufferers or cancers of the female genital tract, 
but supports BME patients of all cancers. The groups was originally developed and run by the 
National Cancer Action Team until this was abolished in 2013 under NHS reforms.  BME 
Cancer Voice aims to increase the cultural competence of the NHS in the treatment of cancer 
patients from British Minority Ethnic groups by identifying cultural, spiritual and religious 
needs specific to BME cancer patients in order to identify solutions for improved 
experiences.  The working group was originally implemented as a result of surveys of cancer 
patient experiences run annually by the Department of Health.  The results of surveys 
indicated that patients of BME backgrounds had poorer experiences of using NHS cancer 
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services than white patients living within the same health authority (Independent Cancer 
Taskforce 2015).  These experiences included lack of appropriate interpreters, information in 
relevant languages and in cases where post-operative prostheses were required, a lack of 
prosthetics in skin tone appropriate colours for ethnic populations. 
 
4.4. Response Rate 
Following identification of and approaches to sample populations (described 
previously) the questionnaire was posted on the research pages of Jo’s Cervical Cancer Trust 
and the Facebook pages of the Teal Ladies and BME Cancer Voice. The questionnaire was 
available on SurveyMonkey for six months from December 2014 to June 2015. According to 
their annual report, Jo’s Trust received 320,000 ‘clicks’ in 2016-2017 (Jo’s Cervical Cancer 
Trust 2017) resulting in over 2.5m web sessions, however no data is given to the amount of 
traffic any specific area of the website receives (in this case, the ‘Research’ pages, where the 
advert for the research project was hosted). The Teal Ladies Facebook group has 
approximately 3,500 members of whom 1,200 are based in the UK. BME Cancer Voice has 
approximately 300 members on social media. Of this combined audience, 111 responses 
were received – of these 4 responses had no data, leaving 107 respondents. Of the 107 
respondents, 81 respondents responded to every question. Data was missing for a question 
on HPV awareness (N = 26), the social support questionnaire (N = 21)) and the perceived 
stress scale (N = 26). The small sample size is accepted as a limitation to the study. 
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4.5. Data Analysis 
Data were gathered via SurveyMonkey™ and exported into SPSS. Descriptive statistics 
were utilised to examine the modal age ranges, employment, ethnicity and relationship 
status of respondents. Cross-tabulations were employed to examine groupings for 
diagnostic/treatment stage and duration of membership to online support groups, and 
between diagnostic/treatment stage and perceived stress and also perceived social support. 
Tables comparing mean scores for social support and perceived stress were used to explore 
whether possible relationships existed between the independent (questionnaire) variables 
and the dependent variables, and inferential statistics were used to examine the significance 
of these relationships. Linear regression was utilised to test the first experimental 
hypothesis; exploring possible associations between perceived social support and disclosure 
intention. Analysis of variance was used to test the second experimental hypothesis – 
examining the relationship between increased scores for social support in women reporting 
a lack of anxiety over HPV positivity. The third and fourth experimental hypotheses were 
tested using multivariate generalised linear modelling to explore the significance of 
differences between mean scores for perceived social support and the reported reasons for 
online support use (exchanging information, helping others, sharing experiences and 
emotional support), and between mean scores for perceived stress and the reported 
outcomes of online support use (improved acceptance of HPV, improved knowledge of HPV). 
The results of analyses are given on the following pages. 
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4.6. Results of Quantitative Data Analysis 
4.6.1. Population Demographics 
Demographic Characteristic   
Age Bracket N  Percent 
18-24 6 5.4% 
25-34 39 36.0% 
35-44 36 33.3% 
45-54 20 19.8% 
55-64 5 4.5% 
65-74 1 0.9% 
Total 107 100 
   Relationship Status   
Married/Civil Union/Co-Habiting 84 78.4% 
Divorced/Separated 11 9.9% 
Single 11 9.9% 
Prefer Not to Say 1 0.9% 
Total 107 100 
   Ethnicity 
  White British 104 97.3% 
White Irish 1 0.9% 
Black Caribbean 1 0.9% 
Bangladeshi 1 0.9% 
Total 107 100 
   Employment Status 
  Employed, working 40+ hours per week 32 29.0% 
Employed, working 1-39 hours per week 38 34.2% 
Not employed, looking for work 10 9.0% 
Not employed, not looking for work 15 13.5% 
Retired 1 0.9% 
Disabled, not able to work 10 9.0% 
Prefer not to say 1 0.9% 
Total 107 100 
Table 4.2: Demographic characteristics of HPV online support subscribers 
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The modal age bracket was 25-34 years (36%, N = 39), with the majority of women 
reporting being in a relationship (78.4%, N = 84) and the overall majority women reporting 
being White British (N = 104, 97.1%) and working 1-39 hours per week. 
 
4.6.2. Cervical Screening Frequency/History 
This section of the research instrument asked women to report their cervical screening 
frequency, knowledge and cervical screening history, to explore the cervical screening 
profiles of women who subscribed to HPV-/cervical cancer-related online support. Cervical 
screening history and frequency were explored to discover the number of women who had 
been diagnosed outside of the screening programme (prior to first call) and what portion of 
the sample population were on follow-up for a previous abnormality. Women indicated their 
cervical screening history as follows: 
Cervical Screening History 
Have you ever had an abnormal smear 
An abnormal result is any of the following:  
‘Borderline’, ‘Mild’, ‘Moderate’, ‘Severe’, ‘?Invasive disease’, ‘?Glandular neoplasia’ 
 N Percent 
No, I have never been screened 2 1.8% 
No, I have never had an abnormal result 9 8.6% 
Yes, I have had an abnormal result 96 89.7% 
Missing Data Nil  
Total 107  
Table 4.3: Distribution of respondents by cervical screening history 
 
Cervical screening frequency was explored by asking women to select from response 
categories: ‘Never’ for women who have never been screened because they choose not to 
participate or due to being too young for screening; ‘Occasionally’, ‘Regularly’, ‘Frequently’ 
(women who opt for additional private screening) and ‘Frequently’ (due to being on followed 
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up for previous treatment). These data were cross-tabulated with the abnormal screening 
history responses, and are given in table 4.4. 
 Have you ever had an abnormal smear 
How often do you participate in cervical 
screening 
No, never  
screened 
No 
abnormal 
result 
Yes, I have had 
an abnormal 
result 
Total 
Never, I choose not to participate 0 0 1 1 
Never, I have not been invited yet 2 0 5 7 
Occasionally, I don’t always go when invited 0 1 7 8 
Regularly, when invited 0 5 16 21 
Frequently, I arrange for additional screens 0 1 6 7 
Frequently, being managed post-treatment 0 2 60 62 
Prefer not to say 0 0 1 1 
Total 2 9 96 107 
Table 4.4: Cross-tabulation of abnormal smear history and cervical screening frequency  
 
The majority of respondents had had an abnormal result (N = 96, 89.7%) and of these, 
60 were being managed post treatment. Women were also asked to report the stage of the 
screening/treatment process they were at.  
Treatment History N Percent 
   
Appointment, not attended yet 2 1.8% 
Offered an appointment, had a biopsy 29 26.1% 
I have had treatment 39 35.1% 
Have had treatment and follow-up 27 24.3% 
Not had treatment 2 1.8% 
Not needed treatment 8 7.2% 
Missing Data Nil  
Total   
Table 4.5: Distribution of respondents by treatment history 
 
The majority of women (61.2%) described being at either the biopsy (N = 29, 26.1%) or 
treatment stage (N = 39, 35.1%). Responses to screening frequency were cross-tabulated 
with treatment stage to further describe the population. The distribution of responses is 
given in Table 4.6. 
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  Have you ever been offered treatment for an abnormal smear  
  No 
treatment 
yet 
Biopsy Treatment Treatment 
and 
Follow-Up 
Not 
had 
treatment 
Not 
needed 
treatment 
Total 
Sc
re
en
in
g 
Fr
eq
u
en
cy
 
Choose not to 
participate 
 
0 1 0 0 0 0 1 
Not invited  
yet 
 
0 3 2 0 1 1 7 
Occasionally 
 
1 3 2 1 0 1 8 
Regularly 
 
0 6 4 5 1 5 21 
Frequently, 
Additional 
screens 
1 2 2 1 0 1 7 
Frequently 
managed post 
treatment 
0 13 29 20 0 0 62 
Prefer not to 
say 
0 1 0 0 0 0 1 
 Total 2 29 39 27 2 8 107 
Table 4.6: Cross-tabulation of screening frequency and treatment stage responses 
 
Results for the demographic and screening history will be further examined in the 
discussion section. 
 
4.6.3. Awareness of HPV, HPV Testing History 
Women who subscribed to HPV/cervical cancer related online support were asked to 
indicate their awareness of HPV, in order to examine what proportion of such a population 
were aware of the existence of the virus. Responses to the question ‘Are you aware of the 
Human Papillomavirus (HPV)?’ and the follow-up question ‘Do you have daughters eligible 
for the HPV vaccine?’ are given in Table 4.7. 
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HPV Awareness Number  Percentage 
Are you aware of the human papillomavirus (HPV)?   
Yes 79 73.8% 
No 2 1.8% 
Missing data 26 24.2% 
   
Do you have daughter(s) eligible for the HPV vaccine?   
Yes 29 27.1% 
No 77 72% 
Prefer not to say 1 0.9% 
Missing data Nil  
Table 4.7: Awareness of HPV  
 
The HPV awareness question was the first instance of missing data so far in the 
questionnaire. Responses to these questions and possible reasons for missing data will be 
examined in the discussion section. In addition to awareness, women were asked to indicate 
whether or not they had had an HPV test. Responses are given in Table 4.8. 
HPV Testing History 
Do you know if you have ever had an HPV test? 
 
Number 
 
Percentage 
No, I am not in the screening programme (not invited yet) 5 4.6 
No, I choose not to participate in the screening programme 1 0.9 
No, I have not been HPV tested 16 14.9 
I don’t know 10 9.3 
Yes, I have had an HPV test 75 70.0 
Total 107 100 
Table 4.8: Distribution of population by HPV testing history   
 
HPV testing history was cross-tabulated with cervical screening frequency to explore 
distributions within response categories. It was clear that the majority of respondents who 
had had an HPV test (N = 75) were being followed up post-treatment (N = 48). Cross-
tabulation of HPV testing history and cervical screening frequency are given in Table 4.9. 
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  HPV Testing Status 
  No, not 
invited 
yet 
No, choose 
not to 
participate 
No, not 
HPV 
tested 
I don’t 
know 
Yes, I have 
had an HPV 
test 
Total 
H
o
w
 o
ft
en
 d
o
 y
o
u
 p
ar
ti
ci
p
at
e 
in
 c
er
vi
ca
l s
cr
ee
n
in
g?
 
Never I choose not 
to participate 
0 0 0 1 0 1 
Never, I have not 
been invited yet 
4 0 1 1 3 7 
Occasionally, I 
don’t always go 
when invited 
0 0 1 3 4 8 
Regularly, when  
invited 
0 0 4 1 14 21 
Frequently, I 
arrange additional 
screening 
0 0 1 0 6 7 
Frequently, I am 
being managed 
post-treatment 
1 1 9 3 48 62 
Prefer not  
to say 
0 0 0 1 0 1 
 
Total 5 1 16 10 75 107 
Table 4.9: Cross-tabulation of HPV testing history and cervical screening frequency 
In addition to awareness of HPV and HPV testing history, women were presented with 
six knowledge statements about HPV, and asked to select which of these statements they 
believed to be true. A frequency table of responses is given below. Where reported, N 
indicates the number of women who selected the statement as true. 
HPV Knowledge Statements 
 
Number  Percent Missing Percent 
HPV is a sexually transmitted infection 87 81.4% 20 18.6% 
HPV is the most common STI in the UK 46 42.9% 61 57.0% 
HPV may go away by itself (self-resolve) 66 61.7% 41 38.3% 
HPV may not be stopped by condoms 53 49.5% 54 50.4% 
HPV may not cause any outward signs 90 84.1% 17 15.8% 
HPV may cause cervical cancer 106 99.1% 1 0.9% 
Table 4.10: Frequency table of knowledge statements for HPV  
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4.6.4. Social Support and Perceived Stress Scores 
Perceived availability of and satisfaction with social support were measured using 
Sarason’s SSQ-6 (Rascle et al. 2005; Sarason et al. 1983). Perceived stress was measured 
using Cohen’s PSS-10 (Cohen & Williamson, 1988). Scores for all respondents are given in the 
table below. 
Measure N Minimum Maximum Mean Std. 
Deviation 
SSQN 86 0.0 4.8 2.1 1.0 
SSQN 86 1.0 5.0 4.2 0.9 
PSS 83 17.0 28.0 20.9 2.5 
Table 4.11: Descriptive statistics of all scores for social support and perceived stress 
 
Scores for availability of social support (SSQN) were given by 86 respondents, and 
ranged from 0.0 to 4.8, with a mean score for the whole group of 2.1 (SD = 1.0). Scores for 
satisfaction with social support (SSQS) were also given by 86 respondents and ranged from 
1.0 to 5.0, with a mean score for the whole group of 4.18 (SD = 0.9). Scores for perceived 
stress were completed by 83 respondents and ranged from 17.0 to 28.0 with a whole group 
mean of 20.9 (SD = 2.5). 
 
4.6.5. Disclosure Intention and Preferred Confidant Group 
Women were asked to indicate whether or not they would confide in anyone 
regarding a positive HPV result. The question was a three item response: “Yes, “No” or 
“Prefer not to say”. There were no missing data for this question. Responses are given in 
Table 4.12. 
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HPV Positivity Disclosure Intention   
Would you confide in anyone about a positive HPV result Number Percentage 
Yes 94 87.9 
No 12 11.2 
Prefer not to say 1 0.9 
Total  107 100.0 
Table 4.12: Distribution of respondents by disclosure intention 
 
Women were grouped by their opinions on disclosure, and mean scores for social 
support availability (SSQN), social support satisfaction (SSQS) and perceived stress were 
compared in Table 4.13. 
Would you confide in anyone about a positive HPV result? 
 
 SSQN SSQS PSS 
Yes Mean 1.79 3.94 20.96 
N 94 94 75 
Std. Deviation 1.24 1.06 2.37 
No Mean 1.24 3.57 20.29 
N 12 12 7 
Std. Deviation 1.16 1.07 3.68 
Prefer not to say Mean 1.00 2.83 20.00 
N 1 1 1 
Std. Deviation . . . 
Table 4.13: Mean scores for SSQN, SSQS and PSS by disclosure intention group 
 
Women who stated that they had or would disclose their HPV positive status 
demonstrated higher mean scores for both availability of and satisfaction with social 
support, but also higher mean scores for perceived stress. In order to examine the first 
experimental hypothesis HE1 – stating that a significant relationship exists between increased 
scores for availability of and satisfaction with social support and intent to disclose HPV 
positivity, linear regression was performed to examine whether a relationship existed 
between perceived stress and/or social support and disclosure intention. When disclosure 
intention was predicted it was found that perceived stress (β = -0.86, p = 0.438), social 
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support availability (β = -0.65, p = 0.595) and social support satisfaction (β = -0.157, p = 
0.199) were not significant predictors. The overall model fit was R2 = 0.044. 
 
Women were asked whom they had or would confide in regarding a positive HPV 
result. Response categories included partner, doctor/nurse, family, friends, online support 
group or counsellor.  Women could select more than one response. All participants (N = 107) 
submitted at least one response – there were no missing data items for this question. 
 
Whom have you or would you confide in regarding a positive 
HPV result (whether you have had one or not)? 
N Percent 
   
Partner 69 62.2 
Doctor/nurse 66 59.5 
Family 50 45.0 
Friends 50 45.0 
Online support group 48 43.2 
Counsellor 14 12.6 
Table 4.14: Frequency table of preferred confidant group for disclosure 
 
4.6.6. Anxiety Over HPV Positivity 
Participants were asked to indicate their anxiety surrounding a previous positive HPV 
result, or a putative positive HPV result in the future (e.g. following cytological surveillance, 
as part of follow-up after biopsy or after treatment). Response categories were originally on 
a five-item Likert scale ranging from 1 – Extremely anxious/worried, 2 – Very 
anxious/worried, 3 – Neither anxious/worried nor unconcerned, 4 – Not anxious/worried, 5 – 
Really not anxious/worried. Due to a small sample size, and none of the participants utilising 
the ‘Neither’ response, the original five item scale was reduced to a binary ‘Anxious/Not 
anxious’ response to reduce the number of items and to increase the number of responses 
per item. There were no missing data for this question. 
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Anxiety Over HPV Positivity 
Please indicate your level of anxiety regarding a positive HPV result  
Number Percentage 
Anxious 79 73.8 
Not anxious 28 26.2 
Total 107  
Table 4.15: Distribution of respondents by level of anxiety over HPV positivity 
 
Mean scores for social support availability (SSQN) and satisfaction (SSQS) and 
perceived stress score (PSS) for women grouped by anxious/not anxious are compared in 
Table 4.16. 
HPV Anxiety SSQN SSQS PSS 
Anxious Mean 1.47 3.66 21.32 
N 79 79 60 
Std. Deviation 1.11 1.06 2.59 
Not anxious Mean 2.41 4.55 19.78 
N 28 28 23 
Std. Deviation 1.34 .76 1.70 
Total Mean 1.72 3.89 20.89 
N 107 107 83 
Std. Deviation 1.24 1.065 2.47 
Table 4.16.: Mean scores for SSQN, SSQS and PSS for HPV anxiety 
 
Analysis of variance was used to test the second experimental hypothesis (HE2) which 
stated that there would be a significant difference in social support and perceived stress 
scores between women who indicated they were ‘Not anxious’ versus women who reported 
being ‘Anxious’. ANOVA showed that between the groups of women (‘Anxious’/’Not 
Anxious’) mean scores for social support availability (SSQN) and social support satisfaction 
(SSQS) and perceived stress (PSS) were significant, as follows: social support availability 
(SSQN) F(1,84) = 13.81, MSE = 13.48, p < 0.001; social support satisfaction (SSQS) F(1,84) = 
16.16, MSE = 11.04, p < 0.001; perceived stress (PSS) F(1,81) = 6.87, MSE = 39.12, p=0.01) 
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indicating that better social support and reduced stress are significant factors in reducing 
anxiety over HPV positivity.  
 
4.6.7. Reasons for Anxiety Over HPV Positivity 
Women were asked to select reasons for anxiety over HPV positivity. There were six 
possible pre-defined items that women could select as responses, and an additional free text 
option to allow the entry of their own reasons if the items offered did not cover this. 
Response choices included: disclosure, stigma, fertility, health (worry over developing 
cancer), life/mortality (fear of dying), none of the above/not concerned. Respondents could 
select multiple responses, therefore the cumulative number and percentage of responses 
exceed the sample number (N = 107) and 100%. Of the 107 respondents who gave at least 
partial data to the questionnaire, all 107 gave at least one response to this question. 
Responses to the question are given in Table 4.17. 
Reasons for anxiety N Percent 
Cancer recurrence 67 61% 
Developing Cancer 63 59% 
Stigma 45 41% 
Disclosure 41 38% 
Dying 10 37% 
Fertility 32 30% 
Other (free text reasons) 10 8% 
Not concerned 3 3% 
Table 4.17: Frequency table of responses to reasons for HPV anxiety 
 
The free text response box allowed space for up to 1,000 characters or several 
sentences. Ten individuals gave free text responses, which are given in Table 4.18. 
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Free text responses to reasons for anxiety 
Respondent Responses/reasons for anxiety 
8 I was worried and it was true. I have cevercal [sic] cancer 
9 Changing the way I interact with possible future partners or sexual 
encounters 
13 Worried about passing this on to children 
31 Severe embarrassment with outward signs (warts) 
40 Peoples [sic] lack of knowledge and assumptions 
47 The affects [sic] on my husband 
61 The effects on my husband 
63 Worried what if I have it in my mouth & what if I pass it onto my 
daughter by sharing a sip of squash every now & then. Well mainly 
scared of passing it onto her risking her life, she is only 2.5 yrs old. 
I'm also worried that my procedures was [sic] in 09.2013 back in 
Hungary as a [sic] have a doctor there I trust my result came back 
normal for the 3& 6 months smear but 2.2014 my result came back 
as Hpv? Parakariosis. I am scared to ask for a follow up smear in 
England as I know how spastic the system is but it'll be even a year 
till I can go to Hungary to have it checked. Anyway fingers crossed 
my immun [sic] system will fight it off. Hoping for the best & hope 
it'll be better for our daughter when she gets older. I do hope that 
hpv tests will be offered as a routine test at the gum clinics & the age 
limit for the smear test will be lowered to 16/18 or offered ASAP 
they become sexually active. I think it's very important. 
66 My daughter died of Cervical Cancer arising from undetected and 
untreated HPV infection 
71 Fear of infecting partner 
Table 4.18: Free text responses to reasons for anxiety over HPV positivity 
 
Free text responses to this question are further discussed in the discussion section. 
 
4.6.8. Embarrassment Over HPV Positivity 
Women who subscribed to HPV/cervical cancer related online support were asked to 
indicate their embarrassment over an HPV positive result. As with the previous question, the 
responses were originally on a five-item Likert style scale ranging from 1 – Very embarrassed, 
2: Embarrassed, 3: Neither embarrassed nor unembarrassed, 4: Not embarrassed, 5: Really 
not embarrassed. Again, due to a small sample size, the original five item scale was collapsed 
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to reduce the number of items, but increase the number of responses per item. Responses 
to a three-item (Embarrassed/Neither/Unembarrassed) were given as follows: 
Embarrassment Over HPV Positivity N Percentage 
Embarrassed 49 46 
Neither embarrassed nor unembarrassed 32 30 
Not embarrassed 25 23.1 
Missing data 1 0.9 
Total 107  
Table 4.19: Distribution of responses to embarrassment over HPV positivity 
 
Mean scores for social support availability (SSQN), social support satisfaction (SSQS) 
and perceived stress scores (PSS) were tabulated for each group of women (embarrassed, 
neither, not embarrassed) and are shown in table 4.20. 
HPV Shame/Embarrassment SSQN SSQS PSS 
Embarrassed/ashamed Mean 1.56 3.69 21.16 
N 49 49 38 
Std. Deviation 1.19 1.10 2.68 
Neither Mean 2.02 4.08 20.07 
N 32 32 26 
Std. Deviation 1.39 1.09 1.49 
Not embarrassed/ashamed Mean 1.65 3.98 21.11 
N 25 25 18 
Std. Deviation 1.11 .90 2.51 
Total Mean 1.72 3.87 20.80 
N 106 106 82 
Std. Deviation 1.24 1.06 2.35 
Table 4.20: Mean scores for SSQN, SSQS and PSS for embarrassment over HPV positivity 
 
Analysis of variance was used to examine for possible relationships between the three 
groups and perceived stress (PSS), social support availability (SSQN) and social support 
satisfaction (SSQS); but did not return any results significant to an alpha level of α ≤ 0.05. 
Embarrassment*Perceived stress: F (2, 79) = F = 1.86, MSE = 10.1, p = 0.16; 
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embarrassment*social support availability: F (2, 103) = F = 1.40, MSE = 2.14, p = 0.25; 
embarrassment*social support satisfaction: F (2, 103) = F = 1.50, MSE = 1.68, p = 0.22. 
 
4.6.9. HPV Knowledge Source 
Women were asked to indicate from where they had or would obtain information 
about HPV. Response options included doctor, nurse, family/friends, internet, internet 
(researching the vaccine), NHS Direct, or ‘Prefer not to say’. Women could select more than 
one response. Missing data analysis indicates that all respondents gave at least one 
response, there were no missing data for this question.  
How did you find out about HPV N Percent 
   
Doctor 50 45.0 
Internet 50 45.0 
Nurse 25 22.5 
Family/friends 11 9.9 
Internet/researching vaccine 6 5.4 
NHS Direct 1 0.9 
Prefer not to say 1 0.9 
Table 4.21: Frequency table of responses for HPV knowledge sources 
 
 
4.6.10. Length of Use of HPV-Related Online Support 
Women were asked to indicate how long they had been members of HPV-related 
online support groups. To put membership in context, it was cross-tabulated with stage of 
treatment to give an indication of whether membership was limited to the immediate period 
(the six to twelve months) of the treatment stage. Distribution of membership duration by 
treatment stage is shown in Table 4.22. 
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How long 
have you 
been  using 
an HPV-
related online 
support 
group 
Have you ever been offered treatment for abnormal smear 
 
       
No 
treatment 
yet 
Biopsy Treatment Treatment 
and  
Follow-Up 
Not had 
treatment 
Not 
needed 
treatment 
Total 
        
I don’t use 
them 
0 1 1 2 0 0 4 
A few weeks 0 4 2 0 0 0 6 
A few months 0 3 5 2 0 0 10 
About a year 0 2 2 6 0 0 10 
Over a year 2 19 23 17 2 8 71 
Prefer not to 
say 
0 0 6 0 0 0 6 
Total 2 29 39 27 2 8 107 
Table 4.22: Cross-tabulation of treatment stage and length of use of online support 
 
Women appear to retain membership of HPV-related online support groups beyond 
the immediate biopsy/treatment period, with 19 of the 29 women who required a biopsy 
(approximately a 6 month process) retaining membership over one year. Women who did 
not require treatment (N = 8) and women who had not received treatment (yet, N= 2) 
reported memberships of over one year. Data were recalculated – combining responses for 
membership of ‘a few weeks’ and ‘a few months’ and also combining responses for ‘about a 
year’ and ‘over a year’, to increase the number of responses per category. Comparison of 
mean scores for social support availability (SSQN), social support satisfaction (SSQS) and 
perceived stress scores (PSS) for these response categories are given in Table 4.23. 
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Duration of Online Support Use SSQN SSQS PSS 
I don’t use them Mean 1.87 4.17 18.75 
N 4 4 4 
Std. Deviation 1.00 1.13 1.50 
A few weeks/months Mean 1.68 3.96 21.53 
N 16 16 13 
Std. Deviation 1.05 0.95 3.30 
A year or more Mean 1.84 3.93 20.89 
N 81 81 66 
Std. Deviation 1.25 1.08 2.28 
Total Mean 1.81 3.95 20.89 
N 101 101 83 
Std. Deviation 1.20 1.05 2.46 
Table 4.23: Mean scores for SSQN, SSQS and PSS for length of online support use 
Analysis of variance did not indicate that length of online support membership was a 
significant factor for availability of or satisfaction with social support, or for perceived stress 
for this group. SSQN: F (2,98) = 0.11; MSE = 0.165, p = 0.89; SSQS: F (2,98) = 0.89; MSE = 
11.89, p = 0.91; PSS: F (2,80) = 1.99; MSE = 11.89, p = 0.14. 
 
4.6.11. Reasons for and Outcomes of Online Support Use 
Uses for online support among women subscribing to HPV-related sites were 
examined using Likert scale agreement with statements about reasons for usage including: 
emotional support, exchanging information, helping others and sharing experiences. Two 
follow up questions examined the outcomes of online support use; women were agree to 
indicate their agreement with feeling better informed about HPV and with developing better 
acceptance of HPV. Small sample size meant that the original 5-item Likert scale (Strongly 
Agree, Agree, Neither, Disagree, Strongly Disagree) was reduced to 3 response categories to 
increase the number of responses per cell (Agree, Neither, Disagree).  
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Reasons women use online support  
Statement Agree Neither Agree 
nor Disagree 
Disagree Missing data 
I use online support for N % N % N % N % 
Emotional support 74 73.2 20 19.8 7 6.9 6 5.6 
Exchanging information 73 72.2 21 20.7 7 6.9 6 5.6 
Helping others 65 60.7 6 5.6 7 8.9 29 27.1 
Sharing Experiences 73 72.2 8 7.4 3 2.8 23 21.4 
  
Since using online support I feel  
Better informed about HPV 68 63.5 8 7.4 5 4.6 26 24.2 
Better acceptance of HPV 41 38.3 31 28.9 9 8.4 26 24.2 
Table 4.24: Frequency table of responses for reasons and outcomes of online support use 
 
Mean scores for social support availability (SSQN), social support satisfaction (SSQS) 
and perceived stress score (PSS) for each reason statement for using online support 
(exchanging information, emotional support, helping others and sharing experiences) are 
shown in Table 4.25. 
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I use online support to exchange information SSQN SSQS 
P
PSS 
Disagree Mean 1.69 3.64 19.20 
N 7 7 5 
Std. Deviation 1.23 1.60 1.64 
Neither agree nor disagree Mean 1.38 3.84 20.3 
N 21 21 15 
Std. Deviation 1.04 .87 2.43 
Agree Mean 1.92 3.98 21.1 
N 74 74 63 
Std. Deviation 1.24 1.07 2.48 
I use online support for emotional support SSQN SSQS PSS 
Disagree Mean 2.09 3.69 19.50 
 N 7 7 6 
 Std. Deviation 1.06 1.85 1.76 
Neither agree nor disagree Mean 1.50 3.84 20.4 
 N 20 20 15 
 Std. Deviation 1.30 .89 1.80 
Agree Mean 1.85 3.98 21.1 
 N 75 75 62 
 Std. Deviation 1.20 1.03 2.62 
Help Others  SSQN SSQS PSS 
Disagree Mean 1.85 3.76 20.0 
 N 9 9 7 
 Std. Deviation 1.16 1.41 2.08 
Neither agree nor disagree Mean 1.13 3.51 20.0 
 N 12 12 8 
 Std. Deviation 1.14 .96 2.00 
Agree Mean 1.89 4.01 21.1 
 N 81 81 68 
 Std. Deviation 1.21 1.04 2.54 
Share Experiences  SSQN SSQS PSS 
Disagree Mean 1.64 3.79 20.0 
 N 8 8 6 
 Std. Deviation 1.23 1.50 1.89 
Neither agree nor disagree Mean .95 3.36 20.4 
 N 11 11 7 
 Std. Deviation 1.02 .93 2.23 
Agree Mean 1.92 4.02 21.0 
 N 83 83 70 
 Std. Deviation 1.19 1.03 2.54 
Table 4.25: Mean SSQS, SSQN and PSS scores for reasons for online support use 
 
Mean scores for perceived stress (PSS), social support availability (SSQN) and social 
support satisfaction (SSQS) for agreement with outcome statements for online support use 
are given in Table 4.27. 
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Better Informed About HPV SSQN SSQS 
P
SS 
Disagree Mean 1.50 3.51 21.40 
N 16 16 10 
Std. Deviation 1.25 1.35 2.50 
Neither agree nor disagree Mean 1.99 4.05 20.18 
N 32 32 27 
Std. Deviation 1.42 1.01 2.33 
Agree Mean 1.77 3.98 21.19 
N 54 54 46 
Std. Deviation 1.05 1.00 2.49 
Better Acceptance of HPV     
Disagree Mean 1.65 3.74 19.80 
 N 13 13 10 
 Std. Deviation 1.34 1.31 2.35 
Neither agree nor disagree Mean 1.76 3.90 20.19 
 N 39 39 31 
 Std. Deviation 1.22 1.15 1.97 
Agree Mean 1.87 4.01 21.66 
 N 50 50 42 
 Std. Deviation 1.19 .95 2.61 
Table 4.26: Mean SSQN, SSQS and PSS scores for outcomes of online support use 
 
Multivariate general linear modelling was used to examine the third and fourth 
experimental hypotheses. HE3 stated that women who reported agreement with the reasons 
for online support use – for emotional support, exchanging information, helping others and 
sharing experiences would show higher scores for availability of and satisfaction with social 
support, and lower scores for perceived stress. HE4 stated that women who reported 
agreement with outcomes for online support use – being better informed about HPV and 
gaining better acceptance of HPV would show higher scores for availability of and 
satisfaction with social support and lower scores for perceived stress. Multivariate GLM did 
not demonstrate any significant outcomes. 
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4.7. Discussion 
4.7.1. Demographics 
 Data from this section of the instrument was used to examine the first research 
question. The modal age brackets (25-34 years, 36% and 35-44 years 33.3%) mirror both the 
peak ages of incidence for cervical cancer (Cancer Research UK 2016) and the peak ages of 
internet use (ONS, 2017). A small percentage of women (5%) were in the 18-24 age bracket, 
indicating that they may have been subject to vaccination or had been diagnosed with HPV 
or CIN earlier than their first call for screening. The modal age brackets were also reflected in 
the ages of the participants who gave qualitative electronic interviews – all of whom were in 
the 25-34 or 35-44 age ranges.  
The majority of respondents to the questionnaire reported being married (78%) with 
equal percentages of women reporting being divorced/separated and single (9.9%). Although 
women in settled relationships report less anxiety over HPV, the preponderance of women in 
settled relationships utilising online support may reflect their ages, or a preference among 
individuals to prefer peer support or ‘weak tie’ support (as offered by online support groups) 
as weak tie support does not presume the fulfilment of roles demanded by close support 
networks (such as family and friends) (Wright & Rains 2013; Wright & Bell 2003). 
The overwhelming majority of respondents were of White British origin. According to 
the National Cancer Intelligence Network [NCIN] 2014, cervical cancer incidence among 
White females is 8.2-8.7 per 100,000 women. In Black females incidence is similar, ranging 
between 6.3-11.2 per 100,000 women. Incidence in Asian females is significantly lower, 
reported as ranging between 3.5 – 6.5 cases per 100,000 women. Therefore it would be 
reasonable to expect that the percentage of Black women using online support might be 
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similar to the rates seen among White females, but as is shown table 4.2 Black and British 
Minority Ethnic women are under-represented in the sample. A lower representation of 
Asian women is to be expected as, as far as is known, the reported incidence in Asian women 
is lower than seen in either White or Black population. Under-representation may also be 
due to a small sample size, as respondents to the survey comprised approximately six per 
cent of the total group (the membership of the online support group was in the region of 
1,500 individuals).  
 
4.7.2  Cervical Screening History and Frequency 
On examining cervical screening history, the majority of women reported that they 
were being followed up for a previous abnormality (N = 62, 57.9%), and the next most 
frequent response was from women who reported being screened regularly (N = 21, 19.6%). 
Numbers of women who indicated frequent (additional) screening, and those that indicated 
they were only screened occasionally were almost identical (‘Frequent/additional’ N = 7 
(6.5%); ‘Occasional’ N =8 (7.4%)). Of the women who reported never having been screened, 
the majority of these were due to age (‘Never/Not invited yet’; N=7). Cross-tabulation of 
cervical screening frequency and treatment history indicates that of these 7 women, 2 had 
had a biopsy, 3 had had treatment, 1 had refused treatment and 1 had not required 
treatment. This indicates that these women have been diagnosed with a cervical abnormality 
or HPV positivity prior to 24 years and 6 months old – the earliest that women can be invited 
for screening. These women may thus have been diagnosed on the basis of symptoms 
instead of screening, as per NHSCSP guidelines, which state that any woman reporting 
symptoms (abnormal bleeding patterns such as intermenstrual or post-coital bleeding) 
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irrespective of age or current recall status should be referred to Colposcopy for further 
investigation (NHSCSP, 2016). Qualitative data in the next chapter indicates at least one 
woman who was diagnosed with HPV and CIN at 22 years on the basis of symptoms. 
Women were asked to indicate if they had been offered treatment, to explore at 
which stage of the diagnostic and treatment process online support users were at. 
Responses categories were “I have an appointment but have not attended yet” – indicating 
that women have been referred and offered an appointment but have not attended for 
colposcopy. An appointment has to be offered within two weeks of a test result (for high 
grade results) or within six weeks (for low grade results) (NHSCSP 2016). Thus women 
selecting this response are at the start of the referral/treatment journey. “I have had an 
appointment but not required treatment” – indicating that the woman had been referred for 
a colposcopy but neither a biopsy nor treatment was required. This occurs in cases where 
the colposcopic examination was normal or showed HPV only (please refer to figure 1.1, 1.2 
and 1.3 in Chapter 1 for an explanation of the treatment algorithms); indicating that the 
woman was offered an appointment within the six week time frame and has been 
discharged back to primary care (her general practitioner). “I have attended a hospital or 
clinic and I have had a biopsy” – women who select this response will have been offered and 
appointment in the two- or six-week timeframe and colposcopic examination will have 
shown a low-grade lesion which indicates the need for a biopsy. This group and the previous 
group who did not require treatment correspond to the ‘liminal’ women who have had HPV 
infection confirmed by cytology/molecular diagnostics but for whom no neoplastic process 
has been identified, or for whom CIN1 has been diagnosed but a conservative management 
process has been recommended, or who show CIN2+ on biopsy and who are currently 
awaiting treatment. “I have attended a hospital or clinic and I have had treatment” – women 
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selecting this response will either have had a low-grade lesion that required biopsy, where 
the biopsy result that indicates the need for treatment in the case of CIN1, CIN2, CIN3 or 
possible invasive disease, or will have demonstrated a high grade lesion on colposcopic 
examination that required immediate treatment (bypassing the requirement for a biopsy). 
These women will be in the later stages of their treatment arc, corresponding to a time-
frame of approximately 6 months since an abnormality was first identified by cytology. “I 
have had treatment and a follow-up test” – women who have selected this response have 
undergone treatment and have had a test-of-cure or are on long-term follow-up for 
minimally invasive disease (FIGO stage 1A1). The timeframe for these women is around 6-12 
months, between 2-6 weeks for referral, 4-8 week between biopsy and treatment 
(depending on severity of abnormality at cytology and on colposcopy), and 6 months 
between treatment and a follow-up appointment (NHSCSP 2016, p.23). The majority of 
women reported being in the treatment arc, either having had a biopsy (N = 29, 27.2%), 
treatment (N=39, 36.5%) or treatment and follow-up (N = 27, 25.2%). Of women who had 
not had treatment, 2 had yet to attend their appointment (1.8%), 8 had not required 
treatment (7.5%) and 2 had refused treatment (1.8%). Reasons for treatment refusal were 
not given, and could not be followed up as the questionnaire was anonymous. The 
proportion of the population who have received treatment and/or treatment and follow-up 
would seem to indicate that women remain part of an online community once treatment is 
complete, either for further reassurance and support or to help others by sharing 
experiences/knowledge. Women who are awaiting treatment make up a small proportion of 
the group (N =2, 1.8%). Women for whom no treatment was required (N=8, 7.2%) would 
most likely make up the population of women who are HPV positive in the absence of CIN – 
the women who were the main focus of the research at the outset, the ‘liminal women’. This 
subset currently makes up only a small proportion of the research population at present (in 
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the absence of HPV primary screening). Similar to the women who remain once treatment is 
complete, these women may remain part of the group in the absence of a need for 
treatment in order to gain further reassurance from the experiences of others, to learn more 
information about their situation or because of doubts surrounding HPV negativity due to 
dormancy rather than clearance (Maglennon 2012; Gravitt et al. 2011). 
  
4.7.3.  Awareness of HPV 
Women were asked to indicate whether they were aware of the human papillomavirus 
(HPV). There were 26 instances of missing data, but of the remaining 81 individuals the 
majority indicated that they were aware of HPV (N = 79, 73.8%), with only 2 women 
reporting that they were not aware. As a follow-up question, to examine where women may 
initially have learned about HPV, respondents were asked whether or not they had 
daughters who were eligible for the HPV vaccine. If the majority indicated that this was the 
case, then awareness of HPV may have been gained through research into the vaccine. As 
indicated in the table, 77 women indicated that they did not have daughters eligible for 
vaccination (72%). All respondents answered the vaccination question. Awareness may thus 
be due to counselling at the point of screening (Everett et al. 2011) or self-directed learning 
after diagnosis (Rager 2006, 2004). 
Women were asked to indicate whether or not they had had an HPV test. The majority 
of women (N = 75, 70%) indicated that they had had an HPV test. Of the negative responses, 
1 chose not to participate (0.9%), 16 had not been tested (14.9%), 5 had not been invited yet 
(4.6%) and 10 women were not sure (9.3%).  The HPV testing history question occurred after 
the question ‘Are you aware of the human papillomavirus’ (missing data N = 26), and was 
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answered by all 107 respondents, indicating that the awareness question may have been 
skipped because women did not understand the question (e.g. what was meant by 
awareness) or because they did not feel it applied to them, rather than through fatigue or 
attrition. 
Of the HPV knowledge statements almost all of the respondents were aware that HPV 
may cause cervical cancer (106 of 107 respondents selecting this statement) although less 
women (among a group of women who subscribe to HPV-related online resources) selected 
as true statements regarding the relative prevalence of HPV (‘HPV is the most common STI in 
the UK’, 46 responses) and relative inefficacy of condoms in preventing genital HPV infection 
(‘HPV may not be stopped by condoms, 54 responses). It should be noted that these 
questions as women to select which items they believed to be true, rather than allowing a 
‘True’/’False’ response. Therefore a missing response may not necessarily indicate a lack of 
agreement with the statement, and this factor is noted as a limitation to the study. However, 
this data may help to highlight that knowledge gaps remain in the awareness of the general 
public and that improving awareness of these issues may help reduce stigma associated with 
HPV.  
 
4.7.4. Disclosure Intention and Preferred Confidant Group 
Data from this section of the instrument were used to test the first experimental 
hypothesis – that social support scores may a predictor of disclosure intention. The majority 
of women indicated that they would confide in someone regarding positive HPV result (N = 
94, 87.9%), with only 12 (11.2%) indicating that they would not disclose HPV positivity to 
anyone, and 1 individual preferring not to indicate their opinions on disclosure (0.9%). This 
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finding indicates that despite reservations reported in research about the disclosure of 
stigmatised conditions (Montgomery et al. 2008; Hult et al. 2012), the majority of women 
would still disclose their condition in current or future relationships. The question over 
preferred confidant group allowed multiple responses. ‘Partner’ was the most common 
response with 69 women (62.2%) selecting this category. Disclosing to or confiding in 
clinicians/nurses was the next most common response (N = 66, 59.5%). ‘Family’ and ‘Friends’ 
drew an equal number of responses (N = 50, 45%), with ‘Online support’ (N=48, 43.2% and 
‘Counsellor’ (N =14, 12.6%) being less popular responses. Comparison of mean scores for 
social support availability and satisfaction was not possible as participants were able to 
select multiple responses. Respondents who had selected only family only vs. non-family 
were not large enough to infer statistical significance to any differences in social support. 
Thus from this exploratory data, it is reasonable to conclude that women do not use online 
support groups to confide their HPV-positivity to the exclusion of other forms of support 
(such as the physical support provided by family, friends and healthcare or mental health 
professionals). Disclosure to internet groups may only occur as an expedient to accessing the 
experiential aspects of online support. 
 
4.7.5. Anxiety Over HPV Positivity 
Data from this section of the instrument was used to test the second experimental 
hypothesis, that women indicating they were ‘Not Anxious’ about HPV positivity would 
report higher social support scores and lower perceived stress scores. Women were asked to 
indicate their level of anxiety on a 5-item Likert scale. However, lack of use of the ‘Neither’ 
category allowed for responses to be divided into ‘Anxious’ and ‘Not anxious’. The group of 
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women who reported anxiety over HPV positivity showed lower mean scores for social 
support availability and satisfaction, and higher mean scores for perceived stress than the 
group who reported no anxiety over HPV positivity. This difference was statistically 
significant at a significance level of P < 0.01, and thus the second experimental hypothesis is 
accepted. 
 
4.7.6. Reasons for Anxiety Over HPV Positivity 
All respondents answered this question (N = 107), although the total number of 
responses and percentage of response exceed the sample total as women were able to 
select more than one item in response. The modal response was “Health – I am worried 
about cancer returning” indicating that for 67 women (62.6%) HPV positivity made them 
anxious about cancer recurrence – it is not possible to know whether these women had 
invasive cervical cancer or CIN3 (this question was not asked as the researcher assumed that 
the majority of women asked might not know the difference between pre-cancer and 
cancer), or whether clinicians used the term ‘cancer’ as shorthand for ‘a highly abnormal pre-
malignant lesion’. The meaning of HPV positivity for these women was anxiety over disease 
recurrence. Disease recurrence was also mentioned as an issue for women in the qualitative 
portion of the study, although framed somewhat differently – through uncertainty over HPV 
latency. The next most frequent responses surrounded fears about developing cancer (N = 
63, 58.8%). Again, the question over whether women meant cancer or pre-cancer in their 
response still applies (but this is due to the wording of the question). Women reported 
similar frequencies for anxieties surrounding stigma (42.1%), disclosure (38.3%) and 
mortality (37.4%). Concerns surrounding fertility were the least commonly reported, with 
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29% of women reporting this as a concern – these may be due to the age ranges of the 
participants, the majority of women may have already completed their families. Only 3 
women in the sample were not concerned, and 10 women reported “Other” concerns and 
gave free text answers. Of these, 5 of the 10 women reporting other reasons for anxiety 
mentioned fears of transmission either to their partners (through sexual contact) or to their 
children (through the sharing of household items such as drinking vessels, towels and bed 
linen). Issues around disclosure and stigma were second only (in frequency of response) to 
fears surrounding recurrent or developing cancer. 
 
4.7.7. Embarrassment Over HPV Positivity 
Encouragingly, less than half of the sample reported that they would be embarrassed 
by a positive HPV result (N=46, 46.2%), compared to 53.8% reporting ‘Neither’ (N=32, 
30.2%) or ‘Not embarrassed’ (N= 25, 23.6%). As the majority of the sample had reported 
being in a committed relationship (78%), and that this factor was associated with decreased 
stigma/anxiety (Kwan et al. 2011; Filiberti et al. 1993) it follows that the majority of the 
sample did not feel any shame or embarrassment surrounding HPV positivity, in addition, 
the development of a collective identity as reported by Bane et al. (2005) may help to 
reduce shame. ANOVA was used to test the differences in scores for social support and 
perceived stress between the three groups (‘Embarrassed’/’Neither’/’Not Embarrassed’) 
was not significant at an alpha level of 0.05 and thus the null hypothesis is accepted.  
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4.7.8. HPV Knowledge Sources 
Women were asked to indicate where they had or would obtain information about 
HPV. The modal response for the question of where women obtained their knowledge about 
HPV was split between ‘Doctor’ and ‘Internet’ (both N=50, 45%), indicating that for this 
group, looking up information on the internet was as likely as asking questions of a clinician. 
In addition, clinical information is only one form of knowledge, and the experiential 
knowledge of disease cannot necessarily be narrated by clinicians, hence the popularity of 
the internet as a source of information for the group. The uses for online support will be 
further examined in section 4.7.10. 
 
4.7.9. Length of Use of Online Support 
Women were asked to indicate how long they had been using an HPV-related online 
support group. The most common response was ‘Over a year’ (N = 71, 63.3%). Women 
reporting membership of ‘About a year’ and ‘A few months’ were equal (N = 10, 9.3%). 
Women who had been members for less time made up fewer of the responses (N = 6, 5.6%), 
with 4 women reporting that they did not use them (3.7%). These women may have been 
recruited from the Jo’s Trust website, since the other two organisations (The Teal Ladies and 
BME Cancer Voice) are set up (on social media) as support groups, whereas the Jo’s Trust site 
has information and research pages, a forum area where individuals can post questions or 
supportive message, but it is possible to access the information pages without interacting 
with other users. The remaining 6 women preferred not to indicate their length of 
membership (5.6%). When treatment stage was cross-tabulated with duration of 
membership it became apparent that the majority of women who reported membership of a 
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year or more (N = 81, 75.6%) were split fairly evenly between ‘Had a biopsy’ (N = 21, 19.6%), 
‘Had treatment’ (N = 25, 23.3%) and ‘Had treatment and a follow-up test’ (N = 23, 21.4%). 
The remaining 12 had retained membership of an online support group despite not having or 
requiring treatment. The figures indicate that women retain membership of support groups 
for longer than the immediate biopsy/treatment period. Whilst it is possible that once the 
immediate need for information or reassurance is over women forget to leave support 
groups, the reasons for popularity of ‘extended’ membership (over a year) are explored in 
section 4.7.10. Women who reported not using online support groups also reported the 
highest mean scores for availability of (SSQN) and satisfaction with (SSQS) social support, and 
the lowest mean scores for perceived stress than all other groups (SSQN = 1.87, SSQS = 4.17, 
PSS = 18.75). Women who reported using online support for a year or more reported higher 
mean scores for social support availability (SSQN = 1.84, N = 81) and lower perceived stress 
(PSS = 20.89, N = 66), than women who had been using online support for weeks to months 
(SSQN = 1.68, N = 16; PSS = 21.53, N = 13), with satisfaction with social support being roughly 
equal in both groups (weeks/months SSQS = 3.96, N = 16; ‘a year or more’ SSQS = 3.93, N = 
81).  
 
4.7.10. Reasons for and Outcomes of Online Support Use 
Data from this section of the instrument was used to test the third and fourth 
experimental hypotheses. HE3 stated that women who agreed with the reasons statements 
for online support use would show the highest scores for social support and lowest scores 
for perceived stress. However, women who agreed with all four statements showed the 
highest mean scores for perceived stress. Women who indicated agreement with ‘I use 
online support groups to exchange information; showed higher mean scores for both 
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availability of and satisfaction with social support. Women who agreed with the statement ‘I 
use online support groups for emotional support’ had lower mean scores for availability of 
social support, but higher mean scores for satisfaction with that support. Women agreed 
with the statement that they use online support to help others showed the highest mean 
scores for both availability of and satisfaction with social support. Finally, of the reason 
statements for using online support, women who agreed with the statement ‘I use online 
support for sharing experiences’  also reported the highest mean scores for both availability 
of and satisfaction with social support. 
Data from the outcome statements for using online support were  used to test the 
fourth experimental hypothesis which stated that women who agreed with outcomes 
statements for online support use would demonstrated higher scores for social support and 
reduced scores for perceived stress. Women who agreed with the statement ‘Since using 
online support I feel better informed about HPV’ did show the higher mean scores for both 
availability of and satisfaction with social support than women who disagreed, but also 
higher mean scores for perceived stress than women who disagreed. Women who neither 
agreed nor disagreed with the statement showed the highest mean scores for social support 
and lowest mean scores for perceived stress than women who either agreed or disagreed 
with the statement. Women who reported agreement with the statement ‘Since using online 
support I have improved acceptance of HPV’ showed the highest mean scores for availability 
of and satisfaction with social support, but also the highest mean scores for perceived stress. 
Multivariate GLM analysis for agreement with online support use reasons (emotional 
support, exchanging information, helping others and sharing experiences) against social 
support availability (SSQN), social support satisfaction (SSQS) and perceived stress (PSS) did 
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not indicate that differences between groups were significant (please refer to Appendix 3 for 
statistical tables for outcomes for this analysis). 
 
4.8. Conclusions 
The aims of the questionnaire study were to examine the characteristics of a 
population of HPV-related online support users; and to explore the reasons for and 
outcomes of online support use among women in terms of increased availability of and 
satisfaction with social support, and reduced perceived stress. The research questions asked 
if the demographic characteristics of HPV-related online support users reflect those of the 
general screening population, whether there was a relationship between increased social 
support and disclosure, and whether the use of online support (in terms of emotional 
support, exchanging information, helping others or sharing experiences) or the outcomes of 
using online support (feeling better informed about HPV, or gaining better acceptance of 
HPV) were associated with increased scores for social support and reduced scores for 
perceived stress. The four experimental hypotheses reflected the aims and the research 
questions. 
The first hypothesis postulated that there would be a significant relationship between 
increased social support scores and the propensity to disclose a possible positive HPV result. 
The linear regression of disclosure intention and social support indicated that social support 
availability (SSQN) and social support satisfaction (SSQS) were not significant predictors of 
disclosure. Therefore in order to avoid Type II errors, the null hypothesis must be accepted – 
for this population, there is no significant relationship between social support and disclosure.  
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The second hypothesis suggested that there would show a significant relationship 
between a reported lack of anxiety over HPV positivity and increased scores for availability of 
and satisfaction with social support. Women were asked to indicate their anxiety over HPV, 
and these responses could be divided into ‘Anxious’ and ’Not anxious’. Comparison of mean 
scores for the dependent variables was made and indicated that the group of women who 
reported a lack of anxiety over HPV showed increased scores for social support and 
availability and reduced scores for perceived stress. Therefore to avoid a Type I error, the 
null hypothesis (that no significant relationship would exist between social support and/or 
perceived stress and anxiety over HPV positivity) must be rejected. 
The third hypothesis made the assumption that agreement with the uses of online 
support (for emotional support, to exchange information, to help others or to share 
experiences) would be associated with increased social support scores and reduced 
perceived stress scores. The fourth hypothesis made similar assumptions, but focused on the 
outcomes of online support (being better informed about HPV and/or gaining better 
acceptance of HPV) – predicting increased social support scores and reduced perceived 
stress scores for the women who agreed with these outcomes. A multivariate generalised 
linear model of the independent and dependent variables did not indicate any significant 
outcomes at an alpha level of 0.05, so in order to avoid a Type II error, the null hypothesis 
must be accepted – no significant relationship exists between online support uses or 
outcomes and social support scores and perceived stress scores. 
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4.9. Summary of Findings from Quantitative Data 
 The majority of women subscribing to an HPV-related online support group were 
between 25-44 years (N = 75, 69.3%), and had had an abnormal smear result (N = 
96, 89.75), an HPV test (N = 53, 49.5%) and had had either a biopsy, treatment or 
were on follow-up post-treatment (N = 95, 85.5%). 
 The majority of women were aware of HPV (N = 79, 73.2%), although there were 
missing data for this question. 
 The majority of women would confide in someone about HPV positivity (N = 94, 
87.9%), with ‘Partner’ being the most popular choice of confidant (N = 69, 62.2%). 
 Of the HPV knowledge statements, the relative ubiquity of HPV and the inefficacy 
of condoms in preventing transmission were the least frequently selected 
knowledge statements (N = 46, 42.9% and N = 53, 49.5% respectively). 
 Women who reported anxiety over HPV positivity reported lower mean scores for 
social support availability and satisfaction and higher mean scores for perceived 
stress than women who reported they were not anxious about HPV positivity. 
 When selecting reasons for HPV anxiety, fears over developing or recurring cancer 
were the most commonly cited reasons, with fears about stigma and disclosure 
being the next most common reasons. Free text entries for anxiety focused on fears 
over transmission to partners and children and of stigma. 
 There were no significant relationships between uses of online support (emotional 
support, exchanging information, helping others or sharing experiences) and either 
increased scores for social support or reduced scores for perceived stress. 
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 There were no significant relationships between outcomes of online support use 
(feeling better informed about HPV, or gaining better acceptance of HPV) and 
either increased scores for social support or reduced scores for perceived stress.  
Page | 143  
 
Chapter Five – Qualitative Data Analysis 
Study 2: Electronic Interview Study Examining Lived Experience of Users of HPV-Related 
Online Support 
5.1. Introduction 
The previous chapter gave details of the aims, methods, analysis and findings for the 
quantitative study data derived from questionnaire responses, Study 1. This chapter will 
examine the qualitative study – Study 2 – conducted to explore women’s lived experiences of 
HPV positivity and the role that online support played in those lived experiences. The study 
employed the follow-up explanations model, using qualitative data to add depth and 
explanations to the findings of the quantitative data analysis. 
 
5.1.1. Aims of the Electronic Interview Study 
The research questions introduced in Chapter 1 examine the possible representation of 
HPV or HPV & CIN as a biographical disruption, contributing factors and the role(s) online 
support might play in the management of the self, stigma and biography during the diagnostic 
and treatment process. The qualitative study aims to answer these questions by examining 
women’s experiences of HPV positivity and their interactions with and experiences of the 
online support processes they solicited during the diagnostic and treatment process. The aims 
for the qualitative electronic interview study are as follows: 
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1. To recruit a population of women from online support resources to participate in and 
obtain qualitative data from electronic interviews. 
2. To analyse transcripts of qualitative data obtained from electronic interviews to 
examine women’s experiences of HPV positivity and online support and identify themes 
that might be common to their individual experiences. 
3. To document the ways in which women interact with online resources and support and 
to examine how both HPV positivity and online support have impacted on their lives. 
 
5.1.2. Research Questions 
Research questions were formulated to fulfil the aims of the qualitative interview study. 
These were informed by the literature reviewed in the first three chapters which examined the 
psychological and sociological impacts of HPV positivity, and the effects of illness on identity, 
and the exploration of phenomenology in the third chapter. The research questions for the 
qualitative study are as follows: 
 
1. Does a diagnosis of HPV or HPV & CIN represent a biographical disruption? 
2. What factors might contribute to this? 
3. What role(s) might online support play in the management of the self, stigma and 
biography during the diagnostic and treatment arc? 
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5.2 Interview Schedule/Questions, Identifying Sample Populations 
An interview schedule of questions was drawn up, drawing on the topics identified in 
the literature review. Broad themes for questions included meaning-making, asking 
participants to reflect on their feelings surrounding the diagnostic process. Additional 
questions included issues of biography, asking women whether a diagnosis of HPV had 
affected their views of themselves or their outlook on life. As the interviews aimed to capture 
lived experience, the interview schedule also asked for description of typical days and ‘good’ 
days. Questions prompting reflections on both physical social support and online support were 
also included. The interview schedule can be found in Appendix 6. The structure of the 
schedule drew on the writing of Smith, Flowers and Larkin (2009, p.60) asking comparative, 
descriptive, evaluative, narrative and circular questions to encourage participants to engage in 
reflection and self-reflection around the topics raised. This was particularly important as all 
participants opted for electronic interviews, meaning interviewer prompting was minimal. The 
interview schedule was forwarded to the supervisory team for review and comment.  
 
5.2.1.  Identifying and Approaching Sample Populations 
Entering these terms into internet search engines returned results for Jo’s Cervical 
Cancer Trust, the Eve Appeal and for several blogs written by women narrating their 
experiences of suffering from cervical cancer.  The Eve Appeal is a charity dedicated to 
research into and support for women suffering from cancers of the female genital tract. The 
Eve Appeal did not respond to or acknowledge several approach emails and was thus excluded 
from the study. Blog authors based in the UK were also approached via email (through 
‘Contact’ buttons/forms) with the approach letter found in Appendix 5, but no responses were 
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received. The researcher decided not to post in the comments on blogs to attempt 
recruitment of individuals commenting on blogs, as she perceived these to be private online 
spaces as opposed to public ones (Hunsinger & Senft 2013, p.145). Positive responses were 
received from Jo’s Trust, which, according to the ‘About Us’ section of the website is ‘the only 
UK charity dedicated to women affected by cervical cancer and cervical abnormalities’ (Jo’s 
Trust 2017). The charity provides an online space for forums within the website for women 
who suffer from cervical abnormalities, including separate forum areas for each grade of 
abnormality (as per the NHSCSP reporting guidelines), including a dedicated space for ‘HPV 
only’ women; and a forum board for each stage of cervical cancer. The website hosts research 
pages whereby researchers can post adverts for their studies, which users can visit and sign up 
to of their own volition. In order to post a research advert on the hosted pages, a copy of the 
project proposal, participant information sheet, consent form and interview schedule plus a 
link to an electronic copy of all of these items (hosted at SurveyMonkey, to allow participants 
to register their consent electronically) was submitted to the Research Department at Jo’s 
Trust Head Office for review in order to gain permission to post on their research pages. In 
total, two individuals were recruited via Jo’s Trust research pages. 
 
5.2.2. Social Media Populations 
In addition to posting with Jo’s Trust a number of groups were identified on Facebook – 
the names of these have been redacted in order to preserve the confidentiality of the 
participants. Forum sources on Reddit were excluded as there was not enough continuity 
between threads/posters, and setting up a private group would take time in comparison to 
approaching established groups. Four social media groups were identified, with memberships 
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ranging from 800 to 2,000 members. Administrators for each group were identified and 
approached using Facebook messaging using the text in the approach letter given in Appendix 
A, and permission to join each group was granted. However, despite being permitted to join 
each group, only one group’s administrator specifically responded to the approach message 
expressing a willingness to support the project and to post the research advert on the 
researcher’s behalf, with the following stipulations: 
‘The only thing I would ask is that you don’t contact people about your research 
directly (either via comments on posts, private messages or postings) – unless they come 
to you of course.’ 
(Gatekeeper, personal communication, Feb 2017) 
 
5.2.3 Gatekeepers – The Recruitment Process 
All of the groups encountered (detailed in Chapters Four and Five) were closed sites, 
which required registration and a request to join the group before users were allowed to post 
to forums or join discussions. Within each of these groups, gatekeepers were approached to 
request to access to participant populations. This permission was granted, but only one 
administrator responded positively to the approach message. All posts about the research 
(using the text from the approach letter and links to the SurveyMonkey consent process) were 
forwarded to the group by the administrator following discussion and agreement with the 
researcher. In addition, as shown above, the administrator requested that no direct requests 
were made by the researcher to group members either by posting, commenting or by direct 
messaging. Thus the administrator fulfilled the role of gatekeeper to the research population 
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in this context. According to (Broadhead & Rist 1976) gatekeepers are persons who are able to 
arbitrate access to a social role, field setting or structure.  
Stewart & Williams drew attention to gate-keeping issues in online-mediated research 
including the danger of such  groups being ‘over-researched’, stating that: ‘of the 60.5 million 
current users, many may become nonchalant toward the myriad of questionnaires, interviews 
and focus groups they are asked to partake in on a weekly basis’. Williams gave an example of 
an online group who were sampled by an undergraduate class in the US who had, the evening 
before, been sampled by a Master’s student in the UK some 12 hours earlier.  They concluded 
that successful gate-keeping encounters relied on trust, rapport and the instance of shared 
history (Stewart & Williams 2005). 
The gate-keeping role fulfilled by staff at Jo’s Cervical Cancer Trust was very formal, and 
the documentation review undertaken was in very similar in rigour and formality to the 
University ethical approval process. From the perspective of Stewart & Williams conclusions 
above, trust was established through the submission of personal details such as curriculum 
vitae and evidence of professional qualifications, along with the documentation review 
procedures. In addition, contact details for the researcher’s employer and the University 
Graduate School Office were supplied in case of any questions about the researcher’s place at 
the University or place of employment.  
The gate-keeping role for peer support groups run through social media platforms was 
fulfilled by volunteers – administrators or founders of groups – but the approach to research 
was met with the same professionalism as was received from the University and from Jo’s 
Trust. ‘Admins’ were sent the same covering letter as the charity (by Facebook messenger or 
by email to addresses specified in ‘Contact Us’ sections of websites). In the case of Facebook 
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groups, an email address for an admin was requested so that all researcher information, 
project proposal documents and SurveyMonkey/CallForParticipants.com links could be 
forwarded. As previously stated, only one administrator responded to the approach message, 
from the five groups that were contacted – several attempts at approach (three in all – original 
and two follow-up messages) were made to the administrators who did not respond, but after 
the second follow-up message the researcher stopped contacting the groups. 
The successful gate-keeping encounter within a social media support group bore out 
Kerekes’ (2006) recommendations of shared interest or common ground as, serendipitously, it 
happened that the administrator for the Facebook-based support group was an alumnus of 
the University, and aware of the need for rigour in the research proposal and ethical approval 
process; thus it was easy to find common ground which greatly facilitated the approach 
process. 
 
5.3. Data Analysis 
Data from online interviews was analysed using thematic analysis (TA). Thematic 
analysis is one of the most common and perhaps oldest form of qualitative data analysis 
(Sandelowski 1995). According to Braun & Clarke (2006) it is particularly useful for the relative 
novice to qualitative data analysis, describing it as “a foundational method for qualitative 
analysis” and the “first that researchers should learn”. Thematic analysis involves the 
examination of qualitative (text-based) data in order to identify themes within the text that 
are apposite to the phenomenon under scrutiny (Guest et al. 2012, p.3). Braun and Clarke 
(2006) describe six stages to thematic analysis – familiarisation with the data (transcription), 
generating initial codes, searching for themes, reviewing themes, defining and naming themes 
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and producing the report. Sandelowski (1995) also advises getting a ‘sense of the whole’ (or 
‘orienting gestalt’). This has been done with the qualitative data here by reflecting on the tone 
and content of each narrative as a whole, prior to identifying individual themes within each 
narrative. The point of identifying themes is a pertinent one in two respects. Anzul et al. (2003, 
p.208) warn that themes do not ‘reside’ in the data, waiting to be discovered – that thematic 
analysis is not a passive act – but that the process of identifying and coding a theme is an 
active process on the part of the researcher. Foster and Parker (1995, p.204) echo this idea of 
an active researcher, stating that analysis of the material is ‘a deliberate and self-consciously 
artful creation’ by the researcher to argue their case to the reader. The other issue in the case 
of identifying themes is deciding what ‘counts’ as a theme. This is particularly significant in the 
case of this research as the number of transcripts is limited. Braun and Clarke do not specify 
that a theme has to be a specific size (i.e. running to several sentences). In the case of this 
research, as will be discussed later, a theme was identified as an item that was mentioned by 
more than one participant. 
Thematic analysis was chosen as it is an accessible and flexible means of analysing 
qualitative data that fits within the epistemological and theoretical assumptions of the 
research (as described in Chapter 3) with a clear process for undertaking the analysis and a 
good history of use in the field of HPV research (Standifer 2016; Batista Ferrer et al. 2015; 
Seale et al. 2012). 
 
5.4. Data from Electronic Interviews 
The following sections will examine the themes that were identified in the stories of the 
women who agreed to participate in online research interviews, as related to and interpreted 
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by the researcher. Three women were recruited to the online interview arm of the study. As 
mentioned in the research methods chapter, several online support groups were approached, 
with memberships ranging from 800 to 3,500 people. Originally, seven women displayed an 
interest in and signed up to the study, going through the consent process, receiving participant 
information and a set of questions, but of these only three returned responses to the 
questions. Respondents who did not return answers were sent two follow up emails, ten days 
apart. If they had not responded after this time, they were not contacted again. Two 
participants returned several pages of answers and surrounding narrative that contained lots 
of description and motifs. One participant returned much thinner data – approximately one A4 
page, but this still contained some profound statements on the effect HPV positivity and CIN 
had had on her life. 
  
5.5.  Participant Stories and Narratives 
A brief summary of women’s stories follows, outlining their situations, followed by 
reflections on the structure of their narratives. A fuller exposition of the themes and sub-
themes that were identified in the retelling of their experiences will follow. 
 
5.5.1.  Jay’s Story 
Jay was recruited via a social media support group, of which she is a founder and group 
adminstrator. Jay was 34 years old at the time of her interview. Jay is married. Her husband is 
aware of her HPV status, and is supportive of her, to the point of becoming a member of the 
support group. They have no children. Jay has multiple co-morbidities including asthma, 
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fibromyalgia and lupus, and works from home. She has been an active member of an online 
support group for approximately five years. Jay was diagnosed with CIN1 and HPV in 2011 and 
decided to “research her way to peace” after finding very little information available through 
her healthcare practitioner. Overall, Jay felt the diagnostic and treatment pathway was a long, 
drawn-out process that was at times confusing, with conflicting information being given. 
 
5.5.2. Claire’s Story 
Claire was recruited after seeing the research advert that had been placed with the Jo’s 
Trust website, as she was a regular user of the site and forums. Claire was the youngest 
woman to participate, at 22 years old. Claire is in a relationship, but she and her partner have 
no children. Claire’s partner was originally unaware of her HPV status/the role of HPV in CIN at 
first, although they ‘talk more openly about it now’. Claire’s responses/narrative indicate that 
she had to push hard to be referred to Colposcopy, attending her GP surgery ‘on a few 
occasions’ as she was below the age for screening and thus would not have been eligible for 
her first screening test for another three years, at age 25. Similar to Jay, Claire reported that 
healthcare practitioners gave conflicting information, which prompted her to research her 
symptoms online. Claire felt that both her diagnostic process and resulting condition were 
‘somewhat different to the norm’ as she had developed symptoms at an early age (22 years) 
and because she had received all three doses of the HPV vaccine at 13/14 years of age. Claire 
feels her experiences will help her be a better healthcare professional. As will be made clear in 
a deeper analysis of her narrative, Claire experiences an onset of symptoms (similar to the 
‘creeping onset of symptoms described’ by Bury) and her repeated efforts to obtain a referral 
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for colposcopic examination constitute a response to disruption through the ‘mobilisation of 
resources’ (Bury, 1991; 1982). 
 
5.5.3.  Jo’s Story 
Jo was recruited via the Jo’s Trust website, having used their ‘Ask a Professional’ service 
(it should be noted here that the researcher is not a member of the ‘Ask a Professional’ panel). 
Jo is a 25 year old student with one daughter. Jo was diagnosed with pre-cancerous cells 
following a miscarriage in February 2016. Jo feels that due to her career choice, she is 
generally well-informed on health matters although she was ‘shocked’ to learn about the role 
of HPV in her diagnosis.  She reports that she was aware ‘that it is extremely common.’ Jo felt 
that overall the experience was positive, as she hopes to become a nurse specialising in 
Gynaecology and that her own experiences will improve her practice. 
  
5.6.  Reflection on Narratives 
Each narrative represents a very different facet of the lived experience of CIN 
treatment, the lived experience of HPV positivity and the uses each respondent made of 
online support (one social media, one via an online professional, one via an internet forum). 
An overall analysis of each of these narratives is given below. A more detailed examination of 
the super-ordinate and sub-themes will follow.  
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5.6.1. Reflection on Jay’s Narrative 
Jay’s narrative uses very emotive and descriptive terms when narrating her lived 
experience of the diagnostic and treatment process. There are several references to darkness, 
oppression and uncertainty: 
 ‘the possible cancer diagnosis hung over me like a dark cloud’, 
‘when I finally did hear back that the biopsy was fine, I was very relieved; only to be 
quickly overshadowed by the news that I’d need the LLETZ procedure.’ 
‘another fling into the unknown’  
 
In the context of her narrative, Jay literally describes being thrown into a new world of 
the unknown, uncertainty, illness and anxiety; which would shortly become another new 
world of clinical terminology and treatment that had already existed without her knowledge of 
it. Jay also mentions the physical experiences, including pain and panic during the diagnosis 
and treatment process in great detail: 
‘I had to go on bed rest… I felt like I had a blow torch burning inside – constantly.’  
Thus the meaning that Jay seems to put on the experience is first one of pain and 
anxiety; followed by fear and waiting. Jay mentions that her partner was fully apprised of her 
disease status, and supportive of her to the point of becoming a member/fellow admin of her 
support group and accompanying her to appointments. The second half of her narrative 
describes the formation of the support group; the role she played in setting up the group and 
leading discussion with others. The meaning of her lived experiences after diagnosis is focused 
on research and learning for herself – both about the virus and about coping strategies; and 
then on teaching, supporting and informing others. Toward the end of her narrative, Jay 
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speaks of the more positive aspects of HPV positivity, describing it as ‘a positive experience 
overall’ whilst being aware that HPV may recur in the future. 
 
5.6.2. Reflection on Claire’s Narrative  
Claire’s narrative is more detached, factual and clinical than Jay’s. This may be in part 
due to her nurse training. She does not describe her symptoms or refer to pain. The overriding 
meaning apparent in the first half of her narrative is that of difference, struggle, and 
frustration – the struggle be heard and to be diagnosed at all. Claire felt her case was different 
‘to the norm’ due to her age at diagnosis – she was below the age for the commencement of 
screening  (‘first call’) – and despite reporting her concerns and symptoms was told to monitor 
them and return to her GP if they returned: 
‘I presented at the GP on a few occasions with some abnormal symptoms; I was 
advised to monitor them and return if they returned.’  
‘I spoke to my GP over the phone and asked about the possibility of having a smear 
test… my GP informed me that …I was not eligible to have a smear because of my 
age.’  
She reports attending the GP surgery on ‘a few occasions’ and being turned away. These 
instances, combined with the extended wait on the waiting list once referred amount, almost, 
to a barrier to accessing healthcare. Claire also reported frustration at the length and pace of 
the process. Thus the meaning for Claire in the first part of her interview narrative is of waiting 
and frustration. She reports that once she was finally diagnosed, she found the formal ‘Ask a 
Professional’ service offered by a cervical cancer charity forum to be: 
‘…the most valuable information I received throughout my whole experience. My 
questions were answered thoroughly…’  
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The second half of Claire’s narrative focuses on her interpretation of the effect of her 
experience on self/biography. Due to the (deliberate) minimal presence of the interviewer, 
respondents were able to choose the questions they answered. Claire was the only individual 
to give specific details at length about the effect of the experience on the self. In terms of the 
benefit-finding aspect of meaning-making, Claire used the experiences she passed through 
during the diagnostic and treatment processes, and the knowledge of HPV she gained to 
improve her practice as a healthcare professional. Claire also reports that she has gained 
personal resilience from the process. Interestingly, Claire was the only individual to report a 
delay in disclosing her HPV positivity to her partner: 
‘I never mentioned the likely cause being HPV until I had digested the information 
myself. I have since discussed it with him and talk more openly about it with him now. I 
didn’t want to cause any unnecessary worry or anyone else.’ 
 
5.6.3.  Reflection on Jo’s Narrative 
Similar to Claire, Jo is also a nursing student, and this, as with Claire, may have shaped 
the format of her narrative, which was detached, brief and factual – although she does on 
occasion describe emotions and mindsets as single words (e.g. ‘confused’ …’positive’). Jo’s 
narrative was the shortest – with some of the detail being provided in text form as a response 
to the invitation/introduction email and some of the detail being provided as short sentences 
and at times single words annotating a print out of the original interview schedule, appended 
as a photograph. This was printed out and typed up in the same manner as the other 
interviews. Due to the nature and brevity of her responses, Jo’s data is the ‘thinnest’ of the 
three narratives, but undoubtedly contains perhaps the most profound episode of biography 
reported in the study: 
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‘To cut a long story short I suffered a miscarriage in Feb 2016 and the smears ever 
since have come back as pre-cancerous and I believe it was the management of the 
miscarriage that contributed to this.’  
This quote was perhaps the most difficult portion of any of the narratives to interpret, 
because the researcher-practitioner mindset was aware that this was an unlikely event – the 
knowledge of HPV incidence, prevalence and a timeline from infection to the appearance of 
microscopic abnormalities makes the mismanagement of her miscarriage as a likely cause 
improbable. Unfortunately, Jo did not respond to emails asking follow-up questions to 
elucidate what she meant by her statement. Jo doesn’t report on the emotional aspects or 
meaning of her miscarriage – emotions such as grief, anxiety, guilt or other negative emotions 
are not mentioned. Nikčevič & Nikolaides (2014) examined meaning making in 127 women 
post miscarriage and report that by seven weeks post-loss, over half of the women reported 
that they had found meaning/understood why the miscarriage occurred, and that providing 
information about the cause of the loss was associated with finding meaning. As a researcher 
(informed by practitioner knowledge) the meaning of Jo’s truth – that her miscarriage caused 
her cervical abnormalities – is that she needed (at both the time of the loss of her pregnancy, 
and at the time of her HPV/CIN diagnosis) better counselling and better HPV information 
provision than she received. 
 
5.7. Themes 
During analysis of the qualitative data, three major themes became apparent. The first 
two of these themes contain three subthemes. The content of the themes and subthemes is 
discussed below. 
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Theme 1: Information, Stress and Anxiety 
5.7.1. Too Much Information: Cancer, Cancer, Cancer  
Jay reports in her narrative that she received an information leaflet about cervical 
cancer along with her result letter informing her that abnormalities had been found on her 
cervix during a routine screening appointment: 
‘I received a letter stating that I would need to see a Consultant because abnormalities 
on my cervix had been found… Along with this letter was a cervical cancer leaflet. At first 
I felt mortified, had I just been told that I had cancer? I read and re-read the letter a few 
more times & read the leaflet, & then realised that cervical cancer was a possible 
outcome. Would it perhaps have been more appropriate to hand out such a leaflet, if 
needed, later in the process? On the other hand, handing out such a leaflet at this early 
stage may help some ladies to realise the gravity of their situation… So I feel quite 
conflicted about the usefulness of the literature – at such an early point anyway. In my 
case, I felt, it added to my stress & anxiety levels.’ 
The inclusion of the cancer leaflet with her result letter caused Jay much anxiety and 
confusion, and she reports feeling conflicted about its usefulness. Jay had to read and re-read 
both the letter and the leaflet ‘a few more times’ to ensure that she had the information 
correctly. She states early on in her responses that her diagnosis was made following a routine 
screening appointment, in other words one with no expectation of an abnormality being 
identified. Her use of the words ‘hand out such a leaflet, if needed’ suggest that she would 
have learned more or been less anxious if she had had the chance to ask questions face-to-
face when learning that cervical cancer was a possible outcome to her diagnostic and 
treatment process. She also states ‘if needed’, indicating that as she was not diagnosed with 
cervical cancer this information was not required, or at least not required this early on in the 
diagnostic journey. Jay’s thoughts echo those found in a study of breast cancer patients by 
Arden-Jones et al who found that attempting to give information to patients regarding options 
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for genetic testing at the time of a breast cancer diagnosis was ‘too much too soon’ (Ardern-
Jones et al. 2005). 
Jo similarly reports that her experience of the Jo’s Trust website was a case of too much 
information, stating: 
‘The Jo’s Cancer Trust website [sic] is informative, but having the word ‘cancer’ all over 
the pages is very daunting and scary’. 
Both women were thus made anxious by the implication through written 
communications – either by letter or by the signposting on a website – that their diagnosis 
meant cancer, even though (in both cases) they did not have cancer. Jay felt that this 
information might have been better given later on in the treatment process if and when 
required rather than at the outset, giving her more time to be accustomed to the possibility of 
cancer as a possible health outcome. The concept of too much information led to increased 
anxiety due to the fear of cancer for both women. 
 
5.7.2. Conflicting information 
In addition to the concept of information furnished too soon (in the participants’ 
opinion), the participants also reported that they were given conflicting information. Jay notes 
that: 
‘When I finally did hear back that the biopsy looked fine, I was very relieved; only to be 
quickly overshadowed by the news that I’d need the LLETZ procedure. Again, another 
fling into the unknown.’ 
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The mention of the biopsy being ‘fine’ only to be followed by the news that Jay would 
require further and more invasive treatment meant more confusion and more anxiety, 
following an initial outcome that seemed to indicate that Jay was healthy.  
Jo also reported confusion over conflicting information, albeit from another source – 
whereas Jay’s experience was conflicting information from her doctor, Jo experience confusion 
over reports of other’s experiences. Feeling that she required further information and answers 
to questions following her diagnosis Jo turned to the Internet. She reports that she did not get 
involved with online support but that she visited forums on online sites devoted to cervical 
cancer and HPV. She reports that she felt: 
‘…confused as people have such different procedures and experiences.’ 
Whereas Jay’s confusion may have arisen from a point of practice (and will be discussed 
in another section surrounding themes derived from a practitioner’s perspective), Jo’s was due 
to examining others’ experiences online. Studies examining peer support in mental health 
have shown that the use of shared experience (Moorhead et al. 2013, Repper & Carter 2011) is 
often helpful in the management of anxiety for individuals who have been newly diagnosed, 
however this was not the case for Jo. In both cases, information was a source of anxiety for 
both women when it conflicted with previous data. 
 
5.7.3. Quality of Information, Time to Assimilate 
The third subtheme associated with information was the quality of the information 
obtained. Claire reports that, feeling that some of her questions had not been answered, she 
visited an online source: 
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‘It was at this point that I sought advice from the online ask a medical professional 
service offered by ‘Jo’s Cervical cancer trust [sic]’…This was the most valuable 
information I received throughout my whole experience. My questions were 
answered thoroughly and it was here that I realised the likelihood of my cell 
change was a result of having HPV.’ 
The provision of good quality information by a professional (a trusted position) which 
answered Claire's questions at a time, place and pace of her own choosing, and delivered in a 
manner that she was able to digest, print, save and/or re-read if necessary was key to her 
notion of the value of the information.  
Similarly, Jo reports that information from friends (particularly nursing friends) was 
more valuable as it was good quality information. Jo also mentioned that the quality of 
information online can be variable: 
‘There are a lot of forums out there which are not always effective and can be 
misconstrued.’ 
When asked if she felt she received different information/support from different 
groups, she replied in the affirmative: 
‘Yes, support from my nursing friends is more evidence based.’ 
The mention by both individuals of ‘valuable’ information [Claire] and effective, 
evidence-based information [Jo] reiterate findings by Cole et al. (2016), who asked medical 
professionals and nonmedical individuals (informed individuals such as the chairs of dedicated 
charities, such as HIV and diabetes) to score the health advice for HIV, chickenpox and 
diabetes on amateur internet discussion boards (on Mumsnet, Reddit and Patient) on a scale 
of 5 to 25 (with 5 being the highest quality and 25 the lowest quality). Cole et al. found that 
good quality information appeared four times as often as poor quality information, and that 
the quality of information varied by condition (with poor advice/information being given out 
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for chickenpox occurring far more often than that for HIV [2 instances] or diabetes [1 
instance]. Healthcare information surrounding HPV may be more variable due to the 
stigmatised nature of the disease (Kosenko et al. 2014) but both individuals were able to 
recognise the value of good information and to dismiss information that was poor. 
 
Theme 2: Uncertainty 
The next theme that became apparent in the individual narratives was that of 
uncertainty. Within this theme, the subtheme of waiting was most apparent within the 
narratives, specifically the length of time spent waiting for results and appointments, which 
added to uncertainty and thus anxiety.  
 
5.7.4. Waiting 
Jay mentions the time spent waiting for results or appointments at several points 
throughout her narrative: 
‘…given the wait times involved, the possible cancer diagnosis hung over me like a 
dark cloud.’  
‘…my first appointment with the Consultant was about a month later – seemed like 
a lifetime. 
‘Again, there was a wait of about 3-4 weeks before I heard anything more – a very 
scary wait.’ 
‘I would say that, I felt, the timescale here in the UK (from positive pap smear to the 
all clear) was a very long & drawn out process. I’d like to think that since 2011, the 
NHS has found ways to reduce the wait times involved. If it hasn’t, then such wait 
times (between appointment & results etc.) should be looked at with a view to 
reducing them. That six months (approximately) was a very difficult time; and 
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without the support of my HPV group & my husband & family, together with my 
research, I wouldn’t have coped half as well as I did.’ 
The time spent waiting for appointments or results contributed greatly to Jay’s anxiety, 
and again she mentions the possibility of a cancer diagnosis. The extended waiting time 
represents a period of uncertainty in her life, where, as Forss et al. (2004, 2001) state, ‘neither 
health nor disease is confirmed nor excluded’. Kosenko et al. (2012) highlighted areas of 
uncertainty in their study of 25 women newly diagnosed with HPV: diagnosis meaning, 
potential for disease progression, finances, source of infection, disclosure, sex and 
reproduction and the HPV vaccine. Although not specifically mentioning HPV until later in her 
account, the focus of uncertainty in Jay’s story centres on the potential for disease 
progression. Jay reveals that she disclosed her disease to her husband (who was supportive) 
and in a follow-up question she revealed that they did not plan to have children, thus ruling 
out anxiety over disclosure and fertility/reproduction. Jay also notes that the support received 
from the online support group and from her partner and family was very valuable during the 
waiting process.  
Claire’s story indicated similar anxieties – fear at the possibility of disease progression: 
‘I presented at the GP on a few occasions, with some abnormal symptoms; I was 
advised to monitor them and return if they continued. They did continue and I was 
then referred to Colposcopy as a routine measure. At the point the nurse 
mentioned that this could be down to ‘abnormal cells’. I took it upon myself to do 
some online research regarding my symptoms and I was aware my symptoms 
resembled those of cervical cancer.’ 
‘A few weeks later I attended a walk-In GUM clinic as my concerns and symptoms 
were ongoing. I was hoping to rule out any infection that may be causing my 
issues. Here, the doctor informed me that from an internal examination he could 
see an abnormal area.’   
Page | 164  
 
Despite having her anxieties confirmed and positive action being undertaken, inasmuch 
as the GUM doctor expediting her Colposcopy referral, further uncertainty and anxiety still 
awaited: 
‘During the colposcopy it was confirmed that my symptoms aligned with those of 
cervical cancer and the cells needed to be removed and tested. Here I had the 
LLETZ procedure and awaited [sic] the agonising 4 weeks for my results to be 
returned. I phoned the colposcopy clinic to receive my results and the cell shad 
been found to be pre-cancerous CIN3 cells (the stage before cells can potentially 
become cancerous). I felt relieved, but had a lot of questions unanswered.’ 
Claire specifies that the wait for the results was ‘agonising’, and it is apparent that 
she took a proactive role in chasing up her results at the clinic by telephone (rather than 
waiting for notification by letter) and that in the mean time she sought advice online, 
consulting a professional through the Jo’s Trust website: 
‘It was at this point that I sought advice from the online ask a medical professional 
service offered by ‘Jo’s cervical cancer trust’. I had come across the website from 
my own online searches and had seen a poster displayed at the hospital. I was 
bemused at how I could have presented with cervical cancer symptoms, yet not 
developed cancerous cell growth, and I equally was concerned regarding the 
cause.’ 
Claire’s anxieties here – surrounding both disease progression (mentioning the stage 
before cancer) and her concern surrounding the cause agree with the broad themes identified 
in the 2012 Kosenko study. She goes on to mention toward the end of her narrative that she 
has now cleared the disease but that: 
 ‘…a part of me felt a little resentful that the process was so drawn out because of 
my age and the guidelines… I do remain to feel frustrated by the guidelines that 
are in place, and I think of the possible outcome had I not persisted to have the 
symptoms and concern addressed’ 
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5.7.5. Accessing Resources 
Two of the respondents, Jay and Claire, mention accessing various resources, to help 
them through their periods of uncertainty. Jay’s coping strategies were focused on learning 
and mindfulness techniques, particularly after suffering a panic attack during her biopsy 
appointment: 
‘I decided to research my way to peace’ –  
‘I used this time to learn about breathing and meditation – ways of keeping myself 
calm and reducing stress. I would never allow myself to get so out of control again. 
I started to discover Buddhism at this point, ways of thinking about things 
differently & more productively. I’ve learnt valuable skills for life, thanks, in part, to 
this whole process.’ 
 
Another positive way in which Jay channelled her need to learn and to cope was in 
the formation of the social media support group: 
‘I found lots of information online, but few support groups; so I decided to set up a 
support group on Facebook – incorporating education, support & awareness. Here 
I posted my research findings, started discussions, & talked to other ladies about 
their experiences…it was a very positive way to navigate throughout the process – 
just knowing that others have been through similar and been ok etc’ 
‘Every week on average, we receive at least twenty new member requests…. It’s 
lovely to see how the group has evolved. There’s a real love and respect for others, 
& members tirelessly repeat the fruits of their experiences and knowledge, so as to 
help any other members who might have missed this information in discussions 
elsewhere. Our members all proactively use the group to help each other.’  
 
Here, Jay’s narrative reiterates findings from the quantitative arm of the study – of the 
use of online support to help others, share information and experiences and provide 
emotional support. In her case, the founding of the group was a coping mechanism, but then 
learning from other’s experiences provided reassurance that the process could be ‘navigated’. 
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This narrative reiterates data presented by LaCoursiere (2001) who outlines a model of social 
support, and research by various authors who argue that individuals benefit from online social 
capital through emotional support, information exchange and reassurance by learning about 
the lived diagnostic and treatment experiences of others (Namkoong et al. 2016; Yoo et al. 
2014; Himelboim & Han 2014; Hersh 2012; van Uden-Kraan 2009, 2008; Beaudoin & Tao 2008, 
2007).  
Claire also briefly mentions using the social capital derived from her experience to 
encourage her friends to participate in screening: 
‘Since having the ‘all clear’ I feel that I can talk more openly about my experience 
and because most of my friends are at the age where they will begin being invited 
for smear tests, I find myself reassuring them of the process and explaining how 
important it is to attend.’ 
 
Jo also briefly mentions posting with regard to cervical screening: 
‘I posted online re: cervical screening and feel very lucky and passionate about it.’  
 
Claire’s methods of coping involved taking action, either with health professionals to 
chase appointments of results, or consulting them online to educate herself about HPV: 
‘I took it upon myself to do some online research...’ 
‘During this wait I spoke to my GP over the phone and asked about the possibility 
of having smear test. I thought that this would alleviate some of my worry by at 
least being able to confirm whether the symptoms were caused by cell change.’ 
‘A few weeks later I attended a walk-in GUM clinic.’ 
‘I phoned the colposcopy clinic to received my results…’ 
‘It was at this point that I sought advice from the online ask a medical professional 
offered by ‘Jo’s cervical cancer trust’  
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Claire coped with the uncertainty and the waiting by taking action through online 
research, contacting her GP, seeking a second opinion and contacting a health professional 
online. It is possible that her actions during this time would have been different if she had not 
had to push quite so hard to be referred in the first place – as if having to push to be referred 
set the tone of her actions for the remainder of her treatment journey. All of the actions 
described above – from learning about ways to control anxiety through breathing and 
meditation, to researching online to contacting health professionals – constitute the 
mobilisation of resources (internal and external) to find ways of meeting the disruption that 
the uncertainty and waiting brought to their lives. 
 
5.7.6. Latency 
The remaining thread within the theme of uncertainty is that of HPV dormancy or 
latency. This is mentioned in the biomedical literature as one of the ‘known unknowns’ of HPV 
positivity (Maglennon 2012; Gravitt et al. 2011; de Witte et al. 2007; Stubenrauch & Laimins 
1999). Such knowledge is filtering down to the general public. The Jo’s Trust website has a 
question dedicated to the topic on its ‘FAQs’ page (Jo’s Trust FAQs 2017). Both Claire and Jay 
mention the possibility that the virus may reactivate or return: 
‘From my own online research and my contact with Jo’s cervical cancer trust I 
understand that it is not yet known whether my body will have completely 
eradicated HPV, or whether it will lie dormant- dependent on the strength of my 
immune system to fight it off’ - Claire 
‘I am aware that HPV could return so I’ve learnt how to build my immune system & 
how to eat myself to the best possible health… If the HPV ever did come back, 
which I sincerely hope it will not, I would least be better equipped at dealing with it 
a second time.’ - Jay 
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The uncertainty surrounding HPV negativity – and confusion over whether it is due 
to viral clearance (‘being cured’) or due to viral dormancy/latency (as means of evading 
the immune system) can be interpreted as analogous to the fears of recurrence among 
cancer survivors (Fardell et al. 2016; Freeman-Gibb et al. 2016; Bellizzi et a. 2008; Park et 
al. 2008; Humphris et al. 2003) which represent biographical and lifecourse disruption 
Koutri & Avdi 2016; Salamonsen et al. 2016; Liamputtong & Suwankhong 2015; Little et 
al. 1998) due to intrusive thoughts. Immediately upon reporting that she is aware of the 
possibility of HPV dormancy, Claire states: 
‘I will never take good health for granted. Most days something triggers my 
thoughts to return to how lucky I have been.’ 
 
Similarly, Jo states that a bad day is ‘one filled with anxiety’ although she does not 
specifically state that this is due to thoughts of HPV recurrence. 
 
Theme 3: Stigma 
5.7.7. Stigma and Self-Stigma 
The final theme that occurred in all the narratives was that of stigma, which was 
referenced in all three narratives. Previous research studies have demonstrated, many times, 
that stigma is a recurring factor in the lived experiences of women with HPV (Waller et al. 
2007; McCaffery et al. 2006), and stigma was mentioned by all three participants. Jay briefly 
mentioned that she ‘felt mortified’, but this quote was given in recollection of the possibility 
that she might have had cervical cancer, rather than HPV. HPV is a fairly late entry in Jay’s 
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narrative, not occurring until the last third of her interview. She does mention that she is 
aware of the stigma surrounding HPV: 
‘I’ve found it particularly interesting how differently HPV is perceived around the world. 
We have alot [sic] of American’s [sic] on the group &, [sic] sadly see alot [sic] of HPV 
dating websites creep up. HPV is so stigmatised there. I’ve lost count of how many time 
[sic] I’ve told people that HPV is a very common set of viruses, & that most people are 
exposed to them at some point in their lives. The condition isn’t as stigmatised here.’ 
Jay does not mention stigma or negative emotions connected with an HPV diagnosis in 
reference to herself; although she reports awareness of the stigma. However, she also reports 
awareness of the relative prevalence of the virus, and of the relative risk of exposure to the 
virus.  Jay’s awareness of these facts may have helped her to reduce the impact of stigma on 
her own life.  In both Claire and Jo’s narratives stigma is internalised, with an acceptance of 
the negative stereotypes mistakenly attributed to women with HPV. Both mentioned that 
their lifestyle choices did not fit with the common assumptions about women with HPV (Nack 
2002). Claire’s first reaction to the news of HPV positivity was puzzlement – ‘this created more 
questions’ as she had received the vaccination and also: 
‘…was a non-smoker with a fairly healthy lifestyle, had not had sexual intercourse at a 
young age and had a very low number of sexual partners’.  
 
Claire’s words indicate her awareness of both the risk factors for contracting HPV (not 
being vaccinated, early onset of sexual activity, multiple partners –  (Franco et al. 1999)), the 
risk factors for persistent HPV infection/malignant transformation such as smoking – (Park et 
al. 2008; Sarian et al. 2004) but also the factors that are perceived to contravene acceptable 
social norms for women – such as multiple sexual partners and early onset of sexarche 
(Forster et al. 2010; Hilton et al. 2010; Collins et al 2008; Herek 2007), social norms that she is 
clear in stating she did not break. Jo was also very clear in specifying that, in regard to HPV: 
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‘I thought it was very common for those whom had several sexual partners. Personally 
this was not the case for me.’ 
Thus although not specifically mentioning the stigma of HPV, both Claire and Jo exhibit 
self-stigma in pointing out that they did not fit the commonly ascribed social model of sexual 
behaviour among females reporting positivity for STDs/HPV. These reports were in keeping 
with the responses specified by women interview by Nack in her 2000 and 2002 papers 
examining the stigma of HPV positivity. In addition, Claire reports that she did not initially 
disclose the likely cause of her dysplasia to her partner: 
‘Interestingly I found myself not wanting to inform my partner of all the details of my 
treatment at the time –he knew the basics. But I never mentioned the likely cause being 
HPV until I had digested the information myself. I have since discussed it with him and 
talk more openly about it with him now.’ 
Claire mentions that she did not disclose the full details of the situation to her partner 
as ‘I didn’t want to cause any unnecessary worry to anyone else.’; but her hesitancy in 
disclosing the cause (HPV) could be interpreted as ‘covering’ –reducing the effect of one’s 
stigma by controlling the information surrounding that stigma (Goffman 1990b, p.102). 
 
5.8. Themes Informing Practice 
As the study formed the largest part of a research degree for a professional doctorate, it 
was important that the researcher identify themes that might point to knowledge gaps in 
practice or areas of practice or the service itself that might be improved. 
Theme 4: Interaction with Healthcare Professionals 
All three women report mixed experiences at the hands of healthcare professionals, 
both positive, helpful encounters and more frustrating or negative encounters. 
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5.8.1. Negative Encounters with Healthcare Practitioners 
Perhaps the most prolonged of these is Claire’s story. Claire reports that she visited her 
GP on ‘a few occasions’ worried about her symptoms and was asked to return if they returned. 
In addition she contacted her GP to request a cervical screening test but was refused on the 
basis of her age. Whilst the GP was correct in refusing her a smear for symptoms and due to 
her age, Claire felt that her healthcare needs were ignored, and growing increasingly 
frustrated with the wait and once referred, the waiting list, eventually sought help from 
another healthcare practitioner at a walk-in clinic. Under NHSCSP guidelines, any woman 
reporting symptoms  associated with cervical cancer (abnormal bleeding patterns such as 
post-coital or inter-menstrual bleeding or pain during intercourse) should be referred to 
Colposcopy for further investigation, irrespective of age (NHSCSP, 2016a). Claire’s referral 
should have been made by her GP at the first appointment when she reported symptoms and 
her appointment at Colposcopy should have occurred within six weeks of her referral 
(NHSCSP, 2016b) 
Jay reports that the punch biopsy procedure was very painful, and that her Consultant 
was not very helpful in making the experience less stressful: 
‘The Consultant asked me to cough but that didn’t help at all. I also felt that he 
was quite rough with me. I had a panic attack on the table… I went home crying & 
wondering whether I would be able to continue with the process.’ 
Although neither of the women reported enacted stigma during their encounters – as 
described by participants in the Kosenko study (2012), the actions of healthcare professionals 
during these encounters were not encouraging of questions or helpful in reducing the stress of 
the situation. 
Page | 172  
 
5.8.2. Positive Encounters with Healthcare Professionals 
However in addition to difficult or challenging encounters with healthcare professionals, 
participants also reported finding humour or support in both face-to-face encounters with 
healthcare professionals and in virtual encounters. Jay reports that during her second 
appointment: 
‘…I had also been practising my breathing & meditation leading up to this 
appointment. I giggled when the Nurse asked the Consultant what size electrical 
loop wire he needed when he replied “small”.’ 
She also reports that the Nurse praised her composure during the second appointment: 
‘The Nurse commented, after the procedure on how good my breathing technique 
was throughout, how she wished all ladies could be so calm & well prepared.’ 
Claire also reports a positive experience with a healthcare professional, albeit an online 
interaction following many frustrating encounters with her own GP: 
‘I felt relieved, but had a lot of questions unanswered. It was at this point that I 
sought advice from the online ask a medical professional service offered by ‘Jo’s 
Cervical Cancer Trust’. I had come across the website from my own online 
searchers and had seen a poster displayed at the hospital. I was bemused at how I 
could have presented with cervical cancer symptoms, yet not have developed a 
cancerous growth, and equally I was concerned regarding the cause. This was the 
most valuable information I received throughout my whole experience. My 
questions were answered thoroughly and it was here that I realised the likelihood 
of my cell change was a result of having HPV.’ 
 
5.8.3. Failure to Follow Protocols 
One major theme that was identified in two of the narratives surrounded best practice, 
and the correct following of standard protocols. In Jay’s narrative, she reports that she was 
told: 
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‘When I did hear back that the biopsy looked fine, I was very relieved; only to be 
quickly over shadowed by the news that I’d need the LLETZ procedure.’ 
Whilst it is possible that Jay was mistaken, or had misinterpreted her biopsy result, in 
clinical terms, these two events – a negative biopsy (‘looked fine’) and a LLETZ procedure are 
mutually exclusive. According to the NHSCSP treatment algorithms, if Jay’s biopsy ‘looked 
fine’, there would be no clinical need for a LLETZ procedure and waste clinic time and 
resources and risk further panic attacks (as reported by Jay) on the examination table. As a 
LLETZ procedure was required, according to the treatment guidelines (NHSCSP 2016a) Jay 
must have demonstrated a lesion of CIN2 or greater on the biopsy – this does not correlate to 
‘fine’. Either way, the end result to Jay was confusion.  
In addition to Jay’s experience, the long fight that Claire had to undertake in order to get 
referred to Colposcopy (a process of repeated visits and ‘watchful waiting’ ending in Claire 
expediting the process by attending a walk-in GUM clinic where a macroscopically visible 
cervical lesion was discovered) was unnecessary. Again, as noted in the NHSCSP practice 
guidelines (2010) any woman reporting abnormal symptoms of the type Claire was reporting 
should be referred to Colposcopy. A routine referral should be seen within six weeks, 
according the NHCSP KC65 key performance indicators (NHSCSP 2010a). 
 
5.9. Reflexivity and Reflections - Chasing Respondents 
Although interviews were conducted online, and lacked face-to-face features such as 
non-verbal or behavioural cues that might indicate distress, these aspects of interaction were, 
nevertheless, often appreciable throughout the research process. For some of the participants 
who consented to take part, it was possible to identify them in support groups as their contact 
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details matched the names/profiles they used in online groups, and from comments, 
questions or statuses posted to groups the researcher was made aware that data collection 
periods coincided with recall letters from healthcare practitioners, the anxious wait for results 
or the confirmation of unwanted news – such as continued HPV-positivity or the progression 
of cervical disease. The perception of these lived-experiences did affect decisions to ‘push for’ 
or ‘chase’ responses to questions posed in email interviews. As it was obvious that the 
participants were distressed by their experiences, it did not seem ethical to chase the 
participants for their email interviews at the risk increasing their anxiety. This (often daily) 
awareness of participants’ distress – despite a lack of face-to-face interaction – was one of the 
most difficult aspects of the research process to cope with.  
 
5.10. Conclusions 
The aims for study 2 included were to recruit a population  of women from online 
support resources to participate in qualitative interviews, and to analyse the transcripts of 
these interviews to document the ways in which women interacted with online support in 
order to answer the research questions given in section 5.1.2 which asked if a diagnosis of 
HPV, or HPV and CIN represent a biographical disruption, what factors contribute to this 
biographical disruption and the role(s) that online support played in the management of that 
disruption. 
In order to answer these questions, seven women were recruited to participate in 
qualitative research interviews and went through the consent process. Of these seven women, 
only three responded to the initial email, and returned material for inclusion in the study. 
These women all opted for or requested asynchronous, electronic interviews – this method of 
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interviewing, and the data returned by the women are both accepted as limitations to the 
study (which will be discussed in the next section). 
From the data returned by the women, several themes were drawn from their 
narratives. Theme 1 concerned anxiety derived from information provision including fears 
surrounding the development of cancer and the provision of ‘too much information’, variation 
in information quality, and conflicting information. Theme 2 surrounded uncertainty, including 
the wait for results or action on the part of healthcare professionals, the development of 
coping strategies to manage the anxiety aroused by uncertainty, and the possibility of HPV 
recurrence or reactivation. Theme 3 focused on stigma – all of the women were aware of the 
stigma surrounding HPV positivity, and 2 made reference to themselves in terms of self-
stigma, feeling the need to explain to the researcher that their lives and behaviours did not fit 
the negative social behaviours commonly associated with the acquisition of an STI. 
In order to examine whether the experiences narrated by the women amounted to a 
disruption to biography, it is sensible to revisit the terms described by Bury in his model of 
disrupted biography. In his writing, Bury describes a ‘creeping onset of symptoms’ which lead 
to the accommodation of changes to ‘taken-for-granted assumptions and behaviours’, 
profound disruptions in the explanatory systems used by people including a fundamental 
rethinking of the self, and a response to disruption through the mobilisation of resources to  
meet these changes. In Chapter 2, the argument was put forward that due to its asymptomatic 
nature, HPV did not show the ‘creeping onset’ of symptoms described by Bury in his writings 
about chronic diseases such as arthritis. In their narratives, Jay nor Jo reported symptoms that 
warranted further investigation, but Claire did, and it was her insistence and struggle to get 
her symptoms recognised and acted on that informed much of her story. Jay and Jo both 
reported anxiety over fears of developing cancer, which amount to a fundamental rethinking 
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of the assumption of the self as a healthy individual. In addition, the narration of self-stigma by 
Claire and Jo indicate that an assessment of the self against the assumed negative social 
behaviours associated with positivity for an STI has taken place. Perhaps the most telling 
argument for the process as a disruption to biography is the ‘mobilisation of resources’ used 
by the women to cope with the changes and uncertainty they were experiencing: Jay decided 
to ‘research her way to peace’, focused on internal resources – learning anxiety management 
techniques through breathing and meditation and mobilising external resources by founding a 
support group as she felt that none existed at the time to meet her needs. Claire’s 
‘mobilisation of resources’ included researching her symptoms online, pushing her GP to take 
a smear, getting a second opinion from a walk-in GUM clinic, chasing the results of her biopsy 
and asking for explanations from online healthcare professionals. From the narration of these 
experiences and actions it is possible to argue that their diagnostic experiences constituted a 
disruption to biography, and that online resources were used to manage the anxiety that 
disruption caused, through obtaining information (in Claire and Jo’s case) to soliciting support 
from similarly placed individuals by founding a support group in Jay’s case. 
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Chapter 6 – Conclusions and Discussion 
6.1. Conclusions 
This research set out to investigate the notion of HPV as a biographical disruption, and 
the role that online support might play in the management of that disruption, in anticipation 
of the move by PHE to implement primary screening of women at increased risk of cervical 
cancer through the detection of HPV nucleic acids, as by this method, more women were likely 
to test positive HPV than are currently diagnosed with CIN (Kjaer et al. 2008). The research 
questions reflected these concerns, asking: 
 Does a diagnosis of HPV, or HPV and CIN represent a biographical disruption? 
 If either diagnosis constitutes a biographical disruption, what factors contribute to this? 
 What roles might online resources play in the management of possible biographical 
disruption? 
In order to answer these questions, a mixed-methods research project was devised, 
formed of two studies. Study 1 was a questionnaire study delivered online via SurveyMonkey™ 
to a group of women subscribing to HPV-related online resources gathering quantitative data. 
Study 2 was a qualitative interview study using online asynchronous email interviews to obtain 
narrative data about women’s experiences of being diagnosed with HPV.   
 
6.1.1. Outcomes for Study 1 
Study 1 measured perceived stress scores (PSS, Cohen et al. 1983) and social support 
scores (Sarason et al. 1985) against a number of questionnaire variables such as anxiety over 
HPV positivity, reasons for anxiety, uses of online support (in terms of emotional support, 
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exchanging information, helping others and sharing experiences) and outcomes of online 
support use (in terms of being better informed about HPV and/or gaining better acceptance of 
HPV). The main outcomes of this study indicated: 
 That anxiety over HPV positivity was significantly associated with reduced mean scores 
for social support (availability and satisfaction) and increased mean scores for perceived 
stress.  
 Reasons given for HPV positivity anxiety included fear of developing cancer, cancer 
recurrence, stigma and disclosure.  
 Free text entries (N =10) of reasons for anxiety over HPV positivity included transmission 
to partners and children and anticipation of stigma.  
 Social support scores as a predictor of disclosure were not found to be significant. 
 The uses of online support (for emotional support, exchanging information, helping 
others and sharing experiences) were associated with increased scores for social 
support, but these relationships were not significant. 
 
6.1.2. Outcomes for Study 2  
Study 2 was composed of a series of asynchronous, electronic interviews conducted by 
email asking women to narrate their experiences of HPV positivity and to derive themes from 
this data. Several themes were identified within the data: 
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 Anxiety over information (too much information, conflicting information, quality of 
information) 
 Uncertainty (waiting, accessing resources to deal with uncertainty, latency) 
 Stigma and Self-Stigma 
 
6.2.Examining Study Outcomes Against the Model of Biographical Disruption 
In reference to the research questions, do any of these outcomes represent a 
biographical disruption? In his writings, Bury (1991, 1982) described three points to his model 
of illness as a biographical disruption: 
 Changes to taken-for-granted assumptions and behaviours; 
 Profound disruptions in the explanatory systems used by people, including a 
fundamental rethinking of biography and self-concept; 
 A response to disruption through the mobilisation of resources  
 
6.2.1. Changes to Taken-for-Granted Assumptions and Behaviours 
In study 1 women reported anxiety over HPV positivity in terms of their fears of cancer 
recurrence (indicating that they had already faced cancer) or cancer development. These fears 
demonstrate changes to their assumptions of a cure (in the case of cancer recurrence) or the 
assumption of health (in the case of cancer development). In addition, in the free-text 
responses, women reported anxiety over transmission to partners (through intercourse) and 
in one case transmission to children (through sharing drinks). Again, these fears represent 
changes to taken-for-granted behaviours. Sexual intercourse with a partner, or the sharing of 
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household items (such as drinks, towels or bedlinen) are now not just normal occurrences that 
form part of loving relationships but become imbued with the risk of adversely affecting a 
loved one’s health and wellbeing through unintended transmission of the virus. 
 
6.2.2. Profound Rethinking of the Self 
Again, in study 1, women reported fears of cancer recurrence – these fears threaten the 
thoughts of self as cured and whole (Brotto & Heiman 2007; Burbie & Polinsky 1992). Fears of 
cancer development prompt the rethinking of self as a putative cancer patient. In addition, 
women reported fears around stigma and disclosure, prompting a reassessment of the self as 
a stigmatised individual. These fears were echoed in the theme of stigma apparent in Study 2, 
where two of the participants demonstrated self-stigma in the narration of commonly held 
assumptions of women with HPV. The act of holding themselves as exceptions to these 
assumptions indicates an assessment of the self against those assumptions, which may not 
have occurred if they had tested negative for HPV or had not demonstrated cervical 
abnormalities. However, not all of these reassessments are negative, as one participant in 
study 2 stated ‘Not so much my diagnosis, but my experience, has made me feel as though I 
have become a more resilient person.’ 
 
6.2.3. Mobilisation of Resources as a Response to Disruption 
Within the context of this research, the disruption to self may be caused by factors 
other than the creeping onset of symptoms Bury describes in his writing. Disruption may be 
caused by the sudden notification of an abnormal cervical cytology result (Rajaram et al. 
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1998), or an HPV positive result. Within study 1, this disruption can be seen in the indication of 
anxieties over HPV positivity – in the anxiety over possible recurrent or developing cancer, in 
the anxiety over stigma and disclosure, and in the anxiety over transmission to others. Within 
study 2, disruption did have physical or external consequences – Jay describes the pain of her 
treatment and the cessation of physical activities (‘I had to go on bed rest’). In addition, Jo 
believed that her cervical abnormalities arose from the mismanagement of her miscarriage – a 
profound event in anyone’s life course, a loss described in itself as a biographical disruption by 
Davidson & Letherby (2014); and Claire also reported physical symptoms. However, in addition 
to these physical causes, the waiting (for referral in Claire’s case and for results of biopsies and 
treatment in Jay’s case) and the anxiety about a possible cancer diagnosis represent 
disruption. In study 1, the demonstration of a mobilisation of resources to meet this disruption 
was not explicitly explored as a question, but can be seen as an outcome in terms of social 
support as a resource (Hobfoll et al. 1990). The group of women who reported a lack of 
anxiety over HPV positivity demonstrated significantly higher mean scores for perceived 
availability of and satisfaction with social support and lower mean scores for perceived stress 
than women who reported being anxious about HPV. Within study 2, a mobilisation of 
resources was more explicitly narrated and drawn upon as a theme within the qualitative data 
– Jay mobilised ‘internal’ resources, stating that she: ‘decided to research [her] way to peace’ 
by obtaining information online, starting a support group and managing stress and anxiety by 
teaching herself meditation, breathing exercises and learning about Buddhism. She also 
accessed physical resources by consulting her GP for medication to manage her anxiety on the 
day of her Colposcopy appointment. Claire also narrates a process of accessing resources – 
presenting at her GP (with symptoms), undertaking online research, getting a second opinion 
through attending a walk-in clinic to obtain a referral to Colposcopy and by seeking advice 
from the ‘Ask a Professional’ service on the Jo’s Trust website. 
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6.2.4. Factors Contributing to Biographical Disruption 
The outcomes for each study were examined to explore the factors that contributed to 
disruption. Both studies specifically mention anxiety – in study 1 this was a researcher-led 
question (‘Please indicate your level of anxiety over a possible HPV positive test result’) but 
with the majority of the population (N = 79, 73.8%) indicating they were anxious. Examination 
of the reasons for anxiety identified fears of the recurrence or development of cancer, anxiety 
surrounding stigma and disclosure, and anxiety surrounding transmission to partners and 
loved ones. Responses from study 2 echoed these findings, with anxiety being identified as 
one of the overall themes, related to the provision of information – either too much 
information, conflicting information or information of variable quality. Anxiety over cancer 
development was mentioned by all three participants in the qualitative study, with Jay 
wondering if she had ‘just been told I had cancer?’, Jo reporting on her experiences of the Jo’s 
Trust website that ‘having the word ‘cancer’ all over the pages is very daunting and scary’ and 
Claire becoming aware through online research that her symptoms ‘resembled those of 
cervical cancer’. Anxiety over stigma in study 1 was the third most commonly selected 
response to the question ‘If you were anxious about HPV, what form would these fears take?’ 
and being mentioned in the free-text responses by one participant as ‘people’s knowledge and 
assumptions’, although when asked if they would disclose a positive HPV test result, the 
majority of women (N =94, 87.9%) indicating that they would disclose. In study 2, Jay 
acknowledged the stigma surrounding HPV, and Claire mentions hesitation in telling her 
partner of the role of HPV in cervical abnormalities. Jo states her assumption that [HPV] ‘was 
very common for those whom had several sexual partners. Personally this was not the case for 
me.’ Claire was also clear that she had avoided stigmatised behaviours and risk factors such as 
smoking, early sexarche and sexual promiscuity. In addition to fears surrounding cancer and 
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stigma, the concept of uncertainty either as diagnostic uncertainty or life-course ‘trajectory 
uncertainty’ occurring as a result of an unlooked-for diagnosis constitute a disruption to 
biography (Williams 2000). 
 
6.2.5. The Role of Online Support in Managing Biographical Disruption 
The final research question asked what role online support might play in the 
management of a biographical disruption such as that which persistent HPV positivity might 
represent. In order to answer this question, it is important to recap the issues that HPV 
positivity represents. Much has been made of the stigmatised nature of HPV, and the anxiety 
surrounding both the threat to identity and the threat to health (in the form of neoplasia) that 
it represents. It is in managing the threats to identity and physical health that online support 
may facilitate the management of HPV positivity as a biographical disruption. Cavanagh (2007, 
p.109) describes community (in the virtual space) as ‘a shorthand for common forms of social 
identity’, therefore the threat to identity may be managed by joining an online groups – virtual 
communities composed of Goffman’s “Own”,  ‘virtual communities of care’ (Chambers 2006, 
p.120) where the reconstruction of self-identity may be  facilitated by the recognition of the 
self amongst peers. In addition to renegotiating identity, women may turn to online support 
for other purposes. Setoyama et al. (2011) compared face-to-face support groups with online 
support groups among women with breast cancer, and found that both groups used peer 
support for advice, emotional expression, emotional support and helper therapy. Within Study 
1, women were asked to indicate their agreement with statements of uses for online support; 
specifically for: emotional support, exchanging information, helping others and sharing 
experiences. Women who agreed with the statement ‘I use online support for emotional 
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support‘ reported the lower mean scores for social support availability than women who 
disagreed with the statement (although this relationship was not statistically significant). 
These women may be using online support as an adjunct resource if the emotional support 
provided by other channels was not as available as they would have wanted. 
On the basis of the findings in the quantitative data (particularly the responses to 
question 20 – fears surrounding HPV positivity), and themes uncovered in the free-text 
responses and the narrative supplied by women through online interviews, it is possible to 
conclude that due to the associated anxiety, uncertainty and stigma, HPV positivity represents 
a biographical disruption; and that the use of online support to share experiences, exchange 
information and help others represents a means of negotiating a path around that disruption, 
helping to resolve it. 
 
6.3. Validity of Data and Interpretation 
It is important to remember that the philosophical underpinnings of the study and the 
role of the researcher are both interpretative. To aid reflection and interpretation summary 
notes were made immediately upon receipt of both communication emails and the responses 
to interview questions. Additionally, notes/journal entries of reflection and self-reflection 
were kept throughout the research project to facilitate the identification of assumptions. As 
interviews were not conducted face-to-face, the researcher did not get the opportunity to 
guide the interview in specific directions, and participants had the opportunity to prioritise the 
questions and issues that were important to them. However, as the role of the researcher is 
interpretative, the results of the study ‘research reflect the researcher as much as the 
researched’ (Salmon, 2003, p.27). 
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Bearing this is in mind, the researcher took pains to separate the original, verbatim 
accounts and the interpretations drawn there from, as recommended by Smith & Osborn 
(2003). These are included in Appendices 10, 11 and 12 in order that the reader can draw their 
own conclusions from the text, and assess the accuracy of the researcher’s interpretation. 
Reid et al. (2005) suggest that independent readings of transcripts by multiple researchers 
may be effective in developing a joint thematic framework, and that these analyses could 
further be checked by other academics – these measures could be utilised as a form of cross-
validation; however, time constraints and the solitary nature of a research degree meant that 
these measures were not possible in the case of this study. Original verbatim accounts and 
researcher interpretations were seen by and discussed with the doctoral supervisor in order to 
perform a check on these interpretations. 
 
6.3.1. Reliability/Generalisability 
Yardley (2000) argues that as the purpose of qualitative research is to offer one of many 
interpretations of the data, and therefore reliability may not be an appropriate criterion 
against which to measure data analysis.  Reflecting on the research process and data gleaned, 
and bearing in mind the vociferous criticisms of Paley in the application of Heideggerian 
research in healthcare, the study does not and cannot make claims of generalisability to an 
entire screening population on the basis of a small questionnaire sample and the narrative 
accounts of three individuals. The sample population for the questionnaire study was too 
small to reliably allow generalisability to the UK screening population. In addition, from the 
perspective of the qualitative data, thematic analysis is inductive, so the researcher was able 
to examine the data in the context of current issues in the field of HPV screening and public 
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health, to highlight the lack of account being taken for the sociological and psychological 
burden this change to the screening method represents, and to make recommendations for 
both further study and future practice. 
 
6.4. Implications of Findings 
Having explored the interactions between online support group use and the 
psychosocial impact of HPV/cervical cancer, the author asks how the findings can be used. 
 Again, with the criticisms of Paley (2016; 2014; 1996) in mind, it would be unwise to 
generalise to an entire population, but the researcher can still use the findings to inform 
practice within her department and make recommendations to PHE for further research to 
further explore issues uncovered. These include: 
 Examine departmental protocols to ensure that NHSCSP referral guidelines are 
followed, and reiterate these to primary care  providers in training sessions 
 Encourage the use of standardised letters with the researchers Colposcopy department 
to prevent the possibility of conflicting information 
 Pass on findings of the study to PHE, and recommend further research into the subject 
of online support and informational needs of HPV affected women. 
 
6.4.1. Actions on Study Findings 
The researcher provides training to sample-takers (practice nurses) and primary care 
(GPs) throughout the Leicester, Northants and Rutlands region (although this is subject to 
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change under the proposed regional reconfigurations that the HPV primary screening 
implementation project demands). Training documentation will be updated to include 
information/research findings on transmission to partners and children, through day-to-day 
living (such as the likelihood of transmission through sharing drinks or bedlinen) including the 
likelihood of perinatal transmission for the counselling of pregnant patients who test HPV 
positive during screening (Thomas, 2001) – even if the advice is to do nothing – in order to 
reassure women raising concerns about transmission via means other than sexual 
transmission. Training documentation will be updated to highlight the value (either as online 
support or for healthcare information gathering) of signposting reliable, evidence-based online 
HPV-related resources such as NHS Choices and Jo’s Trust, and to highlight the difference 
between online support (emotional support and sharing experience) and online clinical advice. 
In her role as liaison to local Colposcopy departments documentation for invitation letters (for 
biopsy/treatment appointments and follow-up discharge letters) and local treatment policies 
will be reviewed to ensure that information given is clear and that treatment algorithms are 
followed. 
The researcher will contact PHE with the findings of the study to highlight the need for 
updated information for patients to be included in the preparation of documentation for the 
implementation of HPV primary screening. PHE is now the publisher of the NHSCSP 
documentation, and the researcher will highlight the need for further information on ‘living 
with HPV’ to be included in the next version NHSCSP Good Practice Guide.  
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6.4.2. Public Awareness: Reduction/Elimination of Stigma 
The findings of this study agree with previous research – HPV still attracts stigma.  The 
findings of Study 1 indicated that of a population of HPV positive women who indicated an 
awareness of HPV (87.9% of the population), only 40 selected the statement that HPV is the 
most commonly acquired STI in the UK as true. In addition, quotes in Study 2 indicated that 
two of the respondents, both aspiring healthcare practitioners (nursing students), who by the 
nature of their training were in the process of acquiring health literacy, and of whom one had 
been vaccinated (and thus presumably given informed consent) expressed little awareness of 
the role of HPV in cervical abnormalities prior to their diagnosis. Thus at present, the ubiquity 
of HPV and the inefficacy of barrier contraceptive in preventing transmission – two factors 
that might reduce stigma – are little known by the general public; being knowledge that is 
acquired on a ‘need-to-know’ basis post-diagnosis. At present there is very little publicity or 
information in the public sphere that attempts to reduce or remove this stigma. Therefore the 
researcher intends to contact both PHE and other stakeholders (Jo’s Trust) with the study 
findings in order to highlight the need to publicise more widely the relative lifetime risk of 
contracting HPV, the limited use of condoms in preventing infection, that individuals of both 
genders can carry and transmit the virus and that individuals do not have to have penetrative 
sex to transmit the virus. 
 
6.5.    Limitations of the Study 
The author is an early-career researcher, studying a relatively post-positivist field from a 
historically positivist standpoint.  The author has little experience of building or administering 
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questionnaires, hence the long iterative phase of development of the research instrument. 
The author is aware of some of the major limitations of the study which are listed as follows: 
 Relatively small sample size 
 Lack of validated measures for some aspects of the survey 
 Reliance on thin data from email interviews 
 Lack of responses to follow-up questions to email interviews 
 Lack of ethnic diversity in the sample/non-English version of questionnaire 
 Difficulty in identifying women who were HPV positive only 
 
6.5.1. Sample Size 
Study 1 recruited just over 100 people to the questionnaire arm (N = 107) and 3 
individuals to the e-mail interview phase. For a quantitative study, a sample size of N =100 is 
very small, and whilst statistical significance was indicated in one relationship between 
variables, this finding may change when explored with a larger sample. The data was therefore 
used as an exploratory study to examine the reasons women might subscribe to HPV related 
online support. The sample size has implications for generalisability as well as for statistical 
power – as such it would not be responsible to generalise the findings to the entire UK 
screening population without further study. Sample sizes for the interview study were similarly 
small. The only difficulty with a small interview sample was the identification of themes. In 
order to report themes within the research, a ‘theme’ was so called when more than one 
individual reported or made reference to it. 
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6.5.2 Lack of Validated Measures in the Questionnaire Study 
The majority of areas of the questionnaire instrument used validated measures – the 
demographic section used questions from the UK Census and the data for the dependent 
measures was gathered using validated measures – the SSQ-6 and the PSS-10. However, the 
questions used to indicate anxiety and embarrassment did not use validated measures such as 
Stait-Trait Anxiety or the Internalised Shame Scale, instead using Likert scales for women to 
indicate their level of anxiety of embarrassment. In addition, the Likert scale for anxiety 
conflated the states of anxiety and worry, which are measured as two separate entities in 
psychological studies. This may have caused confusion among respondents which may in turn 
have affected their responses.  
 
6.5.3. Reliance on Thin Data from Electronic Interviews 
Originally the qualitative aspect of the study was designed with FtF interviewing in 
mind, as this is the gold-standard method for obtaining thick descriptive data. However, all of 
the participants requested to undertake interview by email. This did allow the participants to 
answer the questions they felt were relevant to them, but also meant that the data returned 
was thin, and returned at a time suitable to the participant. In addition, follow-up questions 
asking for further information or clarification on specific answers (such as Jo’s statement that 
her miscarriage caused her cervical abnormalities) were ignored. The lack of responses to 
follow-up emails may be due to a difficulty in establishing rapport via email. Both Claire and Jo 
were recruited to the study via Jo’s Cervical Cancer Trust, therefore the researcher did not 
have to opportunity to establish rapport via social media, as was the case with Jay.  
Page | 191  
 
Another challenge in relying on data derived from email interviews were the issues of 
trustworthiness and authenticity. The use of email interviews does not allow for the 
observation of non-verbal cues such as facial expression, non-verbal vocalisations, pauses or 
body language which may give clues to giving ‘trustworthy’ responses. In addition, the 
asynchronicity of email allows the participant time to consider their response and self-edit to 
allow a more socially desirable response.  Hine (2000, p.118) states that the domain of the 
Internet has provided ‘new problems in judging what is authentic’. James & Busher (2007) also 
highlight this issue, but posit that allowing the participant to dictate the pace of the 
interaction (in their case over several weeks) allows the participant ownership of the 
encounter. 
 
6.5.4. Lack of Ethnic Diversity 
The lack of responses from British Minority Ethnic women is another limitation to the 
study.  Many attempts were made to reach as wide an ethnic audience as possible (within the 
confines of the internet).  The author contacted BME Cancer Voice in order to attempt to 
recruit individuals from ethnically diverse populations.  However, despite contacting several 
organizations (correspondence is supplied in Appendix 2), no response from or contact with an 
administrator or group leader could be established.  There are several possible explanations 
for the lack of uptake of/participation in the study.  Previous research has indicated that 
internet use is associated with increased socio-economic status (to allow access to a personal 
computer and a network connection).  Ethnic diversity research would suggest that individuals 
from BME populations have lower socioeconomic status, and thus possibly less access to the 
Internet (Mesch & Talmud 2011) (Fogel et al. 2008; Fogel et al. 2003).  In addition, no 
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translations of the questionnaire were made available for individuals who spoke English as an 
additional language or did not speak English at all.  Research suggests that lack of participation 
due to a language barrier is a significant contributor to poor uptake of internet-based research 
among BME populations (Im & Chee 2005). 
Another significant contributor could be a lack of affect among BME populations – HPV 
infection and cervical cancer incidence is lower (compared to the national average) in Muslim 
women, for example (Duttagupta et al. 2004), although this may be due to lack of reporting, 
rather lower incidence.  Thus women in these populations may have felt that the research did 
not apply to them and thus chose not to participate in the research.  However, the reduced 
rates of HPV and cervical cancer may not be due to a reduced incidence within the population 
but from lack of reporting among British Asian women due to a reduced uptake in screening 
due to the social, language and cultural barriers that may be encountered during a screening 
appointment.  The stigma associated with cervical screening may extend to research via the 
Internet and it is possible that individuals saw the survey and followed the link but failed to 
complete the survey or navigated away from the page before completing.  As SurveyMonkey™ 
doesn’t count web ‘hits’ it is impossible to know how many individuals opened the survey 
versus how many completed it.  Attitudes among BME communities towards better 
acceptance of HPV and cervical disease (for men as well as women) is a topic that would 
benefit from further research of this type. 
 
6.5.5. Effects of HPV positivity vs. Effects of CIN 
During the recruitment phase, it was not possible during this study to identify any 
women who had tested HPV positive without an accompanying diagnosis of CIN (of any grade) 
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that had not been followed up by biopsy and excisional treatment. However, questionnaire 
data demonstrated a small subsection of women who had tested positive but who had not 
required treatment. Both the structure of the questions in the survey and in the interview 
schedule specifically makes reference to the effects and meanings of HPV positivity on the 
lived experience of affected women rather than CIN.  
 
6.6.  Dissemination of Findings 
From a professional perspective, as an application to practice, the results of this study 
will be communicated to Public Health England in order to facilitate strategic planning for the 
move to HPV primary screening, to highlight the information needs of the screening 
population and refine he information that is disseminated prior to testing (with the invitation 
letter) and for any information that accompanies result letters.  In addition, the author hopes 
to publish the findings of the project in a reputable journal associated with the field (such as 
the Journal of Biomedical Science, Social Science and Medicine, and Patient Education & 
Counselling)nd in reputable journals associated with the method of data collection 
(Telemedicine and Health Informatics). In tandem with liaison with PHE and journal 
publication, the author hopes to produce a poster to display at the biennial conference for the 
Institute of Biomedical Science, the National Association of Cytologists and the British Society 
for Colposcopy and Cervical Pathology. 
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6.7. Further research  
Some of the suggestions for further research are mediated by the suggestions for 
contacting Public Health England with the study findings as described in section 6.4. These 
research suggestions include contacting PHE to establish an electronic survey to be distributed 
to healthcare practitioners (GPs, Colpscopists, Gynaecologists, Nurse Colposcopists, Practice 
Nurses and Health Visitors) to examine the most commonly asked questions that patients ask 
in clinic about living with HPV/transmission to partners and children in order to examine 
knowledge gaps among both patients and healthcare practitioners, in order to inform further 
training. Despite contributing to the body of knowledge on the subject of HPV, particularly the 
role of the Internet in mediating anxiety following diagnosis, many questions remain 
unanswered within the context of the screening programme.  Further research might answer 
these questions.  If the focus of the screening programme shifts to HPV primary screening 
rather than cervical cytology, then Public Health England may consider extending both 
screening and vaccination to males as well as females in order to reduce the likelihood of a 
healthcare inequality and to remove the possibility of gender-blaming (Brankovic et al. 2013). 
 In preparation for HPV primary screening (whether female-specific or for both genders) the 
attitudes and opinions of men should be canvassed (via Internet-based research) to examine 
whether use of online support groups might benefit HPV-positive individuals or the relatives of 
HPV-positive individuals. 
The response to online support in British Minority Ethnic populations still remains 
largely unanswered.  Low responses to the questionnaire have been examined earlier in this 
chapter, but identifying specific groups within the BME population to establish whether their 
information and support needs are currently being met by physical or online provisions should 
be a matter of priority. A matched pairs study of individuals who access the internet and those 
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who rely on physical support and face-to-face communication could be undertaken to examine 
whether the effects of computer-mediated communication are comparable to those of 
women who use face-to-face communication.  In addition, a repeated measures study or 
matched pairs study of women in the process of HPV screening or cervical cancer 
diagnosis/treatment/follow-up could be undertaken to examine whether better information 
(regarding ubiquity of the infection, effects on fertility and expectations of the treatment 
process) may reduce the stigma and attributional responsibility of HPV infection.  
A comparative analysis of stigma in vaccinated and non-vaccinated HPV positive 
individuals in the age cohort who have been routinely offered vaccination might be 
undertaken to examine whether a ‘two-tier’ stigma exists – whether non-vaccinated HPV 
positive individuals feel doubly stigmatised. 
 
6.8. Conflicts of Interest 
No conflicts of interest have been identified.  The author has not received any financial 
or other incentive from any of the charities mentioned or examined as part of this research 
(Jo’s Trust, the Teal Ladies, Macmillan or the British Society for Colposcopy or Cervical 
Pathology).  No financial or other incentives were received by the author from 
SurveyMonkey™.  Costs of the SurveyMonkey™ survey (an annual subscription at a cost of 
£250) were met by the Health and Life Sciences Faculty of De Montfort University – the 
account is a departmental one, rather than a personal account set up for the author.  The 
author continues to work as a Biomedical Scientist Team Leader at Kettering General Hospital 
NHS Foundation Trust which did not make any financial contribution to the completion of this 
project.  All work was completed outside of employment hours (evenings and weekends) or 
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taken as annual leave.  The author’s place on the DHSci programme at De Montfort University 
was in part sponsored by the Learning Beyond Registration contract by the Healthcare 
Workforce Development Federation, for which the author gives her sincere thanks. 
 
6.9. Reflections on Practice Development 
The process of studying for the Doctorate in Health Science has definitely had a 
profound effect on the author’s practice.  At the beginning of the programme, the taught 
phase of the programme definitely highlighted the authors’ previous practice of biomedical 
science for a very positivist perspective – the formation of a hypothesis, the testing of a 
hypothesis, the collation of data and the drawing of a conclusion.  The original project, and 
indeed, this study, were designed from a positivist perspective and dealt almost exclusively 
with the gathering of quantitative data to test a hypothesis.  However, the research methods 
and philosophies modules in the early part of the programme allowed learning and 
appreciation of post-positivist research paradigms and their application to the author’s 
practice.   
Both this study and the author’s field of practice stand at and awkward crossroads of 
research and scientific philosophies.  Biomedical science is largely a ‘hard’ science, relying on 
statistical data to predict or monitor health outcomes.  However, within the field, the 
discipline of cytology is based on the visual appreciation of microscopic appearances, pattern 
recognition and to some extent, gut instinct.  Cytology results can be quantified statistically, as 
specificities and sensitivities, but the degree of malignancy with a nucleus, cannot, within the 
context of the slide being examined at the time.  Instead, the cytologist relies on qualitative 
‘data’ obtained from the slide – physical appearances, the presence of bacteria, inflammatory 
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cells and other pathogens.  It thus seemed quite appropriate (on the failure of the author’s 
first project) to have moved from a project based on the quantitative analysis of nucleic acids 
to a more qualitative research field – if not in the nature of the data, then in the over-arching 
ethos of the research concept, in the examination of the qualitative aspects of life following a 
diagnosis of cervical cancer or HPV.  The move to a relatively new field has definitely aided the 
author’s development both as a researcher and as a practitioner in Cytology.  The author is 
now definitely more aware of applying a label to an individual which they might then have to 
live with or bear the memory of for the remainder of their lives.  The consequences of 
diagnosis as seen at Colposcopy multi-disciplinary team meeting and at invasive cancer audit 
meetings and patient liaison are more profound to the author, particularly since the data 
collection period began and the qualitative narratives were obtained.    
6.10. Claims of Originality 
This study makes a claim to original knowledge based on three factors:  on the basis of 
professional practice, as the first time a biomedical scientist has undertaken a medical 
sociology project using online recruitment methods to better understand the HPV positivity, to 
provide information to improve practice and policy. Second, this is (to date) the first piece of 
research has examined the use of social media in the support of HPV positivity. In addition, it is 
the first study that demonstrates that the notion of HPV dormancy has reached the public 
consciousness as reported by participants in the qualitative arm of the study. This knowledge 
should be built on through the provision of further research in the area of online social 
support, with a view to better publicising online support provision to women in the advent of 
HPV primary screening implementation. 
Word count: 53,968  
Page | 198  
 
References 
Abulafia, O., Pezzullo, J. & Sherer, D., 2003. Performance of ThinPrep liquid-based 
cervical cytology in comparison with conventionally prepared Papanicolaou 
smears: a quantitative survey. Gynecologic Oncology, 90(1), pp.137–144. 
 
Ackerly, B. & True, J., 2008. Reflexivity in Practice: Power and Ethics in Feminist 
Research on International Relations. International Studies Review, 10(4), pp.693–
707. 
 
Albrow, R., Kitchener, H., Gupta, D., & Desia, M., 2012. Cervical Screening in England: 
The Past, Present, and Future. Cancer Cytopathology, 120(2), pp.87–96. 
 
Ali, H., Donovan, B., Wand, H., Read, T., Regan, D., Grulich, A., Fairley C., Guy, R., 
2013. Genital warts in young Australians five years into national human 
papillomavirus vaccination programme: national surveillance data. BMJ (Clinical 
Research Ed.), 346:f2032. 
 
Allmark, P., Boote, J., Chambers, E., Clarke, A., McDonnell, A., Thompson, A. & Tod, 
A.M.,  2009. Ethical Issues in the Use of In-Depth Interviews: Literature Review 
and Discussion. Research Ethics, 5(2), pp.48–54. 
 
Almeida, J., Subramanian, S., Kawachi, I., Molnar, B., 2011. Is blood thicker than 
water? Social support, depression and the modifying role of ethnicity/nativity 
status. Journal of epidemiology and community health, 65(1), pp.51–6. 
 
Alonzo, A.A. & Reynolds, N.R., 1995. Stigma, HIV and AIDS: An exploration and 
elaboration of a stigma trajectory. Social Science & Medicine, 41(3), pp.303–315. 
 
Alvarez, R.D., Helm, C., Edwards, R., Naumann, R., Partridge, E., Shingleton H., McGee, 
J., Hall, J., Higgins, R., Malone, J., 1994. Prospective randomized trial of LLETZ 
versus laser ablation in patients with cervical intraepithelial neoplasia. 
Gynecologic Oncology, 52(2), pp.175–9. 
 
Andermann, A., 2008. Revisiting Wilson and Jungner in the Genomic Age: A Review of 
Screening Criteria Over the Past 40 Years. Bulletin of the World Health 
Organization, 86(4), pp.317–319. 
 
Ang, C., Mukhopadhyay, A., Burnley, C., Faulkner, K., Cross, P., Martin-Hirsch, P., Naik 
R., 2011. Histological recurrence and depth of loop treatment of the cervix in 
women of reproductive age: incomplete excision versus adverse pregnancy 
outcome.  
BJOG 118(6), pp.685–92. 
 
  
Page | 199  
 
Ardern-Jones, A., Kenen, R. & Eeles, R., 2005. Too much, too soon? Patients and 
health professionals’ views concerning the impact of genetic testing at the time 
of breast cancer diagnosis in women under the age of 40.  
European Journal of Cancer Care, 14(3), pp.272–281. 
 
Arksey, H. & Knight, P., 1999. Interviewing for Social Scientists: An Introductory 
Resource with Examples 1st editio., London: SAGE Publications SAGE UK: London, 
England. 
Armstrong, N. & Powell, J., 2009. Patient perspectives on health advice posted on 
Internet discussion boards: A qualitative study. Health Expectations, 12(3), 
pp.313–320. 
 
Atkinson, N.L., Saperstein, S.L. & Pleis, J., 2009. Using the internet for health-related 
activities: findings from a national probability sample.  
Journal of Medical Internet Research, 11(1), p.4. 
 
Bane, C.M.H., Haymaker, C.M.B. & Zinchuk, J., 2005. Social Support as a Moderator of 
the Big-Fish-in-a-Little-Pond Effect in Online Self-Help Support Groups. Journal of 
Applied Biobehavioral Research, 10(4), pp.239–261. 
 
BARB, 2017. Weekly viewing summary | BARB, (Accessed July 27th 2017) 
 
Barnack-Tavlaris, J.L., Serpico, J., Ahluwalia, M., Ports, K., 2016. “I have human 
papillomavirus”: An analysis of illness narratives from the Experience Project.  
Applied Nursing Research, 30, pp.137–141. 
 
Barr, E. & Tamms, G., 2007. Quadrivalent human papillomavirus vaccine.  
Clinical Infectious Diseases, 45(5), pp.609–7. 
 
Barrera, M., Glasgow, R., McKay, H., Boles, S., Feil, E., 2002. Do Internet-Based 
Support Interventions Change Perceptions of Social Support?: An Experimental 
Trial of Approaches for Supporting Diabetes Self-Management. American Journal 
of Community Psychology, 30(5), pp.637–654. 
 
Barrera, M. & Ainlay, S.L., 1983. The Structure of Social Support: A Conceptual and 
Empirical Analysis. Journal of Community Psychology, 11(2), pp.133–143. 
 
Bartlett, Y.K. & Coulson, N.S., 2011. An investigation into the empowerment effects of 
using online support groups and how this affects health professional/patient 
communication. Patient Education and Counseling, 83(1), pp.113–9. 
 
Baseman, J.G. & Koutsky, L. thera A., 2005. The epidemiology of human 
papillomavirus infections. Journal of Clinical Virology, 32 Suppl 1, pp.S16-24. 
 
Batenburg, A. & Das, E., 2015. Virtual Support Communities and Psychological Well-
Page | 200  
 
Being: The Role of Optimistic and Pessimistic Social Comparison Strategies. 
Journal of Computer-Mediated Communication, 20(6). 
 
Beaudoin, C.E. & Tao, C.-C., 2007. Benefiting from social capital in online support 
groups: an empirical study of cancer patients. Cyberpsychology & Behavior, 
10(4), pp.587–90. 
 
Beaudoin, C.E. & Tao, C.-C., 2008. Modeling the impact of online cancer resources on 
supporters of cancer patients. New Media & Society, 10(2), pp.321–344. 
 
Beaulieu, A. & Estalella, A., 2012. Rethinking Research Ethics for Mediated Settings. 
Information, Communication & Society, 15(1), pp.23–42. 
Becker, G. & Arnold, R., 1986. Stigma as a Social and Cultural Construct. In: The 
Dilemma of Difference. Boston, MA: Springer US, pp. 39–57. 
 
Bell, L. & Seale, C., 2011. The reporting of cervical cancer in the mass media: A study 
of UK newspapers. European Journal of Cancer Care, 20(3), pp.389–394. 
 
Bellizzi, K., Latini, D., Cowan, J., DuChane, J., Carroll, P., 2008. Fear of Recurrence, 
Symptom Burden, and Health-Related Quality of Life in Men With Prostate 
Cancer. Urology, 72(6), pp.1269–1273. 
 
Bennett, M.P., 2008. Ethics and the HPV vaccine: considerations for school nurses. 
The Journal of School Nursing, 24(5), pp.275–83. 
 
Berger, P., 1963. Invitation to Sociology, Garden City, NJ: Doubleday-Anchor. 
 
Bergo, B., 2015. Emmanuel Levinas Summer 2017. Zalta, E.N. (Ed.)  
Metaphysics Research Lab, Stanford University. 
 
Berkman, L.F, Glass, T., Brissette, I., and Seeman, T.E., 2000. From Social Integration 
to Health: Durkheim in the New Millennium. Social Science & Medicine, 51, 
pp.843–857. 
 
Bernard, H., Burk, R., Chen, Z., van Doorslaer, K, zur Hausen, H., de Villiers, E., 2010. 
Classification of papillomaviruses (PVs) based on 189 PV types and proposal of 
taxonomic amendments. Virology, 401(1), pp.70–79. 
 
Blows, E., Bird, L., Seymour, J., Cox, K., 2012. Liminality as a framework for 
understanding the experience of cancer survivorship: A literature review. Journal 
of Advanced Nursing, 68(10), pp.2155–2164. 
 
Bosch, F. & Manos, M., 1995. Prevalence of human papillomavirus in cervical cancer: 
a worldwide perspective. JNCI, 87(11), pp.796–802. 
 
Page | 201  
 
Bowyer, H., Marlow, L., Hibbitts, S., Pollock, K., Waller, J., 2013. Knowledge and 
awareness of HPV and the HPV vaccine among young women in the first 
routinely vaccinated cohort in England. Vaccine, 31(7), pp.1051–56. 
 
Brankovic, I., Verdonk, P. & Klinge, I., 2013. Applying a gender lens on Human 
Papillomavirus infection: cervical cancer screening, HPV DNA testing and HPV 
vaccination. International Journal for Equity in Health, 44(1), pp.21–39. 
Braun, V. & Clarke, V., 2013. Successful Qualitative Research: A Practical Guide for 
Beginners, SAGE Publications UK: London, England. 
 
Braveman, P. & Gottlieb, L., 2014. The Social Determinants of Health: It’s Time to 
Consider the Causes of the Causes. Public Health Reports, 129 Suppl(Suppl 2), 
pp.19–31. 
 
Brewer, N.T., Cuite, C., Herrington, J., Weinstein, N., 2007. Risk compensation and 
vaccination: can getting vaccinated cause people to engage in risky behaviors?  
Annals of Behavioral Medicine, 34(1), pp.95–9. 
 
Broadhead, R.S. & Rist, R.C., 1976. Gatekeepers and the Social Control of Social 
Research. Social Problems, 23(3), pp.325–336. 
 
Broom, A. & Willis, E., 2007. Competing Paradigms and Health Research. In M. Saks & 
J. Allsop, eds. Researching Health: Qualitative, Quantitative and Mixed Methods. 
SAGE. 
 
Brotto, L.A. & Heiman, J.R., 2007. Mindfulness in sex therapy: Applications for women with 
sexual difficulties following gynecologic cancer. Sexual and Relationship Therapy, 22(1), 
pp.3–11. 
 
Brown, L., Ritvo, P., Howlett, R., Cotterchio, M., Matthew, A., Rosen, B., Murphy, J., 
Mai, V., 2007. Attitudes toward HPV testing: interview findings from a random 
sample of women in Ontario, Canada. Health Care for Women International, 
28(9), pp.782–798. 
 
van den Brule, A.J.C., Meijer, C., Bakels, V., Kenemans, P., Walboomers, J.M., 1990. 
Rapid Detection of Human Papillomavirus in Cervical Scrapes by Combined 
General Primer-Mediated and Type-Specific Polymerase Chain Reaction. Journal 
of Clinical Microbiology, 28(12), pp.2739–2743. 
 
Bunting, S., 1996. Sources of Stigma Associated with Women with HIV. Advances in 
Nursing Science, 19(2), pp.64–73. 
 
Burbie, G.E. & Polinsky, M.L., 1992. Intimacy and sexuality after cancer treatment. Journal of 
psychosocial oncology, 10(1), pp.19–33. 
Page | 202  
 
 
  
Page | 203  
 
Burchell, A.N., Winer, R., de Sanjosé, S., Franco, E., 2006. Chapter 6: Epidemiology and 
transmission dynamics of genital HPV infection. Vaccine, 24 Suppl 3, p.S3/52-61. 
 
Bury, M., 1982. Chronic illness as biographical disruption. Sociology of Health and 
Illness, 4(2), pp.167–182. 
 
Bury, M., 1991. The sociology of chronic illness: a review of research and prospects. 
Sociology of Health & Illness, 13(4), pp.451–468. 
 
Calhoun, C.J., Gerteis, J., Moody, J., Pfaff, S., Virk, I., 2012. Classical Sociological 
Theory, John Wiley & Sons. 
 
Campbell, H.S., Phaneuf, M.R. & Deane, K., 2004. Cancer peer support programs: Do 
they work? Patient Education and Counseling, 55(1), pp.3–15. 
 
Cancer Research UK, 2016.Cervical Cancer Statistics.  
Available at: http://www.cancerresearchuk.org/health-professional/cancer 
statistics/statistics-by-cancer-type/cervical-cancer [Accessed August 28, 2017]. 
 
Carricaburu, D. & Pierret, J., 1995. From biographical disruption to biographical 
reinforcement: The case of HIV-positive men. Sociology of Health & Illness, 17(1), 
pp.65–88. 
 
Casper, M.J. & Carpenter, L.M., 2008. Sex, drugs, and politics: the HPV vaccine for 
cervical cancer. Sociology of Health & Illness, 30(6), pp.886–99. 
 
Castellsagué, X., 2008. Natural history and epidemiology of HPV infection and cervical 
cancer. Gynecologic Oncology, 110(3), pp.S4–S7. 
 
Castellsague, X., Bosch, F. & Munoz, N., 2002. Environmental co-factors in HPV 
carcinogenesis. Virus Research, 89(2), pp.191-9 
 
Cataldo, J.K., Jahan, T.M. & Pongquan, V.L., 2012. Lung cancer stigma, depression, and 
quality of life among ever and never smokers. European Journal of Oncology 
Nursing, 16(3), pp.264–9. 
 
Catania, J.A., Binson, D., Canchola, J., Pollack, L., Huack, W., Coates, T., 1996. Effects 
of Interviewer Gender, Interviewer Choice, and Item Wording on Responses to 
Questions Concerning Sexual Behavior. Public Opinion Quarterly, 60(3), p.345. 
 
Cavanagh, A., 2007. Sociology in the Age of the Internet, London: McGraw-Hill. 
Cayless, S. Forbat, L., Illingworth, N., Hubbard, G. & Kearney, N., 2010. Men with prostate 
Page | 204  
 
cancer over the first year of illness: Their experiences as biographical disruption. 
Supportive Care in Cancer, 18(1), pp.11–19. 
Chambers, D., 2006. New Social Ties: Contemporary Connections in a Fragemented Society, 
Basingstoke: Palgrave Macmillan. 
Chambers, S.K., Dunn, J., Occhipinti, S., Hughes, S., Beade, P., Sinclair, S., Aitken, J, 
Youl, P. & O'Connell, D.L., 2012. A systematic review of the impact of stigma and 
nihilism on lung cancer outcomes. BMC Cancer, 12(1), p.184. 
 
Chapple, A., Ziebland, S. & McPherson, A., 2004. Stigma, shame, and blame 
experienced by patients with lung cancer: qualitative study. BMJ (Clinical 
Research Ed.), 328(7454), p.1470. 
 
Charles, N., 2014. Injecting and Rejecting, Framing and Failing. Feminist Media 
Studies, 14(6), pp.1071–1089. 
 
Chaudoir, S.R., Earnshaw, V.A. & Andel, S., 2013. “Discredited” Versus “Discreditable”: 
Understanding How Shared and Unique Stigma Mechanisms Affect Psychological 
and Physical Health Disparities. Basic and Applied Social Psychology, 35(1), 
pp.75–87. 
 
Chaudoir, S.R. & Quinn, D.M., 2015. Evidence that anticipated stigma predicts poorer 
depressive symptom trajectories among emerging adults living with concealable 
stigmatized identities. Self and Identity, 15(2), pp.139-51 
 
Cheng, S., Schmidt-Grimminger, D.C., Murant, T., 1995. Differentiation-dependent up-
regulation of the human papillomavirus E7 gene reactivates cellular DNA 
replication in suprabasal differentiated keratinocytes. Genes & Development, 
9(19), pp.2335–2349. 
 
Chesson, H.W., Ekwueme, D., Saraiya, M., Dunne, E., Markowitz, L. 2011. The cost-
effectiveness of male HPV vaccination in the United States. Vaccine, 29(46), 
pp.8443–50. 
 
Chesson, H.W., Dunne, E., Hariri, S., Markowitz, L., 2014. The Estimated Lifetime 
Probability of Acquiring Human Papillomavirus in the United States. Sexually 
Transmitted Diseases, 41(11), pp.660–664. 
 
Choi, B.C.K. & Pak, A.W.P., 2005. A catalog of biases in questionnaires. Preventing 
Chronic Disease, 2(1), p.A13. 
 
Clarke, P., Ebel, C., Catotti, D., Stewart, S., 1996. The psychosocial impact of human 
papillomavirus infection: implications for health care providers. International 
Journal of STD & AIDS, 7, pp.197–200. 
 
Page | 205  
 
Clifford, G., Franceschi, S., Diaz, M., Muñoz, N., Villa, L., 2006. Chapter 3: HPV type-
distribution in women with and without cervical neoplastic diseases. Vaccine, 
24(S3), p.S3/26-34. 
 
Clifton-Soderstrom, M., 2003. Levinas and the patient as other: the ethical foundation 
of medicine. The Journal of Medicine and Philosophy, 28(4), pp.447–60. 
 
Cohen, S., 1988. Psychosocial Models of the Role of Social Support in the Etiology of 
Physical Disease. Health Psychology, 7(3), pp.269–297. 
 
Cohen, S. & Wills, T.A., 1985. Stress, social support, and the buffering hypothesis. 
Psychological Bulletin, 98(2), pp.310–57. 
 
Cole, J., Watkins, C. & Kleine, D., 2016. Health Advice from Internet Discussion 
Forums: How Bad Is Dangerous? Journal of Medical Internet Research, 18(1), 
p.e4. 
 
Collins, P.Y., von Unger, H. & Armbrister, A., 2008. Church ladies, good girls, and locas: 
stigma and the intersection of gender, ethnicity, mental illness, and sexuality in 
relation to HIV risk. Social Science & Medicine (1982), 67(3), pp.389–97. 
 
Compare, A., Zarbo, C., Manzoni, G., Castelnuovo, G., Baldassari, E., Bonardi, A., 
Callus, E., Romagnoni, C., 2013. Social Support, Depression, and Heart Disease: A 
Ten Year Literature Review. Frontiers in Psychology, 4, p.384. 
 
Conrad, P. & Barker, K.K., 2010. The Social Construction of Illness: Key Insights and 
Policy Implications. Journal of Health & Social Behavior 51(S), pp.S67–S79. 
 
Constandinou-Williams, C., Collins, S.I., Roberts, S., Young, L.S., Woodman, C., Murray, 
P., 2010. Is Human Papillomavirus Viral Load a Clinically Useful Predictive 
Marker? A Longitudinal Study. Cancer Epidemiology Biomarkers & Prevention, 
19(3), pp.832–837. 
 
 
Cooke, H., & Philpin, S., 2008. Sociology in Nursing & Healthcare  
Churchill Livingstone/Elsevier. 
 
Corrigan, P.W., 2006. Mental Health Stigma as Social Attribution: Implications for 
Research Methods and Attitude Change. Clinical Psychology: Science and 
Practice, 7(1), pp.48–67. 
 
Corrigan, P.W., River, L., Lundin, R., Wasowski, K., Campion, J., Mathiesen, J., 
Goldstein, H., Bergman, M., Gagnon, C., Kubiak, M., 2000. Stigmatizing 
attributions about mental illness. Journal of Community Psychology, 28(1), 
pp.91–102. 
Page | 206  
 
 
Corrigan, P.W., River, L., Lundin, R., Wasowski, K., Campion, J., Mathiesen, J., 
Goldstein, H., Bergman, M., Gagnon, C., Kubiak, M., 2001. Three strategies for 
changing attributions about severe mental illness. Schizophrenia Bulletin, 27(2), 
pp.187–95. 
 
Costley, C., Elliott, G. & Gibbs, P., 2010. Doing Work Based Research: Approaches to 
Enquiry for Insider-Researchers, SAGE. 
 
Cotten, S.R. & Gupta, S.S., 2004. Characteristics of online and offline health 
information seekers and factors that discriminate between them. Social Science 
and Medicine, 59, pp.1795–1806. 
 
Cotter, P.R., Cohen, J. & Coulter, P.B., 1982. Race-of-Interviewer Effects in Telephone 
Interviews. Public Opinion Quarterly, 46(2), p.278. 
 
Cotton, S., Sharp, L., Little, J., Cuickshank, M., Seth, R., Smart, L., Duncan, I., Harrild, 
K., Neal, K., Waugh, N., 2006. The role of human papillomavirus testing in the 
management of women with low-grade abnormalities: multicentre randomised 
controlled trial.  
BJOG: An International Journal of Obstetrics & Gynaecology, 117(6), pp.645–659. 
 
Cotton, S., Sharp, L., Little, J., Cuickshank, M., Seth, R., Smart, L., Duncan, I., Harrild, 
K., Neal, K., Waugh, N., 2006. Trial of management of borderline and other low-
grade abnormal smears (TOMBOLA): Trial design. Contemporary Clinical Trials, 
27(5), pp.449–71. 
 
Creswell, J.W., Plano-Clark, V.,  Gutmann, M., Hanson, W., 2003. Advanced mixed 
methods research designs. In A. Tashakkorri & C. Teddlie, eds. Handbook of 
Mixed Methods in Social and Behavioural Research. Thousand Oaks, CA: SAGE 
Publications, pp. 209–240. 
 
Creswell, J. & Plano-Clark, V., 2011. Designing and Conducting Mixed-Methods 
Research 2nd Edition, SAGE Publications Ltd. 
 
Crocker, J., 1999. Social Stigma and Self-Esteem: Situational Construction of Self-
Worth. Journal of Experimental Social Psychology, 35(1), pp.89–107. 
 
Cronk, G., 2017. George Herbert Mead. Internet Encyclopedia of Philosophy.  
Available at: http://www.iep.utm.edu/mead/ (Accessed July 17th 2017) 
 
Crotty, M., 1996. Phenomenology and Nursing Research, Churchill Livingstone. 
 
Crotty, M., 1998. The Foundations of Social Research: Meaning and Perspective in the 
Research Process, SAGE Publications. 
Page | 207  
 
 
Daley, E.M., Perrin, K., McDermott, R., Vamos, C., Rayko, H., Packing-Ebuen, J., Webb, 
C., McFarlane, M., 2010. The psychosocial burden of HPV: a mixed-method study 
of knowledge, attitudes and behaviors among HPV+ women. Journal of Health 
Psychology, 15(2), pp.279–290. 
 
Danchev, D. & Ross, A., 2013. Research Ethics for Counsellors, Nurses and Social 
Workers., SAGE Publications Ltd. 
 
Davidson, D. & Letherby, G., 2014. Griefwork online: Perinatal loss, lifecourse disruption 
and online support. Human Fertility, 17(3), pp.214–217. 
 
Davis, R.E., Couper, M., Janz, N., Caldwell, C., Resnicow, K., 2010. Interviewer effects 
in public health surveys. Health Education Research, 25(1), pp.14–26. 
 
Davis, Z. & Steinbock, A., 2016. Scheler, Max. In The Stanford Encyclopedia of 
Philosophy. Stanford University.  
Available at: https://plato.stanford.edu/entries/scheler/ (Accessed July 17th 
2017) 
 
Davison, K.P., Pennebaker, J.W. & Dickerson, S.S., 2000. Who talks? The social 
psychology of illness support groups. American Psychologist, 55(2), pp.205–217. 
 
Dennis, C.L., 2003. Peer support within a health care context : a concept analysis. 
International Journal of Nursing Studies, 40, pp.321–332. 
 
Denzin, N. & Lincoln, Y., 2017. The SAGE Handbook of Qualitative Research 5th 
Edition., Thousand Oaks, California: SAGE Publications. 
 
Department of Health, 2009. JCVI Statement on Human Papillomavirus Vaccines to 
Protect Against Cervical Cancer. 
 
DiCicco-Bloom, B. & Crabtree, B.F., 2006. The qualitative research interview. Medical 
Education, 40(4), pp.314–321. 
 
von Dietze, E. & Orb, A., 2000. Compassionate care: A moral dimension of nursing. 
Nursing Inquiry, 7(3), pp.166–174. 
 
Dillner, J., Arbyn, M., Unger, E., Dillner, L., 2011. Monitoring of human papillomavirus 
vaccination. Clinical and Experimental Immunology, 163(1), pp.17–25. 
 
Dillon, J. & Wals, A.E.J., 2006. On the danger of blurring methods, methodologies and 
ideologies in environmental education research. Environmental Education 
Research, 12(3–4), pp.549–558. 
Page | 208  
 
 
Dodd, R.H., McCaffery, K., Marlow, L., Ostini, R., Zimet, G., Waller, J., 2014. 
Knowledge of human papillomavirus (HPV) testing in the USA, the UK and 
Australia: an international survey. Sexually Transmitted Infections, 90(3), 
pp.201–7. 
 
DoH, 2007. NHS Cancer Reform Strategy 2007, 
 
Doorbar, J., 2006. Molecular biology of human papillomavirus infection and cervical 
cancer. Clinical Science (London, England : 1979), 110(5), pp.525–41. 
 
  
Page | 209  
 
Doorbar, J. Quint, W., Banks, L., Bravo, I., Stoler, M., Broker, T., Stanley, M., 2012. The 
Biology and Life-Cycle of Human Papillomaviruses. Vaccine, 30S(F50-F70).  
 
Douglas, J., 2015. The Social Meanings of Suicide, Princeton University Press. 
 
Duncan, B., Hart, G., Scuolar, A., Bigrigg, A., 2001. Qualitative analysis of psychosocial 
impact of diagnosis of Chlamydia trachomatis: implications for screening. BMJ, 
322(7280). 
 
Duncan, B., Hart, G. & Scuolar, A., 2001. Screening and the Construction of 
Scepticism: The Case of Chlamydia. Health, 5(2), pp.165–185. 
 
Duncombe, J. & Jessop, J., 2002. Doing rapport and the ethics of “faking friendship.” 
In Miller, T., Birch, M., Mauthner, J. Ethics in Qualitative Research. London: SAGE 
Publications Ltd. 
 
Dutta-Bergman, M., 2005. Developing a Profile of Consumer Intention to Seek Out 
Additional Information Beyond a Doctor: The Role of Communicative and 
Motivation Variables. Health Communication, 17(1), pp.1–16. 
 
Dwyer, S.C. & Buckle, J.L., 2009. The Space Between: On Being an Insider-Outsider in 
Qualitative Research. International Journal of Qualitative Methods, 8(1), pp.54–
63. 
 
Earle, V., 2010. Phenomenology as research method or substantive metaphysics? An 
overview of phenomenology’s uses in nursing. Nursing Philosophy, 11(4), 
pp.286–296. 
 
East, L., Jackson, D., Peters & K., O'Brien, L., 2010. Disrupted sense of self: Young 
women and sexually transmitted infections. Journal of Clinical Nursing 19(13–
14), pp.1995–2003. 
 
East, L., Jackson, D., Peters & K., O'Brien, L., 2012. Stigma and stereotypes: Women 
and sexually transmitted infections. Collegian, 19(1), pp.15–21. 
 
Eastin, M.S. & Larose, R., 2005. Alt.support: Modeling social support online. 
Computers in Human Behavior, 21(6), pp.977–992. 
 
Eatough, V. & Smith, J., 2017. Interpretative Phenomenological Analysis.  
In C. Willig & W. Stainton Rogers, eds. The SAGE Handbook of Qualitative 
Research. Thousand Oaks, CA: SAGE Publications Ltd, p. 631. 
 
 
Edwards, P., Roberts, I., Clarke, M., DiGiuseppi, C., Pratap, S., Wentz, R., Kwan, I., 
2002. Increasing response rates to postal questionnaires: systematic review. 
Page | 210  
 
BMJ, 324(7347). 
 
Elliott, A., 2013. Concepts of the Self 3rd Edition, Polity Press. 
 
Elmir, R., Schmied, V., Jackson, D., & Wilkes, L., 2011. Interviewing people about 
potentially sensitive topics. Nurse Researcher, 19(1), pp.12–16. 
 
Else-Quest, N.M., LoConte, N.K., Schiller, J., & Hyde, J., 2009. Perceived stigma, self-
blame, and adjustment among lung, breast and prostate cancer patients.  
Psychology & Health, 24(8), pp.949–64. 
 
Epstein, S., 1973. The self-concept revisited. Or a theory of a theory.  
The American Psychologist, 28(5), pp.404–416. 
 
Evander, M., Edlund, K., Gustafsson, A., Jonsson, M., Karlsson, R., Rylander, E., 
Wadell, G., 1995. Human Papillomavirus Infection Is Transient in Young Women: 
A Population Based Cohort Study. Journal of Infectious Diseases, 171(4), 
pp.1026–1030. 
 
Evans, D., 2002. Database searches for qualitative research. Journal of the Medical 
Library Association, 90(3), pp.290–3. 
 
Everett, T., Bryant, A., Griffin, M., Martin-Hirsch, P., Forbes, C., Jepson, R., 2011. 
Interventions targeted at women to encourage the uptake of cervical screening. 
The Cochrane Database of Systematic Reviews, (5), p.CD002834. 
 
Eysenbach, G., Powell, J., Englesakis, M., Rizo, C. & Stern, A., 2004a Health related 
virtual communities and electronic support groups: systematic review of the 
effects of online peer to peer interactions. BMJ (Clinical Research Ed.), 
328(7449), p.1166. 
 
Eysenbach, G., Powell, J., Englesakis, M., Rizo, C. & Stern, A., 2004b. Primary care 
Health related virtual communities and electronic support groups : BMJ, 
328(May), pp.1–6. 
 
Eysenbach, G., 2001. What is e-health? Journal of Medical Internet Research, 3(2), 
p.E20. 
 
Fahie, D., 2014. Doing Sensitive Research Sensitively: Ethical and Methodological 
Issues in Researching Workplace Bullying. International Journal of Qualitative 
Methods, 13(1), pp.19–36. 
 
Falk, G., 2001. Stigma : How We Treat Outsiders, Prometheus Books. 
 
Fardell, J., Thewes, B., Turner, J., Gilchrist, J., Sharpe, L., Smith, A., Girgis, A. & Butow, 
Page | 211  
 
P., 2016 Fear of cancer recurrence: a theoretical review and novel cognitive 
processing formulation. Journal of Cancer Survivorship, 10(4), pp.663–673. 
 
Fehrmann, F. & Laimins, L.A., 2003. Human papillomaviruses: targeting differentiating 
epithelial cells for malignant transformation. Oncogene, 22(33), pp.5201–7. 
 
  
Page | 212  
 
Feilzer, M.Y., 2010. Doing Mixed Methods Research Pragmatically: Implications for 
the Rediscovery of Pragmatism as a Research Paradigm. Journal of Mixed 
Methods Research, 4(1), pp.6–16. 
 
Fenton, K.A., Korovessis, C., Johnson, A., McCadden, A., mcMAnus, S., Wellings, K., 
Mercer, C., Carder, C., Copas, A.J., Nanchahal, K., Macdowall, W., Ridgway, G., 
Field, J. & Erens, B., 2001. Sexual behaviour in Britain: reported sexually 
transmitted infections and prevalent genital Chlamydia trachomatis infection. 
Lancet, 358(9296), pp.1851–4. 
 
Fife, B.L. & Wright, E.R., 2000. The Dimensionality of Stigma: A Comparison of Its 
Impact on the Self of Persons with HIV/AIDS and Cancer. Journal of Health and 
Social Behavior, 41(1), pp.50–67. 
 
Fife, K.H., Rogers, R.E. & Zwickl, B.W., 1987. Symptomatic and Asymptomatic Cervical 
Infections with Human Papillomavirus During Pregnancy. Journal of Infectious 
Diseases, 156(6), pp.904–911. 
 
Filiberti, A., Tamburini, M., Stefanon, B., Merola., M, Bandieramonte, G., Ventafridda, 
V. &  DePalo, G., 1993. Psychological aspects of genital human papillomavirus 
infection: a preliminary report. Journal of Psychosomatic Obstetrics and 
Gynaecology, 14(2), pp.145–52. 
 
Fitzpatrick, R., Newman, S., Lamb, R. & Shipley, M., 1988. Social Relationships and 
Psychological Well-Being in Rheumatoid Arthritis. Social Science & Medicine, 
27(4), pp.399–403. 
 
Flowers, P., Davis, M., Hart, G., Rosengarten, M., Frankis, J. & Imrie, J., 2006. 
Diagnosis and stigma and identity amongst HIV positive Black Africans living in 
the UK. Psychology & Health, 21(1), pp.109–122. 
 
Forbes, A. & Roger, D., 1999. Stress, social support and fear of disclosure. British 
Journal of Health Psychology, 4(2), pp.165–179. 
 
Ford, P., Clifford, A., Gussy, K & Gartner, C., 2013. A systematic review of peer-
support programs for smoking cessation in disadvantaged groups. International 
Journal of Environmental Research and Public Health, 10(11), pp.5507–5522. 
 
Forss, A., Tishelman, C., Widmark, C., Lundgren, E., Sachs, L. & Törnberg, S., 2001. “I 
got a letter...” A qualitative study of women’s reasoning about attendance in a 
cervical cancer screening programme in urban Sweden. Psycho-Oncology, 10(1), 
pp.76–87. 
 
Forss, A., Tishelman, C., Widmark, C. & Sachs, L. 2004. Women’s experiences of 
cervical cellular changes: An unintentional transition from health to liminality?  
Page | 213  
 
Sociology of Health & Illness, 26(3), pp.306–325. 
 
Page | 214  
 
Forster, A., Wardle, J., Stephenson, J. & Waller, J., 2010. Passport to promiscuity or 
lifesaver: press coverage of HPV vaccination and risky sexual behavior. Journal of 
Health Communication, 15(2), pp.205–17. 
 
Franco, E.L., Villa, L.L., Sobrinho, J.P., Prado, J.M., Rousseau, M., Désy, M. & Rohan, T., 
1999. Epidemiology of acquisition and clearance of cervical human 
papillomavirus infection in women from a high-risk area for cervical cancer. 
Journal of Infectious Diseases, 180(5), pp.1415–23. 
 
Franzese, R.J., 2009. The Sociology of Deviance : Differences, Tradition, and Stigma., 
Charles C Thomas Publisher, LTD. 
 
Freeman-Gibb, L.A., Janz, N.K., Katapodi, M.C., Zikmund-Fisher, B.J. & Northouse, L., 
2016. The relationship between illness representations, risk perception and fear 
of cancer recurrence in breast cancer survivors. Psycho-Oncology 26(9), pp-1270-
77 
 
Gallant, M.P., 2003. The Influence of Social Support on Chronic Illness Self-
Management: A Review and Directions for Research. Health Education & 
Behavior, 30(2), pp.170–195. 
 
Gecas, V., 1982. The Self-Concept. Annual Review of Sociology, 8(1), pp.1–33. 
 
Gergen, K.J., 2011. The Social Construction of Self.  
In: S. Gallagher (Ed.) The Oxford Handbook of the Self. Oxford: Oxford University 
Press. 
 
Glanz, K., Rimer, B.K. & Viswanath, K., 2008. Health Behaviour and Health Education, 
 
Goffman, E., 1990a. Stigma : Notes on the Management of Spoiled Identity, Penguin. 
 
Goffman, E., 1990b. The Presentation of Self in Everyday Life, Penguin. 
 
Goldie, S.J., Kohli, M., Grima, D., Weinstein, M.C., Wright, T.C., Bosch, F.X. & Franco, 
E.L., 2004. Projected clinical benefits and cost-effectiveness of a human 
papillomavirus 16/18 vaccine. Journal of the National Cancer Institute, 96(8), 
pp.604–615. 
 
Gordon, A., Panahian-Jand, M., McComb, F., Melegari, C. & Sharp, S., 2003. 
Characteristics of Women with Vulvar Pain Disorders: Responses to a Web-Based 
Survey. Journal of Sex & Marital Therapy, 29(S1), pp.45–58. 
 
Grafanaki, S., 1996. How research can change the researcher: The need for sensitivity, 
flexibility and ethical boundaries in conducting qualitative research in 
Page | 215  
 
counselling/psychotherapy. British Journal of Guidance & Counselling, 24(3), 
pp.329–338. 
 
  
Page | 216  
 
Gravitt, P.E., 2011. The known unknowns of HPV natural history. The Journal of 
Clinical Investigation, 121(12), pp.4593–9. 
 
Greene, J., 2007. Mixed Methods in Social Inquiry, San Francisco: Jossey-Bass. 
Greene, J., Caracelli, V. & Graham, W., 1989. Toward a conceptual framework for 
mixed-method evaluation designs. Educational Evaluation and Policy Analysis, 
11, pp.255–274. 
 
Gregg, J.L., 2011. An Unanticipated Source of Hope: Stigma and Cervical Cancer in 
Brazil. Medical Anthropology Quarterly, 25(1), pp.70–84. 
 
Gubrium, J.F. & Holstein, J.A., 2002. Handbook of Interview Research: Context & 
Method, SAGE Publications. 
 
Gunasekera, P.C., Phipps, J.H. & Lewis, B. V., 1990. Large loop excision of the 
transformation zone (LLETZ) compared to carbon dioxide laser in the treatment 
of CIN: a superior mode of treatment. BJOG, 97(11), pp.995–998. 
 
Habel, M., Liddon, N. & Stryker, J.E., 2009. The HPV vaccine: a content analysis of 
online news stories. Journal of Women’s Health, 18(3), pp.401–7. 
 
Haber, G., Malow, R.M. & Zimet, G.D., 2007. The HPV vaccine mandate controversy.  
Journal of Pediatric and Adolescent Gynecology, 20(6), pp.325–31. 
 
Hadert, A. & Rodham, K., 2008. The invisible reality of arthritis: A qualitative analysis 
of an online message board. Musculoskeletal Care, 6(3), pp.181–196. 
 
Handsfield, H.H. & Hoel, D., 1997. Sex, science, and society: A look at sexually 
transmitted diseases. Postgraduate Medicine, 101(5), pp.268–278. 
 
Hansen, K.M., 2006. The Effects of Incentives, Interview Length, and Interviewer 
Characteristics on Response Rates in a CATI-Study. International Journal of Public 
Opinion Research, 19(1), pp.112–121. 
 
Harper, D.M., Franco, E.L., Wheeler, C., Ferris, D.G., Jenkins, D., Schiund, A., Zahaf, T., 
Innis, B., Naud, P., De Carvalho, N.S., Roteli-Martins, C.M., Teixeira, J., Blatter, 
M.M., Korn, A.P., Quint, W., Dubin, G., GlaxoSmithKline Vaccine Study Group, 
2004. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of 
infection with human papillomavirus types 16 and 18 in young women: a 
randomised controlled trial.  
Lancet, 364(9447), pp.1757–1765. 
 
  
Page | 217  
 
Harper, D.M., Franco, E.L., Wheeler, C., Moscicki, A., Romanowski, B., Roteli-Martins, 
C.M., Jenkins, D., Schiund, A., Costa Clemens, S.A., Dubin, G., 2006. Sustained 
efficacy up to 4·5 years of a bivalent L1 virus-like particle vaccine against human 
papillomavirus types 16 and 18: follow-up from a randomised control trial. 
Lancet, 367(9518), pp.1247–1255. 
 
Harré, R., 2002. Public Sources of the Personal Mind. Theory & Psychology, 12(5), 
pp.611–623. 
 
Hart, N. & Crawford-Wright, A., 2007. Research as therapy, therapy as research: 
Ethical dilemmas in new-paradigm research. British Journal of Guidance and 
Counselling. 
 
Harvey-Knowles, J.A. & Kosenko, K.A., 2012. Diagnosing women with HPV: The impact 
of diagnosis disclosure methods. Patient Education and Counseling, 88(1), 
pp.152–156. 
 
Heaney, C. & Israel, B., 2008. Social Networks and Social Support. Health Education & 
Behavior, (3), pp.189–210. 
 
Heatherton, T.F., 2003. The Social Psychology of Stigma, Guilford Press. 
 
Heidegger, M., 2010. Being and Time J. Stambaugh & D. J. Schmidt, (Eds.)  
New York: State University of New York Press. 
 
Heijnders, M. & Van Der Meij, S., 2006. The fight against stigma: an overview of 
stigma-reduction strategies and interventions. Psychology, Health & Medicine, 
11(3), pp.353–363. 
 
Helgeson, V.S., Cohen, S., Schulz, R. & Yasko, J., 2000. Group support interventions for 
women with breast cancer: Who benefits from what? Health Psychology, 19(2), 
pp.107–144. 
 
Henderson, S. & Gilding, M., 2004. “I”ve Never Clicked this Much with Anyone in My 
Life’: Trust and Hyperpersonal Communication in Online Friendships. New Media 
& Society, 6(4), pp.487–506. 
 
Herek, G.M., 2007. Confronting sexual stigma and prejudice: Theory and practice. 
Journal of Social Issues, 63(4), pp.905–925. 
 
Hersh, A.C., 2012. Social support online: Testing the effects of highly person-centered 
messages in breast cancer support groups. Dissertation Abstracts International 
Section A: Humanities and Social Sciences, 72(9–A), p.3057. 
Page | 218  
 
 
Higgs, J., 2008. Clinical Reasoning in the Health Professions, Elsevier Health Sciences. 
 
Hildesheim, A. Schiffman, M.H., Gravitt, P.E., Glass, A.G., Greer, C.E., Zhang, T., Scott, 
D.R., Rush, B.B., Lawler, P., Sherman, M.E., Kurman, R.J. & Manos, M.M., 1994. 
Persistence of Type-Specific Human Papillomavirus Infection among Cytologically 
Normal Women. Journal of Infectious Diseases, 169(2), pp.235–240. 
 
Hildesheim, A. & Wang, S.S., 2002. Host and viral genetics and risk of cervical cancer: 
a review. Virus Research, 89(2), pp.229–40. 
 
Hilton, S., Hunt, K., Langan, M., BEdofrd, H. & Petticrew, M., 2010. Newsprint media 
representations of the introduction of the HPV vaccination programme for 
cervical cancer prevention in the UK (2005-2008). Social Science & Medicine, 
70(6), pp.942–50. 
 
Hilton, S. & Hunt, K., 2010. Coverage of Jade Goody’s cervical cancer in UK 
newspapers: a missed opportunity for health promotion? BMC Public Health, 10, 
p.368. 
Himelboim, I. & Han, J.Y., 2014. Cancer Talk on Twitter: Community Structure and 
Information Sources in Breast and Prostate Cancer Social Networks. Journal of 
Health Communication, 19(2), pp.210-25. 
 
Himelein, K., 2015. Interviewer Effects in Subjective Survey Questions: Evidence From 
Timor-Leste. International Journal of Public Opinion Research, p.edv031. 
 
Ho, G.Y.F., Burk, R.D., Klein, S, Kadish, A.S., Chang, C.J., Palan, P., Basu, J., Tachezy, R., 
Lewis, R. & Romney, S.,  1995. Persistent Genital Human Papillomavirus Infection 
as a Risk Factor for Persistent Cervical Dysplasia. JNCI Journal of the National 
Cancer Institute, 87(18), pp.1365–1371. 
 
Hobfoll, S.E., Freedy, J., Lane, C. & Geller, P., 1990. Conversation of social resources: Social 
support resource theory. Journal of Social and Personal Relationships, 7, pp.465–478. 
 
Hockey, J., 2002. The importance of being intuitive: Arnold Van Gennep’s The Rites of 
Passage. Mortality, 7(2), pp.210–217. 
 
Hoey, L.M., Ieropoli, S.C., White, V.M. & Jefford, M., 2008. Systematic review of peer-
support programs for people with cancer. Patient Education and Counseling, 
70(3), pp.315–337. 
 
Holbrook, A.L., Green, M.C. & Krosnick, J.A., 2003. Telephone Versus Face-To-Face 
Interviewing of National Probability Samples With Long Questionnaires 
Page | 219  
 
Comparisons of Respondent Satisficing and Social Desirability Response Bias. 
Public Opinion Quarterly, 67, pp.79–125. 
 
  
Page | 220  
 
Hong, Y., Peña-Purcell, N.C. & Ory, M.G., 2012. Outcomes of online support and 
resources for cancer survivors: A systematic literature review. Patient Education 
and Counseling, 86(3), pp.288–296. 
 
Hood, J.E. & Friedman, A.L., 2011. Unveiling the hidden epidemic: A review of stigma 
associated with sexually transmissible infection. Sexual Health 8(2) 159-170. 
 
Hooley, T., Wellens, J. & Marriott, J., 2012. What is Online Research? Using the 
Internet for Social Science Research, Bloomsbury Academic Publishing. 
 
Horgan, A., McCarthy, G. & Sweeney, J., 2013. An Evaluation of an Online Peer 
Support Forum for University Students With Depressive Symptoms. Archives of 
Psychiatric Nursing, 27(2), pp.84–89. 
 
Howard, K., Salkeld, G., <cCaffery, K. & Irwig, L.,  2008. HPV triage testing or repeat 
Pap smear for the management of atypical squamous cells (ASCUS) on Pap 
smear: is there evidence of process utility? Health Economics 17(5):593-605 
 
Howell, K.E., 2013. An Introduction to the Philosophy of Methodology, SAGE 
Publications Ltd. 
 
Hu, X., Bell, R.A., Kravitz, R.L. & Orrange, S., 2012. The Prepared Patient: Information 
Seeking of Online Support Group Members Before Their Medical Appointments. 
Journal of Health Communication, 17(8), pp.960–978. 
 
Hult, J.R., Wrubel, J., Bränström, R., Acree, M. & Moskowitz, J.T., 2012. Disclosure and 
nondisclosure among people newly diagnosed with HIV: an analysis from a stress 
and coping perspective. AIDS Patient Care & STDs, 26(3), pp.181–90. 
 
Humphris, G.M., Rogers, S., McNally, D., Lee-Jones, C., Brown, J. & Vaughan, D., 2003. 
Fear of recurrence and possible cases of anxiety and depression in orofacial 
cancer patients. International Journal of Oral and Maxillofacial Surgery, 32(5), 
pp.486–491. 
 
Hunsinger, J. & Senft, T.M., (Eds.), 2013. The Social Media Handbook Routledge 
 
Husserl, E., 2001. The Shorter Logical Investigations Eds: M. Dummett, J. Findlay, & D. 
Moran, eds., Routledge. 
 
IARC, 1995. IARC Monographs on the Evaluation of the Carcinogenic Risk to Humans - 
Human Papillomavirus. IARC Monographs on the Evaluation of the Carcinogenic 
Risk to Humans - Human Papillomavirus, 64, p.409. 
 
Inghilleri, P. (Paolo), 1999. From Subjective Experience to Cultural Change. 
Cambridge University Press. 
Page | 221  
 
 
  
Page | 222  
 
Ison, N.L., 2009. Having their say: email interviews for research data collection with 
people who have verbal communication impairment. International Journal of 
Social Research Methodology, 12(2), pp.161–172. 
 
Ivankova, N. V., Creswell, J. & Stick, S., 2006. Using Mixed-Methods Sequential 
Explanatory Design: From Theory to Practice. Field Methods, 18(1), pp.3–20. 
 
James, N. & Busher, H., 2007. Ethical issues in online educational research: Protecting privacy, 
establishing authenticity in email interviewing. International Journal of Research and 
Method in Education, 30(1), pp.101–113. 
 
Janghorban, R., Roudsari, R.L. & Taghipour, A., 2014. Skype interviewing: the new 
generation of online synchronous interview in qualitative research. International 
Journal of Qualitative Studies on Health & Well-Being, 9:1. 
 
Jeynes, C., Chung, M. & Challenor, R., 2009. “Shame on you”–the psychosocial impact 
of genital warts. International Journal of STD & AIDS 20(8), p.557-60 
 
Jo’s Trust, 2017. Jo’s Cervical Cancer Trust - About Us. Jo’s Cervical Cancer Trust.  
 Available at: https://www.jostrust.org.uk/aboutus [Accessed August 28, 2017]. 
 
Jo’s Trust 2017. Jo’s Cervical Cancer Trust - FAQs. Jo’s Cervical Cancer Trust  
Available at: https://www.jostrust.org.uk/faq/hpv [Accessed August 31, 2017]. 
 
Johnson, R.B. & Onwuegbuzie, A.J., 2004. Mixed Methods Research: A Research 
Paradigm Whose Time Has Come. Educational Researcher, 33(7), pp.14–26. 
 
Jones, C., 1987. Stigma: Tattooing and Branding in Graeco-Roman Antiquity. The 
Journal of Roman Studies, 77, pp.139–155. 
 
Jones, E., Farina, A., Hastorf, A., Markus, H., Miller, D. & Scott, R., 1984 Social Stigma : 
The Psychology of Marked Relationships, New York: W.H. Freeman & Co. 
 
Joyce, J.G., Tung, J-S., Pryzysiecki, C.T., Cook, J.C., Lehman, E.D., Sands, J.A., Jansen, 
K.U. & Keller, P.M., 1999. The L1 major capsid protein of human papillomavirus 
type 11 recombinant virus-like particles interacts with heparin and cell-surface 
glycosaminoglycans on human keratinocytes. Journal of Biological Chemistry, 
274(9), pp.5810–22. 
 
Judgeo, N. & Moalusi, K.P., 2014. My secret: The social meaning of HIV/AIDS stigma. 
SAHARA-J : Journal of Social Aspects of HIV/AIDS Research Alliance, 11(1), pp.76–
83. 
 
  
Page | 223  
 
Kahn, J.A., Slap, G.B., BErnstein, D.I., Kollar, L.M., Tissot, A.M., Hillar, P. & Rosenthal, 
S.L,  2005. Psychological, behavioral, and interpersonal impact of human 
papillomavirus and Pap test results. Journal of Women’s Health (2002), 14(7), 
pp.650–9. 
 
Kalichman, S.C., Benotsch, E.G., Weinhardt, L, Austin, J., Luke, W. & Cherry, C., 2003. 
Health-related Internet use, coping, social support, and health indicators in 
people living with HIV/AIDS: preliminary results from a community survey. 
Health Psychology, 22(1), p.111–6. 
 
Kane, E.W. & Macaulay, L.J., 1993. Interviewer Gender and Gender Attitudes. Public 
Opinion Quarterly, 57(1), p.1. 
 
Kanuha, V., 1999. The Social Process of “Passing” to Manage Stigma: Acts of 
Internalized Oppression or Acts of Resistance? Journal of Sociology & Social 
Welfare, 26(4). 
 
Kaufman, R.H. & Irwin, J.F., 1978. The cryosurgical therapy of cervical intraepithelial 
neoplasia. American Journal of Obstetrics and Gynecology, 131(4), pp.381–388. 
 
Keller, M.L., von Sadovszky, V., Pankratz, B. & Hermsen, J., 2000. Self-Disclosure of 
HPV Infection to Sexual Partners. Western Journal of Nursing Research, 22(3), 
pp.285–302. 
 
Kelly, R.S., Patnick, J., Kitchener, H.C. & Moss, S.M., 2011. HPV testing as a triage for 
borderline or mild dyskaryosis on cervical cytology: results from the Sentinel 
Sites study. British Journal of Cancer, 105(7), pp.983–8. 
 
Kerekes, J., 2006. Winning an interviewer’s trust in a gatekeeping encounter. 
Language in Society, 35(1), pp.27–57. 
 
Kerstetter, K., 2012. Insider, Outsider, or Somewhere in Between: the Impact of 
Researchers’ Identities on the Community-Based Research Process. Journal of 
Rural Social Sciences, 27(2), pp.99–117. 
 
Kim, H.W., 2012. Factors associated with human papillomavirus related stigma, 
shame, and intent of HPV test. Journal of Korean Academy of Nursing, 42(2), 
pp.217–225. 
 
Kim, J., Andres-Beck, B. & Goldie, S., 2007. The value of including boys in an HPV 
vaccination programme: A cost-effectiveness analysis in a low-resource setting. British 
Journal of Cancer, 97(9), pp.1322–8. 
 
Kim, K.-M., 2004. Critical Theory Criticized: Giddens’s Double Hermeneutic and the 
Problem of Language Game Change. Cultural Studies ↔ Critical Methodologies, 
Page | 224  
 
4(1), pp.28–44. 
 
Kitchener, H., Gilham, C. & Sargent, A., 2011. A comparison of HPV DNA testing and 
liquid based cytology over three rounds of primary cervical screening: extended 
follow up in the ARTISTIC trial. European Journal of Cancer 47(6), pp.864-71 
Kitchener, H. & Walker, P., 2008. HPV testing as an adjunct to cytology in the follow 
up of women treated for cervical intraepithelial neoplasia. …  BJOG 115(8), 
pp.1001-7 
 
Kitchener, H.C., Almonte, M., Thomson, C., Wheeler, P., Sargent, A., Stoykova, B., 
Gilham, C., Baysson, H., Roberts, C., Dowie, R., Desai, M., Mather, J., Bailey, A., 
Turner, A., Moss, S.M. & Peto, J., HPV testing in combination with liquid-based 
cytology in primary cervical screening (ARTISTIC): a randomised controlled trial. 
The Lancet. Oncology, 10(7), pp.672–82. 
 
Kitchener, H.C., Almonte, M., C., Wheeler, P., Desai, M., Gilham, C., Sargent, A., Peto, 
J., ARTISTIC Trial Study Group, 2006. HPV testing in routine cervical screening: 
cross sectional data from the ARTISTIC trial. British Journal of Cancer, 95(1), 
pp.56–61. 
 
Kjaer, S.K., Breugelmans, G., Munk, C., Junge, J., Watson, M. & Iftner, T., 2008. Population-
based prevalence, type- and age-specific distribution of HPV in women before 
introduction of an HPV-vaccination program in Denmark. International Journal of 
Cancer, 123(8), pp.1864–70. 
 
Klemm,P. Bunnell, D., Cullen, M., Soneji, R., Gibbons, P. & Holecek, A., 2003. Online 
cancer support groups: a review of the research literature. Computers, 
Informatics, Nursing: CIN, 21(3), pp.136–142. 
 
Kling, A.R., 1992. Genital warts--therapy. Seminars in Dermatology, 11(3), pp.247–55. 
 
Klug, S.J., Hukelmann, M. & Blettner, M., 2008. Knowledge about infection with 
human papillomavirus: a systematic review. Preventive Medicine, 46(2), pp.87–
98. 
 
Knapp, S., Marziliano, A. & Moyer, A., 2014. Identity threat and stigma in cancer 
patients. Health Psychology Open, 1(1), p.205510291455228. 
 
Koller, M., Kussman, J., Lorenz, W., Jenkins, M., Voss, M., Arens, E., Richter, E. & 
Rothmund, M., 1996. Symptom reporting in cancer patients: the role of negative 
affect and experienced social stigma. Cancer, 77(5), pp.983–95. 
 
Kong, B-H., 2008. Levinas’ Ethics of Caring: Implications and Limits in Nursing. Asian 
Nursing Research, 2(4), pp.208–213. 
Page | 225  
 
 
Kosenko, K.A., Craig, E. & Harvey-Knowles, J., 2012. Helpful and Challenging Support 
Encounters in the Aftermath of HPV Infection and Diagnosis. Issues in Mental Health 
Nursing, 33(6), pp.355–362. 
 
Kosenko, K., Harvey-Knowles, J. & Hurley, R., 2014. The Information Management 
Processes of Women Living with HPV. Journal of Health Communication, 19(7), 
pp.813–24. 
 
Kosenko, K., Hurley, R. & Harvey, J., 2012. Sources of the Uncertainty Experienced by 
Women With HPV. Qualitative Health Research, 22(4), pp.534–545.  
Koutri, I. & Avdi, E., 2016. The suspended self: Liminality in breast cancer narratives 
and implications for counselling. European Journal of Counselling Psychology, 
5(1), pp.78–96. 
 
Koutsky, L., 1997. Epidemiology of Genital Human Papillomavirus Infection. American 
Journal of Medicine, 5;102(5A), pp.3-8. 
 
Kozinets, R., 2015. Netnography. In The International Encyclopedia of Digital 
Communication and Society. Hoboken, NJ, USA: John Wiley & Sons, Inc., pp. 1–8. 
 
Kremsdorf, D., Soussan, P., Paterlini-Brechot, P. & Brechot, C., 2006. Hepatitis B virus-
related hepatocellular carcinoma: paradigms for viral-related human 
carcinogenesis. Oncogene, 25(27), pp.3823–33. 
 
Krosnick, J., 2000. The Threat of Satisficing in Surveys: The Shortcuts Respondents 
Take in Answering Questions. Survey Methods Newsletter, 20(1), pp.4–8. 
 
Kryzszczuk, M., 2001. Trust: A Sociological Theory. Studia Socjologiczne, 2(161), 
pp.90–102. 
 
Kuhn, T.S., 2012. The Structure of Scientific Revolutions 4th Edition. Hacking, I. (Ed.), 
University of Chicago Press. 
 
Kuijpers, W., Groen, W.G., Aaronson, N.K. & van Harten, W.H., 2013. A systematic 
review of web-based interventions for patient empowerment and physical 
activity in chronic diseases: Relevance for cancer survivors. Journal of Medical 
Internet Research, 15(2):e37 
 
Kvale, S., 2006. Dominance Through Interviews and Dialogues. Qualitative Inquiry, 
12(3), pp.480–500. 
 
Kvale, S., 1996. InterViews: An introduction to qualitative research interviewing.  
SAGE Publications Ltd. 
 
Page | 226  
 
Kvale, S. & Brinkmann, S., 2009. InterViews: Learning the Craft of Qualitative Research 
Interviewing, SAGE Publications Ltd. 
 
Kwan, T.T.C., Cheung, A.N., Lo, S.S., Tam, K.F., Chan K.K. & Ngan, H.Y., 2011. 
Psychological burden of testing positive for high-risk human papillomavirus on 
women with atypical cervical cytology: a prospective study. Acta Obstetricia et 
Gynecologica Scandinavica, 90(5), pp.445–51. 
 
LaCoursiere, S.P., 2001. A Theory of Online Social Support. Advances in Nursing 
Science, 24(1), p.60. 
 
Lam-Po-Tang, J. & McKay, D., 2010. Dr Google, MD: A Survey of Mental Health-
Related Internet Use in a Private Practice Sample. Australasian Psychiatry, 18(2), 
pp.130–133. 
 
Landoni, F., Mandoni, A., Cormio, G., Perego, P., Milani, R., Caruso, O. & Mangioni, C., 
2001. Class II versus Class III Radical Hysterectomy in Stage IB–IIA Cervical 
Cancer: A Prospective Randomized Study. Gynecologic Oncology, 80(1), pp.3–12. 
 
Larkin, M., 2007. HPV vaccine mandate stirs controversy in USA. Lancet Infectious 
Diseases, 7(4), p.251. 
 
Laverty, S.M., 2008. Hermeneutic Phenomenology and Phenomenology: A 
Comparison of Historical and Methodological Considerations. International 
Journal of Qualitative Methods, 2(3), pp.21–35. 
 
Leary, K., 1999. Passing, Posing, and "Keeping it Real"Constellations, 6(1), pp.85–96. 
 
Lee, K., Hoti, K., Hughes, J.D. & Emmerton, L.M., 2015. Consumer Use of “Dr Google”: 
A Survey on Health Information-Seeking Behaviors and Navigational Needs. 
Journal of Medical Internet Research, 17(12), p.e288. 
 
Lee, K., Hoti, K., Hughes, J.D. & Emmerton, L.M., 2014. Dr Google and the Consumer: 
A Qualitative Study Exploring the Navigational Needs and Online Health 
Information-Seeking Behaviours of Consumers With Chronic Health Conditions. 
Journal of Medical Internet Research, 16(12), pp.1–13. 
 
Lee, R.M. & Renzetti, C.M., 1990. The Problems of Researching Sensitive Topics. 
American Behavioral Scientist, 33(5), pp.510–528. 
 
Liamputtong, P. & Suwankhong, D., 2015. Breast cancer diagnosis: biographical 
disruption, emotional experiences and strategic management in Thai women 
with breast cancer. Sociology of Health & Illness, 37(7), pp.1086–101. 
 
Page | 227  
 
Link, B.G. & Phelan, J., 2001. Conceptualizing Stigma. Annual Review of Sociology, 
27(Lewis 1998), pp.363–385. 
 
Little, M., Jordens, C.F., Paul, K., Montgomery, K. & Philipson, B., 1998. Liminality: A 
Major Category of the Experience of Cancer Illness. Social Science & Medicine, 
47(10), pp.1485–1494. 
 
Lloyd, P.A., Briigs, E.V., Kane, N., Jeyarajah, A.R. & Shepherd, J.H., 2014. Women’s 
experiences after a radical vaginal trachelectomy for early stage cervical cancer. 
A descriptive phenomenological study. European Journal of Oncology Nursing 
18(4), pp.362–71. 
 
  
Page | 228  
 
LoConte, N.K., Else-Quest, N.M., Eickhoff, J., Hyde, J. & Schiller J.H., 2008. Assessment 
of guilt and shame in patients with non-small-cell lung cancer compared with 
patients with breast and prostate cancer. Clinical Lung Cancer, 9(3), pp.171–8. 
 
Louvanto, K., Rintala, M.A., Syrjänen, K.J., Grénman, S.E. & Syrjänen S.M., 2010. 
Genotype‐Specific Persistence of Genital Human Papillomavirus (HPV) Infections 
in Women Followed for 6 Years in the Finnish Family HPV Study. Journal of 
Infectious Diseases, 202(3), pp.436–444. 
 
Luhtanen, R. & Crocker, J., 1992. A Collective Self-Esteem Scale: Self-Evaluation of 
One’s Social Identity. Personality and Social Psychology Bulletin, 18(3), pp.302–
318. 
 
Maggino, T., Casadei, D., Panontin, E., Fadda, E., Zampieri, M.C., Donà, M.A., Soldà, A. 
& Altoè, G., 2007. Impact of an HPV diagnosis on the quality of life in young 
women. Gynecologic Oncology, 107(S1), pp.S175-9. 
 
Maglennon, G.A., 2012. The Biology of Papillomavirus Latency. The Open Virology 
Journal, 6(1), pp.190–197. 
 
Magnezi, R., Gorsberg, D., Novikov, I., Ziv, A., Shani, M. & Freedman, L.S., 2015. 
Characteristics of patients seeking health information online via social health 
networks versus general Internet sites: a comparative study. Informatics for 
Health and Social Care. 
 
Maguire, R. Stoddart, K., Flowers, P., McPhelim, J. & Kearney, N., 2014. An 
Interpretative Phenomenological Analysis of the lived experience of multiple 
concurrent symptoms in patients with lung cancer: A contribution to the study of 
symptom clusters. European Journal of Oncology Nursing, 18(3), pp.310–315. 
 
Maines, D.R., 2000. The Social Construction of Meaning. Contemporary Sociology, 
29(4), p.577. 
 
Maissi, E., Marteau, T.M., Hankins, M., Moss, S., Legood, R. & Gray, A, 2004. The 
psychological impact of human papillomavirus testing in women with borderline 
or mildly dyskaryotic cervical smear test results: 6-month follow-up. British 
Journal of Cancer, 92(May), pp.1–6. 
 
Major, B. & O’Brien, L.T., 2005. The Social Psychology of Stigma.  
Annual Review of Psychology, 56(1), pp.393–421. 
 
Manhart, L. & Koutsky, L., 2002. Do Condoms Prevent Genital HPV Infection, External 
Genital Warts, or Cervical Neoplasia? A Meta-Analysis. Sexually Transmitted 
Diseases, 29(11), pp.725–735. 
Page | 229  
 
 
Mann, S., 2016. The Research Interview : Reflective Practice and Reflexivity in 
Research Processes, Palgrave Macmillan. 
 
Marhefka, S.L.S., Daley, E.M., Anstey, E.H., Vamos, C.A., Buhi, E.R. & Giuliano A,R., 
2012. HPV-related information sharing and factors associated with US men’s 
disclosure of an HPV test result to their female sexual partners. Sexually 
Transmitted Infections, 88, pp.171–176. 
 
Marlow, L., Wardle, J., Forster, A. S., 2009. Ethnic differences in human papillomavirus 
awareness and vaccine acceptability. Journal of Epidemiology and Community 
Health, 63(12), pp.1010–1015. 
 
Marlow, L., Zimet, G.D., McCaffery, K.J., Ostini, R. & Waller, J., 2013. Knowledge of 
human papillomavirus (HPV) and HPV vaccination: An international comparison. 
Vaccine, 31(5), pp.763–769. 
 
Marlow, L.A. & Wardle, J., 2014. Development of a scale to assess cancer stigma in 
the non-patient population. BMC Cancer, 14(1), p.285. 
 
Marlow, L., Waller, J. & Wardle, J., 2015a. Barriers to cervical cancer screening among 
ethnic minority women: a qualitative study. Journal of Family Planning & 
Reproductive Health Care, 41(4), pp.248–54. 
 
Marlow, L., Waller, J. & Wardle, J., 2015b. Does lung cancer attract greater stigma 
than other cancer types? Lung Cancer, 88(1), pp.104–107. 
 
Marlow, L., Waller, J. & Wardle, J., 2007. Public awareness that HPV is a risk factor for 
cervical cancer. British Journal of Cancer, 97(5), pp.691–4. 
 
Matua, G.A., 2015. Choosing phenomenology as a guiding philosophy for nursing 
research. Nurse Researcher, 22(4), pp.30–34. 
 
Matua, G. & Van Der Wal, D., 2015. Differentiating between descriptive and 
interpretive phenomenological research approaches. Nurse Researcher, 22(6), 
pp.22–27. 
 
McCaffery, K., Forrest, S., Waller, J., Desai, M., Szarewski, A. & Wardle, J., 2003. 
Attitudes towards HPV testing: a qualitative study of beliefs among Indian, 
Pakistani, African-Caribbean and white British women in the UK. British Journal 
of Cancer, 88(1), pp.42–6. 
 
McCaffery, K., Waller, J., Nazroo, J. & Wardle, J., 2006. Social and psychological 
impact of HPV testing in cervical screening: a qualitative study. Sexually 
Transmitted Infections, 82(2), pp.169–74. 
Page | 230  
 
 
 
 
McCaffery, K., Waller, J., Forrest, S., Cadman, L., Szarewski, A. & Wardle, J., 2004. 
Testing positive for human papillomavirus in routine cervical screening: 
examination of psychosocial impact. BJOG, 111(12), pp.1437–43. 
 
McCaffery, K., Irwig, L. & Turner, R., 2010. Psychosocial outcomes of three triage 
methods for the management of borderline abnormal cervical smears: an open 
randomised trial. BMJ: British Medical  …. 
 
McCurdy, S., Fernández, M., Tyson, S.K., Useche, B., Arvey, S., LaRue, D., Lopez, A. & 
Sanderson M., 2011. Hispanic Women’s Concerns About Disclosure of Their 
HPV+ Status. Hispanic Health Care International, 9(4), pp.168–173. 
 
McRae, J., Martin, C., O'Leary, J. & Sharp, L., 2014. “If you can’t treat HPV, why test 
for it?” Women’s attitudes to the changing face of cervical cancer prevention: a 
focus group study. BMC Women's Health, 14(1), p.64. 
 
Mead, G.H., 2015. Mind, Self & Society: The Definitive Edition  
Morris, C.W. (Ed.), University of Chicago Press. 
 
Mealer, M. & Jones, J., 2014. Methodological and ethical issues related to qualitative 
telephone interviews on sensitive topics. Nurse Researcher, 21(4), pp.32–37. 
 
Melkert, P.W.J., van den Brule, A.J.C., Risse, E.J.K., van Diest, P.J., Meijer, C.J.L.M., 
Walboomers, J.M.M., Helmerhorst, T., Hopman, E., Bleker, O.P. & Schipper, 
M.E.I., 2009. Prevalence of HPV in cytomorphologically normal cervical smears, 
as determined by the polymerase chain reaction, is age-dependent. International 
Journal of Cancer, 53(6), pp.919–923. 
 
Mertens, D.M., 2005. Research and Evaluation in Education and Psychology: 
Integrating Diversity with Quantitative, Qualitative and Mixed Methods 2nd ed.,  
Thousand Oaks, CA: SAGE Publications Ltd. 
 
Montgomery, K., Gonzalez, E.W. & Montgomery, O.C., 2008. Self-Disclosure of 
Sexually Transmitted Diseases. Holistic Nursing Practice, 22(5), pp.268–279. 
 
Moorhead, S.A., Hazlett, D.E., Harrison, L., Carroll, J.K., Irwin, A. & Hoving, C., 2013. A 
new dimension of health care: systematic review of the uses, benefits, and 
limitations of social media for health communication. Journal of Medical Internet 
Research, 15(4). 
 
Morgan, M., 2003. The Doctor-Patient Relationship. In Sociology as Applied to 
Medicine. pp. 49–65. 
Page | 231  
 
 
Morrow, O., Hawkins, R. & Kern, L., 2015. Feminist research in online spaces. Gender, 
Place & Culture, 22(August), pp.526–543. 
 
Morse, J. & Field, P., 1996. Nursing Research: The Application of Qualitative 
Approaches 
 
 
van de Mortel, T.F., 2008. Faking it : social desirability response bias in self- report 
research report research. Australian Journal of Advanced Nursing, 25(4), pp.40–
48. 
 
Moscicki, A., 2005. Impact of HPV infection in adolescent populations. Journal of 
Adolescent Health. 
 
Muñoz, N., Castellsagué, X., Berrington de Gonzalez, A. & Gissmann, L., 2006. Chapter 
1: HPV in the Etiology of Human Cancer. Vaccine, 24 (S3), p.S3/1-10. 
 
Murphy, R.F., Scheer, J., Murphy, Y. & Mack, R., 1988. Physical disability and social 
liminality: A study in the rituals of adversity. Social Science & Medicine, 26(2), 
pp.235–242. 
 
Nack, A., 2002. Bad Girls and Fallen Women: Chronic STD Diagnoses as Gateways to 
Tribal Stigma. Symbolic Interaction, 25(4), pp.463–485. 
 
Nack, A., 2000. Damaged goods: Women Managing the Stigma of STDs. Deviant 
Behavior, 21(2), pp.95–121. 
 
Nack, A., 2008. Damaged Goods? : Women Living with Incurable Sexually Transmitted 
Diseases, Temple University Press. 
 
Nam, K., Chung, S., Kim, J., Jeon, S. & Bae, D., 2009. Factors associated with HPV 
persistence after conization in patients with negative margins. Journal of 
Gynecologic Oncology, 20(2), p.91. 
 
Namkoong, K., Shah, D. V. & Gustafson, D.H., 2016. Offline Social Relationships and 
Online Cancer Communication: Effects of Social and Family Support on Online 
Social Network Building. Health Communication, 0(0), pp.1–8. 
 
Nederhof, A.J., 1985. Methods of coping with social desirability bias: A review. 
European Journal of Social Psychology, 15(3), pp.263–280. 
 
Nettleton, S., 2006. The Sociology of Health & Illness. Polity Press. 
 
Newton, D. & McCabe, M., 2008. Effects of sexually transmitted infection status, 
Page | 232  
 
relationship status, and disclosure status on sexual self-concept. Journal of Sex 
Research, 45(2), pp.187–192. 
 
Newton, D. & McCabe, M., 2005. The impact of stigma on couples managing a 
sexually transmitted infection. Sexual and Relationship Therapy, 20(1), pp.51–63. 
 
 
NHS Cancer Screening Programmes, 2011. HPV Triage and Test of Cure 
Implementation Guide. NHSCSP Good Practice Guide No. 3, July(3), pp.1–2. 
 
NHSCSP, 2013. Achievable Standards, Benchmarks for Reporting, and Criteria for 
Evaluating Cervical Cytopathology. 
NHSCSP, 2016. Colposcopy and Programme Management NHSCSP Publication No. 20,  
3rd Edition, March 2016 
 
NICE, 2016. Cervical Cancer Overview National Institute for Health & Care Excellence.  
Available at: https://pathways.nice.org.uk/pathways/cervical-cancer  
[Accessed August 10th, 2017]. 
 
Nikčević, A. V. & Nicolaides, K.H., 2014. Search for meaning, finding meaning and 
adjustment in women following miscarriage: A longitudinal study. Psychology & 
Health, 29(1), pp.50–63. 
 
Nordtug, B., 2015. Levinas’s ethics as a basis of healthcare - challenges and dilemmas. 
Nursing Philosophy, 16(1), pp.51–63. 
 
Novick, G., 2008. Is there a bias against telephone interviews in qualitative research? 
Research in Nursing and Health, 31(4), pp.391–398. 
 
Oakley, 1990. Interviewing Women. In H. Roberts, ed. Doing Feminist Research. 
Routledge, p. 203. 
 
Oakley, A., 1998. Gender, methodology and people’s ways of knowing: some 
problems with feminism and the paradigm debate in social science. Sociology, 
32(4), pp.707–731. 
 
Oakley, A., 2015. Interviewing Women Again: Power, Time and the Gift. Sociology, 
50(1), p.0038038515580253-. 
 
Oh, H., Rizo, C., Enkin, M. & Jadad, A., 2005. What is e-Health (3): A Systematic 
Review of Published Definitions. Journal of Medical Internet Research, 7(1), p.e1. 
 
Oliver, D.P., Washington, K., Wittenberg-Lyles, E., Gage, A., Mooney, M. & Demiris, G., 
2015. Lessons Learned from a Secret Facebook Support Group. Health & Social 
Work, 40(2), pp.125–133. 
Page | 233  
 
 
ONS, 2016. Internet Access - Households and Individuals - Office for National 
Statistics. 
 Internet Access - Households and Individuals: 2015, p.1. Available at: 
https://www.ons.gov.uk/peoplepopulationandcommunity/householdcharacteris
tics/homeinternetandsocialmediausage/bulletins/internetaccesshouseholdsandi
ndividuals/2015-08-06 [Accessed July 18, 2017]. 
 
ONS, 2017. Internet Users in the UK - Office for National Statistics, 
Opdenakker, R., 2006. Advantages and Disadvantages of Four Interview Techniques in 
Qualitative Research. Forum Qualitative Sozialforschung / Forum: Qualitative 
Social Research, 7(4). 
 
Oyserman, D. & Swim, J.K., 2001. Stigma : An Insider’s View. Journal of Social Issues, 
57(1), pp.1–14. 
Paechter, C., 2013. Researching sensitive issues online: implications of a hybrid 
insider/outsider position in a retrospective ethnographic study. Qualitative 
Research, 13(1), pp.71–86. 
 
Paley, J., 1996. How not to clarify concepts in nursing. Journal of Advanced Nursing, 
24(3), pp.572–578. 
 
Paley, J., 1997. Husserl, phenomenology and nursing. Journal of Advanced nursing, 
26(1), pp.187–193. 
 
Paley, J., 2005. Phenomenology as rhetoric. Nursing Inquiry, 12(2), pp.106–116. 
 
Paley, J., 2014. Heidegger, lived experience and method. Journal of Advanced Nursing, 
70(7), pp.1520–1531. 
 
Paley, J., 2016. Phenomenology as Qualitative Research., Taylor & Francis. 
 
Park, J.Y., Lee, K.H., Ddong, S.M., Kang, S., Park, S.Y. & Seo, S.S., 2008. The association 
of pre-conization high-risk HPV load and the persistence of HPV infection and 
persistence/recurrence of cervical intraepithelial neoplasia after conization. 
Gynecologic Oncology, 108(3), pp.549–554. 
 
Patel, A., Galaal, K., Burnely, C., Faulkner, K., Martin-Hirsch, P., Bland, M.J., Leeson, S., 
Beer, H., Paranjothy, S., Sasieni, P. & Naik, R., 2012. Cervical cancer incidence in 
young women: a historical and geographic controlled UK regional population 
study.  
British Journal of Cancer, 106(11), pp.1753–9. 
 
Patton, M.Q., Patton & Quinn, M., 2005. Qualitative Research. In Encyclopedia of 
Statistics in Behavioral Science. Chichester, UK: John Wiley & Sons, Ltd. 
Page | 234  
 
 
PDQ Adult Treatment Editorial Board, P.A.T.E., 2002. Cervical Cancer Treatment 
(PDQ®): Health Professional Version, National Cancer Institute (US). 
 
Penninx, B.W., van Tilburg, T., Kriegsman, D.M., Deeg, D.J., Boeke, A.J. & van Eijk, J.T., 
1997. Effects of Social Support and Personal Coping Resources on Mortality in 
Older Age: The Longitudinal Aging Study Amsterdam. American Journal of 
Epidemiology, 146(6). 
 
 
 
Perino, A., Giovannelli, L., Schillaci, R., Ruvolo, G., Fiorentino, F.P., Alimondi, P., 
Cefalù, E. & Ammatuna, P., 2011. Human papillomavirus infection in couples 
undergoing in vitro fertilization procedures: impact on reproductive outcomes. 
Fertility & Sterility, 95(5), pp.1845–8. 
 
Perpich, D., 2008. The Ethics of Emmanuel Levinas, Stanford University Press. 
 
Perrin, K., Daley, E.M., Naoom, S.F., Packing-Ebuen, J.L., Rayko, H.L., McFarlane, M. & 
McDermott, R.J., 2006. Women’s Reactions to HPV Diagnosis: Insights from In-
Depth Interviews. Women & Health, 43(2), pp.93–110. 
Peter, J. & Valkenburg, P.M., 2011. The Impact of "Forgiving" Introductions on the 
Reporting of Sensitive Behavior in Surveys: The Role of Social Desirability 
Response Style and Developmental Status. Public Opinion Quarterly, 75(4), 
pp.779–787. 
 
Peto, J., Gilham, C., Deacon, J., Taylor, C., Evans, C., Binns, W., Haywood, M., Elanko, 
N., Coleman, D., Yule, R. & Desai, M., 2004. Cervical HPV infection and neoplasia 
in a large population-based prospective study: the Manchester cohort. British 
Journal of Cancer, 91(5), pp.942–53. 
 
Petrovskaya, O., 2014. Is there nursing phenomenology after Paley? Essay on rigorous 
reading. Nursing Philosophy, 15(1), pp.60–71. 
 
PHE, 2016a. HPV Vaccination for men who have sex with men programme  
 Available at: https://www.gov.uk/government/collections/hpv-vaccination-for-
men-who-have-sex-with-men-msm-programme [Accessed April 13th, 2018] 
 
PHE, 2016b. HPV primary screening in the cervical screening programme PHE 
Screening Blogs.  
Available at: https://phescreening.blog.gov.uk/2016/04/13/hpv-primary-
screening-in-the-cervical-screening-programme/ [Accessed May 30, 2017]. 
 
Phelps, W.C., Yee, C.L., Münger, K. & Howler, P.M., 1988. The human papillomavirus 
type 16 E7 gene encodes transactivation and transformation functions similar to 
Page | 235  
 
those of adenovirus E1A. Cell, 53(4), pp.539–547. 
 
Pías-Peleteiro, L., Cortés-Bordoy, J. & Martinón-Torres, F., 2013. Dr Google: What 
about the HPV Vaccine? Human Vaccines & Immunotherapeutics, 9(8), pp.1712–
1719. 
 
van der Pijl, K., 2007. Hermeneutics, Weber, Constructivism. A Survey of Global 
Political Economy, pp.88–113. 
 
Piñeros, M., Hernàndez-Suárez, G., Orjuela, L., Vargas, J.C. & Pérez, G., 2013. HPV 
Knowledge and Impact of Genital Warts on Self Esteem and Sexual Life in 
Colombian Patients. BMC Public Health, 13, p.272. 
 
del Pino, M., Rodriguez-Carunchio, L., Alonso, I., Tomé, A., Rodriguez, A., Fusté, P., 
Castillo, P., Nonell, R., Abu-Lhiga, N. & Ordi, J., 2011. Clinical, colposcopic and 
pathological characteristics of cervical and vaginal high-grade lesions negative 
for HPV by Hybrid Capture 2. Gynecologic Oncology, 122(3), pp.515–520. 
 
Pirotta, M., Ung, L., Stein, A., Conway, E.L., Mast, T.C., Fairley, C.K. & Garland, S., 
2009. The psychosocial burden of human papillomavirus related disease and 
screening interventions. Sexually Transmitted Infections, 85(7), pp.508–513. 
 
Piver, M.S., Rutledge, F. & Smith, J.P., 1974. Five classes of extended hysterectomy for 
women with cervical cancer. Obstetrics and Gynecology, 44(2), pp.265–72. 
 
Poggi, G., 2000. Durkheim (Founders of Modern Political and Social Thought), Oxford 
University Press. 
 
Pollock, K.G.J., Kavanagh, K., Potts, A., Love, J., Cuschieri, K., Cubie, H., Robertson, C., 
Palmer, T.J., Nicoll, S. & Donaghy, M., 2014. Reduction of low- and high-grade 
cervical abnormalities associated with high uptake of the HPV bivalent vaccine in 
Scotland. British Journal of Cancer, 111(9), pp.1824–30. 
 
Pomel, C., Atallah, D., Le Bouedec, G., Rouzier, R., Morice, P., Castaigne, D. & Dauplat, 
J.,  2003. Laparoscopic radical hysterectomy for invasive cervical cancer: 8-year 
experience of a pilot study. Gynecologic Oncology, 91(3), pp.534–539. 
 
Powell, J., Inglis, N., Ronnie, J. & Large, S., 2011. The characteristics and motivations 
of online health information seekers: cross-sectional survey and qualitative 
interview study. Journal of Medical Internet Research, 13(1), p.e20. 
 
Presser, S. & Stinson, L., 1998. Data Collection Mode and Social Desirability Bias in 
Self-Reported Religious Attendance. American Sociological Review, 63(1), p.137. 
 
Rager, K., 2004. A thematic analysis of the self‐directed learning experiences of 13 
Page | 236  
 
breast cancer patientsy. International Journal of Lifelong Education, 23(1), 
pp.95–109. 
 
Rager, K.B., 2006. Self‐directed learning and prostate cancer: a thematic analysis of 
the experiences of twelve patients. International Journal of Lifelong Education, 
25(5), pp.447–461. 
 
Raheim, M., 2006. Lived Experience of Chronic Pain and Fibromyalgia: Women’s 
Stories From Daily Life. Qualitative Health Research, 16(6), pp.741–761. 
 
Rains, S., Peterson, E. & Wright, K., 2015. Communicating Social Support in Computer-
mediated Contexts: A Meta-analytic Review of Content Analyses Examining 
Support Messages Shared Online among Individuals Coping with Illness. 
Communication Monographs, 82(4), pp.403–430. 
 
Rajaram, S.S., Hill, J., Rave, C. & Crabtree, B.F., 1997. A biographical disruption: The 
case of an abnormal pap smear. Health Care for Women International, 18(6), 
pp.521–31. 
 
Read, T.R.H., Hocking, J.S., Chen, M.Y., Donovan, B.M., Bradshaw, C.S. & Fairley, C.K.,  
2011. The near disappearance of genital warts in young women 4 years after 
commencing a national human papillomavirus (HPV) vaccination programme. 
Sexually Transmitted Infectionsfections, 87(7), pp.544–7. 
 
Reblin, M. & Uchino, B.N., 2008. Social and emotional support and its implication for 
health. Current Opinion in Psychiatry, 21(2), pp.201–205. 
 
Reed, B.D., Ruffin, M.T., Gorenflo, D.W., Zazove, P., 1999. The psychosexual impact of 
human papillomavirus cervical infections. Journal of Family Practice, 48(2), 
pp.110–6. 
 
Reeves, C.L., 2010. A difficult negotiation: fieldwork relations with gatekeepers. 
Qualitative Research, 10(3), pp.315–331. 
 
Reid, L., 2017. Truth or Spin? Disease Definition in Cancer Screening. The Journal of 
Medicine and Philosophy: A Forum for Bioethics and Philosophy of Medicine, 
42(4), pp.385–404. 
 
Reiter, P., McRee, A.L., Kadis, J.A. & Brewer, N.T., 2011. HPV vaccine and adolescent 
males. Vaccine, 29(34), pp.5595–5602. 
 
Reiter, P.L., Brewer, N.T., Gottlieb, S.L., McRee, A-L. & Smith, J.S., 2009. How much 
will it hurt? HPV vaccine side effects and influence on completion of the three-
dose regimen. Vaccine, 27(49), pp.6840–6844. 
Page | 237  
 
 
Repper, J. & Carter, T., 2011. A review of the literature on peer support in mental 
health services. Journal of mental health (Abingdon, England), 20(4), pp.392–
411. 
 
Rice, R.E., 2006. Influences, usage, and outcomes of Internet health information 
searching: Multivariate results from the Pew surveys. International Journal of 
Medical Informatics, 75(1), pp.8–28. 
 
Robertson, N., Polonsky, M. & McQuilken, L., 2014. Are my symptoms serious Dr 
Google? A resource-based typology of value co-destruction in online self-
diagnosis. Australasian Marketing Journal (AMJ), 22(3), pp.246–256. 
 
Rogers, A., Brooks, H., Vassilev, I., Kennedy, A., Blickem, C. & Reeves, D., 2014. Why 
less may be more: a mixed methods study of the work and relatedness of “weak 
ties” in supporting long-term condition self-management. Implementation 
Science, 9(1), p.19. 
 
 
Ryan, S., 2010. “Meltdowns”, surveillance and managing emotions; going out with 
children with autism. Health & Place, 16(5), pp.868–875. 
 
Salamonsen, A., Kiil, M.A., Kristofferson, A.E., Stub, T. & Berntsen, G.R., 2016. “My 
cancer is not my deepest concern”: Life course disruption influencing patient 
pathways and health care needs among persons living with colorectal cancer. 
Patient Preference and Adherence, 10, pp.1591–600. 
 
de Sanjosé, S., Diaz, M., Castellsagué, X., Clifford, G., Bruni, L., Muñoz, N. & Bosch, 
F.X., 2007. Worldwide prevalence and genotype distribution of cervical human 
papillomavirus DNA in women with normal cytology: a meta-analysis. The Lancet 
Infectious Diseases, 7(7), pp.453–9. 
 
Sarian, L.O.Z., Derchain, S.F., Pitta Dda, R., Morais, S.S. & Rabelos-Santos, S.H., 2004. 
Factors associated with HPV persistence after treatment for high-grade cervical 
intra-epithelial neoplasia with large loop excision of the transformation zone 
(LLETZ). Journal of Clinical Virology, 31(4), pp.270–274. 
 
 
Sasieni, P., Castanon, A. & Cuzick, J., 2010. The impact of cervical screening on young 
women: a critical review of the literature 2002 – 2009, 
 
Scambler, G., 2009. Health-related stigma. Sociology of Health & Illness, 31(3), 
pp.441–455. 
 
Page | 238  
 
Scambler, G., 2006. Sociology, social structure and health-related stigma. Psychology, 
Health & Medicine, 11(3), pp.288–295. 
 
Scheler, M., 1973. Selected philosophical essays., Northwestern University Press. 
 
Schiffman, M.H., Bauer, H.M., Lorincz, A.T., Manos, M.M., Byrne, J.C., Glass, A.G., 
Cadell, D.M. & Howley, P.M., 1991. Comparison of Southern blot hybridization 
and polymerase chain reaction methods for the detection of human 
papillomavirus DNA. Journal of Clinical Microbiology, 29(3), pp.573–7. 
 
Schiffman, M.H., 1992. Recent Progress in Defining the Epidemiology of Human 
Papillomavirus Infection and Cervical Neoplasia. JNCI, 84(6), pp.394–398. 
 
Schlecht, N.F., 2003. Human Papillomavirus Infection and Time to Progression and 
Regression of Cervical Intraepithelial Neoplasia. JNCI 95(17), pp.1336–1343. 
 
Schneider, A. & Koutsky, L.A., 1992. Natural history and epidemiological features of 
genital HPV infection. IARC scientific publications, (119), pp.25–52. 
 
 
Setoyama, Y., Yamazaki, Y. & Nakayama, K., 2011. Comparing support to breast 
cancer patients from online communities and face-to-face support groups. 
Patient Education and Counseling, 85(2), pp.e95–e100. 
 
 
Sharp, L., Cotton, S., Gray, N., Avis, M., Russell, I., Walker, L., Waugh, N., Wynes, D., 
Woolley, C., Thornton, A., Smart, L., Cruickshank, M. & Little, J., TOMBOLA 
Group, 2011. Long-term psychosocial impact of alternative management policies 
in women with low-grade abnormal cervical cytology referred for colposcopy: a 
randomised controlled trial. British Journal of Cancer, 104(2), pp.255–64. 
 
Shaw, C., Abrams, K. & Marteau, T.M., 1999. Psychological impact of predicting 
individuals’ risks of illness: a systematic review. Social Science & Medicine, 
49(12), pp.1571–1598. 
 
Sheikh, S., Mansor, M. & Haque, M., 2016. Psychosocial burden differences between 
women of reproductive age and menopausal age due to abnormal Pap smear: A 
pilot study of the East Coast of Malaysia. Archives of Pharmacy Practice, 7(3), 
p.95. 
 
Shepherd, M.A. & Gerend, M.A., 2013. The blame game: cervical cancer, knowledge 
of its link to human papillomavirus and stigma. Psychology & Health, 29(1), 
pp.94–109. 
 
Sieber, J.E. & Stanley, B., 1988. Ethical and professional dimensions of socially 
Page | 239  
 
sensitive research. The American Psychologist, 43(1), pp.49–55. 
 
Silverman, D., 2006. Interpreting Qualitative Data: Methods for Analyzing Talk, Text 
and Interaction 3rd Ed., SAGE Publications Ltd. 
 
Simbayi, L.C., Kalichman, S., Strebel, A., Cloete, A., Henda, N. & Mgeketo, A., 2007. 
Internalized stigma, discrimination, and depression among men and women 
living with HIV/AIDS in Cape Town, South Africa. Social Science & Medicine 
(1982), 64(9), pp.1823–31. 
 
Smith, J., 2017. Phenomenology. The Internet Encyclopedia of Philosophy.  
Available at: http://www.iep.utm.edu/phenom/ [Accessed August 27, 2017]. 
 
Smith, J.A., 1996. Beyond the divide between cognition and discourse: Using 
interpretative phenomenological analysis in health psychology. Psychology and 
Health, 11(May 2015), pp.261–271. 
 
Smith, J.A., 2007. Hermeneutics, human sciences and health: Linking theory and 
practice. International Journal of Qualitative Studies on Health and Well-being, 
2(1), pp.3–11. 
 
Smith, J.A., Flowers, P. & Larkin, M., 2009. Interpretative Phenomenological Analysis: 
Theory, Method and Research, SAGE Publications. 
 
Smith, J.S., Melendy, A., Rana, R.K. & Pimenta, J.M., 2008. Age-specific prevalence of 
infection with human papillomavirus in females: a global review. Journal of 
Adolescent Health, 43(4 Suppl), pp.S5-25, NaN-41. 
 
Smith, R.A., 2012. Segmenting an Audience into the Own, the Wise, and Normals: A 
Latent Class Analysis of Stigma-Related Categories. Communication Research 
Reports, 29(4), pp.257–265. 
 
Solomon, P., 2004. Peer Support/Peer Provided Services Underlying Processes, 
Benefits, and Critical Ingredients. Psychiatric Rehabilitation Journal, 27(4), 
pp.392–401. 
 
Sontag, S., 2002. Illness as metaphor; AIDS and its Metaphors. Penguin. 
 
Spader, P.H., 2002. Scheler’s Ethical Personalism : Its Logic, Development, and 
Promise, Fordham University Press. 
 
Srivastava, S., Gupta, S. & Roy, J.K., 2012. High prevalence of oncogenic HPV-16 in 
cervical smears of asymptomatic women of eastern Uttar Pradesh, India: A 
population-based study. Journal of Biosciences, 37(1), pp.63–72. 
 
Page | 240  
 
Srivastava, S., Hanash, S.M. & Meijer, C.J.L.M., 2001. Global Strategies for Disease 
Detection and Treatment : Proteomics. Disease Markers, 17(4), pp.203-4 
 
Stanley, M., 2014. HPV vaccination in boys and men. Human Vaccines & 
Immunotherapeutics, 10(7), pp.2109–2111. 
 
Stensen, S., Kjaer, S.K., Jensen, S.M., Frederiksen, K., Junge, J., Iftner, T. & Munk, C., 
2016. Factors associated with type-specific persistence of high-risk human 
papillomavirus infection: A population-based study. International Journal of 
Cancer, 138(2), pp.361–368. 
 
Stets, J.E. & Burke, P.J., 2000. Theory and Social Identity Identity. Social Psychology 
Quarterly, 63(3), pp.224–237. 
 
Stewart, K. & Williams, M., 2005. Researching online populations: the use of online 
focus groups for social research. Qualitative Research, 5(4), pp.395–416. 
 
Stieger, S. & Göritz, A.S., 2006. Using Instant Messaging for Internet-Based Interviews. 
CyberPsychology & Behavior, 9(5), pp.552–559. 
 
Stryker, S. & Burke, P.J., 2013. The Past , Present , and Future of an Identity Theory. 
Social Psychology Quarterly, 63(4), pp.284–297. 
 
Stubenrauch, F. & Laimins, L.A., 1999. Human papillomavirus life cycle: active and 
latent phases. Seminars in cancer biology, 9(6), pp.379–86. 
 
Suler, J., 2004. The Online Disinhibition Effect. Cyberpsychology & Behavior (3), 
pp.321–326. 
 
Sundar, S.S., 2015. The Handbook of the Psychology of Communication Technology, 
John Wiley & Sons. 
 
Suzich, J.A., Ghim, S.J., Palmer-Hill, F.J., White, W.I., Tamura, J.K., Bell, J.A., Newsome, 
J.A., Jenson, A.B. & Schlegel, R., 1995. Systemic immunization with 
papillomavirus L1 protein completely prevents the development of viral mucosal 
papillomas. Proceedings of the National Academy of Sciences, 92(25), pp.11553–
11557. 
 
Svenaeus, F., 2011. Illness as unhomelike being-in-the-world: Heidegger and the 
phenomenology of medicine. Medicine, Health Care and Philosophy, 14(3), 
pp.333–343. 
 
Swann, W.B., 1987. Personality &amp; Dyadic Interaction: Identity Negotiation: 
Where Two Roads Meet. Journal of Personality & Social Psychology, 53(6), 
pp.1038–1051. 
Page | 241  
 
 
Syrjänen, K., Hakama, M., Saarikoski, S,., Väyrynen, M., Syrjänen, S., Kataja, V. & 
Castrén, O., 1990. Prevalence, incidence, and estimated life-time risk of cervical 
human papillomavirus infections in a nonselected Finnish female population. 
Sexually Transmitted Diseases, 17(1), pp.15–9. 
 
Syrjänen, K. & Syrjänen, S., 1990. Epidemiology of human papilloma virus infections and 
genital neoplasia. Scandinavian Journal of Infectious Diseases. Supplementum, 69, pp.7–
17. 
 
Syrjänen, S., Shabalova, I., Petrovichev, N., Kozachenko, V., Zakharova, T., Pajanidi, J, 
Podistov, J., Chemeris, G., Sozaeva, L., Lipova, E., Tsidaeva, I., Ivanchenko, O., 
Pshepurko, A., Zahkarenko, S., Nerovjna, R., Kljukina, L., Erokhina, O., 
Branovskaja, M., Nikitina, M., Grunberga, V., Grunberg, A., Juschenko, A., 
Cintorino, M., Santopietro, R., Tosi, P. & Syrjänen, K., 2005. Factors predicting 
persistence of high-risk human papillomavirus (HPV) infections in women 
prospectively followed-up in three New Independent States (NIS) of the former 
Soviet Union. European Journal of Gynaecological Oncology, 26(5), pp.491–8. 
 
Tajfel, H., 1974. Social identity and intergroup behaviour. Social Science Information, 
13(2), pp.65–93. 
 
Tajfel, H., 2010. Social Identity and Intergroup Relations, Cambridge University Press. 
 
Tang, T.S., Ayala, G.X., Cherrington, A. & Rana, G., 2011. A review of volunteer-based 
peer support interventions in diabetes. Diabetes Spectrum, 24(2), pp.85–98. 
 
  
Page | 242  
 
Tashakkori, A.M. & Teddlie, C.B., 2010. SAGE Handbook of Mixed Methods in Social & 
Behavioural Research 2nd Ed. A. M. Tashakkori & C. B. Teddlie, eds., 1000 Oaks 
California: SAGE Publications. 
 
Teroni, F. & Deonna, J.A., 2008. Differentiating shame from guilt. Consciousness and 
Cognition, 17, pp.725–740. 
 
Thomassen, B., 2009. The uses and meanings of liminality. International Political 
Anthropology, 2(1), pp.5–27. 
 
Ticconi, C., Pietropolli. A., Fabbri, G., Capoga, M.V., Perno, C.F. & Piccione. E., 2013. 
Recurrent Miscarriage and Cervical Human Papillomavirus Infection. American 
Journal of Reproductive Immunology, 70(5), pp.343-46 
 
Tieben, L.M., ter Schegget, J., Minnaar, R.P., Bouwes Bavinck, J.N., Berkhout, R.J., 
Vermeer, B.J., Jebbink, M.F. & Smits, H.L., 1993. Detection of cutaneous and 
genital HPV types in clinical samples by PCR using consensus primers. Journal of 
Virological Methods, 42(2–3), pp.265–279. 
 
Trottier, H. & Franco, E.L., 2006. The epidemiology of genital human papillomavirus 
infection. Vaccine, 24 Suppl 1, pp.S1-15. 
 
Trusson, D., Pilnick, A. & Roy, S., 2016. A new normal?: Women’s experiences of 
biographical disruption and liminality following treatment for early stage breast 
cancer. Social Science & Medicine, 151, pp.121–129. 
 
Tsatou, P., 2016. Internet Studies: Past, Present and Future Directions, London: 
Routledge. 
 
Uchino, B.N., Cacioppo, J.T. & Kiecolt-Glaser, J.K., 1996. The Relationship Between 
Social Support and Physiological Processes: A Review With Emphasis on 
Underlying Mechanisms and Implications for Health. Psychological Bulletin, 
119(3), pp.488–531. 
 
van Uden-Kraan, C.F., Drossaert, C.H., Taal, E., Seydel, E.R. & van de Laar, M.A., 2009. 
Participation in online patient support groups endorses patients’ empowerment. 
Patient Education and Counseling, 74(1), pp.61–69. 
 
van Uden-Kraan, C.F., Drossaert, C.H., Taal, E., Seydel, E.R. & van de Laar, M.A., 2008. 
Self-reported differences in empowerment between lurkers and posters in 
online patient support groups. Journal of Medical Internet Research, 10(2), 
p.e18. 
 
 
 
Page | 243  
 
 
 
 
Villa, L.L., Costa, R.L., Petta, C.A., Andrade, R.P., Ault, K.A., Giuliano, A.R., Wheeler, 
C.M., Koutsky, L.A., Malm, C., Lehtinen, M., Skjeldestad, F.E., Olsson, S.E., 
Steinwall, M., Brown, D.R., Kurman, R.J., Ronnett, B.M., Stoler, M.H., Ferenczy, 
A., Harper, D.M., Tamms, G.M., Yu, J., Lupinacci, L., Railkar, R., Taddeo, F.J., 
Jansen, K.U., Esser, M.T., Sings, H.L., Saah, A.J. & Barr, E., 2005. Prophylactic 
quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle 
vaccine in young women: a randomised double-blind placebo-controlled 
multicentre phase II efficacy trial. The Lancet Oncology, 6(5), pp.271–278. 
 
Villa, L.L. & Franco, E.L.F., 1989. Epidemiologic Correlates of Cervical Neoplasia and 
Risk of Human Papillomavirus Infection in Asymptomatic Women in Brazil. JNCI, 
81(5), pp.332–340. 
 
de Villiers, E.M., Fauquet, C., Broker, T.R. Bernard, H.U. & zur Hausen, H., 2004. 
Classification of papillomaviruses. Virology, 324(1), pp.17–27. 
 
Visser, M.J., Makin, J.D. & Lehobye, K., 2006. Stigmatizing attitudes of the 
community towards people living with HIV/AIDS. Journal of Community and 
Applied Social Psychology, 16(1), pp.42–58. 
 
Voloder, L. & Kirpitchenko, L., 2016. Insider Research on Migration and Mobility: 
International Perspectives on Researcher Positioning, London: Routledge. 
 
Walboomers, J., Jacobs, M.V., Manos, M.M., Bosch, F.X., Kummer, J.A., Shah, K.V., 
Snijders, P.J., Peto, J., Meijer, C. & Muñoz, N., 1999. Human Papillomavirus is a 
necessary case of invasive cervical cancer worldwide. Journal of Pathology, 
189(May), pp.12–19. 
 
Walboomers, J. & Meijer, C., 1997. Do HPV‐negative cervical carcinomas exist? 
Journal of Pathology. 
 
Waller, J., McCaffery, K., Forrest, S., Szarewski, A., Cadman, L. & Wardle J., 2003. 
Awareness of human papillomavirus among women attending a well woman 
clinic. Sexually Transmitted Infections 79(4), pp.320–2. 
 
Waller, J., McCaffery, K.J., Forrest, S. & Wardle, J., 2004. Human papillomavirus and 
cervical cancer: issues for biobehavioral and psychosocial research. Annals of 
behavioral medicine :, 27(1), pp.68–79. 
 
Waller, J., McCaffery, K., Nazroo, J. & Wardle, J., 2005. Making sense of information 
about HPV in cervical screening: a qualitative study. British Journal of Cancer, 
92(2), pp.265–70. 
Page | 244  
 
 
Waller, J., Marlow, L. & Wardle, J., 2009. Anticipated shame and worry following an 
abnormal Pap test result: the impact of information about HPV. Preventive 
medicine. 
 
Waller, J., Marlow, L. & Wardle, J., 2007. The association between knowledge of HPV 
and feelings of stigma, shame and anxiety. Sexually Transmitted 
Infectionsfections, 83(2), pp.155–9. 
 
Walter, M., 2013. Social research methods 3rd Editio., Oxford University Press, ANZ. 
 
Werness, B.A., Levine, A.J. & Howley, P.M., 1990. Association of human 
papillomavirus types 16 and 18 E6 proteins with p53. Science, 248(4951), pp.76–
80. 
 
Wheeler, M., 2016. Heidegger, Martin. In Stanford Encyclopedia of Philsophy. 
Stanford University. 
 
White, M. & Dorman, S.M., 2001. Receiving social support online: Implications for 
health education. Health Education Research, 16(6), pp.693–707. 
 
Williams, S.J., 2000. Chronic illness as biographical disruption or biographical 
disruption as chronic illness? Reflections on a core concept. Sociology of Health 
& Illness, 22(1), pp.40–67. 
 
de Witte, L., Zoughlami, Y., Aengeneyndt, B., David, G., van Kooyk, Y. & 
Geijtenbeek T.B., 2007. Binding of human papilloma virus L1 virus-like particles 
to dendritic cells is mediated through heparan sulfates and induces immune 
activation. Immunobiology, 212(9–10), pp.679–91. 
 
Wong, J. & Shoham, M., 2011. The Emotional Strength of Weak Ties: Reevaluating 
Social Support Online. 2011 44th Hawaii International Conference on System 
Sciences, pp.1–9. 
 
Woodman, C.B.J., Collins, S.I. & Young, L.S., 2007. The natural history of cervical HPV 
infection: unresolved issues. Nature reviews. Cancer, 7(1), pp.11–22. 
 
Wright, K., 2016. Communication in health-related online social support 
groups/communities: A review of research on predictors of participation, 
applications of social support theory, and health outcomes. Review of 
Communication Research, 4, pp.65–87. 
 
Wright, K. & Rains, S. a, 2013. Weak-Tie Support Network Preference, Health-Related 
Stigma, and Health Outcomes in Computer-Mediated Support Groups. Journal of 
Applied Communication Research, 41(3), pp.309–324. 
Page | 245  
 
 
Yildiz, M., 2007. E-government Research: Reviewing the Literature, Limitations and 
Ways Forward. Government Information Quarterly, 24, pp.646–665. 
 
 
 
 
Yoo, W., Namkoong, K., Choi, M., Shah, D.V., Tsang, S., Hong, Y., Aguilar, M. & 
Gustafson, D.H., 2014. Giving and Receiving Emotional Support Online: 
Communication Competence as a Moderator of Psychosocial Benefits for 
Women with Breast Cancer. Computers in Human Behavior, 30, pp.13–22. 
 
Young, L.S. & Murray, P.G., 2003. Epstein-Barr virus and oncogenesis: from latent 
genes to tumours. Oncogene, 22(33), pp.5108–21. 
 
 
Page | 246  
 
Appendices 
Appendices 
Appendices 
 Appendix 1 Original Ethical Approval for Questionnaire Study .................................  248 
 Appendix 2 Questionnaire Document ........................................................................   249 
 Appendix 3 Inferential Statistic Analyses for Questionnaire Study ............................  262 
 Appendix 4 Ethical Approval for Amendments to Include Interviews  ......................  
(screenshots of email conversation with graduate school 
office) ......................................................................................................  
268 
 Appendix 5 Approach Letters to Gatekeepers ...........................................................  269 
 Appendix 6 Approach Letters to Social Media Gatekeepers ......................................  270 
 Appendix 7 Participant Information Sheet .................................................................  271 
 Appendix 8 Interview Schedule/Broad Themes .........................................................  278 
 Appendix 9 Record of Informed Consent for Interviews ............................................  279 
 Appendix 10 Jay’s Narrative .........................................................................................  280 
 Appendix 11 Claire’s Narrative .....................................................................................  284 
 Appendix 12 Jo’s Narrative ...........................................................................................  289 
 
  
Page | 247  
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Appendix 2: Text of Questionnaire Document 
Introduction, Patient Information and Consent 
The purpose of this study is to examine the use of the nternet in managing stress in women following a 
diagnosis of human papillomavirus (HPV), the virus associated with cervical cancer. This research is 
being undertaken by a research student at De Montfort University as partial fulfillment of a Doctorate in 
Health Science. 
Your participation in this research is voluntary. You may choose not to participate, or you may withdraw 
at any time by closing the browser window. If you decide not to participate, or decide to withdraw, this 
will not affect any treatment you are currently undergoing, or waiting for. The procedure involved filling 
in an online survey, which takes about 20 minutes to complete. 
Your responses are anonymous and confidential. Identifying information such as your name, email or IP 
address is NOT collected. The survey is made up of severeal sections, asking questions about your age, 
ethnicity, relationship and education status; your HPV/cervical screening history and knowledge; your 
internet usage and two short measures of perceived stress and perceived social support. If you consent 
to participate, this means that you given permission for the researcher to use your anonymous 
responses in the study, to analyse these responses, and to publish the results or papers based on the 
results of these anlayses. You cannot be identified by your responses. 
Contact Information 
If you have any questions or complaints about this study please contact: 
Dr G Basten/Dr S Oldroyd 
Hawthorn Building, De Montfort University, The Gateway, Leicester, LE1 9BH 
Or contact: 0116 250 6070  
and ask for Dr S Oldroyd, Head of Health & Life Sciences regarding the HPV Social Media Study 
 
Privacy, Anonymity and Confidentiality 
Whilst your information is confidential at the point of collection, you may wish that the topic of this 
research (HPV) is kept private from family and friends. It is therefore receommended that you clear your 
browser history after you have completed the questionnaire or withdrawn from the study. Your privacy 
is protected as your identity including your email address, is hidden from the researcher. You are 
anonymous. 
 
 Your privacy is protected as your identity; including your email address will not be known or identified 
in the publication of any results. Your privacy is protected as all your responses are anonymous - your 
personal responses may be shared with the research supervisor or published in a research article, but 
you will not be identifiable by your responses to the questionnaire. 
 
Your personal information cannot be sold, exchanged or given to a third party as it is not known to the 
researcher. Participation in this study will not pose any risk to your health or wellbeing, nor affect any 
treatment you may be having. Responses to this questionnaire are automatically encrypted. 
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Benefits/Disadvantages 
What are the potential disadvantages of participating in this study? 
 
The questions in this research may cause you to worry. This research is not intended or designed to 
cause you harm, either physically or psychologically. If the contents of this questionnaire upset you or 
cause you worry, you may wish to contact your GP for advice. In addition, you may find the following 
sources of information helpful: 
 
www.cancerscreening.org.uk 
www.jostrust.org.uk 
www.macmillan.org.uk 
www.samaritans.org 
www.relate.org.uk 
 
What are the possible advantages or participating in this study? 
 
You may learn more about HPV, whether or not you have the condition. This knowledge may provide 
you with reassurance about the virus, or the knowledge and skills to comfort a family member or friend 
who may have HPV. 
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DEMOGRAPHIC DATA 
1 Please indicate your age 
  
  Age Range Reason for Question 
  18-24 
 
Do age ranges follow screening programme 
demographics. Older age brackets not eligible for 
screening but may still be on ten year follow-up under 
old system. Originally going to be a freetext box, but 
Professor Jin recommended categories. 
  25-34 
 
  35-44 
 
  45-54 
 
  55-64 
 
  65-74 
 
  
2 Relationship status 
Marital status might influence whether and to whom 
volunteer confides in/asks advice of 
  Single   
  
Long term relationship 
/marriage/civil partnership 
  Divorced   
  Widowed   
  
3 Ethnicity 
Possible health inequality exists re: uptake of 
screening/health literacy/access to internet/health 
advice. 
  White/British 
  White/Other 
  Indian 
  Pakistani 
  White/Irish 
  Mixed 
  Black Carribean 
  Black African 
  Bangladeshi 
  Chinese 
  Other Asian (Non-Chinese) 
  Black (Other) 
  Other 
  Prefer not to say 
  
4 Residential status 
Residential status might influence whether and to 
whom volunteer confides in/asks advice of 
  Alone 
  Live with parents/family 
  Live with friends/housemates 
  Living with partner 
  
5 Employment status 
  Employed 37+ hrs per wk Again, may affect social support - support by 
colleagues? Unemployed, not seeking work (e.g. full 
time mums) may not have access to support from 
colleagues/managers, or may indicate more support 
  Employed <37hrs per wk 
  Unemployed, seeking work 
  Unemployed, not seeking work 
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  Retired due to confiding in other mums?  
May affect perceived stress.    Disabled, not able to work 
  
6 Awareness of HPV 
  Are you aware of the human papillomavirus (HPV) 
  Yes 
Gauge level of awareness within the population 
  No 
  
7 HPV anxiety 
  Please indicate your level of anxiety over an HPV positive result 
  Very worried/anxious 
Likert scale  
  Worried/anxious 
  Neither worried nor unconcerned 
  Not worried/anxious 
  Really not worried/anxious 
  Prefer not to answer 
 
  
  
    
  
8 Shame/embarrassment over HPV 
  Please indicate your level of embarrassment at a positive HPV result. 
  Very embarrassed 
 
  
  Embarrassed 
 
  
  Neither embarrassed nor unembarrassed   
  Not embarrassed 
 
  
  Really not embarrassed 
 
  
  
9 Do you have daughters eligible for the HPV vaccine 
  Yes 
 
  
  No 
 
  
  
10 HPV Testing History 
  
 
Have you ever had an HPV test? 
  
 
No I am not in the screening programme 
  
 
No, I choose not to participate 
  
 
No I have not been HPV tested 
  
 
I don't know 
  
 
Yes I have had an HPV test 
  
 
Prefer not to answer 
  
      
11 Screening Frequency 
  Please indicate how often you participate in cervical screening. 
  Never  I choose not to participate   
  Never, not been invited yet   
  Occasionally - I don't always go when I receive my invitation letter   
  Regaularly - when I receive my invitation   
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  Frequently, I arrange for additional screening   
  Frequently, I am being managed by my local hospital following previous treatment 
  
    
  
 
12 Screening History 
  
Have you ever had an abnormal smear result? 
An abnormal result includes any of the following: 
 
Borderline, mild or low-grade dyskaryosis; moderate, severe or high-grade dyskaryosis, ?invasive 
cancer, ?glandular abnormalityor result codes 3, 4, 5, 6, 7 or 8; or result letters B, E or M. 
  
  
  
  
  No, I have never been screened 
 
  
  No I have never had an abnormal result 
 
  
  Yes, I have had an abnormal result 
 
  
  I don't know 
 
  
  Prefer not to say 
 
  
      
13 Treatment History 
  
 
Have you ever been offered or undergone treatment for an abnormal 
smear?  
 
I have an appointment but have not attended yet 
 
 
I have been to hospital and had a biopsy 
 
 
I have been to hospital and had treatment (a LLETZ, cone biopsy, cold coagulation or laser 
ablation) 
 
I have received treatment and had a follow-up test 
 
 
I have not required treatment 
  
 
Prefer not to say 
  
      
14 HPV Knowledge Measure 
  
 
Please select the statements you believe to be true 
 
 
HPV is a sexually transmitted infection 
 
 
HPV is the most common sexually transmitted infection in the UK 
 
 
HPV may go away on its own 
 
 
HPV may not produce any outward signs or symptoms 
 
 
HPV may cause cervical cancer 
 
 
HPV transmission may not be not stopped by condoms 
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15 HPV Knowledge Source 
 
 
How did you find out about HPV 
 
 
From my doctor 
 
 
From nurses/other staff at the surgery/clinic 
 
 
From doing research on the internet for myself 
 
 
From doing research on the HPV vaccine for my daughters 
 
 
From family/friends/partner(s)/colleagues 
 
 
From NHS Direct 
 
 
Prefer not to answer 
 
 
16 Disclosure 
   
 
Would you confide in anyone over a positive HPV result 
 
 
Yes 
   
 
No 
    
 
Prefer not to say 
  
      
17 Whom would you speak to? 
  
 
My partner 
   
 
Family member(s) 
  
 
Friend(s) 
   
 
A doctor or nurse 
  
 
An online support group 
  
 
Prefer not to say 
  
      
18 If you were anxious about a positive HPV result what form would your worries take? 
 
Please select all that apply: 
  
 
Disclosure - telling my partner, family, friends or colleagues 
 
 
Fertility - how HPV will affect this 
  
 
Health - I am worried about developing cancer 
 
 
Health - I am worried about cancer returning 
 
 
Life - I am scared of dying 
  
 
None of the above - I am not concerned 
  
 
Other (please specify) [freetext response up to 1000 characters] 
 
      
19 Do you use the Internet to look up healthcare information 
 
 
No I would use other ways to research healthcare information 
 
 
I sometimes use the internet to look up healthcare information 
 
 
I frequently use the internet to look up healthcare information 
 
      
20 Would you use the internet to look up advice/information or reassurance on HPV 
 
No I have never thought of using the internet for this kind of support 
 
 
Yes I would use the Internet to seek advice/reassurance if I could remain anonymous 
 
Yes, I use the Internet to seek advice, information and reassurance on various aspects of my life 
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and this would be no different. 
      
21 Which of the following resources have you heard of 
 
 
NHS Direct 
   
 
NHS Cancer Screening (Website) 
  
 
Jo's Trust (Website) 
  
 
British Society for Colposcopy and Cervical Pathology 
 
      
 
22 How often do you log into internet forums or online support groups 
 
 
Less than a few times a month 
  
 
A few times a month 
  
 
A few times a week  
  
 
About once a day 
  
 
More than once a day 
  
      
23 How long have you been using an HPV-related online support group 
 
 
I don't use them 
  
 
A few weeks 
   
 
A few months 
   
 
About a year 
   
 
Over a year 
   
 
Prefer not to say 
  
      
24 If you use online support groups, when did you last post on a forum or message board. 
 
I don't use them 
  
 
I don't post, I just read 
  
 
I've posted in the last week 
  
 
I've posted in the last month 
  
 
I've posted in the last few weeks 
  
 
I've posted in the last few months 
  
 
I've posted in the last year 
  
 
Prefer not to say 
  
   
25 Please indicate your agreement with the following statement: 
 
 
"I use social media or online support groups for  exchanging information." 
 
 
Strongly disagree 
  
 
Disagree 
   
 
Neither agree nor disagree 
  
 
Agree 
   
 
Strongly agree 
   
      
26 Please indicate your agreement with the following statement: 
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"I use social media or online support groups for emotional support." 
 
 
Strongly disagree 
  
 
Disagree 
   
 
Neither agree nor disagree 
  
 
Agree 
   
 
Strongly agree 
   
      
 
27 Please indicate your agreement with the following statement: 
 
 
"I use social media or online support groups to help others." 
 
 
Strongly disagree 
  
 
Disagree 
   
 
Neither agree nor disagree 
  
 
Agree 
   
 
Strongly agree 
   
      
28 Please indicate your agreement with the following statement: 
 
 
"I use social media or online support groups for sharing experiences." 
 
 
Strongly disagree 
  
 
Disagree 
   
 
Neither agree nor disagree 
  
 
Agree 
   
 
Strongly agree 
   
      
29 Please indicate your agreement with the following statement: 
 
 
"Since using social media or online support groups I feel better informed about HPV." 
 
Strongly disagree 
  
 
Disagree 
   
 
Neither agree nor disagree 
  
 
Agree 
   
 
Strongly agree 
   
      
30 Please indicate your agreement with the following statement: 
 
 
"Since using social media or online support groups I have better acceptance of HPV." 
 
Strongly disagree 
  
 
Disagree 
   
 
Neither agree nor disagree 
  
 
Agree 
   
 
Strongly agree 
   
      
 
Social Support Questionnaire starts on next page 
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Social Support 
The following questions are based on the 6-item Social Support Measure (Short-Form). 
You will be asked to list a number of individuals you feel you can rely on in specific situations (you do 
not need to name them, you may use nicknames, or initials, or titles /roles [such as 'brother']. 
You will then be asked to rate your satisfaction with their support on a scale of 1 to 5. 
31 Whom can you count on to be dependable when you need help, to listen when you need to talk? 
 
Please list individuals by initials, or by role (e.g. A.T. or 'cousin' or 'best friend' or 'neighbour') 
 
1 
  
6 
 
 
2 
  
7 
 
 
3 
  
8 
 
 
4 
  
9 
 
 
5 
    
      
32 Of the people mentioned above, how satisfied are you with the support you receive 
 
Very dissatisfied 
  
 
Dissatisfied 
   
 
Neither satisfied nor dissatisfied 
  
 
Satisfied 
   
 
Very satisfied 
   
      
33 
Whom can you really count on to help you feel more relaxed when you are under pressure or 
tense 
 
Please list individuals by initials, or by role (e.g. A.T. or 'cousin' or 'best friend' or 'neighbour') 
 
1 
  
6 
 
 
2 
  
7 
 
 
3 
  
8 
 
 
4 
  
9 
 
 
5 
    
      
34 Of the people mentioned above, how satisfied are you with the support you receive 
 
Very dissatisfied 
  
 
Dissatisfied 
   
 
Neither satisfied nor dissatisfied 
  
 
Satisfied 
   
 
Very satisfied 
   
      
35 Who accepts you totally, including your best and worst points? 
 
 
1 
  
6 
 
 
2 
  
7 
 
 
3 
  
8 
 
 
4 
  
9 
 
 
5 
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36 Of the people mentioned above, h ow satisfied are you with the support you receive 
 
Very dissatisfied 
  
 
Dissatisfied 
   
 
Neither satisfied nor dissatisfied 
  
 
Satisfied 
   
 
Very satisfied 
   
      
37 Whom can you count on to care about you, regardless of what is happening to you? 
 
1 
  
6 
 
 
2 
  
7 
 
 
3 
  
8 
 
 
4 
  
9 
 
 
5 
    
  
38 Of the people mentioned above, how satisfied are you with the support you receive 
 
Very dissatisfied 
  
 
Dissatisfied 
   
 
Neither satisfied nor dissatisfied 
  
 
Satisfied 
   
 
Very satisfied 
   
      
39 Whom can you count on to help you feel better when you are down in the dumps? 
 
1 
  
6 
 
 
2 
  
7 
 
 
3 
  
8 
 
 
4 
  
9 
 
 
5 
    
      
40 Of the people mentioned above, how satisfied are you with the support you receive 
 
Very dissatisfied 
  
 
Dissatisfied 
   
 
Neither satisfied nor dissatisfied 
  
 
Satisfied 
   
 
Very satisfied 
   
      
41 Who can you count on to console you when you are very upset 
 
 
1 
  
6 
 
 
2 
  
7 
 
 
3 
  
8 
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4 
  
9 
 
 
5 
    
      
 
42 Of the people mentioned above, how satisfied are you with the support you receive 
 
Very dissatisfied 
  
 
Dissatisfied 
   
 
Neither satisfied nor dissatisfied 
  
 
Satisfied 
   
 
Very satisfied 
   
      
Perceived stress 
The following questions form the Perceived Stress Scale.  
Please read the question and use the scale to identify your response. 
      
43 How often have you been upset by something that happened unexpectedly? 
 
Never 
   
 
Almost never 
   
 
Sometimes 
   
 
Fairly often 
   
 
Very often 
   
      
44 How often have you felt unable to control the important things in your life 
 
 
Never 
   
 
Almost never 
   
 
Sometimes 
   
 
Fairly often 
   
 
Very often 
   
   
45 How often have you felt nervous or stressed? 
 
 
Never 
   
 
Almost never 
   
 
Sometimes 
   
 
Fairly often 
   
 
Very often 
   
      
46 How often have you felt confident in your ability to handle your problems 
 
 
Never 
   
 
Almost never 
   
 
Sometimes 
   
 
Fairly often 
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Very often 
   
      
47 How often have you felt things were going your way 
 
 
Never 
   
 
Almost never 
   
 
Sometimes 
   
 
Fairly often 
   
 
Very often 
   
      
48 How often have you felt you could not cope with all the things you had to do 
 
 
Never 
   
 
Almost never 
   
 
Sometimes 
   
 
Fairly often 
   
 
Very often 
   
      
49 How often have you been able to control irritations in your life 
 
 
Never 
   
 
Almost never 
   
 
Sometimes 
   
 
Fairly often 
   
 
Very often 
   
      
50 How often have you felt that you were on top of things 
 
 
Never 
   
 
Almost never 
   
 
Sometimes 
   
 
Fairly often 
   
 
Very often 
   
      
51 How often have you been angered because of things that were outside your control 
 
Never 
   
 
Almost Never 
   
 
Sometimes 
   
 
Fairly often 
   
 
Very often 
   
      
52 How often have you felt difficulties were piling up so high you could not overcome them? 
 
Never 
   
 
Almost Never 
   
 
Sometimes 
   
 
Fairly often 
   
 
Very often 
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Appendix 3 – Inferential Statistic Analyses for Questionnaire Study 
ANOVA of mean scores for social support availability (SSQN), social support satisfaction (SSQS) 
and perceived stress (PSS) against HPV anxiety. 
ANOVA 
 
Sum of 
Squares df 
Mean 
Square F Sig. 
S
SQN 
Between 
Groups 
13.486 1 13.486 13.
813 
.000 
Within 
Groups 
82.010 84 .976 
  
Total 95.495 85    
S
SQS 
Between 
Groups 
11.041 1 11.041 16.
160 
.000 
Within 
Groups 
57.392 84 .683 
  
Total 68.433 85    
P
SS 
Between 
Groups 
39.128 1 39.128 6.8
76 
.010 
Within 
Groups 
460.896 81 5.690 
  
Total 500.024 82    
 
 
Linear Regression of PSS, SSQN and SSQS against Disclosure Intention 
 
Variables Entered/Removeda 
M
odel 
Variables 
Entered 
Variables 
Removed Method 
1 PSS, 
SSQS, SSQN
b
 
. Enter 
a. Dependent Variable: Would you confide in anyone about a positive HPV result? 
b. All requested variables entered. 
 
Model Summary 
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M
odel R 
R 
Square 
Adjusted R 
Square Std. Error of the Estimate 
1 .211
a
 .044 .008 .34821 
a. Predictors: (Constant), PSS, SSQS, SSQN 
 
ANOVAa 
Model 
Sum of 
Squares df 
Mean 
Square F Sig. 
1 Regressi
on 
.445 3 .148 1.22
4 
.307
b
 
Residual 9.579 79 .121   
Total 10.024 82    
a. Dependent Variable: Would you confide in anyone about a positive HPV result? 
b. Predictors: (Constant), PSS, SSQS, SSQN 
 
ANOVA for Embarrassment*Perceived stress, Social Support Availability & Social Support 
Satisfaction  
 
Sum of 
Squares df 
Mean 
Square F Sig. 
P
SS 
Between 
Groups 
20.201 2 10.101 1.8
61 
.162 
Within 
Groups 
428.677 79 5.426 
  
Total 448.878 81    
S
SQN 
Between 
Groups 
4.296 2 2.148 1.4
01 
.251 
Within 
Groups 
157.901 103 1.533 
  
Total 162.197 105    
S
SQS 
Between 
Groups 
3.367 2 1.684 1.5
01 
.228 
Within 
Groups 
115.551 103 1.122 
  
Total 118.919 105    
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Multivariate GLM of SSQN, SSQS and PSS for Reasons for Online Support Use  
(emotional support, exchanging information, helping others and sharing experiences) and 
Outcomes of Online Support Use  
(better informed about HPV, better acceptance of HPV) 
 
Effect Value F Hypothesis df Error df Sig. 
Intercept 
 
Pillai's Trace .998 1093.913b 1.000 2.000 .001 
Wilks' Lambda .002 1093.913b 1.000 2.000 .001 
Hotelling's Trace 546.956 1093.913b 1.000 2.000 .001 
Roy's Largest Root 546.956 1093.913b 1.000 2.000 .001 
SSQN Pillai's Trace .946 1.861b 19.000 2.000 .407 
Wilks' Lambda .054 1.861b 19.000 2.000 .407 
Hotelling's Trace 17.682 1.861b 19.000 2.000 .407 
Roy's Largest Root 17.682 1.861b 19.000 2.000 .407 
SSQS Pillai's Trace .928 2.335b 11.000 2.000 .338 
Wilks' Lambda .072 2.335b 11.000 2.000 .338 
Hotelling's Trace 12.843 2.335b 11.000 2.000 .338 
Roy's Largest Root 12.843 2.335b 11.000 2.000 .338 
PSS Pillai's Trace .902 1.834b 10.000 2.000 .404 
Wilks' Lambda .098 1.834b 10.000 2.000 .404 
Hotelling's Trace 9.168 1.834b 10.000 2.000 .404 
Roy's Largest Root 9.168 1.834b 10.000 2.000 .404 
SSQN * SSQS Pillai's Trace .000 .b .000 .000 . 
Wilks' Lambda 1.000 .b .000 2.000 . 
Hotelling's Trace .000 .b .000 2.000 . 
Roy's Largest Root .000 .000b 1.000 1.000 1.000 
SSQN * PSS Pillai's Trace .631 1.140b 3.000 2.000 .499 
Wilks' Lambda .369 1.140b 3.000 2.000 .499 
Hotelling's Trace 1.710 1.140b 3.000 2.000 .499 
Roy's Largest Root 1.710 1.140b 3.000 2.000 .499 
SSQS * PSS Pillai's Trace .000 .000b 1.000 2.000 1.000 
Wilks' Lambda 1.000 .000b 1.000 2.000 1.000 
Hotelling's Trace .000 .000b 1.000 2.000 1.000 
Roy's Largest Root .000 .000b 1.000 2.000 1.000 
SSQN * SSQS * PSS Pillai's Trace .000 .b .000 .000 . 
Wilks' Lambda 1.000 .b .000 2.000 . 
Hotelling's Trace .000 .b .000 2.000 . 
Roy's Largest Root .000 .000b 1.000 1.000 1.000 
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Tests of Between-Subjects Effects 
Source Dependent Variable 
Type III 
Sum of Squares df 
Mean 
Square F Sig. 
Corrected Model Since using OSGs I feel better 
informed about HPV 
39.886
a
 80 .499 1.994 .392 
Since using OSGs I have better 
acceptance of HPV 
39.663
b
 80 .496 . . 
Intercept Since using OSGs I feel better 
informed about HPV 
273.478 1 273.478 1093.913 .001 
Since using OSGs I have better 
acceptance of HPV 
284.519 1 284.519 . . 
SSQN Since using OSGs I feel better 
informed about HPV 
8.841 19 .465 1.861 .407 
Since using OSGs I have better 
acceptance of HPV 
7.054 19 .371 . . 
SSQS Since using OSGs I feel better 
informed about HPV 
6.422 11 .584 2.335 .338 
Since using OSGs I have better 
acceptance of HPV 
5.152 11 .468 . . 
PSS Since using OSGs I feel better 
informed about HPV 
4.584 10 .458 1.834 .404 
Since using OSGs I have better 
acceptance of HPV 
4.833 10 .483 . . 
SSQN * SSQS Since using OSGs I feel better 
informed about HPV 
.000 0 . . . 
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Since using OSGs I have better 
acceptance of HPV 
.000 0 . . . 
SSQN * PSS Since using OSGs I feel better 
informed about HPV 
.855 3 .285 1.140 .499 
Since using OSGs I have better 
acceptance of HPV 
.484 3 .161 . . 
SSQS * PSS Since using OSGs I feel better 
informed about HPV 
.000 1 .000 .000 1.000 
Since using OSGs I have better 
acceptance of HPV 
.250 1 .250 . . 
SSQN * SSQS * PSS Since using OSGs I feel better 
informed about HPV 
.000 0 . . . 
Since using OSGs I have better 
acceptance of HPV 
.000 0 . . . 
Error Since using OSGs I feel better 
informed about HPV 
.500 2 .250 
  
Since using OSGs I have better 
acceptance of HPV 
.000 2 .000 
  
Total Since using OSGs I feel better 
informed about HPV 
532.000 83 
   
Since using OSGs I have better 
acceptance of HPV 
512.000 83 
   
Corrected Total Since using OSGs I feel better 
informed about HPV 
40.386 82 
   
Since using OSGs I have better 
acceptance of HPV 
39.663 82 
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a. R Squared = .988 (Adjusted R Squared = .492) 
b. R Squared = 1.000 (Adjusted R Squared = 1.000) 
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Appendix 4: Ethical Approval for Amendments to Include Interviews  
(Screenshots of email conversation with graduate school office)
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Appendix 5: Approach Letters to Gatekeepers 
Approach to Jo’s Trust 
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Appendix 6: Approach to Social Media Gatekeepers 
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Appendix 7: Participant Information Sheet
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Appendix 7: Consent Form
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Appendix 8: Interview Schedule 
 TYPE OF QUESTION 
THEME TO EXPLORE DESCRIPTIVE NARRATIVE STRUCTURAL CONTRAST EVALUATIVE CIRCULAR COMPARATIVE 
Meaning making: 
Feelings 
surrounding 
diagnosis/diagnostic 
process 
Can you describe 
how you felt after 
you were diagnosed 
Can you tell me 
how you came 
to your diagnosis 
(letter/face to 
face 
appointment) 
So what stages 
were involved in 
the diagnostic or 
treatment 
process 
Can you tell me 
what you 
thought about 
HPV before 
your diagnosis? 
How does it 
differ from 
your thoughts 
now? 
Can you tell me 
what your 
diagnosis means 
to you? 
If you could go 
back – what 
advice would 
you give to 
yourself about 
hearing the 
news for the 
first time? 
 
Biographical work – 
The Self 
How would you 
describe yourself as a 
person? 
 Has your outlook 
or your role 
changed since 
your diagnosis? 
Has your 
diagnosis 
changed the 
way you think 
about yourself? 
Do you feel you 
are a different 
person – since 
diagnosis/ since 
getting the all-
clear? 
Overall, has this 
been a positive 
or a negative 
experience in 
your life? 
 
Daily Life Can you describe a 
typical day? 
 Do you plan days 
or events around 
how you are 
feeling? 
Can you tell me 
about a good 
day, and a bad 
day? 
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Appendix 8: Interview Schedule (continued) 
 TYPE OF QUESTION 
THEME TO EXPLORE DESCRIPTIVE NARRATIVE STRUCTURAL CONTRAST EVALUATIVE CIRCULAR COMPARATIVE 
Support Can you tell me 
about a time when 
HPV came up in 
conversation with a 
partner/friend/family 
member? 
Do you post online, 
or do you just read – 
can you explain why 
you just read? 
Can you tell me 
about your first 
online post? 
 What was the 
process of 
getting involved 
with online 
support? 
 
How did you 
become an 
advisor 
administrator 
 
Do you plan 
posts or 
questions in 
advance, or do 
you respond to 
what you 
see/read? 
 How do you feel 
after 
conversations 
about it? 
 
How do you feel 
after forum 
visit? 
 
How do you feel 
after you’ve 
posted 
 Do you feel you 
get different 
information or 
support from a 
particular group, 
say, your 
physical friends 
or your online 
friends? 
Relationships Can you tell me how 
your diagnosis 
affects your 
relationships with 
partner/family 
friends 
 Can you tell me 
where you fit in 
your 
relationships? 
 How do you 
think other 
people see you? 
 
Has your role 
changed since 
your diagnosis? 
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Appendix 9: Record of Informed Consent for Interviews 
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Appendix 10: Jay’s Narrative 
Question 
Response 
Researcher interpretation Practitioner interpretation 
Notes on the process/practice points that should 
have been followed 
How did you learn about your diagnosis? 
During January 2011, after a routine pap smear test, I received a 
letter stating that I would need to see a Consultant because 
abnormalities on my cervix had been found – which I later learnt 
was CIN 2 & 3. Along with this letter was a cervical cancer leaflet. 
At first I felt mortified, had I just been told that I had cancer? 
I re-read the letter a few more times & read the leaflet, & then 
realised that cervical cancer was a possible outcome. I have very 
mixed views on this. Would it perhaps have been more appropriate 
to hand out such a leaflet, if needed, later in the process? 
On the other hand, handing out such a leaflet at this early stage 
may help some ladies to realise the gravity of their situation; & 
thus, they are more likely to go through with Colposcopy, biopsy & 
LLETZ procedures. So I feel quite conflicted about the usefulness of 
the literature – at such an early point anyway. 
In my case, I felt, it added to my stress & anxiety levels. Even 
though I had rationalised in my head that it was being issued to 
prepare me, just in case; given the wait times between 
appointment & results, & the months involved, the possible cancer 
diagnosis hung over me like a dark cloud. 
 
I had hear about HPV prior to this date, however I didn’t know 
much about it. After receiving this letter, I decided to research my 
way to peace. 
 
 
 
 
 
‘Mortification – embarrassment?’ Confusion. 
 
Already self-reflecting. More confusion? 
 
Swamped with information?  
Does leaflet lead to catastrophising?  
 
Differential perspectives – early in diagnostic 
process, but disease is already significantly 
advanced – Goffman’s invisible stigma 
Conflict, over level of information, type of 
information 
Being informed added to stress/anxiety. 
Rationalisation 
Waiting 
 
“Hung over me like a dark cloud” 
 
Minimal knowledge of HPV – follow up on 
 
Diagnosed before HPV triage/TOC came in. 
What was grade of abnormality – must have been 
high grade to go straight to Colp. 
 
 
 
 
 
Are we frightening patients by trying to give them all 
the information at once – different responsibilities – 
trying to inform vs. trying to protect peace of mind as 
long as possible? 
Want people to be treated, but not out of fear. 
 
Does the literature need reviewing – Delphi technique 
type focus groups? 
How long was wait for results – staffing in our 
histology lab is low – we don’t have enough 
consultant to report cases. This is a nationwide issue. 
Colpososcopy clinics cannot keep up with demand, 
because referrals are up 20% since triage/TOC came 
in. Need more clinics, more Ob/Gyn consultants and 
nurses, more lab staff and pathologists. 
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I found lots of information online but few support groups; so I 
decided to set up a support group on Facebook – incorporating 
education, support & awareness. Here I posted my research 
findings, started discussions, & talked to other ladies about their 
experiences. Some opinions caused me anxiety, e.g. how painful 
certain procedures are, & other opinions put my mind to rest. But 
by & large it was a very positive way to navigate throughout the 
process – just knowing that others have been through similar & 
have been ok etc. 
how she knew. 
Letter was prompt toward personal research. 
Knowledge = peace. 
 
 
Sharing experiences can be as confusing as 
formal leaflet-based information. 
Anxiety over pain. 
Positivity through shared experience.  
 
Should PHE work more closely with charities and 
support groups to signpost incoming patients to 
support procedures? 
So, going back to the diagnostic process, my first appointment with 
the Consultant was about a month later – seemed like a lifetime. I 
can’t recall if the first appointment was a sit down and talk 
assessment, or if I went straight to Colposcopy & biopsy. But I do 
remember the Colposcopy & biopsy well. I found the punch biopsy 
part very painful. The Consultant asked me to cough but that didn’t 
help at all. I also felt he was quite rough with me.  
I had a panic attack on the table. My husband, who was allowed to 
sit with me, tried his best to calm me – bless him.  
I went home crying & wondering whether I would be able to 
continue with the process. Just to add more context, at the point, I 
had been diagnosed with M.E. following a prolonged illness due to 
the Epstein-Barr virus. So I was already very unwell. 
 
Again, there was a wait of about 3—4 weeks before I heard 
anything more – a very scary wait. I used this time to learn about 
breathing and meditation – ways of keeping calm & reducing 
stress. I would never allow myself to get so out of control again. I 
started to discover Buddhism at this point, ways of thinking about 
things differently & more productively. I’ve learnt valuable skills for 
life, thanks, in part, to this whole process. 
Waiting. 
‘Seemed like a lifetime’ 
 
 
 
Pain. Not a helpful/supportive diagnostic 
encounter. 
 
Support. Appreciation of supportive 
relationship. 
 
Anxiety at being able to continue/cope with 
pain. What outcomes were. 
 
Multiple co-morbidities. 
 
Waiting. Fear. 
 
Proactive. Learning coping techniques. 
Control – over process? Over body? Already 
been diagnosed with other illnesses, so very 
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When I did finally hear back that the biopsy looked fine, I was very 
relieved; only to be quickly overshadowed by the news that I’d 
need the LLETZ procedure. Again, another fling into the 
unknown.At this point, my support group had quickly grown in 
numbers. I was able to discuss the procedure in a private forum – 
as it is a closed group – meaning people can post without friends or 
family seeing their postings in their newsfeed. (I know I value my 
privacy on such matters. And I know others on the group do also). 
Some women said the procedure hardly hurt & they were able to 
go back to work the next day, others stated that it made them 
poorly for a few weeks. Bearing in mind that few ladies I spoke to 
found the biopsy painful, I wondered how the LLETZ would 
compare. 
 
I took myself off to my GP & asked if he could give me anything for 
the day to help me manage my stress & anxiety levels. I explained 
what happened on biopsy day & that I’ve been learning some 
breathing exercises etc. He gave me Diazepam. 
 
My LLETZ took place about a month after I received my results.  
I definitely felt more relaxed that day – possibly because of the 
Diazepam – but I had also been practising my breathing & 
meditation leading up to this appointment. I giggled when the 
Nurse asked the Consultant what size electrical wire loop he 
needed when he replied “small”. As the procedure took place, I did 
my special breathing that kept me really calm, & I had my 
wonderful husband at my side again, which really helped too. They 
numbed my cervix with a local anaesthetic this time – unlike during 
the biopsy & Colposcopy. (Looking back, I think a local anaesthetic 
should actually be offered for the biopsy & Colpscopy too). The 
little control over the ill self? 
Some positive outcomes. Skills. Coping 
strategies. Gratitude? 
 
Relief. 
Conflicting information. ‘Overshadowed’ – 
couple of references to dark/shadows/cloud 
now. 
‘Fling’ literally Heidegger’s “throwness”. 
Unknown, not knowing, angst. 
Private group – fear of disclosure/reluctance 
to disclose/Goffman’s ‘the wise’ 
Privacy 
Comparing lived experiences.  
Self-comparison. 
 
Self-reflection 
 
‘Took myself off to GP’ – mobilisation of 
resources? 
Empowerment – actively seeking solutions. 
‘biopsy day’ – definitely an event in her life. 
Breathing/coping exercises 
 
Think she means results of the Bx. 
Mobilisation of resources – breathing and 
medication. 
 
 
Managed to find humour in the situation. 
 
 
 
Who on earth gave this information?! 
 If the biopsy was fine, there would be no need for a 
LLETZ. So conflicting information being given – if this 
is the opposite scenario to the leaflet (e.g. trying to 
reassure/drip feed bad news as opposed to preparing 
the patient for the worst), this was the worst possible 
way it could have been done “you’re fine, but you 
need a deeper, more invasive treatment”.  
Really bad point of practice. 
 
 
 
 
 
GP doesn’t know what drugs are going to be 
administered during procedure. If the respondent had 
to have a GA the Diazepam might have made 
prescribing very difficult during the procedure. 
Midazolam and/or Diazepam are often prescribed as 
sedatives during the procedure – she might have 
ended up with an overdose. 
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Nurse commented, after the procedure on how goof my breathing 
technique was throughout, how she wishes all ladies could be so 
calm & well prepared, & that I could teach my breathing technique 
to others. That felt good. I had worked very hard to keep my 
composure – through teach yourself breathing & meditation. 
Funnily enough, my husband & I laughed afterward that we could 
smell bacon during the procedure. It’s very true! :0D From what 
I’ve learnt about the procedure, they burn away a certain amount 
of layers of the cervix. 
 
Supportive partner 
 
 
Recommendations on future practice. 
 
 
Teaching/empowering others. 
 
 
Humour. Using emojis – helps convey emotion 
in absence of FTF cues. 
Research into procedure.  
‘The cervix’ – not ‘my cervix’ – distancing from 
Rx/damage? 
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Appendix 11: Claire’s Narrative 
Question 
Response 
Researcher interpretation Practitioner interpretation 
Notes on the process/practice points that should 
have been followed 
What stages were involved in the diagnostic or treatment process? 
My diagnosis process was somewhat different to the norm, mainly 
because I was age 22 and not entitled to a smear test.  
I presented at the GP on a few occasions with some abnormal 
symptoms; I was advised to monitor them and return if they 
continued. They did continue and I was then referred to Colposcopy 
as a routine measure. At this point the nurse mentioned that it 
could be down to ‘abnormal cells’.  
I took it upon myself to do some online research regarding my 
symptoms and I was aware my symptoms resembled those of 
cervical cancer.  
 
 
 
The symptoms and my worry continued, as did the waiting list for 
my hospital appointment. During this wait I spoke to my GP over 
the phone and asked about the possibility of having a smear test. I 
thought that this would alleviate some of my worry by at least 
being able to confirm whether the symptoms were caused by cell 
change. 
 
However, the GP informed me that due to NHS guidelines, I was 
not eligible to have a smear because of my age. 
 
 
 
Awareness of difference 
 
 
Awareness of abnormal symptoms 
 
 
Awareness of abnormal symptoms 
Why? Not enough information from nurse? 
‘Took it upon myself’ – empowerment? Control? 
First use of online health information seeking 
‘My symptoms’ – ownership?  
First mention of ‘cancer’. 
 
Anxiety. Waiting. Frustration? 
 
Active health seeking behaviour. Reassurance. 
 
‘At least’ – almost pleading. Level of desperation. 
Knowing/confirmation vs. current state of 
uncertainty 
‘Cell change’ – health literate – occurs after her 
mention of research; so, learned, not told. 
 
 
 
Underage for screening 
Should have been referred straight away 
 
 
This shouldn’t have been a ‘routine’ referral.  
This should have been an urgent referral. 
 
 
 
 
 
She should have been referred on a ‘two week wait’ 
at her first GP appointment.  
 
 
 
 
 
The GP was correct, and a smear would not have 
altered her treatment pathway/clinical outcome, but 
it might have saved her the wait. 
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A few weeks later I attended a walk-in GUM clinic as my concerns 
and symptoms were ongoing. I was hoping to rule out any infection 
that may be causing my issues. Here, the doctor informed me that 
from an internal examination he could see an abnormal area. 
Frustration? Denied healthcare when in need? 
 Denied reassurance. Denied a sense of control 
 
Taking control.  
Stigma of attending GUM clinic, initially?  
Use of abbreviations – specialist language. 
Ongoing worry, illness, otherness of body 
‘Hoping’ for an infection = desperation. Infection - 
?first inkling of HPV? 
‘An abnormal area’ = otherness, not me. 
Not: ‘my cervix looked abnormal´ 
Goffman’s deformity of the body (even if not visible 
to others, you know now) 
 
If her GP/practice nurse had examined her at her first 
appointment (irrespective of a smear test) this lesion 
would have been visible. This, plus her reported 
symptoms would have saved her a six month wait and 
possibly caught her disease earlier. 
 
At this point (6 months since I had initially presented at the GP with 
my concerns), the waiting list for routine Colposcopy had increased 
to 12 weeks, so I was referred urgently for a colposcopy 
examination and was seen within two weeks of the GUM 
appointment. 
 
During the colposcopy it was confirmed that my symptoms aligned 
with those of cervical cancer and the cells needed to be removed 
and tested. Here I had the LLETZ procedure and awaited the 
agonising 4 weeks for my results to be returned. 
I phoned the colposcopy clinic to receive my results and the cells 
had been found to be pre-cancerous CIN3 cells (the stage before 
cells can potentially become cancerous). I felt relieved, but had a 
lot of questions unanswered. 
 
 
 
She’s angry, you can hear it. A 6 month wait.  
Rising anxiety – more waiting. 
Relief at being referred, being seen, being heard 
Worry at urgency? Relief 
 
 
‘Aligned with’ – very detached way of phrasing it – 
distancing herself? 
Use of terminology – researched this, it wasn’t 
used before. 
More waiting. Agonzing – emotive terms. It was 
painful. 
Phoned to chase – active? Anxious? Trying to 
minimise the wait/make it mean something.  
Minimise the liminality? 
‘Pre-cancerous CIN3 cells’ – not my cells –
detachment? 
6 months could have been the difference between 
CIN3 and cancer. Once you have been labelled a 
cancer patient your life insurance goes through the 
roof, you’re not getting a mortgage and employers 
might be reluctant to take you if you explain the gap 
in your CV as ‘I was having cancer treatment’. 
Any Colposcopy department with a twelve week wait 
is failing their key performance standard of seeing 
everyone in 6 weeks. 
 
‘Aligned with cervical cancer’ – I suspect this is a 
quote from the colpsocopist/gynaecologist – it’s a 
very circumspect, very careful way of putting it – this 
could be a form of care – it’s gentler than saying 
‘suspicious of’ or ‘likely to be’. Having been told her 
(long!) history of attempting to seek treatment, s/he 
was possibly trying not to drop the GP in it for the 
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It was at this point that I sought advice from the online ask a 
medical professional service offered by ‘Jo’s cervical cancer trust’. I 
had come across the website from my own online searches and 
had seen a poster displayed at the hospital. I was bemused at how 
I could have presented with cervical cancer symptoms, yet not yet 
developed cancerous cell growth, and I equally was concerned 
regarding the cause. 
This was the most valuable information I received throughout my 
whole experience. My questions were answered thoroughly and it 
was here that I realised the likelihood of my cell change was a 
result of having had HPV. 
 
Mentions of stages of CIN, and knows the 
difference between cancer and pre-cancer – has 
done some serious reading. 
Relief, but then more questions – what were they? 
Concerns? Anger? Did she voice the questions or 
did she not feel able to? 
 
 
‘My own online searches’ – ownership of 
condition/information. 
Bemused – light-hearted term? Not 
confused/bewildered. Past tense. Talks about 
cancerous cells as if they are different to her own 
cells. Non-self. 
How did this happen to me? 
‘How’/’why’ – most valuable. Online info exchange 
valuable. Thoroughly – time to process, time to 
think 
‘My cell change’ – after treatment it’s hers again, 
or accepting responsibility 
‘having had HPV’ – past tense.  
Covering/passing (to me?) 
‘I did, but I don’t now’? Or, ‘I didn’t know I had it’? 
delayed referral whilst providing as much accurate 
information as possible. 
As a practitioner, I take this knowledge for granted.  
Again, this created more questions as I had received my course of 
HPV injections at 13/14 years of age, was a non-smoker with a 
fairly healthy lifestyle, had not had sexual intercourse at a young 
age and had a very low number of sexual partners. It seemed that I 
had been unlucky- and gone against the risk factors and statistics. I 
was informed that I must have had a very high risk type of HPV 
that is not yet immunised against, and that my immune system 
Aware of stigma/attribution – I did everything 
right. 
Justification. 
 
 
Ill-luck/fortune 
 Follow up on this – how did she feel about having 
13/14years, and she’s 22. So born in 1995 ish.  
= Part of the catch-up as vaccine was implemented in 
2008 and administered at age 12 
 
 
Correct. Current vaccine protects against two strains 
responsible for 70% of CaCx in the UK. Check no. of 
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was not strong enough to fight the virus- thus causing cells 
changes to begin. 
Following my LLETZ treatment, my wound was not healing as it 
should and I had to return to the hospital twice more. I had some 
treatment to address this and a biopsy was taken, which came 
back clear. 
Having had CIN3, I was now entitled to have a smear test three 
months following this last treatment as a ‘test of cure’. My luck 
continued, and the result for this returned negative for both 
abnormal cells and HPV. This was the best outcome I could have 
wished for. Somehow, my immune system had managed to fight 
off HPV and thus no abnormal changes had occurred, by this point 
it had been just over a year since my initial visit to the GP; although 
a part of me felt a little resentful that the process was so drawn 
out because of my age and the guidelines, I also felt extremely 
lucky and had a sense of closure from the ordeal. 
an immunisation that didn’t work. 
 
 
Not healing – more anxiety 
More visits = more invasion, more disruption 
Biopsy result barely mentioned – used to it by now? 
 
 
She sees this as lucky. Wow.  
 
Reassurance. 
Active response, not passive healing. 
 
Waiting. Recall – a year of disruptions. 
 
‘Because of my age’ – justifying the wait because 
her case was not the norm? 
Lucky not to have had cancer? Lucky not to have 
died? Lucky to retain fertility? She mentioned 
unlucky earlier. Confusion? 
Closure. Ordeal (not journey/experience) – pain, 
fear, anxiety. For a year. 
doses given so far, and extrapolate number of girls 
vaccinated but still vulnerable. 
 
 
 
 
Correct procedure is a follow up TOC at six months. 
Earlier than this (especially were there have been 
complications) and there is a risk of a false positive 
HPV test of cure, or reparatory debris affecting 
sample quality = more treatment, more invasion. 
 
The process was drawn out because the GP didn’t 
refer her straight away. 
From my own online research and my contact with Jo’s cervical 
cancer trust I understand that it is not yet known whether my body 
will have completed eradicated HPV, or whether it will lie dormant- 
dependent on the strength of my immune system to fight it off. As 
a result I will never take good health for granted. Most days 
something triggers my thoughts to return to how lucky I have been. 
I do remain to feel frustrated by the guidelines that are in place, 
and I think of the possible outcome had I not persisted to have the 
Uncertainty. 
Possibility of a lifetime of infections. 
 
 
This is gratitude, but also a massive burden. 
Emotional/outlook positivity. BUT... intrusive 
thoughts? 
What are her triggers? How to live with this? 
Dormancy/latency is still an issue. If she tests HPV 
negative in the future is it because she has cleared it, 
or because it is dormant.  
If she tests positive in the future is it the same virus 
reactivating, or a new infection with a different strain 
– we don’t know yet. 
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symptoms and concern addressed. 
For this reason, I think patient information and education 
surrounding HPV, smear tests and cell changes is vital. 
 
Before this experience I knew little about HPV- just that I had had 
some vaccinations for it, and recalled the campaign surrounding 
Jade Goody. Now I feel much more informed through my own 
online research and ensuring I ask appropriate questions at 
medical appointments. 
However, it has highlighted that further research appears to be 
required around HPV- and I feel information provision could have 
helped inform me better from an earlier stage. I will always 
wonder about the origin of how I contracted it and feel concern for 
having potentially passed it on to my partner. 
Blame? Blame of the system? 
Dread – of what could have been.  
Persistence – take back power, over body, over 
healthcare relationship. 
Information and education - empowerment 
 
Lack of knowledge 
 
Self taught. Empowered. 
Expectations of health professionals 
Further research - failed by lack of knowledge by 
health professionals? 
 
How did I get this – blame? 
Transmission. 
 
 
 
 
‘Just that I had had some vaccinations for it’ – HPV 
awareness campaign not effective in her case then, 
and negates the idea of disinhibition following 
vaccination. 
‘Jade Goody’ – died the year after vaccination was 
implemented. 
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Appendix 12: Jo’s Narrative 
Question/prompt 
Response/Narrative 
Researcher Interpretation Practitioner Interpretation 
Tell me a little bit about yourself 
Basically I’m a student adult nurse. I’m nearing the 
end of my training and am currently in the process 
of selecting my choices of roles at (name of 
institution redacted). I am really interested in 
getting into gynaecology and I’m hoping that my 
selections will help me get there. 
 
Health literate 
 
 
 
?Hopes to use experience to help her practice 
 
Health literate 
Can you tell me about your diagnosis? 
To cut a long story short I suffered a miscarriage in 
Feb 2016 and the smears ever since have come 
back as pre-cancerous and I believe it was the 
management of the miscarriage that contributed to 
this. 
I received the all clear (as far as not needing further 
colposcopy treatment ) in May and have just got to 
have another check up at the hospital Colposcopy 
clinic next May. 
 
So when I found out about the HPV positive I was 
shocked but was also aware that it is extremely 
common. I felt a little embarrassed but I think that’s 
fairly normal. The only thing about the treatment 
process which could have been better was the letter 
to inform me of my colposcopy appointment. It was 
worded as if it was inevitable that I’d require 
 
Miscarriage is a massive life event. Disruption? 
Pre-cancerous (vs. cancerous)  
= she knows the difference. Terminology 
Senselessness of miscarriage (Neimeyer 2000) – 
individuals driven to find meaning. Has this 
translated to her experience of CIN/HPV? 
Meaning making – sense making vs. benefit finding? 
A wait of 12 months, but doesn’t mention this as 
difficult  
HPV positive. Shock. Doesn’t mention anxiety etc. 
Awareness of ubiquity = less stigma? 
Embarrassment, then rationalisation. 
 No mention of partner or whether she disclosed.  
 
She mentions no need for treatment, but then later 
mentions she definitely had it. Does she mean again 
(‘further treatment’). Wording of communications. 
My response to this as a practitioner is confusion. 
Does she mean that, say, curettage caused injury to 
her cervix that left her vulnerable to HPV infection? 
Theoretically possible. Research it. 
‘Smears ever since’ – indicates more than one?  
Miscarriage is treated the same as delivery – she 
would have had to wait three months after 
miscarriage to have a smear = May 2016 earliest? 
There is no repeat in 6 months any more, so that 
one smear would have had to be her referring 
(abnormal) smear. She had treatment, so she must 
have had a TOC... and recall to Colposcopy 12 
months post treatment indicates that she was HPV 
positive post-treatment.  
All clear in May 2017, less 1 month to refer back to 
colp  
= Six month follow up in Apr 2017.  
Less the six months post treatment... 
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further treatment but this was not the case. Would 
have been better if the letter was clear about the 
fact that further loop diathermy may not be needed 
as I had planned for recovery time and someone to 
take me so I didn’t have to drive afterwards.  
Also think that information about HPV should be 
included in correspondence so that the patient is 
more informed. There are a lot of forums out there 
which are not always effective and can be 
misconstrued. The Jo’s Cancer Trust [sic] website is 
informative but having the word ‘cancer’ all over 
the pages is very daunting and scary. 
Terminology again – health literacy (?due to training 
rather than research?) 
Mobilisation of resources/physical support (drivers 
etc.) 
More information on HPV 
Patient should be more informed 
Lots of access to info.  
Quality of information not always guaranteed. 
 
Cancer – fear when not required? 
= treated in October 2016.  
Less one month for referral 
= HPV positive/referring smear probably  
September 2016 
So between May 2016 (earliest) and Sep 2016 
(latest) 
Practice point: NHSCSP result letters are 
standardised. Hospital/gynae/colp letters are not – 
should they be – quality of info and care should be 
the same across the nation. Would save time and 
money. 
Jo’s trust is evidence based/peer reviewed, so info 
would be good. 
Meaning  making – feelings surrounding 
diagnosis/diagnostic process 
Can you describe how you felt after you were 
diagnosed? 
 
Worried. Just one thing after another. 
 
Can you tell me how you came to your diagnosis 
(letter/face to face  appointment). 
Found out by letter 
 
Can you tell me what stages were involved in the 
diagnostic process? 
 
Tissue sent off taken from loop diathermy 
 
 
 
 
 
 
 
Anxiety. ‘One thing  after another’ – reference to 
miscarriage? 
 
 
No opportunity to ask questions. 
 
 
 
 
Definitely had treatment then, but doesn’t say how 
many appointments she had. 
 
 
 
 
 
 
 
 
Patients have the opportunity to ask questions, but 
this is when you are gowned up and on the table... 
 
 
A ‘See and Treat’ appointment means they saw a 
high grade lesion on Colp right from the get-go. 
If she had had a biopsy first, it means they saw a 
low grade lesion that came back high grade. 
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Can you tell me what you thought about HPV 
before your diagnosis? How does it differ from your 
thoughts now? 
I thought it was very common for those whom had 
several sexual partners, personally this was not the 
case for me. 
 
 
 
 
 
Assumptions about ‘women who get HPV’ – see 
Nack 2002, 2000. ‘Good girls/Fallen women’? 
“I am not like that”? Can happen to anyone? 
 
 
 
Can you tell me what your diagnosis means to you? 
Heightened awareness 
 
 
If you could go back – what advice would you give 
to yourself about hearing the news for the first 
time? 
 
To not worry as is completely normal.[sic] 
 
 
 
More aware of what? HPV? 
Her gynaecological/reproductive health? 
Her overall health? 
 
 
 
 
Learned from her experience that ‘it is very common’ 
– see earlier comment 
 
Biographical work – the self 
How would you describe yourself as a person? 
 
Informed. Anxious. Kind. Caring. 
 
 
Has your outlook changed since your diagnosis? 
Outlook yes, as I feel I will be a better nurse having 
these personal experiences. ‘Roles’: No. 
(Jo also mentions that the way she sees/thinks 
 
 
 
Informed via health literacy/training? 
Anxious in general or due to condition/events? 
 
 
Interesting that both individuals who were 
healthcare professionals mention that they will use 
this experience to improve their practice.  
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about herself has not changed since her diagnosis.) 
 
Overall, has this been a positive or a negative 
experience in your life. 
Positive in terms of my professional career. 
 
 
 
 
 
 
No reference to her private life or feelings/emotions. 
Compartmentalising? 
 
 
Daily Life 
 
Can you describe a typical day? 
 
Student nurse, so can be exams, reports or on 
placements. 
 
(Jo also notes that she doesn’t plan her days around 
how she is feeling) 
 
Can you tell me about a good day, and a bad day? 
Good day – spent with daughter 
Bad day – filled with anxiety 
 
 
 
 
Again, doesn’t mention her personal life - 
?interviewer effect – she doesn’t know me. I can’t 
prompt. 
Should have made the questioning for this more 
clear. 
 
Again, should have been clearer 
Family. 
Anxiety – over HPV? Recurrence? Fertility? 
Mortality? Career/deadlines? 
 
Page | 292  
 
Support 
 
Do you post online, or do you just read? 
Can you tell me why you ‘just read’?  
(if you just read) 
Can you tell me about your first online post? 
 
I posted online re cervical screening and feel very 
lucky and passionate about it. I haven’t posted 
directly about HPV 
 
How do you feel after conversations about your 
experiences? 
Open, honest, positive. 
 
How do you feel after a forum visit? 
Confused as people have such different experiences. 
(Jo also mentioned she felt positive after she had 
posted) 
 
Do you feel you get different information or 
support from a particular group – say your physical 
friends vs online individuals 
Yes, support from my nursing friends is more 
evidence based. 
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